archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00011241,1.537,1.2608,1,1
1,GO BLEB ASSEMBLY,7.5427e-07,1.4154,1.3489,1,1
1,GO MEMBRANE RAFT ASSEMBLY,4.4712e-06,1.2358,1.5163,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00021167,1.2056,0.95503,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,9.8628e-07,1.1754,1.0451,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,7.547e-05,1.1571,1.0689,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,1.3441e-06,1.1242,0.91694,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,1.2308e-06,1.1203,0.98856,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,1.2308e-06,1.1023,0.88733,1,1
1,GO TROPHOBLAST CELL MIGRATION,1.4268e-07,1.0912,0.96573,1,1
1,GO RESPONSE TO INTERFERON ALPHA,2.7343e-05,1.0659,1.0305,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,7.0571e-06,1.0451,0.84663,1,1
1,GO NEUTROPHIL HOMEOSTASIS,6.8936e-07,1.0348,0.95632,1,1
1,GO HYALURONAN CATABOLIC PROCESS,8.8325e-08,1.0272,1.0677,1,1
1,GO RESPONSE TO INTERFERON BETA,5.2837e-06,1.0058,0.95522,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,6.8936e-07,1.005,0.97272,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,6.6003e-08,0.99651,0.93643,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,9.0179e-06,0.97374,0.88506,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,2.0833e-05,0.96933,0.86163,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,5.9841e-06,0.92892,0.81475,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,1.0184e-05,0.92141,0.85013,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,2.2524e-05,0.9193,0.83878,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,2.9532e-05,0.91599,0.76443,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,1.8251e-06,0.90962,0.8913,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,6.8936e-07,0.90337,0.8783,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,8.2505e-07,0.89939,0.9415,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,1.0311e-06,0.89792,0.86043,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,2.0833e-05,0.89618,0.8202,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,1.4039e-05,0.88685,0.90152,1,1
1,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00017796,0.88164,0.67859,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.1964e-05,0.87587,1.0178,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,1.0311e-06,0.8661,0.79589,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,8.2505e-07,0.86521,0.73738,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.725e-07,0.86182,0.85373,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,5.6999e-08,0.85508,0.86054,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,4.3218e-05,0.84298,0.69293,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,1.906e-06,0.84221,0.79432,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,1.4963e-07,0.83936,0.88264,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,8.628e-07,0.83891,0.79643,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,4.7955e-07,0.83422,0.76919,1,1
1,GO CD40 SIGNALING PATHWAY,2.6322e-07,0.82693,0.75279,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,6.5896e-07,0.82175,0.75757,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,8.628e-07,0.81759,0.9393,1,1
1,GO REGULATION OF PLASMINOGEN ACTIVATION,0.0001547,0.81247,0.80749,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,9.7801e-06,0.80802,0.65228,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,1.7118e-05,0.80747,0.79519,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,3.7791e-06,0.80446,0.61049,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,4.4712e-06,0.80137,0.63953,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,1.2366e-07,0.79893,0.77862,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,1.4609e-05,0.78483,0.71869,1,1
1,GO BONE TRABECULA FORMATION,0.0013872,0.77688,0.68728,1,1
1,GO CYSTEINE METABOLIC PROCESS,9.0179e-06,0.77326,0.70772,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,9.7801e-06,0.77167,0.65368,1,1
1,GO HEMIDESMOSOME ASSEMBLY,8.7323e-05,0.7686,0.96727,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,1.9263e-05,0.76795,0.76236,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,9.0551e-05,0.76685,0.59459,1,1
1,GO MEMBRANE RAFT ORGANIZATION,3.4728e-06,0.76502,0.90504,1,1
1,GO ENDODERM FORMATION,1.9873e-07,0.76452,0.7813,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,5.0226e-05,0.75597,0.61585,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,9.3916e-06,0.75467,0.60584,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,1.4039e-05,0.75269,0.81062,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,3.6228e-06,0.74902,0.79816,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,3.3287e-06,0.74535,0.69776,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,6.0198e-07,0.74381,0.73628,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00032948,0.74124,0.68579,1,1
1,GO EPIBOLY,8.2505e-07,0.73565,0.74625,1,1
1,GO FIBRINOLYSIS,4.5813e-07,0.73217,0.84192,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,2.5774e-06,0.73207,0.72211,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,1.071e-07,0.72741,0.70426,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,6.5896e-07,0.72416,0.70257,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.4728e-06,0.71898,0.62269,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,8.4205e-05,0.71653,0.54698,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,9.3916e-06,0.71488,0.59952,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,1.1237e-07,0.7087,0.76602,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,4.3763e-07,0.70559,0.65939,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.9263e-05,0.7019,0.62981,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,1.1267e-06,0.69998,0.66072,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.2879e-07,0.69817,0.63569,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,3.0689e-05,0.69677,0.5846,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.00026903,0.69422,0.59941,1,1
1,GO REGULATION OF FIBRINOLYSIS,2.0833e-05,0.69285,0.65659,1,1
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,2.7578e-07,0.69195,0.65986,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,5.4977e-07,0.6903,0.68842,1,1
1,GO VASCULOGENESIS,2.8891e-07,0.68204,0.60772,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,3.9926e-07,0.67903,0.82883,1,1
1,GO ZYMOGEN INHIBITION,9.8628e-07,0.67684,0.76927,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,4.2876e-06,0.67397,0.58869,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,4.2876e-06,0.66972,0.61669,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,5.2533e-07,0.66879,0.67063,1,1
1,GO MUCUS SECRETION,0.0010206,0.66378,0.54299,1,1
1,GO LATERAL MESODERM DEVELOPMENT,0.00013433,0.6614,0.51919,1,1
1,GO GAP JUNCTION ASSEMBLY,1.906e-06,0.65852,0.64444,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.906e-06,0.65837,0.64209,1,1
1,GO T CELL EXTRAVASATION,7.9801e-06,0.65778,0.67023,1,1
1,GO CYTIDINE TO URIDINE EDITING,0.00079435,0.65408,0.59279,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,1.4609e-05,0.65247,0.63607,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00021167,0.65225,0.43711,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,2.3418e-05,0.64875,0.58355,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00019079,0.64754,0.61095,1,1
1,GO APOPTOTIC CELL CLEARANCE,1.9873e-07,0.64512,0.6998,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,2.2658e-06,0.64417,0.57289,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.4772e-07,0.64148,0.62079,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,5.2837e-06,0.64011,0.58999,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.6015e-06,0.64007,0.63919,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00047456,0.63816,0.57281,1,1
1,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,4.6597e-05,0.63785,0.69186,1,1
1,GO CYTOLYSIS,6.5896e-07,0.63631,0.52563,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00016595,0.6359,0.61335,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,8.3127e-06,0.6355,0.55588,1,1
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.00011241,0.63336,0.52638,1,1
1,GO PLASMINOGEN ACTIVATION,0.00012074,0.632,0.59402,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,2.2658e-06,0.63149,0.72703,1,1
1,GO PIGMENT GRANULE MATURATION,5.8301e-05,0.63062,0.45628,1,1
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00016595,0.63061,0.60135,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,5.7413e-06,0.62864,0.5387,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,5.0683e-06,0.6273,0.62028,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,5.9841e-06,0.62689,0.54878,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,4.5813e-07,0.6261,0.58698,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.00021909,0.62305,0.4791,1,1
1,GO AMYLOID BETA CLEARANCE,8.8325e-08,0.61524,0.54771,1,1
1,GO ENDODERM DEVELOPMENT,5.2533e-07,0.61414,0.62754,1,1
1,GO VAGINA DEVELOPMENT,1.8251e-06,0.61256,0.63281,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,3.3132e-05,0.61217,0.5207,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.0604e-05,0.61142,0.69842,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.0011199,0.60891,0.68414,1,1
1,GO SNRNA PROCESSING,0.0014299,0.60744,0.61019,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,3.9418e-06,0.60598,0.65011,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,1.1493e-05,0.60518,0.44499,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,7.0571e-06,0.60394,0.54883,1,1
1,GO DNA DEAMINATION,0.00017796,0.60388,0.54412,1,1
1,GO HIPPO SIGNALING,4.0073e-05,0.60314,0.52158,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,4.1617e-05,0.60059,0.45143,1,1
1,GO COLLAGEN METABOLIC PROCESS,1.6015e-06,0.60033,0.58713,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,4.6623e-06,0.60007,0.60259,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00038934,0.59872,0.59526,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,1.071e-07,0.59871,0.52846,1,1
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0017641,0.59711,0.44239,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,7.3528e-06,0.59621,0.4713,1,1
1,GO LIVER REGENERATION,7.2756e-08,0.59611,0.58887,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,3.4728e-06,0.59505,0.62581,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0015653,0.59432,0.41219,1,1
1,GO HEME METABOLIC PROCESS,8.628e-07,0.59409,0.5417,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0017123,0.59369,0.71293,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,0.00010092,0.59323,0.52915,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,1.1493e-05,0.59277,0.52879,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,7.2111e-07,0.59276,0.57948,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,9.3916e-06,0.59215,0.56794,1,1
1,GO CELLULAR RESPONSE TO IRON ION,2.1663e-05,0.59125,0.52586,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.2454e-05,0.59078,0.51763,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,1.104e-05,0.58993,0.54238,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.7791e-06,0.58951,0.60575,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,2.0033e-05,0.5891,0.54928,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.5331e-06,0.58654,0.63837,1,1
1,GO VASCULAR TRANSPORT,0.00040247,0.58499,0.60959,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,3.4728e-06,0.58346,0.51086,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0001165,0.58306,0.53845,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,7.547e-05,0.58261,0.48879,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00044439,0.58163,0.50904,1,1
1,GO NOTOCHORD DEVELOPMENT,4.4712e-06,0.58159,0.62701,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.011904,0.58136,0.47177,1,1
1,GO MACROPHAGE PROLIFERATION,2.9532e-05,0.57999,0.57871,1,1
1,GO GERMINAL CENTER FORMATION,7.8282e-05,0.5783,0.49181,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,8.628e-07,0.57664,0.56484,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,1.104e-05,0.57606,0.61619,1,1
1,GO ELASTIC FIBER ASSEMBLY,0.00028792,0.57588,0.6732,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,7.6603e-06,0.5743,0.4517,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,1.3441e-06,0.57329,0.58982,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,2.9301e-06,0.57042,0.78019,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,3.7145e-05,0.56884,0.44019,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00011241,0.5673,0.55614,1,1
1,GO SALIVARY GLAND DEVELOPMENT,9.3916e-06,0.56562,0.57411,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,6.4994e-06,0.56519,0.48699,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,7.6603e-06,0.56348,0.58536,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.0001165,0.56287,0.48441,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,2.6322e-07,0.5619,0.60744,1,1
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0073363,0.55977,0.4192,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,2.8077e-06,0.55959,0.50285,1,1
1,GO REGULATION OF PINOCYTOSIS,8.1192e-05,0.55809,0.59329,1,1
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.047551,0.55357,0.3317,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.906e-06,0.55258,0.48156,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.00036427,0.5513,0.44875,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,0.00010845,0.5513,0.55142,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.6015e-06,0.55084,0.57227,1,1
1,GO CELLULAR RESPONSE TO X RAY,0.00019079,0.5507,0.44553,1,1
1,GO TYPE 2 IMMUNE RESPONSE,1.6455e-05,0.5506,0.52926,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,1.4674e-06,0.5505,0.53454,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.00037661,0.54938,0.66246,1,1
1,GO OLIGOPEPTIDE TRANSPORT,4.6597e-05,0.54807,0.58807,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,3.3287e-06,0.54645,0.50099,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.0027346,0.54596,0.47813,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,1.8521e-05,0.54574,0.57904,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.00017796,0.54443,0.47833,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.00084609,0.54281,0.39211,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0014738,0.54243,0.41268,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,6.2367e-06,0.53952,0.49564,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,4.4878e-05,0.53714,0.47846,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.4609e-05,0.53683,0.50142,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,2.8891e-07,0.53474,0.5653,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,6.5149e-05,0.53468,0.59405,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,8.3127e-06,0.53405,0.60437,1,1
1,GO COLLAGEN CATABOLIC PROCESS,2.9532e-05,0.53243,0.53651,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,8.1192e-05,0.53094,0.50812,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00026903,0.53002,0.4861,1,1
1,GO BLOOD VESSEL REMODELING,1.4039e-05,0.52826,0.45572,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,5.8301e-05,0.5282,0.56509,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,1.0311e-06,0.52641,0.5637,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,2.4692e-06,0.52558,0.45121,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00074557,0.52543,0.41595,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,2.5122e-07,0.52369,0.48616,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,1.0779e-06,0.52137,0.49501,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00013917,0.52118,0.45354,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,2.6307e-05,0.52103,0.45467,1,1
1,GO RESPONSE TO X RAY,1.7474e-06,0.51835,0.48479,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.00022676,0.51653,0.52593,1,1
1,GO RESPONSE TO ANGIOTENSIN,4.5813e-07,0.51612,0.49285,1,1
1,GO CELLULAR RESPONSE TO DSRNA,7.889e-07,0.51519,0.54181,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00044439,0.51399,0.4838,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,2.0784e-06,0.51344,0.44181,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,3.1904e-06,0.51198,0.61663,1,1
1,GO CERAMIDE CATABOLIC PROCESS,3.0689e-05,0.51182,0.41253,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,8.6584e-06,0.51169,0.42884,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00055855,0.51114,0.39945,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00026903,0.51094,0.41409,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.030383,0.51089,0.27329,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,4.1617e-05,0.51052,0.48797,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.00011241,0.50936,0.49799,1,1
1,GO REGULATION OF MYOBLAST FUSION,0.0001547,0.50823,0.52942,1,1
1,GO RESPONSE TO TYPE I INTERFERON,0.00055855,0.50777,0.54666,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,4.1802e-07,0.50775,0.53009,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,2.1831e-07,0.50662,0.58609,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00044439,0.50574,0.46614,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,7.2754e-05,0.5042,0.52851,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.010773,0.50407,0.30699,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,4.5813e-07,0.50241,0.4823,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,5.4977e-07,0.50231,0.48178,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.8084e-07,0.50054,0.48803,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,8.2505e-07,0.49918,0.49475,1,1
1,GO PEPTIDE CROSS LINKING,0.00010462,0.49844,0.4696,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,1.6452e-07,0.49828,0.50718,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,1.8958e-07,0.49818,0.49215,1,1
1,GO NCRNA 3 END PROCESSING,0.011326,0.49751,0.39701,1,1
1,GO SNRNA METABOLIC PROCESS,0.00050664,0.49715,0.49267,1,1
1,GO LYMPHANGIOGENESIS,4.8612e-06,0.49659,0.46652,1,1
1,GO STORE OPERATED CALCIUM ENTRY,2.6902e-06,0.49539,0.42828,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0010528,0.49536,0.42819,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,4.2876e-06,0.49519,0.53925,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,2.0033e-05,0.49238,0.43112,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,2.8077e-06,0.49232,0.55277,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,1.0184e-05,0.492,0.43273,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,9.389e-05,0.49198,0.43036,1,1
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.00063551,0.49094,0.4742,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,2.8891e-07,0.49069,0.48807,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00057693,0.49024,0.43283,1,1
1,GO ENTRY INTO HOST,1.2308e-06,0.4882,0.54455,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,7.9801e-06,0.48819,0.40833,1,1
1,GO AORTIC VALVE DEVELOPMENT,0.00023468,0.48593,0.46465,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0013457,0.48586,0.37887,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,6.5896e-07,0.48568,0.46434,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,5.753e-07,0.48462,0.48376,1,1
1,GO BIOLOGICAL PHASE,0.0016129,0.48375,0.47289,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0001165,0.48285,0.39629,1,1
1,GO PROTEIN OXIDATION,0.0021062,0.48177,0.44301,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,7.5427e-07,0.48147,0.49939,1,1
1,GO TOLERANCE INDUCTION,0.00054072,0.4814,0.44512,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,5.9841e-06,0.48118,0.49495,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,2.7343e-05,0.48075,0.43882,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.00029782,0.48075,0.46732,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0041716,0.47847,0.34278,1,1
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0028141,0.47736,0.39927,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,7.547e-05,0.47731,0.48538,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.00042998,0.47719,0.58203,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,1.1237e-07,0.4766,0.42098,1,1
1,GO LEUKOCYTE AGGREGATION,0.0017123,0.47612,0.50773,1,1
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0028141,0.47559,0.36338,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,2.1702e-06,0.47554,0.37848,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,2.6902e-06,0.47487,0.4906,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.9263e-05,0.47429,0.42041,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00024286,0.47378,0.44706,1,1
1,GO HYALURONAN METABOLIC PROCESS,3.6414e-07,0.47297,0.50332,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,4.2876e-06,0.47292,0.65896,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.1663e-05,0.47181,0.45684,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,9.3916e-06,0.47118,0.39525,1,1
1,GO REGULATION OF TRANSPOSITION,0.00067758,0.47114,0.4247,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,1.104e-05,0.47006,0.44936,1,1
1,GO ENTRY OF BACTERIUM INTO HOST CELL,0.001662,0.46949,0.4101,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,5.508e-06,0.4693,0.50794,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,5.2139e-05,0.46878,0.38492,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,3.7145e-05,0.46805,0.43633,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,7.2754e-05,0.46771,0.45471,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,0.0030654,0.46719,0.41668,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,3.9418e-06,0.46564,0.6276,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,1.5201e-05,0.46553,0.47111,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00072223,0.46486,0.42236,1,1
1,GO RESPONSE TO HYPEROXIA,0.00017186,0.4646,0.45097,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,5.7413e-06,0.46434,0.44191,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,1.7806e-05,0.46419,0.46842,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,2.7343e-05,0.46346,0.49951,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.00098941,0.46336,0.4039,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,5.508e-06,0.46301,0.65301,1,1
1,GO PROTEIN ACTIVATION CASCADE,2.9301e-06,0.46284,0.48885,1,1
1,GO OSTEOBLAST DEVELOPMENT,0.00013433,0.46245,0.41804,1,1
1,GO PROGESTERONE METABOLIC PROCESS,0.011612,0.46232,0.34341,1,1
1,GO VIRAL RNA GENOME REPLICATION,2.4692e-06,0.46228,0.40926,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,1.4609e-05,0.46103,0.58362,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,3.9926e-07,0.46054,0.51588,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,1.8521e-05,0.46005,0.47417,1,1
1,GO REGULATION OF MRNA BINDING,5.8301e-05,0.45842,0.3778,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,2.7343e-05,0.45818,0.47404,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,0.00012512,0.45815,0.40308,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,3.3132e-05,0.45784,0.49634,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,2.2658e-06,0.45774,0.48419,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,1.1493e-05,0.45741,0.42755,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,4.8612e-06,0.45695,0.41531,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,7.0571e-06,0.45694,0.44243,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,9.3916e-06,0.45662,0.40273,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,1.906e-06,0.45594,0.4245,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,2.8077e-06,0.4558,0.44992,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,3.0576e-06,0.45481,0.38617,1,1
1,GO PROTEASOME ASSEMBLY,3.3132e-05,0.45437,0.34344,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,4.4712e-06,0.45315,0.50815,1,1
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.00026903,0.453,0.4399,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,1.0779e-06,0.4525,0.47427,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.2308e-06,0.45234,0.47015,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,9.389e-05,0.45187,0.34083,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,3.8131e-07,0.4502,0.4325,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.00026003,0.45014,0.41233,1,1
1,GO ZYMOGEN ACTIVATION,6.2786e-05,0.4498,0.46659,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.9904e-06,0.44963,0.37917,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,5.2837e-06,0.44934,0.51209,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,3.7791e-06,0.44908,0.43108,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,4.3763e-07,0.44889,0.44875,1,1
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0073363,0.44839,0.35817,1,1
1,GO CYTOPLASMIC TRANSLATION,0.00014418,0.44817,0.37272,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,1.6455e-05,0.44693,0.39643,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,1.8521e-05,0.44634,0.33629,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,9.0179e-06,0.44429,0.34274,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0001547,0.4436,0.39892,1,1
1,GO ANIMAL ORGAN REGENERATION,2.8891e-07,0.44352,0.49892,1,1
1,GO BONE TRABECULA MORPHOGENESIS,0.023741,0.44343,0.38215,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.001986,0.44264,0.34268,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.0779e-06,0.44195,0.47215,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.0010859,0.44193,0.32697,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,3.6414e-07,0.44172,0.39394,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00022676,0.44142,0.36744,1,1
1,GO PINOCYTOSIS,2.0833e-05,0.44128,0.55129,1,1
1,GO VIRAL TRANSLATION,1.0184e-05,0.44097,0.43034,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,2.8418e-05,0.44096,0.43973,1,1
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00019079,0.43955,0.53118,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,2.0833e-05,0.43912,0.40917,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,6.5896e-07,0.43851,0.39324,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,1.7806e-05,0.43848,0.39092,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,0.00011241,0.43709,0.44855,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,7.889e-07,0.43604,0.47937,1,1
1,GO CYTOKINE METABOLIC PROCESS,5.7413e-06,0.43528,0.38378,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,1.0311e-06,0.43504,0.59842,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00012512,0.43425,0.42242,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,2.7343e-05,0.434,0.45995,1,1
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0056288,0.43397,0.30406,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,2.8418e-05,0.4337,0.41835,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00010092,0.43306,0.39178,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.6729e-06,0.43302,0.39028,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,8.4205e-05,0.43301,0.44875,1,1
1,GO T CELL MEDIATED IMMUNITY,2.3418e-05,0.43294,0.43132,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0016129,0.43223,0.31898,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.0039469,0.43152,0.3404,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00011241,0.43024,0.37407,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,9.7346e-05,0.42954,0.3678,1,1
1,GO REGULATION OF STEROL TRANSPORT,5.4977e-07,0.42921,0.38506,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0010859,0.4288,0.38788,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,1.7474e-06,0.42879,0.41779,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,0.00057693,0.42801,0.44989,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,3.1888e-05,0.42797,0.31308,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,9.7346e-05,0.42792,0.36368,1,1
1,GO RIBOSOME ASSEMBLY,0.00014935,0.42689,0.38359,1,1
1,GO VIRAL GENOME REPLICATION,9.0551e-05,0.42635,0.38899,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,4.7955e-07,0.42457,0.53885,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,4.0073e-05,0.42431,0.5105,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,2.6902e-06,0.42352,0.4317,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0017641,0.42316,0.36181,1,1
1,GO RESPONSE TO INTERLEUKIN 12,8.2505e-07,0.42189,0.42007,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,5.4121e-05,0.42162,0.37435,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,7.0571e-06,0.42144,0.40671,1,1
1,GO IMMATURE T CELL PROLIFERATION,2.6307e-05,0.42026,0.49836,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,4.5813e-07,0.41976,0.37619,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,4.6623e-06,0.41936,0.45435,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,0.0018173,0.41897,0.34452,1,1
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00081984,0.41897,0.41049,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,9.3916e-06,0.4188,0.38159,1,1
1,GO DETECTION OF BIOTIC STIMULUS,2.9532e-05,0.41854,0.43909,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00017796,0.41852,0.35019,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,6.0504e-05,0.41844,0.38278,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0006154,0.41814,0.3531,1,1
1,GO ARGININE METABOLIC PROCESS,0.00010462,0.4181,0.41107,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00074557,0.41809,0.42156,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.00063551,0.41768,0.5798,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,9.0179e-06,0.41632,0.42222,1,1
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.024288,0.41519,0.26605,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,3.9926e-07,0.41452,0.41836,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,4.8379e-05,0.41433,0.45873,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0011199,0.41409,0.46453,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.00081984,0.41356,0.41999,1,1
1,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.02268,0.41255,0.42416,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.5759e-05,0.41234,0.37726,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,3.0264e-07,0.41168,0.36706,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,9.0221e-07,0.41158,0.35183,1,1
1,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.02166,0.41127,0.47968,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0022992,0.41106,0.33093,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,4.1617e-05,0.41104,0.37512,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.7806e-05,0.41091,0.55035,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,2.8077e-06,0.41089,0.55163,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,7.6603e-06,0.41081,0.45724,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00040247,0.41069,0.35544,1,1
1,GO EPOXYGENASE P450 PATHWAY,0.0015653,0.41068,0.31208,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,1.104e-05,0.41012,0.39364,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.00042998,0.41007,0.58424,1,1
1,GO BONE GROWTH,1.7806e-05,0.40957,0.49196,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,2.9301e-06,0.40911,0.47525,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00081984,0.40881,0.33209,1,1
1,GO PLATELET AGGREGATION,9.7801e-06,0.40867,0.35177,1,1
1,GO GALACTOSE METABOLIC PROCESS,0.00022676,0.40834,0.34613,1,1
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00016023,0.40829,0.42981,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,4.6623e-06,0.40786,0.36784,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,5.4121e-05,0.40756,0.40881,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,3.1888e-05,0.40731,0.41164,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,1.9904e-06,0.40661,0.45923,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00028792,0.4064,0.45695,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,9.7801e-06,0.40615,0.40005,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,5.2837e-06,0.40585,0.37506,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0056288,0.40564,0.29879,1,1
1,GO RESPONSE TO INTERFERON GAMMA,1.6455e-05,0.40522,0.47059,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00059588,0.4051,0.34899,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,3.3132e-05,0.40466,0.35495,1,1
1,GO I KAPPAB PHOSPHORYLATION,0.00069957,0.40407,0.25504,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,3.7791e-06,0.40407,0.4811,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,4.2876e-06,0.40378,0.46616,1,1
1,GO EMBRYO IMPLANTATION,1.8251e-06,0.40352,0.49936,1,1
1,GO RESPONSE TO SALT STRESS,3.6228e-06,0.40292,0.36979,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,7.2754e-05,0.40291,0.3783,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,6.2985e-07,0.40182,0.39726,1,1
1,GO TRANSLATIONAL INITIATION,0.00012512,0.40113,0.34676,1,1
1,GO COPPER ION HOMEOSTASIS,7.013e-05,0.40065,0.43269,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0039469,0.40052,0.40235,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,1.5331e-06,0.40003,0.35478,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,8.4205e-05,0.39932,0.38771,1,1
1,GO REGULATION OF HIPPO SIGNALING,0.00353,0.39848,0.28745,1,1
1,GO RECEPTOR CATABOLIC PROCESS,5.0683e-06,0.39806,0.41105,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,2.6307e-05,0.3978,0.43566,1,1
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.00054072,0.39738,0.56699,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,5.8301e-05,0.39652,0.36412,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.2308e-06,0.39626,0.42411,1,1
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00012512,0.39596,0.32744,1,1
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0050528,0.39577,0.44972,1,1
1,GO ENAMEL MINERALIZATION,0.0060989,0.3951,0.35062,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,1.4609e-05,0.39508,0.47439,1,1
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.001662,0.39493,0.31427,1,1
1,GO MATURATION OF SSU RRNA,0.00018427,0.39468,0.35995,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00063551,0.39437,0.35727,1,1
1,GO PHAGOCYTOSIS RECOGNITION,9.0551e-05,0.39416,0.53215,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.001662,0.39414,0.30097,1,1
1,GO MUSCLE CELL FATE COMMITMENT,0.004408,0.39382,0.34936,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.7806e-05,0.39375,0.36255,1,1
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.001872,0.39327,0.39788,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00025131,0.39326,0.38694,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,1.2862e-06,0.3928,0.36984,1,1
1,GO PLATELET DEGRANULATION,6.2367e-06,0.39201,0.44332,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,1.1493e-05,0.39129,0.34242,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.6015e-06,0.39081,0.39597,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,8.6584e-06,0.38981,0.33762,1,1
1,GO PULMONARY VALVE DEVELOPMENT,0.00092958,0.3896,0.43877,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0016129,0.38956,0.44264,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,3.4772e-07,0.38928,0.36477,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,8.1192e-05,0.38855,0.34552,1,1
1,GO NIK NF KAPPAB SIGNALING,2.8077e-06,0.38828,0.37791,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,7.3528e-06,0.38815,0.34372,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00027832,0.38806,0.33187,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.8521e-05,0.38784,0.37162,1,1
1,GO INTERLEUKIN 1 PRODUCTION,2.6307e-05,0.38763,0.42949,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,2.6307e-05,0.38715,0.40294,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,1.4609e-05,0.38665,0.37361,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.007729,0.38663,0.26781,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,2.2658e-06,0.38657,0.36238,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0042883,0.38622,0.2631,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,6.5896e-07,0.38616,0.36261,1,1
1,GO RESPONSE TO ESTROGEN,1.8251e-06,0.38605,0.38527,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,1.7118e-05,0.38565,0.34917,1,1
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.001191,0.38558,0.39717,1,1
1,GO INTERACTION WITH SYMBIONT,1.4609e-05,0.38551,0.3132,1,1
1,GO MUSCLE FILAMENT SLIDING,8.3127e-06,0.38506,0.38801,1,1
1,GO REGULATION OF GASTRULATION,3.8131e-07,0.38483,0.3985,1,1
1,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0019282,0.38462,0.3193,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.0031536,0.38451,0.46419,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00040247,0.38394,0.35213,1,1
1,GO ERAD PATHWAY,4.3763e-07,0.3822,0.3356,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00050664,0.3818,0.35294,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.01282,0.38142,0.44127,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0016129,0.3813,0.34476,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,3.3132e-05,0.38085,0.37999,1,1
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.00065623,0.38048,0.33666,1,1
1,GO MATURATION OF 5 8S RRNA,0.00054072,0.38036,0.29417,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,0.0022332,0.38035,0.39456,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,5.4121e-05,0.38004,0.3727,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0037331,0.37968,0.29113,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00032948,0.37959,0.40143,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,3.7145e-05,0.37932,0.35011,1,1
1,GO MRNA TRANSCRIPTION,1.7806e-05,0.37828,0.37027,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,4.8612e-06,0.37824,0.32762,1,1
1,GO TRACHEA MORPHOGENESIS,0.001228,0.37823,0.28537,1,1
1,GO NEGATIVE REGULATION OF CELL SIZE,1.2454e-05,0.37795,0.32154,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,2.2658e-06,0.37791,0.45673,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,9.7801e-06,0.37751,0.41373,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,2.5308e-05,0.37681,0.39881,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.004408,0.37671,0.39976,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,9.4334e-07,0.37668,0.41834,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,0.00017186,0.37616,0.39524,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00023468,0.37615,0.3754,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.00098941,0.37609,0.31495,1,1
1,GO VIRAL LIFE CYCLE,4.1112e-06,0.37592,0.37706,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00052342,0.37505,0.28395,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,6.7596e-05,0.37455,0.40034,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,8.6584e-06,0.37454,0.30846,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,4.1112e-06,0.37434,0.3106,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,2.9532e-05,0.37424,0.32414,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0062634,0.37378,0.29908,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00063551,0.37329,0.28967,1,1
1,GO B CELL MEDIATED IMMUNITY,3.6228e-06,0.37314,0.34566,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,5.2139e-05,0.37214,0.32511,1,1
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0022992,0.3718,0.31992,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,1.2366e-07,0.37145,0.36907,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,3.7145e-05,0.37105,0.57021,1,1
1,GO SMOOTH MUSCLE CELL MIGRATION,0.038561,0.37062,0.21752,1,1
1,GO INTERLEUKIN 17 PRODUCTION,5.2837e-06,0.37025,0.45293,1,1
1,GO PROTEIN DEGLYCOSYLATION,6.2786e-05,0.36992,0.36676,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.4039e-05,0.36944,0.40058,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,4.3218e-05,0.36943,0.34803,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00037661,0.36934,0.42686,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,3.3287e-06,0.36899,0.44836,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0022332,0.36879,0.2984,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0010859,0.36839,0.3766,1,1
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0031536,0.36793,0.27519,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,3.7145e-05,0.3679,0.31367,1,1
1,GO FOREGUT MORPHOGENESIS,2.1663e-05,0.36774,0.42836,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00026903,0.36747,0.32269,1,1
1,GO MEMBRANE INVAGINATION,2.7578e-07,0.36711,0.3797,1,1
1,GO VIRAL GENE EXPRESSION,5.6174e-05,0.36689,0.35832,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,8.6584e-06,0.36683,0.4031,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00031859,0.36675,0.29582,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.00012964,0.36654,0.36218,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0012662,0.36646,0.31732,1,1
1,GO CARNITINE METABOLIC PROCESS,0.00049035,0.36612,0.34316,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,9.3916e-06,0.36579,0.41093,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.00023468,0.36535,0.38754,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,6.0504e-05,0.36524,0.34463,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00047456,0.36523,0.35379,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,7.547e-05,0.36486,0.36554,1,1
1,GO REGULATION OF COAGULATION,2.2524e-05,0.3648,0.41692,1,1
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.014138,0.36446,0.24899,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,0.00011241,0.36424,0.42569,1,1
1,GO INTERFERON BETA PRODUCTION,0.00098941,0.36403,0.25876,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,2.0033e-05,0.36381,0.41762,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,2.4346e-05,0.3636,0.31759,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,7.8282e-05,0.3634,0.46777,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,4.6623e-06,0.36329,0.47993,1,1
1,GO EOSINOPHIL MIGRATION,0.0020453,0.36287,0.39334,1,1
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.038561,0.36277,0.36805,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00057693,0.36221,0.29613,1,1
1,GO INTERLEUKIN 13 PRODUCTION,0.00063551,0.36215,0.39509,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,6.5149e-05,0.36169,0.35785,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,3.4421e-05,0.36163,0.32911,1,1
1,GO IMMUNOGLOBULIN SECRETION,0.00030804,0.36159,0.33424,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00040247,0.36122,0.45759,1,1
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0025083,0.36107,0.39992,1,1
1,GO PRIMARY MIRNA PROCESSING,0.00010462,0.36098,0.35786,1,1
1,GO MEMBRANE DISASSEMBLY,0.00081984,0.36097,0.28046,1,1
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.011326,0.36038,0.22668,1,1
1,GO RRNA PSEUDOURIDINE SYNTHESIS,0.0050528,0.36023,0.28442,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00013433,0.36021,0.3424,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00098941,0.36016,0.33777,1,1
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.00045924,0.35941,0.28838,1,1
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00035231,0.3591,0.33544,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,6.0504e-05,0.35868,0.31711,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,8.6584e-06,0.35858,0.35493,1,1
1,GO ETHER BIOSYNTHETIC PROCESS,0.0028141,0.35804,0.30273,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00038934,0.35803,0.39665,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.00024286,0.35799,0.26362,1,1
1,GO COMPLEMENT ACTIVATION,1.9904e-06,0.35716,0.33147,1,1
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,4.6597e-05,0.35696,0.29767,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,6.4994e-06,0.35555,0.36526,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0059384,0.35551,0.38726,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,3.7791e-06,0.35539,0.37605,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,8.4205e-05,0.35492,0.38537,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0029794,0.3548,0.43176,1,1
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.8418e-05,0.35458,0.29481,1,1
1,GO CELL REDOX HOMEOSTASIS,7.0571e-06,0.35446,0.31273,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,1.7806e-05,0.35382,0.38829,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,4.4878e-05,0.35382,0.36658,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.0081404,0.35323,0.27821,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,6.0504e-05,0.35295,0.32595,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,5.9841e-06,0.35225,0.31952,1,1
1,GO INTERACTION WITH HOST,3.4728e-06,0.35211,0.38531,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0014299,0.35206,0.3438,1,1
1,GO INTERLEUKIN 2 PRODUCTION,5.2837e-06,0.35194,0.40041,1,1
1,GO PEPTIDE CATABOLIC PROCESS,2.2658e-06,0.3514,0.33042,1,1
1,GO PIGMENT ACCUMULATION,0.00017186,0.35138,0.30007,1,1
1,GO RESPONSE TO MANGANESE ION,5.6174e-05,0.35094,0.31756,1,1
1,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.00040247,0.35092,0.32178,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,8.3127e-06,0.35072,0.35452,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.1964e-05,0.35064,0.3842,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.001662,0.35002,0.3871,1,1
1,GO STEROL IMPORT,0.00014935,0.34946,0.48474,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,0.00040247,0.3493,0.35453,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,5.4121e-05,0.34914,0.42489,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00016023,0.34882,0.31859,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.8521e-05,0.34857,0.45195,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.2139e-05,0.34844,0.37431,1,1
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,7.8282e-05,0.34756,0.27125,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.033894,0.34753,0.24139,1,1
1,GO DEFENSE RESPONSE TO VIRUS,0.00018427,0.34722,0.3618,1,1
1,GO ERBB2 SIGNALING PATHWAY,0.00049035,0.34701,0.26388,1,1
1,GO LENS FIBER CELL DEVELOPMENT,0.0017641,0.34645,0.37603,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00030804,0.34625,0.32705,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00092958,0.346,0.32294,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.027188,0.34586,0.26881,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00041602,0.34569,0.3965,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.0001165,0.34546,0.3106,1,1
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014138,0.34523,0.26141,1,1
1,GO FIBROBLAST PROLIFERATION,7.2754e-05,0.34473,0.31209,1,1
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.029719,0.34465,0.38839,1,1
1,GO T CELL APOPTOTIC PROCESS,1.349e-05,0.34464,0.32233,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.104e-05,0.34461,0.36997,1,1
1,GO NCRNA PROCESSING,8.4205e-05,0.34461,0.28622,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0034322,0.34434,0.25027,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00079435,0.34412,0.31669,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,5.6174e-05,0.34369,0.36476,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,6.5149e-05,0.34364,0.31605,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,1.7118e-05,0.34358,0.3233,1,1
1,GO INTERLEUKIN 8 PRODUCTION,4.8379e-05,0.34287,0.34114,1,1
1,GO L GLUTAMATE IMPORT,0.00069957,0.34248,0.34083,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0015189,0.3422,0.26861,1,1
1,GO NUCLEOSIDE SALVAGE,0.0075304,0.34187,0.39781,1,1
1,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0013872,0.34158,0.35852,1,1
1,GO GASTRULATION,5.753e-07,0.34155,0.35375,1,1
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.00069957,0.34141,0.25457,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.001662,0.34048,0.60189,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.2862e-06,0.34036,0.42252,1,1
1,GO TYPE I INTERFERON PRODUCTION,0.00012964,0.34016,0.29242,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.00069957,0.33985,0.28992,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0071468,0.33959,0.27577,1,1
1,GO STEROID ESTERIFICATION,0.015574,0.3394,0.26258,1,1
1,GO BASEMENT MEMBRANE ASSEMBLY,0.0014299,0.33884,0.44823,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.00024286,0.3383,0.34272,1,1
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0012662,0.33799,0.29857,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,4.6597e-05,0.33793,0.30707,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00079435,0.33769,0.27747,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.001872,0.33762,0.34175,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.8583e-05,0.33751,0.2902,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,1.4609e-05,0.33744,0.28317,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00047456,0.3374,0.29433,1,1
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0031536,0.33719,0.29311,1,1
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0013054,0.33709,0.29155,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00042998,0.33702,0.37908,1,1
1,GO REGULATION OF LIPASE ACTIVITY,2.0033e-05,0.33699,0.27071,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,2.6307e-05,0.33693,0.31502,1,1
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,2.8418e-05,0.33688,0.36014,1,1
1,GO FIBROBLAST MIGRATION,6.2786e-05,0.33648,0.36292,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.00026903,0.33586,0.42069,1,1
1,GO REGULATION OF PHAGOCYTOSIS,2.8077e-06,0.33562,0.37146,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.00090094,0.33556,0.32385,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,3.3287e-06,0.33541,0.30406,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,2.1831e-07,0.33511,0.3177,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,7.2754e-05,0.33476,0.28537,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,2.9301e-06,0.33466,0.4082,1,1
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.027803,0.33462,0.21742,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,0.00021167,0.33426,0.38879,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,3.0576e-06,0.3341,0.41314,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,2.0033e-05,0.33349,0.40429,1,1
1,GO CYCLOOXYGENASE PATHWAY,0.046579,0.33342,0.29811,1,1
1,GO DECIDUALIZATION,0.0042883,0.33303,0.39013,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,0.00019753,0.33299,0.34253,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.02068,0.33282,0.33429,1,1
1,GO CELL SUBSTRATE ADHESION,8.3127e-06,0.33236,0.36747,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,9.7801e-06,0.33194,0.38149,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00065623,0.33181,0.3048,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00052342,0.3317,0.37624,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00029782,0.33169,0.31674,1,1
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00057693,0.33142,0.24826,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.6307e-05,0.33137,0.44931,1,1
1,GO CHYLOMICRON ASSEMBLY,0.0085714,0.33093,0.24478,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,3.8583e-05,0.33059,0.28725,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00019753,0.33016,0.31645,1,1
1,GO SPROUTING ANGIOGENESIS,5.6174e-05,0.3294,0.32542,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,3.5759e-05,0.32917,0.29849,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,2.2658e-06,0.3284,0.3232,1,1
1,GO PULMONARY VALVE MORPHOGENESIS,0.016339,0.32801,0.42791,1,1
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.0031536,0.32797,0.30753,1,1
1,GO MESODERM MORPHOGENESIS,4.4712e-06,0.32796,0.33244,1,1
1,GO PIGMENT METABOLIC PROCESS,5.2837e-06,0.32794,0.31617,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0022992,0.32768,0.27284,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.5308e-05,0.32752,0.30053,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.7806e-05,0.32725,0.37807,1,1
1,GO OSTEOCLAST DEVELOPMENT,5.0226e-05,0.3271,0.37941,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00012074,0.32695,0.25945,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0021062,0.32691,0.34883,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,1.349e-05,0.32683,0.35903,1,1
1,GO GLIAL CELL ACTIVATION,8.7323e-05,0.32655,0.33759,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,3.6228e-06,0.32641,0.36147,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00032948,0.32625,0.25598,1,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00079435,0.32567,0.2931,1,1
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00028792,0.32549,0.36101,1,1
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.035393,0.32506,0.18889,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,0.00038934,0.32476,0.27149,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.036164,0.32433,0.2982,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00017186,0.32402,0.28187,1,1
1,GO XENOBIOTIC TRANSPORT,0.00012964,0.32348,0.34371,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00024286,0.32296,0.34319,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,1.1964e-05,0.3221,0.35049,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.025994,0.32175,0.1945,1,1
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0087944,0.32174,0.3836,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.001986,0.32125,0.27967,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0001547,0.32093,0.38266,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,1.2862e-06,0.32031,0.31402,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,1.104e-05,0.32021,0.3217,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00032948,0.32,0.40818,1,1
1,GO STEROL TRANSPORT,1.5816e-05,0.3199,0.27835,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,4.1617e-05,0.31989,0.27908,1,1
1,GO REGENERATION,2.4692e-06,0.31985,0.29033,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,9.7801e-06,0.31928,0.25774,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.0040578,0.31924,0.19311,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,1.7118e-05,0.31917,0.37203,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,5.6174e-05,0.31903,0.35121,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,0.0011199,0.31864,0.31829,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00019753,0.31827,0.28433,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,9.3916e-06,0.31788,0.29115,1,1
1,GO PROTEIN TARGETING TO VACUOLE,1.4609e-05,0.31767,0.28005,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00022676,0.3167,0.26454,1,1
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0041716,0.31665,0.37183,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0010859,0.31639,0.2379,1,1
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.011612,0.31575,0.28647,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00038934,0.3152,0.26446,1,1
1,GO LIPOPROTEIN LOCALIZATION,1.5201e-05,0.31491,0.42758,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,1.5816e-05,0.31482,0.3313,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,1.6455e-05,0.31461,0.34434,1,1
1,GO ASTROCYTE ACTIVATION,0.0040578,0.3141,0.2812,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.00069957,0.31353,0.32601,1,1
1,GO FOCAL ADHESION ASSEMBLY,4.3218e-05,0.3134,0.3458,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00042998,0.31336,0.28864,1,1
1,GO REGULATION OF PROTEIN MATURATION,1.9263e-05,0.31318,0.31931,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,1.8521e-05,0.31282,0.2931,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.9532e-05,0.31274,0.31394,1,1
1,GO MULTI ORGANISM LOCALIZATION,9.2696e-08,0.31267,0.39481,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.035393,0.31188,0.22418,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0057817,0.31176,0.24307,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,1.1493e-05,0.31173,0.29015,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,7.8282e-05,0.31172,0.29648,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,5.508e-06,0.31138,0.32949,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,1.5816e-05,0.31079,0.30918,1,1
1,GO VESICLE CARGO LOADING,0.00012074,0.31075,0.28228,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0028957,0.31042,0.28734,1,1
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.0038387,0.31041,0.2579,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,7.6603e-06,0.30986,0.38895,1,1
1,GO MUSCLE CELL PROLIFERATION,8.3127e-06,0.30978,0.30248,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,6.2786e-05,0.30967,0.28478,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.00026003,0.30939,0.29388,1,1
1,GO RESPONSE TO PROGESTERONE,0.0028957,0.30884,0.28714,1,1
1,GO RRNA METABOLIC PROCESS,0.00059588,0.30865,0.2759,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,4.4878e-05,0.30839,0.32298,1,1
1,GO TRNA 5 LEADER REMOVAL,7.547e-05,0.30833,0.32904,1,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.020205,0.30809,0.25944,1,1
1,GO VASCULATURE DEVELOPMENT,2.1663e-05,0.30803,0.27843,1,1
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,2.6307e-05,0.30763,0.2608,1,1
1,GO CHONDROCYTE DIFFERENTIATION,1.5816e-05,0.30761,0.31313,1,1
1,GO SYNCYTIUM FORMATION,0.00014935,0.30751,0.30735,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,3.4421e-05,0.30748,0.24653,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,0.00014935,0.30748,0.25314,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,1.906e-06,0.30743,0.27574,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.7806e-05,0.30724,0.27564,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.00029782,0.30683,0.26034,1,1
1,GO RNA 5 END PROCESSING,0.0006154,0.30678,0.27477,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.017137,0.30664,0.45029,1,1
1,GO CHOLESTEROL EFFLUX,2.9301e-06,0.30658,0.32701,1,1
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00055855,0.30656,0.36215,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,2.0833e-05,0.30651,0.34083,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,4.8379e-05,0.30647,0.33515,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,3.7791e-06,0.30577,0.46217,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,3.8583e-05,0.30552,0.28185,1,1
1,GO RESPONSE TO DEXAMETHASONE,0.0025817,0.30549,0.25958,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,9.7346e-05,0.30525,0.25152,1,1
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,1.8521e-05,0.30497,0.34962,1,1
1,GO NCRNA METABOLIC PROCESS,0.00020448,0.30479,0.25039,1,1
1,GO LYMPH VESSEL DEVELOPMENT,0.02166,0.30457,0.291,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00047456,0.3043,0.20931,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.00017186,0.30383,0.29238,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0006154,0.3038,0.28275,1,1
1,GO GLUTATHIONE METABOLIC PROCESS,0.0007696,0.30362,0.27073,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00040247,0.30354,0.27221,1,1
1,GO REPLICATIVE SENESCENCE,0.0056288,0.3035,0.35725,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0053338,0.30343,0.34291,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.8583e-05,0.30314,0.26005,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,7.6603e-06,0.30281,0.3271,1,1
1,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.0019282,0.3027,0.30538,1,1
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.013798,0.30232,0.32532,1,1
1,GO TRANSLATIONAL TERMINATION,0.00020448,0.30227,0.26005,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,1.1267e-06,0.30227,0.39455,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,2.4692e-06,0.30181,0.34719,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.00026003,0.30164,0.27295,1,1
1,GO SELECTIVE AUTOPHAGY,5.753e-07,0.30121,0.31157,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,4.4878e-05,0.30117,0.29564,1,1
1,GO IRON ION HOMEOSTASIS,3.9418e-06,0.30112,0.2716,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,4.8379e-05,0.30087,0.3547,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.4346e-05,0.30077,0.32689,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.00023468,0.3006,0.27651,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,1.5816e-05,0.30054,0.30942,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00065623,0.30023,0.30066,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00040247,0.30018,0.32099,1,1
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0022332,0.30016,0.28472,1,1
1,GO T CELL CYTOKINE PRODUCTION,1.1964e-05,0.29996,0.40171,1,1
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.033166,0.29984,0.18303,1,1
1,GO SPERM EGG RECOGNITION,7.0571e-06,0.29954,0.26285,1,1
1,GO ETHANOL OXIDATION,0.025994,0.2994,0.34528,1,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.024846,0.29933,0.17885,1,1
1,GO COAGULATION,9.3916e-06,0.29928,0.29345,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,7.0571e-06,0.29871,0.33008,1,1
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00031859,0.2987,0.32752,1,1
1,GO FOAM CELL DIFFERENTIATION,0.00021909,0.29858,0.32187,1,1
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00037661,0.29845,0.3388,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,7.9801e-06,0.29839,0.31096,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00044439,0.29837,0.24867,1,1
1,GO ENDOTHELIAL CELL MIGRATION,3.8583e-05,0.29833,0.32035,1,1
1,GO HISTONE PHOSPHORYLATION,7.013e-05,0.29794,0.26461,1,1
1,GO GENITALIA MORPHOGENESIS,0.0051916,0.29794,0.26145,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.6902e-06,0.29785,0.37812,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,9.0179e-06,0.29783,0.28229,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0022332,0.29761,0.28685,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,2.5308e-05,0.29729,0.30696,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.014841,0.29695,0.33142,1,1
1,GO RIBOSOME BIOGENESIS,0.00022676,0.29663,0.30191,1,1
1,GO RESPONSE TO INTERLEUKIN 1,6.2367e-06,0.29659,0.32397,1,1
1,GO RRNA MODIFICATION,0.0064317,0.29658,0.20815,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.0059384,0.2965,0.28176,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,4.3218e-05,0.29604,0.33321,1,1
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0025083,0.29562,0.2379,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.9301e-06,0.2948,0.27844,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,1.349e-05,0.2947,0.2881,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,8.4205e-05,0.29465,0.46101,1,1
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,2.7343e-05,0.29455,0.31929,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,0.00044439,0.2945,0.41243,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,2.1702e-06,0.29382,0.32347,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,9.7346e-05,0.29352,0.30949,1,1
1,GO RNA CATABOLIC PROCESS,1.0604e-05,0.29348,0.25048,1,1
1,GO GLAND MORPHOGENESIS,0.00025131,0.29338,0.34541,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.001872,0.29263,0.22975,1,1
1,GO NUCLEOTIDE SALVAGE,0.0085714,0.29261,0.35796,1,1
1,GO REGULATION OF PROTEIN IMPORT,1.7806e-05,0.29254,0.33553,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,7.0571e-06,0.29254,0.29431,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,5.2139e-05,0.29231,0.25315,1,1
1,GO CYTOKINETIC PROCESS,0.00059588,0.29205,0.24649,1,1
1,GO ACUTE PHASE RESPONSE,0.0081404,0.29174,0.26684,1,1
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,8.4205e-05,0.29144,0.28589,1,1
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0022332,0.29141,0.23291,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0037331,0.2912,0.38334,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0049174,0.29098,0.32068,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.0025083,0.29091,0.26861,1,1
1,GO HYPOTONIC RESPONSE,0.001872,0.29084,0.27435,1,1
1,GO CELLULAR HYPEROSMOTIC RESPONSE,0.00021167,0.29074,0.33648,1,1
1,GO NATURAL KILLER CELL ACTIVATION,3.0689e-05,0.29073,0.29608,1,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.015203,0.29056,0.27687,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00095906,0.29044,0.34307,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,9.0179e-06,0.2904,0.2884,1,1
1,GO MYOBLAST DIFFERENTIATION,2.8418e-05,0.29037,0.29657,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,6.2786e-05,0.29035,0.25548,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.5201e-05,0.29034,0.28593,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,2.0833e-05,0.29014,0.25417,1,1
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.001228,0.29011,0.30343,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,1.2454e-05,0.28985,0.24381,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00014418,0.28974,0.29344,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,6.5149e-05,0.28965,0.42812,1,1
1,GO REGULATION OF CELL AGING,7.9801e-06,0.28901,0.29885,1,1
1,GO TRNA 5 END PROCESSING,0.00019753,0.28894,0.29483,1,1
1,GO FATTY ACID BETA OXIDATION,0.0001547,0.28883,0.26101,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0011199,0.28817,0.28423,1,1
1,GO AMYLOID FIBRIL FORMATION,0.041093,0.28798,0.23184,1,1
1,GO PLASMA MEMBRANE TUBULATION,8.3127e-06,0.28789,0.32541,1,1
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00037661,0.28779,0.28148,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.9263e-05,0.28753,0.28626,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,5.8301e-05,0.2875,0.30316,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00081984,0.28737,0.29265,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0049174,0.28678,0.1505,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0001165,0.28677,0.2568,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0037331,0.28653,0.26852,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00022676,0.28627,0.27082,1,1
1,GO TISSUE REGENERATION,0.00028792,0.286,0.27952,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0075304,0.28584,0.43039,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0001547,0.28566,0.28832,1,1
1,GO TRNA WOBBLE BASE MODIFICATION,0.001228,0.2856,0.20845,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0033369,0.28493,0.20442,1,1
1,GO REGULATION OF RNA BINDING,9.7346e-05,0.28465,0.27196,1,1
1,GO MACROPHAGE APOPTOTIC PROCESS,0.0010206,0.28428,0.36524,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,0.00012512,0.2842,0.23611,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,6.2367e-06,0.28364,0.22215,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.0073e-05,0.28352,0.26008,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0024367,0.28352,0.25791,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00010845,0.28284,0.27477,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,4.6623e-06,0.28283,0.30362,1,1
1,GO MACROPHAGE MIGRATION,7.2754e-05,0.2827,0.31274,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,3.7791e-06,0.28258,0.23106,1,1
1,GO RESPONSE TO REDOX STATE,0.014138,0.28225,0.22447,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,3.7145e-05,0.28186,0.2801,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.0053338,0.28167,0.30166,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00042998,0.28105,0.26236,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.00038934,0.2808,0.21745,1,1
1,GO RESPONSE TO VIRUS,0.00011241,0.28059,0.31142,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.035393,0.28043,0.22074,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,0.0037331,0.28031,0.32364,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00014418,0.2802,0.30751,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00079435,0.28011,0.28781,1,1
1,GO CELL CELL RECOGNITION,2.3654e-06,0.27998,0.27849,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00074557,0.27998,0.2521,1,1
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0039469,0.27995,0.27049,1,1
1,GO CARTILAGE DEVELOPMENT,0.00010462,0.27982,0.26426,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00074557,0.27969,0.24075,1,1
1,GO CERAMIDE TRANSPORT,0.00072223,0.27968,0.28907,1,1
1,GO MACROPHAGE DIFFERENTIATION,0.00042998,0.27938,0.31408,1,1
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0022332,0.27913,0.22429,1,1
1,GO TISSUE REMODELING,0.00027832,0.27882,0.26003,1,1
1,GO RIG I SIGNALING PATHWAY,0.00022676,0.2788,0.32239,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0059384,0.27878,0.20371,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.8251e-06,0.27864,0.27152,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0019282,0.27833,0.23393,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,7.6603e-06,0.27832,0.25706,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.015203,0.27828,0.25675,1,1
1,GO NECROTIC CELL DEATH,0.00032948,0.27799,0.36252,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0040578,0.27774,0.23828,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,8.4205e-05,0.27769,0.2571,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,0.0017123,0.27753,0.27471,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00027832,0.27752,0.33925,1,1
1,GO RESPONSE TO THYROID HORMONE,0.00010092,0.27749,0.33802,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00016595,0.27727,0.27958,1,1
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0013872,0.2772,0.282,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.3528e-06,0.27713,0.27992,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,0.00035231,0.27707,0.31298,1,1
1,GO MUSCLE CELL MIGRATION,0.030383,0.27703,0.20333,1,1
1,GO FATTY ACID HOMEOSTASIS,0.02068,0.27702,0.19798,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0010528,0.2769,0.22858,1,1
1,GO PROTEIN FOLDING,4.6623e-06,0.27687,0.25493,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,6.7596e-05,0.27685,0.27706,1,1
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0029794,0.27677,0.23845,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.1904e-06,0.27661,0.43311,1,1
1,GO ASYMMETRIC CELL DIVISION,0.0006154,0.27633,0.2671,1,1
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,2.2524e-05,0.27631,0.25036,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,8.1192e-05,0.27628,0.25984,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,7.013e-05,0.27611,0.31835,1,1
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0011549,0.27596,0.26297,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00072223,0.27573,0.2931,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0017641,0.27462,0.24484,1,1
1,GO T CELL MIGRATION,0.00013433,0.27459,0.28752,1,1
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.00040247,0.27412,0.28372,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,9.0179e-06,0.27378,0.23665,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.00024286,0.27365,0.25213,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00353,0.27355,0.26567,1,1
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0050528,0.27267,0.27392,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.00057693,0.27264,0.29138,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.1964e-05,0.27254,0.24116,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0022332,0.27247,0.30455,1,1
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.0042883,0.27242,0.24876,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00090094,0.27235,0.33254,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.00065623,0.27225,0.27178,1,1
1,GO REGULATION OF LIGASE ACTIVITY,0.0031536,0.27215,0.24825,1,1
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00023468,0.27167,0.29317,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,4.4878e-05,0.27138,0.24915,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.0010859,0.27069,0.27304,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0025083,0.27045,0.20339,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,0.00027832,0.27043,0.28966,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,1.1493e-05,0.27039,0.24042,1,1
1,GO AUTOPHAGOSOME MATURATION,2.0033e-05,0.27008,0.27774,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,3.1888e-05,0.26991,0.24044,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,3.3287e-06,0.26972,0.35679,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0017123,0.26948,0.22757,1,1
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00010845,0.2694,0.26344,1,1
1,GO REGULATION OF KIDNEY DEVELOPMENT,8.7323e-05,0.2693,0.31086,1,1
1,GO NEURAL CREST CELL MIGRATION,0.024846,0.26889,0.213,1,1
1,GO WOUND HEALING,1.7118e-05,0.26848,0.31277,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.5201e-05,0.26843,0.30732,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0097392,0.26835,0.25864,1,1
1,GO AUTOPHAGY OF NUCLEUS,0.00040247,0.26828,0.25305,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00040247,0.26823,0.22811,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0046564,0.26799,0.21459,1,1
1,GO RESPONSE TO IONIZING RADIATION,3.0689e-05,0.26769,0.21093,1,1
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.00059588,0.26756,0.22398,1,1
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.007729,0.26744,0.20208,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0012662,0.26717,0.31953,1,1
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,9.0551e-05,0.26705,0.2558,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,4.6623e-06,0.26683,0.33035,1,1
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.001191,0.26681,0.22061,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.0059384,0.26669,0.30031,1,1
1,GO RESPONSE TO WOUNDING,2.5308e-05,0.26666,0.26625,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0012662,0.26639,0.25762,1,1
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0042883,0.26596,0.26721,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.033894,0.26595,0.17465,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00059588,0.2659,0.32457,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00010092,0.2657,0.36794,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0012662,0.26553,0.2286,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0011199,0.26549,0.24274,1,1
1,GO KERATINOCYTE MIGRATION,0.0010859,0.26548,0.30483,1,1
1,GO ERK1 AND ERK2 CASCADE,1.6455e-05,0.26541,0.24267,1,1
1,GO CHONDROCYTE DEVELOPMENT,0.0017123,0.26522,0.34044,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00047456,0.26516,0.23725,1,1
1,GO SEQUESTERING OF METAL ION,0.0022992,0.265,0.26248,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,0.0028957,0.26489,0.26142,1,1
1,GO ASTROCYTE DEVELOPMENT,0.00092958,0.26471,0.27358,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,1.104e-05,0.26463,0.27783,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.00035231,0.26455,0.21453,1,1
1,GO TRABECULA FORMATION,0.0051916,0.26432,0.38548,1,1
1,GO TRANSPOSITION,0.033166,0.26424,0.2001,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0013872,0.26397,0.22525,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.001986,0.26389,0.22297,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.00087311,0.26365,0.25668,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00047456,0.2636,0.23742,1,1
1,GO OSTEOBLAST DIFFERENTIATION,4.3218e-05,0.26351,0.27413,1,1
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.050569,0.26345,0.26964,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.00019753,0.2633,0.29087,1,1
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.01282,0.26327,0.24,1,1
1,GO RESPONSE TO DSRNA,4.4712e-06,0.26311,0.35276,1,1
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00038934,0.26306,0.35165,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00018427,0.26292,0.20817,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00040247,0.2628,0.23588,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.00030804,0.26219,0.24028,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,5.2139e-05,0.2621,0.3582,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,2.1702e-06,0.26207,0.26085,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0081404,0.26201,0.33709,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00084609,0.26192,0.27023,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0010859,0.26192,0.20667,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.021165,0.26173,0.2186,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.00059588,0.26168,0.25116,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00098941,0.2616,0.2968,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.4044e-06,0.26143,0.32046,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,2.3418e-05,0.26141,0.30087,1,1
1,GO MONOCYTE CHEMOTAXIS,0.00092958,0.2614,0.30752,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,5.4121e-05,0.261,0.21045,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,2.0033e-05,0.26079,0.25306,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.042857,0.26057,0.16455,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,3.9418e-06,0.26056,0.30914,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,5.8301e-05,0.26053,0.29154,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,3.3287e-06,0.26052,0.21318,1,1
1,GO TRANSEPITHELIAL TRANSPORT,0.00026903,0.26035,0.29849,1,1
1,GO REGULATION OF GENE SILENCING,4.8612e-06,0.25966,0.23508,1,1
1,GO RNA DESTABILIZATION,2.9532e-05,0.25959,0.2442,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00084609,0.25947,0.2843,1,1
1,GO TRANSLATIONAL ELONGATION,0.00023468,0.25944,0.22865,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.00026903,0.2593,0.27559,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.0013457,0.25898,0.21123,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,7.8282e-05,0.25867,0.27227,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.0604e-05,0.25854,0.26951,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,4.3218e-05,0.25835,0.24482,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00049035,0.25819,0.23027,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,0.00059588,0.25753,0.28494,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00069957,0.25728,0.24972,1,1
1,GO CELL MATRIX ADHESION,6.2786e-05,0.25728,0.30955,1,1
1,GO COPPER ION TRANSPORT,0.00012964,0.25727,0.26811,1,1
1,GO HYPEROSMOTIC RESPONSE,0.00063551,0.25712,0.24306,1,1
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00012964,0.25682,0.28251,1,1
1,GO VIRAL RELEASE FROM HOST CELL,0.0011199,0.25661,0.23054,1,1
1,GO PEROXISOMAL TRANSPORT,0.0010859,0.25657,0.20495,1,1
1,GO DE NOVO PROTEIN FOLDING,0.00040247,0.25653,0.20866,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00020448,0.25642,0.25059,1,1
1,GO CHONDROCYTE PROLIFERATION,0.0083534,0.25635,0.33533,1,1
1,GO PROTEIN DENEDDYLATION,0.00037661,0.25587,0.21676,1,1
1,GO PEPTIDE METABOLIC PROCESS,3.7791e-06,0.25568,0.22655,1,1
1,GO ALDITOL METABOLIC PROCESS,0.0006154,0.25555,0.22148,1,1
1,GO REGULATION OF VASOCONSTRICTION,8.1192e-05,0.25539,0.26592,1,1
1,GO P38MAPK CASCADE,5.0226e-05,0.25495,0.32666,1,1
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.014841,0.25492,0.22429,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.001986,0.25489,0.23494,1,1
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.024846,0.25432,0.2084,1,1
1,GO PROTEIN KINASE B SIGNALING,2.7343e-05,0.25431,0.21321,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,3.8583e-05,0.25405,0.24707,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0006154,0.25399,0.29968,1,1
1,GO REGULATION OF MACROPHAGE ACTIVATION,0.0022332,0.25386,0.21283,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.001662,0.25378,0.30928,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,5.508e-06,0.25366,0.23089,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,7.547e-05,0.25329,0.23484,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.0051916,0.25309,0.15727,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,9.7346e-05,0.25285,0.24654,1,1
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0013872,0.25269,0.28184,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0012662,0.25267,0.2615,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,4.3218e-05,0.25241,0.29873,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,2.4346e-05,0.25239,0.36995,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.001228,0.2522,0.21407,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0017123,0.25203,0.25859,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,3.7145e-05,0.25203,0.28064,1,1
1,GO REGULATION OF HEART GROWTH,0.00012512,0.25195,0.253,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,5.4121e-05,0.25174,0.27464,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,7.547e-05,0.25155,0.27506,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,2.9532e-05,0.25146,0.20936,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,7.547e-05,0.25138,0.31439,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0015653,0.25053,0.22678,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00031859,0.25006,0.26585,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0069616,0.24987,0.1668,1,1
1,GO FIBROBLAST ACTIVATION,0.0017123,0.24974,0.31119,1,1
1,GO INNATE IMMUNE RESPONSE,7.8282e-05,0.24955,0.24117,1,1
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0024367,0.24951,0.25624,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,9.0179e-06,0.24942,0.20866,1,1
1,GO LYMPHOCYTE MIGRATION,0.00044439,0.24937,0.20977,1,1
1,GO CARDIOLIPIN METABOLIC PROCESS,0.0066042,0.24934,0.18346,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,2.7343e-05,0.24926,0.27419,1,1
1,GO SYMBIOTIC PROCESS,2.1702e-06,0.24921,0.25465,1,1
1,GO REGULATION OF ORGAN GROWTH,1.7474e-06,0.24884,0.2961,1,1
1,GO DETECTION OF OTHER ORGANISM,0.014138,0.24871,0.25884,1,1
1,GO LIPID IMPORT INTO CELL,0.010506,0.24871,0.21907,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,8.1192e-05,0.24866,0.18607,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.1112e-06,0.24865,0.27965,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0001165,0.24857,0.22413,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,1.9904e-06,0.2484,0.24239,1,1
1,GO AMINO SUGAR CATABOLIC PROCESS,0.00013917,0.24825,0.29861,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,8.6584e-06,0.24795,0.24763,1,1
1,GO TOXIN TRANSPORT,0.00353,0.24783,0.16488,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,1.2454e-05,0.24769,0.22989,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,7.6603e-06,0.2467,0.33632,1,1
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0075304,0.24667,0.24946,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.033166,0.24652,0.307,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00029782,0.24651,0.29361,1,1
1,GO UV PROTECTION,0.035393,0.24647,0.21394,1,1
1,GO RESPONSE TO CYTOKINE,3.4421e-05,0.24614,0.27416,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,3.7145e-05,0.24599,0.25647,1,1
1,GO MITOCHONDRIAL DNA REPLICATION,0.00095906,0.24564,0.18294,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.0022332,0.24528,0.22393,1,1
1,GO PHAGOCYTOSIS,3.7791e-06,0.2452,0.30331,1,1
1,GO LUNG MORPHOGENESIS,0.0087944,0.24487,0.18886,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,7.0571e-06,0.24477,0.2447,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,4.3218e-05,0.24469,0.25139,1,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.029068,0.24469,0.12373,1,1
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00059588,0.2446,0.18566,1,1
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.037747,0.24452,0.15409,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,2.0033e-05,0.24432,0.23734,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00074557,0.244,0.22176,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,0.00063551,0.24394,0.21521,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0010859,0.24364,0.25578,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,7.013e-05,0.24311,0.20688,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0025083,0.24281,0.36934,1,1
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.033894,0.24259,0.35673,1,1
1,GO REGULATION OF MITOPHAGY,0.015203,0.24256,0.19602,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0060989,0.24249,0.24991,1,1
1,GO SEQUESTERING OF TRIGLYCERIDE,0.0057817,0.24247,0.31467,1,1
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0030654,0.2422,0.216,1,1
1,GO LIPID STORAGE,0.00032948,0.24203,0.24591,1,1
1,GO REGULATION OF CALCIUM ION IMPORT,0.0038387,0.24167,0.18055,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.9532e-05,0.24101,0.27936,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00026903,0.2409,0.20714,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0050528,0.24076,0.20615,1,1
1,GO RESPONSE TO TESTOSTERONE,0.00038934,0.24076,0.23237,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.00042998,0.2407,0.2695,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,4.6597e-05,0.24051,0.19471,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00021167,0.24023,0.22143,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00031859,0.24011,0.32537,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,3.8583e-05,0.24009,0.25335,1,1
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0006154,0.24005,0.20228,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,9.7801e-06,0.24005,0.2344,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,1.0311e-06,0.23991,0.25795,1,1
1,GO CELLULAR RESPONSE TO VIRUS,0.0049174,0.23945,0.20956,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,9.0551e-05,0.23943,0.21103,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.0015189,0.23939,0.17646,1,1
1,GO RESPONSE TO OSMOTIC STRESS,0.00019079,0.23932,0.20562,1,1
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.0087944,0.23915,0.28976,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.0010528,0.23891,0.24992,1,1
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.013465,0.23889,0.251,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,2.9532e-05,0.23874,0.36917,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0097392,0.23864,0.20217,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,3.1888e-05,0.23845,0.29123,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.02068,0.23809,0.23026,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0010528,0.23799,0.25792,1,1
1,GO REGULATION OF TOLERANCE INDUCTION,0.0087944,0.23785,0.27543,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,0.00010092,0.23777,0.27645,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,4.3218e-05,0.2376,0.22836,1,1
1,GO GONADOTROPIN SECRETION,0.033894,0.23735,0.21726,1,1
1,GO PLATELET ACTIVATION,0.00084609,0.23675,0.21716,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00052342,0.23659,0.30264,1,1
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.001872,0.23651,0.26648,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00021167,0.23563,0.22252,1,1
1,GO MACROPHAGE CHEMOTAXIS,0.00010462,0.2356,0.31174,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.0033e-05,0.23525,0.28973,1,1
1,GO DNA LIGATION,0.0011199,0.23519,0.24137,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,2.4346e-05,0.23499,0.27588,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.001662,0.23439,0.1937,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.0056288,0.2343,0.18511,1,1
1,GO PROTEIN TARGETING,2.8418e-05,0.2342,0.20124,1,1
1,GO TRNA PROCESSING,0.00098941,0.23411,0.1781,1,1
1,GO PEPTIDYL ARGININE N METHYLATION,0.033166,0.23352,0.15885,1,1
1,GO MESODERM DEVELOPMENT,0.00037661,0.23329,0.17728,1,1
1,GO SULFUR COMPOUND TRANSPORT,4.4712e-06,0.23329,0.26602,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00028792,0.23319,0.28166,1,1
1,GO RESPONSE TO PH,0.00041602,0.23317,0.26305,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,1.7474e-06,0.23313,0.26392,1,1
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0036303,0.23311,0.17998,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,4.1112e-06,0.2331,0.26075,1,1
1,GO MEMBRANE BIOGENESIS,0.035393,0.23287,0.1775,1,1
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00052342,0.23282,0.21221,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,7.2754e-05,0.23272,0.23448,1,1
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.031748,0.23255,0.18525,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00030804,0.23253,0.30301,1,1
1,GO INTERLEUKIN 4 PRODUCTION,0.0034322,0.23194,0.18264,1,1
1,GO CRISTAE FORMATION,0.012203,0.23155,0.20042,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0019282,0.23144,0.21763,1,1
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.017969,0.23124,0.16584,1,1
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0025083,0.2312,0.18091,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,0.026586,0.23105,0.16121,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,4.4878e-05,0.23071,0.28204,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.00084609,0.2307,0.33682,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,1.5816e-05,0.23069,0.22498,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.023205,0.23068,0.1924,1,1
1,GO MITOPHAGY,5.8301e-05,0.2301,0.25019,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.029719,0.22985,0.3475,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0019282,0.22952,0.2642,1,1
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.027803,0.2295,0.17556,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,8.1192e-05,0.22948,0.22999,1,1
1,GO RRNA METHYLATION,0.014486,0.22941,0.17624,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,3.3287e-06,0.22929,0.23198,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.00079435,0.22915,0.17578,1,1
1,GO PODOSOME ASSEMBLY,0.0011199,0.22897,0.30391,1,1
1,GO PEROXISOME ORGANIZATION,0.00065623,0.22882,0.19624,1,1
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.017137,0.22833,0.34774,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,3.5759e-05,0.22807,0.23393,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00020448,0.22771,0.19873,1,1
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00074557,0.2277,0.24524,1,1
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.0029794,0.22763,0.23455,1,1
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00014935,0.22762,0.24166,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0085714,0.22756,0.2165,1,1
1,GO MYOBLAST FUSION,0.00092958,0.22732,0.29882,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.0001547,0.22729,0.32015,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0066042,0.22693,0.17165,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00072223,0.22633,0.20584,1,1
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.023741,0.22623,0.1912,1,1
1,GO SUPEROXIDE ANION GENERATION,0.0028957,0.22601,0.25458,1,1
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,8.4205e-05,0.22582,0.21601,1,1
1,GO RNA 3 END PROCESSING,0.0029794,0.22577,0.17401,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.00353,0.22558,0.17691,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,4.3218e-05,0.22528,0.21702,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.00012512,0.22483,0.22143,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0007696,0.22451,0.29784,1,1
1,GO BONE MORPHOGENESIS,0.00067758,0.22448,0.23455,1,1
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.00021167,0.2244,0.21491,1,1
1,GO VIRION ASSEMBLY,0.0031536,0.22433,0.15878,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.8521e-05,0.22396,0.33896,1,1
1,GO RESPONSE TO RETINOIC ACID,0.00026003,0.22393,0.2271,1,1
1,GO T CELL CHEMOTAXIS,0.00010092,0.22383,0.24521,1,1
1,GO RESPONSE TO BACTERIUM,3.5759e-05,0.22374,0.25043,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00014418,0.22367,0.24554,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,0.0014299,0.22224,0.23157,1,1
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.010506,0.22222,0.17829,1,1
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,5.6174e-05,0.22182,0.20397,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.017969,0.22171,0.15606,1,1
1,GO OSTEOCLAST DIFFERENTIATION,0.00050664,0.22122,0.18974,1,1
1,GO TISSUE MIGRATION,0.00012964,0.22101,0.27629,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.00074557,0.22086,0.2022,1,1
1,GO INTEGRIN ACTIVATION,0.0087944,0.22079,0.19335,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,1.8521e-05,0.22065,0.27193,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.0007696,0.22058,0.18725,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0011549,0.22031,0.37458,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0057817,0.22008,0.19272,1,1
1,GO IMMUNE EFFECTOR PROCESS,2.7343e-05,0.21949,0.25781,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00034072,0.21924,0.21958,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.349e-05,0.21904,0.23556,1,1
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0071468,0.21884,0.15974,1,1
1,GO FATTY ACID CATABOLIC PROCESS,0.001228,0.21844,0.18741,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.014841,0.21837,0.26201,1,1
1,GO REGULATION OF VASCULOGENESIS,0.025994,0.2178,0.27389,1,1
1,GO DNA DEALKYLATION,0.010506,0.21762,0.18777,1,1
1,GO RESPONSE TO INTERLEUKIN 15,0.00079435,0.21761,0.32068,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,9.0551e-05,0.2176,0.18842,1,1
1,GO TRNA METABOLIC PROCESS,0.0022332,0.21758,0.16383,1,1
1,GO METANEPHROS DEVELOPMENT,0.0071468,0.21727,0.16327,1,1
1,GO URETER DEVELOPMENT,0.019283,0.21691,0.2134,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.0689e-05,0.2169,0.24889,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.0056288,0.21662,0.26556,1,1
1,GO RNA MODIFICATION,0.00019753,0.21654,0.1872,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0056288,0.21653,0.1954,1,1
1,GO REGULATION OF URINE VOLUME,0.00026003,0.21647,0.24333,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,7.547e-05,0.21637,0.2547,1,1
1,GO REGULATION OF WOUND HEALING,0.00065623,0.2163,0.27508,1,1
1,GO CHEMOKINE PRODUCTION,0.007729,0.21626,0.21076,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.00067758,0.21617,0.17887,1,1
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.030383,0.21604,0.17602,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00030804,0.216,0.18635,1,1
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.0097392,0.21594,0.14677,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.009256,0.21593,0.21181,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.6597e-05,0.21583,0.21554,1,1
1,GO INTERFERON ALPHA PRODUCTION,0.010773,0.2155,0.18745,1,1
1,GO POSITIVE REGULATION OF HEMOPOIESIS,0.0014299,0.21518,0.18012,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0025817,0.21477,0.20658,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.001191,0.21465,0.2486,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,4.6597e-05,0.21463,0.18851,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.00052342,0.21436,0.21518,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0026572,0.21412,0.21996,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0017641,0.21411,0.26717,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00038934,0.21398,0.1916,1,1
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.00044439,0.21394,0.24524,1,1
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.011612,0.21359,0.19559,1,1
1,GO COPII COATED VESICLE CARGO LOADING,0.00057693,0.21325,0.23537,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,7.5427e-07,0.21325,0.2127,1,1
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0021062,0.21323,0.18102,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,3.7145e-05,0.21259,0.26038,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,8.7323e-05,0.21252,0.23964,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00041602,0.21162,0.27415,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.00057693,0.21094,0.21144,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0006154,0.2109,0.21137,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,4.3218e-05,0.21076,0.19207,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0042883,0.21057,0.20764,1,1
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.001872,0.21035,0.23326,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0025083,0.21008,0.2039,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,2.1663e-05,0.21005,0.23867,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00025131,0.21005,0.20279,1,1
1,GO HEAD MORPHOGENESIS,0.0016129,0.21003,0.23744,1,1
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0028957,0.2098,0.19104,1,1
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0066042,0.20969,0.15718,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,0.00024286,0.20959,0.19367,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00063551,0.20948,0.19846,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,6.7596e-05,0.20944,0.19811,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.015203,0.20934,0.20268,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0030654,0.20929,0.17862,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0028141,0.20909,0.2525,1,1
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.029068,0.20847,0.22748,1,1
1,GO PHOSPHOLIPID CATABOLIC PROCESS,0.014841,0.20819,0.15681,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0099891,0.20806,0.1628,1,1
1,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0081404,0.20762,0.22912,1,1
1,GO REGULATION OF CELLULAR RESPIRATION,0.04854,0.20735,0.13198,1,1
1,GO RESPONSE TO KETONE,0.0037331,0.2073,0.15105,1,1
1,GO CELLULAR DEFENSE RESPONSE,0.0056288,0.20728,0.25872,1,1
1,GO REGULATION OF LIPID STORAGE,0.00090094,0.20727,0.23765,1,1
1,GO BLASTOCYST GROWTH,0.001662,0.20725,0.23881,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.00034072,0.20696,0.18331,1,1
1,GO CYTOKINE PRODUCTION,6.7596e-05,0.20687,0.24059,1,1
1,GO PLATELET MORPHOGENESIS,0.0027346,0.2068,0.18649,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.050569,0.20646,0.13341,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,7.547e-05,0.20632,0.19292,1,1
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00063551,0.20625,0.22606,1,1
1,GO TOOTH MINERALIZATION,0.044685,0.2058,0.20521,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0015653,0.2057,0.19745,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,4.8379e-05,0.20569,0.22161,1,1
1,GO COENZYME A METABOLIC PROCESS,0.0056288,0.20558,0.18203,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00072223,0.20538,0.18739,1,1
1,GO RETINOL METABOLIC PROCESS,0.0025083,0.20526,0.26604,1,1
1,GO CELLULAR RESPONSE TO ATP,6.2786e-05,0.2048,0.22956,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,3.1904e-06,0.20451,0.19158,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.00045924,0.20436,0.16143,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,5.4121e-05,0.20401,0.26813,1,1
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.015203,0.20391,0.14333,1,1
1,GO PROSTATE GLAND DEVELOPMENT,0.0047853,0.20338,0.26387,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0053338,0.20333,0.21691,1,1
1,GO REGULATION OF BODY FLUID LEVELS,0.00027832,0.20285,0.19223,1,1
1,GO NEUROINFLAMMATORY RESPONSE,0.0039469,0.20285,0.23706,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,1.0184e-05,0.2026,0.18584,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00016595,0.20259,0.22825,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0050528,0.20253,0.1806,1,1
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0056288,0.20239,0.26155,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0046564,0.2023,0.21458,1,1
1,GO REGULATION OF PROTEOLYSIS,4.4878e-05,0.20227,0.18819,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.0064317,0.20192,0.25524,1,1
1,GO RESPONSE TO VITAMIN A,0.029068,0.2018,0.20832,1,1
1,GO MYELOID CELL HOMEOSTASIS,5.8301e-05,0.2016,0.19613,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00041602,0.20144,0.23486,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,1.7118e-05,0.20137,0.20491,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00353,0.20123,0.22492,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,7.5427e-07,0.20121,0.16593,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE,0.0015189,0.20117,0.18085,1,1
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0029794,0.20055,0.15339,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00038934,0.20037,0.21244,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.00054072,0.20027,0.21725,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.9904e-06,0.20027,0.18311,1,1
1,GO HOMOTYPIC CELL CELL ADHESION,0.0033369,0.20026,0.22317,1,1
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,5.6174e-05,0.20019,0.23506,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00044439,0.19975,0.21679,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.00072223,0.19966,0.19195,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,0.00010845,0.19958,0.26307,1,1
1,GO PROTEIN REFOLDING,0.033166,0.19938,0.16315,1,1
1,GO NUCLEAR EXPORT,2.5308e-05,0.19868,0.17592,1,1
1,GO RESPONSE TO INTERLEUKIN 7,0.049546,0.19839,0.1668,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.011326,0.19838,0.18058,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,4.4878e-05,0.19829,0.22937,1,1
1,GO REGULATION OF BONE DEVELOPMENT,0.00084609,0.19824,0.25885,1,1
1,GO PROTEIN N LINKED GLYCOSYLATION,0.00050664,0.19783,0.17903,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.011904,0.19754,0.14355,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.013465,0.19748,0.18192,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0027346,0.19748,0.20325,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.001191,0.19739,0.17131,1,1
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0060989,0.19738,0.22686,1,1
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00026903,0.19711,0.22214,1,1
1,GO CELL AGING,6.5149e-05,0.19708,0.19676,1,1
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.031059,0.19694,0.099016,1,1
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.043763,0.1968,0.22342,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0066042,0.19663,0.30776,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00017186,0.19663,0.24126,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,2.9532e-05,0.19651,0.20253,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.041093,0.19618,0.19627,1,1
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.001191,0.19604,0.21682,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.011612,0.19602,0.27393,1,1
1,GO INTERFERON GAMMA PRODUCTION,0.00029782,0.196,0.24369,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.004408,0.19587,0.19322,1,1
1,GO SUPEROXIDE METABOLIC PROCESS,0.01282,0.19586,0.13807,1,1
1,GO VESICLE TARGETING,0.00019753,0.19585,0.21512,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.050569,0.19568,0.13477,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0015189,0.19561,0.17211,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.00040247,0.1955,0.18762,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0013054,0.1954,0.20548,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.024288,0.19506,0.16905,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00036427,0.19487,0.2301,1,1
1,GO GRANULOCYTE MIGRATION,0.00034072,0.19483,0.2609,1,1
1,GO REGULATION OF RESPONSE TO WOUNDING,0.00090094,0.1948,0.22922,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.02166,0.19479,0.26578,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.050569,0.19444,0.17051,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.004408,0.1944,0.22723,1,1
1,GO OXALATE TRANSPORT,0.0024367,0.19428,0.17281,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0015653,0.19376,0.20578,1,1
1,GO REGULATION OF HEMOPOIESIS,0.00017796,0.19367,0.17188,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.0029794,0.19352,0.17088,1,1
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00054072,0.19346,0.1934,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.033166,0.19313,0.13798,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0037331,0.19292,0.17585,1,1
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.015203,0.19275,0.1257,1,1
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00095906,0.19266,0.17756,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,2.0784e-06,0.19244,0.18052,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.025414,0.19226,0.12251,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0028957,0.19214,0.20358,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0046564,0.19172,0.2187,1,1
1,GO NATURAL KILLER CELL PROLIFERATION,0.0083534,0.19166,0.32409,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,0.00012074,0.19156,0.19386,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.017969,0.19106,0.13369,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.0015653,0.19097,0.15238,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.00021167,0.19085,0.18422,1,1
1,GO BODY FLUID SECRETION,0.00030804,0.1905,0.20494,1,1
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.02068,0.1905,0.14566,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,0.0013872,0.19043,0.20103,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0054795,0.19035,0.23448,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,2.2524e-05,0.19027,0.19624,1,1
1,GO SECRETION BY TISSUE,0.025994,0.18996,0.16438,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,1.9904e-06,0.18985,0.1755,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0017641,0.18973,0.19389,1,1
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.00036427,0.18966,0.14411,1,1
1,GO INFLAMMATORY RESPONSE,0.00013433,0.18964,0.23165,1,1
1,GO BONE REMODELING,0.001228,0.18964,0.1998,1,1
1,GO MITOTIC CYTOKINESIS,0.015203,0.18938,0.14429,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0022992,0.18912,0.2938,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00041602,0.1887,0.23182,1,1
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00042998,0.18864,0.15948,1,1
1,GO BODY MORPHOGENESIS,0.0069616,0.18856,0.16146,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.011612,0.18844,0.17893,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.0025083,0.18839,0.14197,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.00020448,0.1883,0.19676,1,1
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0047853,0.18812,0.22023,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,5.2139e-05,0.1879,0.1827,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,4.5813e-07,0.18718,0.1775,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.017969,0.18713,0.16553,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,3.3132e-05,0.18678,0.21959,1,1
1,GO CARNITINE SHUTTLE,0.053746,0.18677,0.15195,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,6.4994e-06,0.18634,0.22356,1,1
1,GO PROTEIN DEMANNOSYLATION,0.0083534,0.18607,0.23504,1,1
1,GO CELLULAR LIPID CATABOLIC PROCESS,0.0013872,0.18605,0.14893,1,1
1,GO ENDOTHELIAL CELL PROLIFERATION,0.0010859,0.18591,0.18684,1,1
1,GO DEFENSE RESPONSE,0.0001547,0.1859,0.20176,1,1
1,GO DRUG METABOLIC PROCESS,0.0032441,0.18571,0.15716,1,1
1,GO CELLULAR RESPONSE TO LIPID,0.00020448,0.18567,0.18437,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,5.0226e-05,0.18534,0.19726,1,1
1,GO ISOPRENOID METABOLIC PROCESS,0.018398,0.1848,0.14923,1,1
1,GO POSITIVE REGULATION OF CELL AGING,0.0071468,0.18468,0.27192,1,1
1,GO CELLULAR RESPONSE TO PH,0.02268,0.18423,0.13389,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00016595,0.18421,0.17208,1,1
1,GO FACE DEVELOPMENT,0.00054072,0.18399,0.22677,1,1
1,GO TUBE MORPHOGENESIS,0.00042998,0.18388,0.18362,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.009256,0.18374,0.13591,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.00013433,0.18355,0.19307,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,4.5813e-07,0.18352,0.17865,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0090226,0.18339,0.21099,1,1
1,GO STEROL HOMEOSTASIS,0.02268,0.18324,0.12976,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00032948,0.18319,0.15661,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.004408,0.18319,0.18307,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,0.00010845,0.18318,0.15641,1,1
1,GO REGULATION OF T CELL CHEMOTAXIS,0.027188,0.18316,0.14589,1,1
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.034637,0.18268,0.12608,1,1
1,GO PEPTIDYL ARGININE METHYLATION,0.010773,0.18262,0.14353,1,1
1,GO MESENCHYME DEVELOPMENT,0.0022992,0.18252,0.18625,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.00092958,0.18244,0.27006,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,5.9841e-06,0.18241,0.20403,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.0013872,0.18194,0.16516,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.00012964,0.18187,0.17916,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00059588,0.18182,0.23001,1,1
1,GO FLUID TRANSPORT,0.00087311,0.18171,0.18846,1,1
1,GO OVULATION,0.033894,0.18151,0.2627,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.0018173,0.18071,0.14682,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,0.00069957,0.18018,0.23089,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,2.6902e-06,0.18013,0.18546,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.0041716,0.18,0.1462,1,1
1,GO STRESS FIBER ASSEMBLY,0.0024367,0.17983,0.19675,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0025083,0.17982,0.20421,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0029794,0.17969,0.14267,1,1
1,GO T CELL PROLIFERATION,0.0018173,0.17934,0.17807,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.00011241,0.1793,0.19226,1,1
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.033166,0.17914,0.19029,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.00084609,0.17888,0.16935,1,1
1,GO PROTEIN KINASE A SIGNALING,0.0001547,0.17858,0.21538,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,0.0018173,0.17844,0.35723,1,1
1,GO DIOL BIOSYNTHETIC PROCESS,0.011612,0.1778,0.13423,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00024286,0.17718,0.23667,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00016023,0.1768,0.2551,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,1.8521e-05,0.17676,0.19562,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00014935,0.17673,0.20373,1,1
1,GO RESPONSE TO STEROID HORMONE,0.00092958,0.17672,0.16669,1,1
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.0059384,0.17666,0.17945,1,1
1,GO LEUKOCYTE PROLIFERATION,0.0045306,0.17649,0.15313,1,1
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00054072,0.1761,0.23454,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.004408,0.17602,0.13656,1,1
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.041967,0.17592,0.20342,1,1
1,GO T CELL DIFFERENTIATION IN THYMUS,0.00012512,0.17575,0.18015,1,1
1,GO CELL ACTIVATION,5.8301e-05,0.17569,0.21438,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.00026003,0.17564,0.14802,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00014935,0.17562,0.18547,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.00095906,0.17561,0.19831,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0028957,0.1756,0.13733,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00040247,0.17514,0.18312,1,1
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.027803,0.17493,0.20602,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,7.9801e-06,0.17487,0.16646,1,1
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0056288,0.17479,0.1412,1,1
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.015953,0.17475,0.14728,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.036948,0.17454,0.14395,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.0029794,0.17445,0.16573,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0013054,0.17419,0.17739,1,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0047853,0.17402,0.14301,1,1
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.052669,0.17397,0.15423,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.0079323,0.17384,0.14892,1,1
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.02268,0.17357,0.12989,1,1
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.00063551,0.17353,0.15789,1,1
1,GO HISTONE H2B UBIQUITINATION,0.047551,0.17351,0.11235,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,4.3218e-05,0.17328,0.16006,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0045306,0.17324,0.14326,1,1
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00019753,0.17295,0.19293,1,1
1,GO AGING,0.0001165,0.17285,0.17198,1,1
1,GO PEPTIDYL ARGININE MODIFICATION,0.0027346,0.17279,0.13282,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,1.0311e-06,0.17273,0.16812,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0038387,0.17268,0.19195,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00031859,0.17247,0.17471,1,1
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00063551,0.17242,0.16713,1,1
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0015653,0.17233,0.17409,1,1
1,GO RESPONSE TO CHEMOKINE,0.010506,0.17226,0.1937,1,1
1,GO DEFENSE RESPONSE TO BACTERIUM,0.004408,0.17219,0.15038,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0053338,0.17213,0.14796,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.012203,0.17202,0.12345,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,6.0504e-05,0.17194,0.18266,1,1
1,GO LYSOSOMAL TRANSPORT,0.00016023,0.17172,0.17593,1,1
1,GO GRANULOCYTE CHEMOTAXIS,0.0066042,0.1716,0.22069,1,1
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.033166,0.17153,0.11873,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00041602,0.1715,0.23614,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.035393,0.17149,0.17172,1,1
1,GO GOLGI VESICLE TRANSPORT,1.7118e-05,0.17119,0.16327,1,1
1,GO REGULATION OF CELL ACTIVATION,0.00049035,0.17119,0.16844,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00090094,0.17104,0.14414,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,0.00026903,0.17057,0.18771,1,1
1,GO VACUOLAR TRANSPORT,0.00050664,0.17011,0.14489,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0036303,0.17001,0.15965,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00055855,0.16996,0.18211,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,0.00025131,0.16984,0.15981,1,1
1,GO REGULATION OF IMMUNE RESPONSE,9.389e-05,0.16961,0.19226,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,1.9263e-05,0.16941,0.17695,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0031536,0.16934,0.16578,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,0.00041602,0.16914,0.18842,1,1
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.041967,0.1691,0.16031,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.004408,0.16855,0.16765,1,1
1,GO NEURAL TUBE PATTERNING,0.029068,0.16812,0.14849,1,1
1,GO AEROBIC RESPIRATION,0.025994,0.1676,0.10393,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,5.0683e-06,0.16748,0.15451,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.011612,0.16736,0.25925,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.014841,0.16732,0.17006,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00059588,0.16683,0.16525,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0069616,0.16679,0.13913,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.036948,0.16664,0.16179,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.053746,0.1665,0.20365,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00031859,0.16619,0.21434,1,1
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.017137,0.16616,0.17919,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.026586,0.16599,0.18423,1,1
1,GO ASTROCYTE DIFFERENTIATION,0.019739,0.16589,0.14262,1,1
1,GO OSSIFICATION,0.0013872,0.16572,0.18465,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0047853,0.16556,0.12184,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,7.889e-07,0.16539,0.18005,1,1
1,GO SPINDLE LOCALIZATION,0.00034072,0.16534,0.16821,1,1
1,GO SMOOTHENED SIGNALING PATHWAY,0.0040578,0.16529,0.13787,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0019282,0.16525,0.16262,1,1
1,GO RNA CAPPING,0.00028792,0.16511,0.16155,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0053338,0.16487,0.17361,1,1
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.004408,0.16483,0.14411,1,1
1,GO FATTY ACID METABOLIC PROCESS,0.0013457,0.16474,0.13468,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0017641,0.16429,0.12938,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.0019282,0.16417,0.1501,1,1
1,GO REGULATION OF RESPONSE TO STRESS,8.4205e-05,0.16413,0.14832,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.014138,0.16405,0.13503,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0015653,0.1638,0.14961,1,1
1,GO VACUOLE ORGANIZATION,8.1192e-05,0.16375,0.15449,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,7.547e-05,0.16367,0.15474,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,5.7413e-06,0.16349,0.24456,1,1
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00067758,0.16347,0.20729,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.017549,0.16333,0.17875,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00019753,0.16327,0.18155,1,1
1,GO RNA DECAPPING,0.00079435,0.16313,0.16857,1,1
1,GO INTERMEMBRANE LIPID TRANSFER,0.0028141,0.16311,0.17001,1,1
1,GO REGULATION OF ERAD PATHWAY,5.508e-06,0.16299,0.19997,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,0.00019079,0.16282,0.17744,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,7.2111e-07,0.16273,0.16007,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.00017186,0.16272,0.23239,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0033369,0.16251,0.17216,1,1
1,GO SULFATE TRANSPORT,3.1888e-05,0.16227,0.18152,1,1
1,GO ORGANELLE INHERITANCE,0.0027346,0.16215,0.16437,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.001191,0.16207,0.14492,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.0017123,0.16205,0.21821,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,0.0006154,0.16192,0.19177,1,1
1,GO MYELOID CELL DIFFERENTIATION,0.00016023,0.16177,0.15119,1,1
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0036303,0.16174,0.11042,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.026586,0.16173,0.1307,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,2.4346e-05,0.16168,0.1835,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.0017123,0.16122,0.20934,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.00034072,0.16094,0.1535,1,1
1,GO GLOMERULUS DEVELOPMENT,0.00095906,0.16071,0.30176,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00353,0.1607,0.12855,1,1
1,GO TRANSLESION SYNTHESIS,0.023741,0.16065,0.11507,1,1
1,GO MUSCLE ADAPTATION,0.015953,0.1606,0.11035,1,1
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.010506,0.16022,0.13772,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0050528,0.16009,0.22129,1,1
1,GO T CELL ACTIVATION,0.00074557,0.15913,0.17288,1,1
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.00026903,0.159,0.1453,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0021689,0.1587,0.28981,1,1
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0067808,0.15855,0.17187,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0010206,0.15852,0.17217,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,7.889e-07,0.15824,0.17142,1,1
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00098941,0.15804,0.1463,1,1
1,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00023468,0.15773,0.27416,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0016129,0.15767,0.19632,1,1
1,GO PROTEIN POLYUBIQUITINATION,0.00059588,0.15752,0.11977,1,1
1,GO ORGANIC ACID METABOLIC PROCESS,0.00021167,0.15735,0.13349,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.014841,0.1573,0.13989,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0056288,0.15718,0.15719,1,1
1,GO LIPID CATABOLIC PROCESS,0.0017123,0.15687,0.12025,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00025131,0.15682,0.15007,1,1
1,GO ERBB SIGNALING PATHWAY,0.00095906,0.1568,0.20645,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0010206,0.15661,0.20956,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,0.0017641,0.15647,0.18786,1,1
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00044439,0.15647,0.1907,1,1
1,GO LYMPHOCYTE ACTIVATION,0.00041602,0.15622,0.16288,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.014486,0.15558,0.11678,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.012508,0.15539,0.16851,1,1
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.015574,0.15529,0.16438,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.00020448,0.15474,0.1697,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0023671,0.15449,0.20261,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.05161,0.15441,0.15714,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.024846,0.15429,0.1288,1,1
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.031748,0.15415,0.20239,1,1
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0064317,0.15401,0.15353,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.029719,0.15399,0.13957,1,1
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.013798,0.15383,0.18928,1,1
1,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0021062,0.1537,0.15512,1,1
1,GO PROTEIN IMPORT,0.00017796,0.15338,0.14214,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.033894,0.1531,0.11471,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,9.4334e-07,0.15283,0.16324,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,4.6597e-05,0.15261,0.16028,1,1
1,GO TELOMERE ORGANIZATION,0.0030654,0.15251,0.10648,1,1
1,GO MAINTENANCE OF LOCATION,5.8301e-05,0.15245,0.16646,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.0064317,0.15232,0.15718,1,1
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.017969,0.15217,0.18717,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0021062,0.15197,0.14681,1,1
1,GO PROTEIN STABILIZATION,0.00012512,0.15163,0.14007,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.040234,0.15162,0.10915,1,1
1,GO REGULATION OF DEFENSE RESPONSE,0.00040247,0.15087,0.17696,1,1
1,GO HEART GROWTH,0.0071468,0.15054,0.15243,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00036427,0.15054,0.13107,1,1
1,GO HUMORAL IMMUNE RESPONSE,0.0081404,0.15051,0.12033,1,1
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0073363,0.15048,0.15646,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,3.3287e-06,0.15033,0.14399,1,1
1,GO MACROPHAGE ACTIVATION,0.016339,0.14995,0.15586,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.013139,0.14992,0.12982,1,1
1,GO CELL KILLING,0.013798,0.14984,0.1285,1,1
1,GO GOLGI VESICLE BUDDING,0.0010528,0.14979,0.17832,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0015189,0.14968,0.12168,1,1
1,GO PROTEIN CATABOLIC PROCESS,2.4692e-06,0.14928,0.14378,1,1
1,GO REGULATION OF LIPID TRANSPORT,0.00090094,0.14923,0.13881,1,1
1,GO REGULATION OF B CELL ACTIVATION,0.02268,0.14921,0.10072,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.00010092,0.1492,0.12053,1,1
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.001872,0.14899,0.12804,1,1
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00013917,0.14841,0.13167,1,1
1,GO NEUTROPHIL MIGRATION,0.0036303,0.1484,0.22611,1,1
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00024286,0.14825,0.12998,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,0.00031859,0.14819,0.12762,1,1
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0081404,0.1481,0.15544,1,1
1,GO ALPHA BETA T CELL ACTIVATION,0.0017123,0.14809,0.18845,1,1
1,GO RESPONSE TO LIPID,0.0010528,0.148,0.15452,1,1
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0099891,0.14694,0.11183,1,1
1,GO REGULATION OF MUSCLE ADAPTATION,0.04854,0.1468,0.096196,1,1
1,GO REGULATION OF CATABOLIC PROCESS,1.8251e-06,0.14674,0.1534,1,1
1,GO PROTEOLYSIS,3.3132e-05,0.14668,0.13285,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,0.0019282,0.14623,0.20615,1,1
1,GO RESPONSE TO LEPTIN,0.040234,0.14618,0.16901,1,1
1,GO LEUKOCYTE MIGRATION,0.004408,0.14574,0.17027,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,0.0090226,0.14538,0.11596,1,1
1,GO MITOTIC RECOMBINATION,0.021165,0.14529,0.14765,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.0059384,0.14525,0.10739,1,1
1,GO POSITIVE REGULATION OF BINDING,0.00092958,0.14507,0.13924,1,1
1,GO CELLULAR RESPONSE TO UV,0.0022332,0.14497,0.1358,1,1
1,GO NUCLEAR TRANSPORT,9.389e-05,0.14458,0.12429,1,1
1,GO RNA LOCALIZATION,0.00072223,0.14429,0.16848,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0037331,0.14414,0.14374,1,1
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.009256,0.14388,0.20218,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00010092,0.14377,0.13671,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0038387,0.14376,0.23148,1,1
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0032441,0.14364,0.13886,1,1
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0010206,0.14352,0.20597,1,1
1,GO CELLULAR RESPONSE TO RADIATION,0.001191,0.14326,0.13364,1,1
1,GO RESPONSE TO UV,0.001228,0.14281,0.13018,1,1
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00029782,0.14275,0.15571,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,0.00029782,0.1427,0.15963,1,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.012508,0.14261,0.13551,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0010206,0.14239,0.14346,1,1
1,GO COPII COATED VESICLE BUDDING,0.0027346,0.14234,0.17351,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00016023,0.14229,0.14699,1,1
1,GO FATTY ACID BIOSYNTHETIC PROCESS,0.029068,0.14156,0.083702,1,1
1,GO HISTONE DEACETYLATION,0.0032441,0.14151,0.11148,1,1
1,GO REGULATION OF NUCLEAR DIVISION,0.0017641,0.14151,0.10732,1,1
1,GO RNA PROCESSING,0.00081984,0.14111,0.14663,1,1
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0040578,0.14109,0.11285,1,1
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00042998,0.14103,0.15178,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.00081984,0.14087,0.16713,1,1
1,GO GOLGI ORGANIZATION,0.00079435,0.14082,0.12747,1,1
1,GO PROTEIN MATURATION,0.00035231,0.14056,0.13927,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.012508,0.14055,0.098786,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.034637,0.14052,0.13358,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,9.0221e-07,0.14045,0.16487,1,1
1,GO TRABECULA MORPHOGENESIS,0.0087944,0.14038,0.2327,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.00021909,0.14025,0.18092,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0010859,0.14011,0.12621,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00041602,0.13999,0.13417,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,8.1192e-05,0.13975,0.16103,1,1
1,GO MORPHOGENESIS OF AN EPITHELIUM,0.0047853,0.13958,0.12705,1,1
1,GO DNA BIOSYNTHETIC PROCESS,5.0683e-06,0.13951,0.14674,1,1
1,GO REGULATION OF ENDOCYTOSIS,0.0015653,0.13918,0.13088,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.0024367,0.13907,0.15564,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00054072,0.13896,0.16604,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,4.4712e-06,0.13892,0.16024,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0021062,0.13853,0.16544,1,1
1,GO ORGAN GROWTH,0.00081984,0.13827,0.17608,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.01282,0.13823,0.11367,1,1
1,GO REGULATION OF MAPK CASCADE,0.00037661,0.13812,0.15013,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00074557,0.13775,0.1546,1,1
1,GO RESPONSE TO INTERLEUKIN 4,0.0057817,0.13752,0.14792,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00019079,0.13733,0.1878,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.0050528,0.13659,0.13214,1,1
1,GO ALPHA BETA T CELL PROLIFERATION,0.045624,0.13656,0.19835,1,1
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0024367,0.13656,0.18657,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.0060989,0.13651,0.11176,1,1
1,GO ALPHA AMINO ACID METABOLIC PROCESS,0.009256,0.13643,0.12188,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.040234,0.13629,0.10284,1,1
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.037747,0.13625,0.10553,1,1
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.030383,0.13559,0.13415,1,1
1,GO REGULATION OF T CELL ACTIVATION,0.0024367,0.13554,0.14722,1,1
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00021167,0.1353,0.15152,1,1
1,GO POSTREPLICATION REPAIR,0.019283,0.13502,0.093146,1,1
1,GO RECEPTOR RECYCLING,0.011047,0.13488,0.1176,1,1
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.019283,0.13471,0.20065,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.00081984,0.13462,0.14953,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0021689,0.13435,0.14069,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0054795,0.13398,0.15623,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,0.00055855,0.13374,0.15661,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0006154,0.13345,0.13871,1,1
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.011326,0.13339,0.10542,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0038387,0.13337,0.17088,1,1
1,GO REGULATION OF TUBE SIZE,0.0028957,0.13331,0.15857,1,1
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0062634,0.1333,0.10197,1,1
1,GO REGULATION OF CHEMOTAXIS,0.0087944,0.13307,0.12612,1,1
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.009256,0.13301,0.16506,1,1
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.034637,0.13289,0.13456,1,1
1,GO GOLGI TO ENDOSOME TRANSPORT,0.0031536,0.13271,0.1861,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0037331,0.13234,0.12712,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.012203,0.13223,0.096783,1,1
1,GO EPITHELIAL CELL PROLIFERATION,0.0036303,0.13195,0.15698,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.004408,0.1317,0.15371,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0099891,0.13161,0.11896,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00098941,0.13161,0.11007,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.0046564,0.13123,0.083306,1,1
1,GO GLYCOPROTEIN METABOLIC PROCESS,0.0056288,0.13122,0.095844,1,1
1,GO ESTROGEN METABOLIC PROCESS,0.0045306,0.1312,0.21379,1,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.033166,0.13109,0.1099,1,1
1,GO MYELOID LEUKOCYTE MIGRATION,0.018398,0.13042,0.17991,1,1
1,GO GENITALIA DEVELOPMENT,0.024288,0.13028,0.10052,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.04854,0.13023,0.12712,1,1
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00074557,0.13009,0.14656,1,1
1,GO STEM CELL DIFFERENTIATION,0.00074557,0.13003,0.14406,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,9.7346e-05,0.12978,0.15804,1,1
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00021909,0.12951,0.16883,1,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.023205,0.1295,0.1359,1,1
1,GO PLASMA MEMBRANE ORGANIZATION,0.0054795,0.12937,0.15265,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00034072,0.12898,0.14932,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.00036427,0.12896,0.11852,1,1
1,GO LIPID HOMEOSTASIS,0.0075304,0.12884,0.11767,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00020448,0.12869,0.15823,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00016595,0.12868,0.12138,1,1
1,GO REGULATION OF CELL ADHESION,0.0071468,0.12826,0.14991,1,1
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.013798,0.12798,0.14332,1,1
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.0039469,0.12772,0.11019,1,1
1,GO SPHINGOID METABOLIC PROCESS,0.038561,0.12687,0.091166,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0099891,0.12658,0.16782,1,1
1,GO EXOCYTOSIS,0.0011549,0.12645,0.1365,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00079435,0.12642,0.11659,1,1
1,GO MRNA METABOLIC PROCESS,0.00063551,0.12576,0.13509,1,1
1,GO RESPONSE TO HORMONE,0.0013872,0.12561,0.11326,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.013465,0.12488,0.11042,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0059384,0.12466,0.13618,1,1
1,GO MRNA CLEAVAGE,0.0038387,0.12463,0.11476,1,1
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0014738,0.1243,0.12751,1,1
1,GO RESPONSE TO DRUG,0.027188,0.12422,0.0933,1,1
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00069957,0.1236,0.1215,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,7.9801e-06,0.12358,0.12318,1,1
1,GO TUBE DEVELOPMENT,0.0022992,0.12345,0.1417,1,1
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.016734,0.12307,0.10088,1,1
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0045306,0.12232,0.095736,1,1
1,GO AMINE METABOLIC PROCESS,0.015574,0.12209,0.09778,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00065623,0.12208,0.12198,1,1
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.036164,0.12201,0.094771,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00013433,0.12199,0.13636,1,1
1,GO MODIFIED AMINO ACID TRANSPORT,0.0049174,0.12174,0.22391,1,1
1,GO APOPTOTIC PROCESS,0.00049035,0.12164,0.1131,1,1
1,GO RUFFLE ORGANIZATION,0.033166,0.12151,0.11262,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.033894,0.12121,0.10027,1,1
1,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.015574,0.12119,0.23406,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.010245,0.12118,0.082715,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.0011199,0.12107,0.095532,1,1
1,GO CELLULAR SENESCENCE,0.0049174,0.12096,0.11824,1,1
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0024367,0.12088,0.099654,1,1
1,GO B CELL ACTIVATION,0.0041716,0.12078,0.11358,1,1
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0021062,0.12063,0.10171,1,1
1,GO TRANSITION METAL ION TRANSPORT,0.00095906,0.12045,0.091814,1,1
1,GO BONE RESORPTION,0.016734,0.12039,0.13276,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.019283,0.12031,0.095259,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.024288,0.11968,0.071051,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.0036303,0.11961,0.098563,1,1
1,GO GENE SILENCING,0.00047456,0.11959,0.1052,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.052669,0.11952,0.10832,1,1
1,GO RESPONSE TO PEPTIDE HORMONE,0.0036303,0.11934,0.088891,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.021165,0.11915,0.086832,1,1
1,GO REGULATION OF PROTEIN BINDING,0.0011199,0.11912,0.13759,1,1
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.0066042,0.1189,0.084199,1,1
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0039469,0.11889,0.10019,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.018836,0.11866,0.12005,1,1
1,GO REGULATION OF CELL DEATH,0.0007696,0.11828,0.11533,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00057693,0.11806,0.12714,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0041716,0.11793,0.11511,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00098941,0.11784,0.12546,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.04854,0.11724,0.12419,1,1
1,GO RESPONSE TO PEPTIDE,0.00095906,0.11713,0.10566,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00353,0.11704,0.15824,1,1
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.041967,0.11677,0.2058,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0012662,0.11674,0.12603,1,1
1,GO ORGANELLE DISASSEMBLY,6.7596e-05,0.11624,0.13366,1,1
1,GO CELL DIVISION,0.033166,0.11603,0.064421,1,1
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0090226,0.11602,0.10396,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.001872,0.1157,0.098597,1,1
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.001872,0.11558,0.10881,1,1
1,GO REGULATION OF MAP KINASE ACTIVITY,0.0023671,0.11557,0.12127,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0029794,0.11529,0.11674,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0013457,0.11487,0.1161,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.009256,0.11482,0.12054,1,1
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0017123,0.11406,0.10015,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.041093,0.114,0.082113,1,1
1,GO NUCLEUS ORGANIZATION,0.0022332,0.11397,0.11021,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00014418,0.11372,0.12071,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.015203,0.11346,0.08548,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,5.6174e-05,0.1134,0.12098,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0031536,0.11331,0.11122,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,9.7346e-05,0.11317,0.13437,1,1
1,GO TISSUE MORPHOGENESIS,0.0034322,0.11287,0.13088,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.004408,0.11266,0.12768,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.018398,0.11212,0.092914,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.009256,0.1119,0.084189,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00084609,0.11173,0.16788,1,1
1,GO RNA SURVEILLANCE,0.0025817,0.11171,0.18862,1,1
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00087311,0.11126,0.13647,1,1
1,GO MEMBRANE ORGANIZATION,0.0019282,0.11121,0.10019,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.046579,0.1108,0.085237,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE,0.0021689,0.11067,0.091016,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,9.3916e-06,0.11022,0.12181,1,1
1,GO REGULATION OF PROTEIN STABILITY,0.001228,0.10983,0.099934,1,1
1,GO ALCOHOL METABOLIC PROCESS,0.017969,0.10979,0.09155,1,1
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.049546,0.10976,0.1203,1,1
1,GO PIGMENT GRANULE ORGANIZATION,0.030383,0.10963,0.1429,1,1
1,GO LIPID LOCALIZATION,0.019739,0.10962,0.08383,1,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.010773,0.10955,0.073269,1,1
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.038561,0.10947,0.10366,1,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.033894,0.1092,0.1072,1,1
1,GO NUCLEOTIDE EXCISION REPAIR,0.0010859,0.10897,0.12139,1,1
1,GO MRNA TRANSPORT,0.0023671,0.10885,0.14504,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00045924,0.10882,0.20137,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.015203,0.10828,0.081241,1,1
1,GO REGULATION OF AUTOPHAGY,0.00020448,0.10801,0.12626,1,1
1,GO REGULATION OF BINDING,0.004408,0.10774,0.11089,1,1
1,GO INTRACELLULAR LIPID TRANSPORT,0.053746,0.10765,0.14814,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0023671,0.10743,0.11347,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.031059,0.10726,0.060164,1,1
1,GO REGULATION OF CHROMOSOME SEPARATION,0.037747,0.10726,0.12695,1,1
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.00098941,0.10715,0.10501,1,1
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0041716,0.10665,0.097192,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,0.0018173,0.10649,0.10604,1,1
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.026586,0.10637,0.079326,1,1
1,GO ENDOSOME ORGANIZATION,0.0067808,0.10635,0.11225,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.0032441,0.10498,0.15251,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.052669,0.10386,0.12376,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00012512,0.10295,0.14151,1,1
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0023671,0.10227,0.11742,1,1
1,GO MACROAUTOPHAGY,3.3132e-05,0.10204,0.13102,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0026572,0.10156,0.10504,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.022165,0.10081,0.098573,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.031059,0.10072,0.064933,1,1
1,GO CELLULAR LIPID METABOLIC PROCESS,0.018836,0.10034,0.070884,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.016734,0.099295,0.08854,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.052669,0.099202,0.085092,1,1
1,GO REGULATION OF PHOSPHORYLATION,0.0020453,0.099168,0.1049,1,1
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0075304,0.099043,0.1249,1,1
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.013465,0.098844,0.10236,1,1
1,GO EMBRYONIC MORPHOGENESIS,0.02068,0.098714,0.090272,1,1
1,GO MITOTIC CELL CYCLE,0.017137,0.097865,0.073566,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.010506,0.097647,0.067536,1,1
1,GO REGULATION OF CELL CELL ADHESION,0.022165,0.096985,0.1069,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0020453,0.096464,0.089919,1,1
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0062634,0.096153,0.19151,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.05161,0.095704,0.11133,1,1
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.024846,0.095113,0.072107,1,1
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.0018173,0.094944,0.092787,1,1
1,GO MONOSACCHARIDE METABOLIC PROCESS,0.0090226,0.094927,0.079496,1,1
1,GO REGULATION OF PROTEIN TARGETING,0.033894,0.094425,0.076724,1,1
1,GO IRON ION TRANSPORT,0.0059384,0.094137,0.092237,1,1
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.052669,0.094119,0.12079,1,1
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.01282,0.094044,0.11085,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0012662,0.093582,0.073772,1,1
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.01282,0.093459,0.09369,1,1
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.009256,0.092602,0.085195,1,1
1,GO RESPONSE TO GROWTH FACTOR,0.0050528,0.092486,0.12975,1,1
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.011904,0.092341,0.077757,1,1
1,GO FEMALE GAMETE GENERATION,0.010506,0.092027,0.081161,1,1
1,GO ORGANELLE FISSION,0.041967,0.09179,0.064505,1,1
1,GO CELL CYCLE PROCESS,0.016734,0.091379,0.061397,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0050528,0.091064,0.10055,1,1
1,GO CARBOHYDRATE METABOLIC PROCESS,0.0013054,0.090818,0.090659,1,1
1,GO ENDOCYTOSIS,0.00052342,0.090729,0.13266,1,1
1,GO LIPID METABOLIC PROCESS,0.009256,0.090616,0.074221,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.019283,0.0906,0.08505,1,1
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.017137,0.090032,0.084838,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.025994,0.089848,0.086138,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,0.0011199,0.089732,0.10857,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.052669,0.089708,0.12396,1,1
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0039469,0.089576,0.094815,1,1
1,GO MACROMOLECULE DEACYLATION,0.019283,0.089207,0.073475,1,1
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0036303,0.089055,0.098192,1,1
1,GO REGULATION OF HYDROLASE ACTIVITY,0.010773,0.088977,0.085759,1,1
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.03245,0.088046,0.05433,1,1
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0033369,0.087693,0.092003,1,1
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.012508,0.087675,0.13449,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.0062634,0.08754,0.062304,1,1
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0062634,0.087472,0.11474,1,1
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0045306,0.087284,0.087382,1,1
1,GO VESICLE ORGANIZATION,0.02166,0.087253,0.078672,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0051916,0.086983,0.11228,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.0001165,0.086551,0.095347,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.00090094,0.086383,0.07513,1,1
1,GO REGULATION OF CELL CYCLE,0.021165,0.086329,0.051161,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0036303,0.085498,0.090485,1,1
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.033894,0.085489,0.088794,1,1
1,GO NEGATIVE REGULATION OF TRANSPORT,0.015203,0.085441,0.081388,1,1
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.02268,0.085261,0.055854,1,1
1,GO HEART DEVELOPMENT,0.0057817,0.084846,0.11847,1,1
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.019739,0.084262,0.09466,1,1
1,GO CELL CELL SIGNALING BY WNT,0.049546,0.083516,0.079892,1,1
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0021062,0.083293,0.077974,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0079323,0.082353,0.074466,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.031059,0.082329,0.098216,1,1
1,GO PROTEIN TETRAMERIZATION,0.0032441,0.081875,0.10924,1,1
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.052669,0.081689,0.067064,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.0014299,0.081321,0.081777,1,1
1,GO POLYOL METABOLIC PROCESS,0.015953,0.081257,0.072481,1,1
1,GO CHROMOSOME CONDENSATION,0.012508,0.080985,0.10983,1,1
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.047551,0.080774,0.074369,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.0027346,0.080359,0.073048,1,1
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.049546,0.079753,0.083091,1,1
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.011047,0.079508,0.066618,1,1
1,GO AMMONIUM TRANSPORT,0.038561,0.079287,0.16962,1,1
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.02843,0.07644,0.075022,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00065623,0.075665,0.074404,1,1
1,GO DNA METABOLIC PROCESS,0.004408,0.07527,0.065823,1,1
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.02843,0.075054,0.074653,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00090094,0.07495,0.073843,1,1
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.049546,0.071957,0.067535,1,1
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0051916,0.071891,0.084881,1,1
1,GO CELL CYCLE,0.02166,0.071665,0.048243,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.052669,0.06974,0.055211,1,1
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.047551,0.068365,0.07433,1,1
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.004408,0.066826,0.12945,1,1
1,GO SNRNA TRANSCRIPTION,0.0054795,0.066311,0.081546,1,1
1,GO REGULATION OF DNA REPLICATION,0.0087944,0.065776,0.079769,1,1
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.011326,0.064378,0.081993,1,1
1,GO MITOTIC NUCLEAR DIVISION,0.038561,0.064163,0.069412,1,1
1,GO INTRACELLULAR TRANSPORT,0.0015653,0.063527,0.06897,1,1
1,GO RESPONSE TO NITROGEN COMPOUND,0.05161,0.062695,0.054534,1,1
1,GO REGULATION OF MACROAUTOPHAGY,0.0027346,0.060104,0.11703,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.023741,0.055721,0.07687,1,1
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.0032441,0.054613,0.064768,1,1
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0090226,0.054601,0.073468,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.014841,0.051543,0.11681,1,1
1,GO SECRETION,0.036164,0.04739,0.064008,1,1
2,GO ETHER BIOSYNTHETIC PROCESS,2.3975e-07,1.2188,0.98077,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0038387,1.138,0.85188,1,1
2,GO ETHANOL OXIDATION,6.8936e-07,1.0574,0.91957,1,1
2,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.00025131,0.96721,0.71972,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00353,0.96422,0.68716,1,1
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0028957,0.8366,0.52159,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,3.6414e-07,0.82551,0.76751,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.00049035,0.82084,0.6559,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,3.7791e-06,0.80051,0.61412,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00024286,0.79234,0.65233,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.4963e-07,0.77703,0.7163,1,1
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.00012074,0.75668,0.61402,1,1
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.0001547,0.7414,0.61311,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00067758,0.73434,0.48717,1,1
2,GO RESPONSE TO INTERLEUKIN 18,8.4205e-05,0.71907,0.69033,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,9.7801e-06,0.70935,0.70201,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00353,0.70604,0.44328,1,1
2,GO T HELPER 2 CELL DIFFERENTIATION,0.00021909,0.69788,0.51912,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.2876e-06,0.68144,0.51662,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,3.8131e-07,0.68021,0.52836,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,3.3202e-07,0.67989,0.64115,1,1
2,GO T HELPER 1 CELL DIFFERENTIATION,2.0833e-05,0.67581,0.59002,1,1
2,GO BIOLOGICAL PHASE,5.8301e-05,0.67252,0.64455,1,1
2,GO MUCUS SECRETION,0.00041602,0.66447,0.62258,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,0.00014418,0.66081,0.48671,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00012512,0.65356,0.55602,1,1
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0032441,0.64671,0.46843,1,1
2,GO NEGATIVE REGULATION OF CELL KILLING,0.0025083,0.63952,0.43062,1,1
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.00079435,0.63924,0.56895,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0067808,0.63783,0.41816,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,8.1192e-05,0.62672,0.54969,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00026903,0.62238,0.47929,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,7.9801e-06,0.61743,0.54446,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00079435,0.6163,0.43915,1,1
2,GO MYOBLAST MIGRATION,0.012203,0.61214,0.48969,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,1.9904e-06,0.61141,0.58141,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0006154,0.60615,0.39289,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,2.8077e-06,0.59842,0.53565,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,7.013e-05,0.59822,0.57271,1,1
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0050528,0.59403,0.40774,1,1
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,3.4421e-05,0.59241,0.56255,1,1
2,GO BARBED END ACTIN FILAMENT CAPPING,0.001662,0.5892,0.41026,1,1
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0037331,0.58809,0.38473,1,1
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0014738,0.58398,0.48389,1,1
2,GO PROSTATE GLAND GROWTH,2.6902e-06,0.58277,0.66094,1,1
2,GO PROSTANOID METABOLIC PROCESS,1.2454e-05,0.57692,0.50387,1,1
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0036303,0.57617,0.5243,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00072223,0.5746,0.41042,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,4.8612e-06,0.5727,0.41492,1,1
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,8.3127e-06,0.57002,0.51339,1,1
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00054072,0.56861,0.49296,1,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,5.0226e-05,0.56849,0.50487,1,1
2,GO HAIR FOLLICLE MATURATION,5.0226e-05,0.56535,0.46299,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,4.8379e-05,0.56446,0.5591,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,7.547e-05,0.56443,0.52748,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,6.0504e-05,0.5639,0.50941,1,1
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.00029782,0.55977,0.55728,1,1
2,GO ETHER METABOLIC PROCESS,2.2658e-06,0.55969,0.52151,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00041602,0.55842,0.38525,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.00057693,0.54504,0.45648,1,1
2,GO LYSINE METABOLIC PROCESS,0.00027832,0.54427,0.50937,1,1
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.5331e-06,0.53953,0.52941,1,1
2,GO OTIC VESICLE DEVELOPMENT,0.00035231,0.53863,0.44538,1,1
2,GO GLYCEROL ETHER METABOLIC PROCESS,5.2533e-07,0.5381,0.50383,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,1.1493e-05,0.53748,0.58244,1,1
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00035231,0.53501,0.54111,1,1
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0014299,0.53424,0.37862,1,1
2,GO PSEUDOPODIUM ORGANIZATION,0.0085714,0.53404,0.37151,1,1
2,GO RETINAL METABOLIC PROCESS,0.011612,0.52399,0.33519,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,1.5201e-05,0.52013,0.45297,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,8.1192e-05,0.50824,0.40378,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00040247,0.50678,0.4586,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0023671,0.50474,0.3476,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00045924,0.50334,0.43411,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,1.0184e-05,0.50221,0.42961,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00012964,0.50121,0.46953,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,2.8418e-05,0.50099,0.40463,1,1
2,GO REGULATION OF GASTRIC ACID SECRETION,0.00013433,0.49905,0.45815,1,1
2,GO HEPATOCYTE DIFFERENTIATION,0.0034322,0.49763,0.40906,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0014299,0.49496,0.35548,1,1
2,GO CYCLOOXYGENASE PATHWAY,0.0073363,0.49416,0.4227,1,1
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.00037661,0.49345,0.43814,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0010206,0.48643,0.35473,1,1
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.00034072,0.48059,0.47727,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.4692e-06,0.47901,0.43059,1,1
2,GO ACTIN FILAMENT SEVERING,0.03939,0.47803,0.31778,1,1
2,GO IMMUNE RESPONSE TO TUMOR CELL,0.00011241,0.47764,0.43602,1,1
2,GO OXYGEN TRANSPORT,0.0097392,0.47714,0.44234,1,1
2,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,6.7728e-06,0.47699,0.47013,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,5.2139e-05,0.4752,0.43857,1,1
2,GO ETHANOL METABOLIC PROCESS,3.9418e-06,0.47423,0.53454,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0094949,0.47382,0.31455,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,1.7806e-05,0.47187,0.42891,1,1
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.043763,0.47024,0.31162,1,1
2,GO RESPONSE TO INTERFERON BETA,0.014841,0.46842,0.33406,1,1
2,GO MUSCLE ATROPHY,0.0056288,0.46832,0.35363,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00074557,0.46758,0.36777,1,1
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,2.8077e-06,0.46665,0.46345,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.017969,0.46374,0.33599,1,1
2,GO REGULATION OF HIPPO SIGNALING,0.052669,0.46175,0.2215,1,1
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0039469,0.46115,0.3362,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00010092,0.45356,0.32321,1,1
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,5.0683e-06,0.45162,0.44542,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0025083,0.45013,0.35679,1,1
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,5.2139e-05,0.44985,0.38143,1,1
2,GO NEPHRON TUBULE FORMATION,0.0051916,0.44818,0.29165,1,1
2,GO SKELETAL MUSCLE TISSUE REGENERATION,1.8521e-05,0.44531,0.36481,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.2139e-05,0.44416,0.39268,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,3.4421e-05,0.44402,0.44861,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00038934,0.4434,0.31054,1,1
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00079435,0.44175,0.41148,1,1
2,GO OTIC VESICLE MORPHOGENESIS,0.00065623,0.43886,0.40518,1,1
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.0012662,0.43534,0.28381,1,1
2,GO PSEUDOURIDINE SYNTHESIS,0.00065623,0.43487,0.32608,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0037331,0.43454,0.36136,1,1
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.021165,0.4339,0.38552,1,1
2,GO DENDRITIC CELL MIGRATION,0.00023468,0.43328,0.35887,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0013054,0.43308,0.34556,1,1
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0014738,0.43185,0.41882,1,1
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.43045,0.34009,1,1
2,GO HEME METABOLIC PROCESS,0.0001165,0.43026,0.36397,1,1
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.0042883,0.42078,0.35767,1,1
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0099891,0.41912,0.31179,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.00081984,0.41675,0.40011,1,1
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.0019282,0.41489,0.4172,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,8.7323e-05,0.41199,0.35263,1,1
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,7.6603e-06,0.41126,0.34496,1,1
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.00095906,0.40983,0.34481,1,1
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.00067758,0.40915,0.3631,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.013798,0.40864,0.36164,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0013872,0.40716,0.36921,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.036948,0.40538,0.21569,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.00059588,0.40313,0.31314,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00024286,0.40309,0.35282,1,1
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0021689,0.40206,0.36819,1,1
2,GO PIGMENT GRANULE MATURATION,0.0064317,0.40113,0.28935,1,1
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,5.8301e-05,0.39563,0.37481,1,1
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0007696,0.39535,0.36431,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00084609,0.39496,0.37627,1,1
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.012508,0.39302,0.25517,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,1.4609e-05,0.39275,0.36363,1,1
2,GO NEURAL CREST FORMATION,0.001986,0.39274,0.31258,1,1
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.00010462,0.39259,0.33245,1,1
2,GO TOLERANCE INDUCTION,0.0081404,0.39066,0.29059,1,1
2,GO PORE COMPLEX ASSEMBLY,1.5331e-06,0.39017,0.3861,1,1
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00012512,0.39002,0.30019,1,1
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0036303,0.38886,0.24956,1,1
2,GO NEUTROPHIL HOMEOSTASIS,0.0056288,0.38851,0.34701,1,1
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.0057817,0.3878,0.26355,1,1
2,GO CELLULAR RESPONSE TO SALT STRESS,0.0021062,0.38673,0.39568,1,1
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00024286,0.38641,0.33182,1,1
2,GO CYSTEINE METABOLIC PROCESS,0.00052342,0.38428,0.45613,1,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0071468,0.3838,0.34373,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,3.6228e-06,0.38376,0.3767,1,1
2,GO GAS TRANSPORT,0.0027346,0.38344,0.3948,1,1
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00047456,0.38307,0.29409,1,1
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00034072,0.38284,0.29717,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.0085714,0.38202,0.30739,1,1
2,GO RRNA PSEUDOURIDINE SYNTHESIS,0.010506,0.38191,0.27894,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.00013917,0.37995,0.34824,1,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,5.2139e-05,0.3795,0.44891,1,1
2,GO FATTY ACID HOMEOSTASIS,0.0060989,0.37871,0.24295,1,1
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.0059384,0.37771,0.34512,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0022992,0.3771,0.31748,1,1
2,GO LIMB BUD FORMATION,0.004408,0.37637,0.45708,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,3.6228e-06,0.37556,0.3522,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,7.9801e-06,0.37499,0.34095,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00081984,0.37398,0.26276,1,1
2,GO LEFT RIGHT AXIS SPECIFICATION,0.00020448,0.3725,0.44521,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00019753,0.37234,0.31057,1,1
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,1.6015e-06,0.37228,0.38208,1,1
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00059588,0.37187,0.25297,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,0.001986,0.37038,0.27804,1,1
2,GO VESICLE CARGO LOADING,7.6603e-06,0.36955,0.32422,1,1
2,GO LAMELLIPODIUM MORPHOGENESIS,0.00079435,0.36948,0.30425,1,1
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.00017186,0.36863,0.3066,1,1
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.011612,0.36735,0.27613,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,8.1192e-05,0.36734,0.34248,1,1
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.00095906,0.36619,0.34868,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,3.4421e-05,0.36571,0.30276,1,1
2,GO ACETYL COA METABOLIC PROCESS,0.00050664,0.36557,0.26279,1,1
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.042857,0.36536,0.1533,1,1
2,GO POSITIVE REGULATION OF CELL MATURATION,0.015574,0.36517,0.32126,1,1
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0015189,0.36464,0.39153,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0025083,0.3632,0.3316,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0099891,0.36188,0.30721,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0007696,0.36136,0.28495,1,1
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.00013433,0.36053,0.30139,1,1
2,GO PENTOSE METABOLIC PROCESS,9.389e-05,0.36036,0.36299,1,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,2.5308e-05,0.35899,0.36324,1,1
2,GO ERYTHROCYTE MATURATION,0.0032441,0.35683,0.33047,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00055855,0.3557,0.30435,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,5.4121e-05,0.35549,0.35851,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0011199,0.35417,0.25943,1,1
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.044685,0.35396,0.22261,1,1
2,GO I KAPPAB PHOSPHORYLATION,0.0040578,0.35337,0.21368,1,1
2,GO SENSORY PERCEPTION OF BITTER TASTE,4.4878e-05,0.35275,0.36296,1,1
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.015203,0.35094,0.22572,1,1
2,GO INTERLEUKIN 13 PRODUCTION,0.00079435,0.35091,0.3868,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0013872,0.35069,0.28011,1,1
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0006154,0.35048,0.29794,1,1
2,GO TYPE 2 IMMUNE RESPONSE,0.00037661,0.34998,0.27938,1,1
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,3.7791e-06,0.3499,0.32381,1,1
2,GO HEMOGLOBIN METABOLIC PROCESS,6.5149e-05,0.34977,0.29849,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,4.8379e-05,0.34956,0.49294,1,1
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0011199,0.34881,0.38049,1,1
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.020205,0.34859,0.23365,1,1
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00029782,0.34843,0.37059,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0001165,0.34839,0.33558,1,1
2,GO TETRAPYRROLE METABOLIC PROCESS,8.7323e-05,0.34835,0.24901,1,1
2,GO PROTEIN DEMANNOSYLATION,0.0015653,0.34824,0.25943,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.00017796,0.34744,0.30255,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.016734,0.34708,0.26331,1,1
2,GO T CELL MEDIATED IMMUNITY,0.00047456,0.34696,0.27333,1,1
2,GO GLYCINE METABOLIC PROCESS,0.0010859,0.34597,0.28162,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.017969,0.34567,0.21733,1,1
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.020205,0.34249,0.23351,1,1
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.0028957,0.34167,0.22797,1,1
2,GO PRE MIRNA PROCESSING,0.0024367,0.34144,0.21951,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.015953,0.34087,0.33089,1,1
2,GO REGULATION OF PROTEIN IMPORT,0.0001165,0.33992,0.29113,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0022992,0.33906,0.28396,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0099891,0.33904,0.22043,1,1
2,GO REGULATION OF DNA METHYLATION,0.00049035,0.3388,0.242,1,1
2,GO NEUROBLAST DIVISION,0.00072223,0.33846,0.37127,1,1
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.017969,0.33702,0.30073,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00057693,0.33599,0.28252,1,1
2,GO MATURE B CELL DIFFERENTIATION,0.0024367,0.33597,0.23208,1,1
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.038561,0.3359,0.18055,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0019282,0.33542,0.26919,1,1
2,GO NOTOCHORD DEVELOPMENT,0.00017186,0.3353,0.50849,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.021165,0.33524,0.21581,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.027803,0.3351,0.19838,1,1
2,GO RESPONSE TO STEROL DEPLETION,0.00011241,0.33447,0.3165,1,1
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0033369,0.3344,0.33026,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0083534,0.33389,0.21814,1,1
2,GO RNA DECAPPING,1.1493e-05,0.33388,0.25129,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00035231,0.3336,0.25115,1,1
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,1.6455e-05,0.33295,0.37286,1,1
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.00353,0.33197,0.20721,1,1
2,GO REGULATION OF PODOSOME ASSEMBLY,0.001662,0.33102,0.3149,1,1
2,GO ERBB2 SIGNALING PATHWAY,0.00074557,0.33092,0.25496,1,1
2,GO TONGUE MORPHOGENESIS,0.019283,0.33071,0.29047,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.001228,0.33066,0.33854,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,2.5308e-05,0.33032,0.35008,1,1
2,GO RETINOL METABOLIC PROCESS,8.1192e-05,0.33001,0.34236,1,1
2,GO FIBROBLAST ACTIVATION,0.00032948,0.32998,0.33966,1,1
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0018173,0.32972,0.32863,1,1
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.001662,0.32941,0.2276,1,1
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00031859,0.32938,0.3004,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,0.0087944,0.32827,0.20394,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00084609,0.32825,0.27999,1,1
2,GO MICROVILLUS ASSEMBLY,0.010506,0.32748,0.307,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0062634,0.3265,0.22607,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0067808,0.32616,0.21725,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.017969,0.32523,0.24907,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00063551,0.32312,0.24574,1,1
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0057817,0.32299,0.26181,1,1
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,9.7801e-06,0.32178,0.32829,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.0011199,0.32154,0.29743,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0010528,0.32145,0.2392,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.0036303,0.32106,0.27455,1,1
2,GO FOREGUT MORPHOGENESIS,0.001228,0.32032,0.36484,1,1
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.0066042,0.3199,0.31447,1,1
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00013917,0.31908,0.42465,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00022676,0.31757,0.28225,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,2.4692e-06,0.31751,0.26071,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,4.3218e-05,0.31731,0.30741,1,1
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0059384,0.31716,0.23558,1,1
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.024288,0.31666,0.21477,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0012662,0.31647,0.25098,1,1
2,GO REGULATION OF TELOMERASE ACTIVITY,6.2985e-07,0.31647,0.29308,1,1
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.0053338,0.31633,0.24956,1,1
2,GO RESPONSE TO NITROSATIVE STRESS,0.014486,0.31618,0.27754,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0013054,0.31594,0.27754,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00011241,0.31574,0.2736,1,1
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00013917,0.31551,0.29973,1,1
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0034322,0.31543,0.26202,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00021909,0.31514,0.27835,1,1
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.012203,0.31502,0.22058,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,2.6902e-06,0.31497,0.33393,1,1
2,GO PHAGOCYTOSIS RECOGNITION,0.0075304,0.31489,0.24774,1,1
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0081404,0.31474,0.29061,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,0.00050664,0.3143,0.2573,1,1
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.02268,0.31397,0.26268,1,1
2,GO MIDDLE EAR MORPHOGENESIS,0.011326,0.31389,0.23893,1,1
2,GO RESPONSE TO ANGIOTENSIN,0.00017186,0.3137,0.29961,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.00027832,0.31301,0.28947,1,1
2,GO CARNITINE SHUTTLE,4.4878e-05,0.31298,0.32458,1,1
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0069616,0.31284,0.29225,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.0022992,0.31212,0.25508,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0073363,0.31211,0.22347,1,1
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.001228,0.31164,0.26226,1,1
2,GO GERMINAL CENTER FORMATION,0.047551,0.31157,0.1849,1,1
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,3.6228e-06,0.3115,0.30406,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,1.0604e-05,0.31107,0.26557,1,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0040578,0.31092,0.30449,1,1
2,GO HISTONE SERINE PHOSPHORYLATION,0.00087311,0.31004,0.25051,1,1
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00050664,0.30986,0.21472,1,1
2,GO REGULATION OF LIPASE ACTIVITY,1.6455e-05,0.3096,0.24778,1,1
2,GO AMP METABOLIC PROCESS,0.0083534,0.30824,0.24605,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.015953,0.30823,0.22793,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0013872,0.30794,0.20978,1,1
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.0025817,0.30789,0.24625,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00017186,0.3076,0.27318,1,1
2,GO OVULATION,7.547e-05,0.30732,0.34627,1,1
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.00055855,0.30703,0.26567,1,1
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0097392,0.30686,0.26815,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,0.0028957,0.30673,0.22582,1,1
2,GO DNA LIGATION,0.0013872,0.30662,0.22916,1,1
2,GO THYMOCYTE APOPTOTIC PROCESS,0.0087944,0.30646,0.24362,1,1
2,GO MONOCYTE CHEMOTAXIS,0.00059588,0.30575,0.26266,1,1
2,GO MONONUCLEAR CELL MIGRATION,5.4121e-05,0.3057,0.27806,1,1
2,GO INTERLEUKIN 2 PRODUCTION,5.8301e-05,0.30565,0.2589,1,1
2,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00072223,0.30557,0.27088,1,1
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.014138,0.305,0.3023,1,1
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.019283,0.30472,0.30503,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0010528,0.30438,0.22548,1,1
2,GO CHONDROCYTE PROLIFERATION,0.0016129,0.30433,0.37661,1,1
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.0087944,0.30363,0.18653,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0010859,0.30308,0.29313,1,1
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0010528,0.30198,0.25207,1,1
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00016595,0.29938,0.32981,1,1
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00072223,0.29931,0.23673,1,1
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.0020453,0.2993,0.2478,1,1
2,GO PROTEIN DEGLYCOSYLATION,0.0020453,0.2992,0.25235,1,1
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.035393,0.29898,0.22937,1,1
2,GO PHOSPHOLIPID CATABOLIC PROCESS,2.3418e-05,0.29884,0.2868,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,0.00010092,0.29871,0.25627,1,1
2,GO RESPONSE TO GONADOTROPIN,0.0030654,0.29827,0.2272,1,1
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0064317,0.29801,0.21124,1,1
2,GO INTERLEUKIN 8 PRODUCTION,0.00040247,0.29755,0.24907,1,1
2,GO RESPONSE TO TUMOR CELL,0.001228,0.29688,0.2561,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00012512,0.29589,0.29569,1,1
2,GO URETER DEVELOPMENT,0.017137,0.29587,0.27349,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0001165,0.29584,0.32224,1,1
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0028141,0.29582,0.18248,1,1
2,GO NUCLEAR PORE ORGANIZATION,5.9841e-06,0.29577,0.36087,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0010859,0.29556,0.20829,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0021689,0.29527,0.28158,1,1
2,GO ENTRY INTO HOST,0.0021689,0.29495,0.21752,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00010092,0.29466,0.24138,1,1
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0012662,0.29446,0.24354,1,1
2,GO REGULATION OF VIRAL TRANSCRIPTION,7.2111e-07,0.29425,0.2659,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0046564,0.2937,0.26234,1,1
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00022676,0.29315,0.29834,1,1
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0010206,0.29304,0.23921,1,1
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0038387,0.29291,0.19189,1,1
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0097392,0.29273,0.26839,1,1
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00032948,0.29162,0.30054,1,1
2,GO MATURATION OF LSU RRNA,0.0025083,0.29137,0.3167,1,1
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,7.013e-05,0.29107,0.24873,1,1
2,GO HISTONE H4 DEACETYLATION,4.4878e-05,0.29103,0.3279,1,1
2,GO ZYMOGEN INHIBITION,0.010245,0.29042,0.24546,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0032441,0.29041,0.22435,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0001547,0.29001,0.29361,1,1
2,GO PODOSOME ASSEMBLY,0.0022332,0.28995,0.25805,1,1
2,GO REGULATION OF GTP BINDING,0.050569,0.28956,0.18015,1,1
2,GO GRANULOCYTE DIFFERENTIATION,0.0034322,0.28871,0.23378,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0038387,0.28853,0.27612,1,1
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0010859,0.28853,0.22523,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00022676,0.28845,0.29004,1,1
2,GO MRNA MODIFICATION,0.001191,0.28832,0.21786,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00017796,0.28826,0.26875,1,1
2,GO GASTRIC ACID SECRETION,0.0024367,0.28823,0.22976,1,1
2,GO RIG I SIGNALING PATHWAY,9.389e-05,0.2881,0.25117,1,1
2,GO VIRAL TRANSLATION,0.00029782,0.2879,0.3207,1,1
2,GO EPIBOLY,0.053746,0.28775,0.16702,1,1
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.023741,0.28738,0.34516,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00027832,0.28729,0.27398,1,1
2,GO PEPTIDE CROSS LINKING,0.0021689,0.28685,0.26412,1,1
2,GO FRUCTOSE METABOLIC PROCESS,0.020205,0.28525,0.3749,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0060989,0.28503,0.23448,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00018427,0.28472,0.21719,1,1
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.00032948,0.28463,0.2552,1,1
2,GO TELOMERASE RNA LOCALIZATION,0.001872,0.28431,0.27043,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,3.1888e-05,0.28428,0.28014,1,1
2,GO RESPONSE TO INTERLEUKIN 12,0.00012074,0.28381,0.26318,1,1
2,GO BLASTODERM SEGMENTATION,0.027803,0.28377,0.28331,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0054795,0.28375,0.24407,1,1
2,GO DETOXIFICATION,0.00023468,0.28367,0.25648,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0001547,0.28128,0.25224,1,1
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00065623,0.28103,0.19887,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0037331,0.28095,0.2198,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00016023,0.28011,0.24105,1,1
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.00050664,0.27965,0.2655,1,1
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00023468,0.27964,0.36523,1,1
2,GO EPITHELIAL CELL CELL ADHESION,0.001228,0.27896,0.4369,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00031859,0.27855,0.2719,1,1
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0037331,0.2768,0.36624,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00054072,0.27659,0.25955,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0017641,0.27646,0.20075,1,1
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,2.0033e-05,0.27471,0.25233,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,4.3218e-05,0.27462,0.37623,1,1
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0013457,0.27447,0.17784,1,1
2,GO PROSTATE GLAND DEVELOPMENT,0.0059384,0.27414,0.33267,1,1
2,GO REGULATION OF CELL KILLING,0.0036303,0.27402,0.19491,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.001872,0.27392,0.26244,1,1
2,GO ARACHIDONIC ACID SECRETION,0.00029782,0.27323,0.27101,1,1
2,GO HIPPO SIGNALING,0.0017123,0.27315,0.33362,1,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.029719,0.27292,0.33387,1,1
2,GO CHROMATIN DISASSEMBLY,0.0033369,0.27261,0.19177,1,1
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.00052342,0.2726,0.39055,1,1
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.0038387,0.27242,0.24319,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0015189,0.27208,0.20134,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00072223,0.27153,0.26824,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0036303,0.27045,0.252,1,1
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.04854,0.2695,0.16692,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0013457,0.26947,0.21333,1,1
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.0032441,0.26892,0.23371,1,1
2,GO RESPONSE TO INTERFERON GAMMA,0.0081404,0.26871,0.20036,1,1
2,GO MIRNA METABOLIC PROCESS,2.7343e-05,0.26846,0.21557,1,1
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,7.013e-05,0.2683,0.23074,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,8.1192e-05,0.26805,0.24199,1,1
2,GO L PHENYLALANINE METABOLIC PROCESS,0.0017641,0.26734,0.28463,1,1
2,GO GTP METABOLIC PROCESS,0.0021689,0.26711,0.27004,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.00047456,0.26689,0.19917,1,1
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.018398,0.26687,0.20717,1,1
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00031859,0.26667,0.23997,1,1
2,GO VIRAL GENE EXPRESSION,0.0013872,0.26609,0.24196,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00049035,0.2655,0.24123,1,1
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.009256,0.26545,0.19744,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0087944,0.2652,0.21549,1,1
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.046579,0.26516,0.14257,1,1
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0017123,0.26478,0.19242,1,1
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.001191,0.26443,0.29381,1,1
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.0064317,0.26433,0.24907,1,1
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0019282,0.26382,0.2562,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0019282,0.26309,0.20352,1,1
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.026586,0.263,0.21919,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.0020453,0.26282,0.18821,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0057817,0.26253,0.26756,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.017549,0.26251,0.14963,1,1
2,GO RESPONSE TO CADMIUM ION,0.04854,0.26217,0.18851,1,1
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.004408,0.26155,0.19522,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,0.001986,0.26104,0.19359,1,1
2,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.0040578,0.26074,0.30895,1,1
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.00092958,0.26067,0.25007,1,1
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00041602,0.26031,0.22615,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0013054,0.26006,0.18805,1,1
2,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.019739,0.26004,0.24362,1,1
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.017969,0.25969,0.15241,1,1
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.00017186,0.25959,0.22385,1,1
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00035231,0.25894,0.24524,1,1
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0067808,0.25804,0.21197,1,1
2,GO T CELL CHEMOTAXIS,0.00018427,0.25766,0.2468,1,1
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0016129,0.25764,0.2328,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0024367,0.25744,0.20189,1,1
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.007729,0.2573,0.15246,1,1
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.04854,0.25722,0.18507,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0011549,0.25712,0.20929,1,1
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.00069957,0.2569,0.2449,1,1
2,GO MATURATION OF SSU RRNA,0.00084609,0.25673,0.29059,1,1
2,GO AMINE CATABOLIC PROCESS,0.0036303,0.25667,0.29734,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.04854,0.25663,0.21703,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,0.00081984,0.25639,0.41676,1,1
2,GO CELL REDOX HOMEOSTASIS,0.00019079,0.25586,0.23492,1,1
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.021165,0.25578,0.2371,1,1
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0047853,0.25545,0.30462,1,1
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.00069957,0.255,0.2861,1,1
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0014738,0.25496,0.20245,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0046564,0.25488,0.20254,1,1
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0028957,0.25469,0.27699,1,1
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.010773,0.25458,0.16782,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.7118e-05,0.2542,0.27672,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0021689,0.2539,0.28436,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0034322,0.25361,0.27097,1,1
2,GO HYPEROSMOTIC RESPONSE,0.0015653,0.25339,0.25632,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.011047,0.2531,0.31198,1,1
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0040578,0.25298,0.25278,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0013457,0.25295,0.22878,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,4.8379e-05,0.25284,0.22507,1,1
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0041716,0.25283,0.28006,1,1
2,GO AMINO SUGAR METABOLIC PROCESS,0.0013054,0.25253,0.19678,1,1
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.0062634,0.25197,0.248,1,1
2,GO HISTONE H3 K9 ACETYLATION,7.2754e-05,0.25194,0.23856,1,1
2,GO NUCLEAR MIGRATION,0.015203,0.25191,0.17003,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0047853,0.25176,0.16018,1,1
2,GO LAMELLIPODIUM ORGANIZATION,0.00014418,0.25118,0.24104,1,1
2,GO CELLULAR RESPONSE TO ETHANOL,0.0024367,0.25058,0.24338,1,1
2,GO OSTEOBLAST DEVELOPMENT,0.0007696,0.25012,0.29923,1,1
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.001986,0.25005,0.2615,1,1
2,GO TRNA METHYLATION,0.00032948,0.25004,0.22206,1,1
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0010206,0.24986,0.17177,1,1
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.044685,0.24969,0.14031,1,1
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00026003,0.24904,0.27761,1,1
2,GO MITOCHONDRIAL TRANSLATION,0.00063551,0.24882,0.23474,1,1
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.03245,0.24865,0.26531,1,1
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0049174,0.2486,0.2264,1,1
2,GO L SERINE METABOLIC PROCESS,0.010245,0.24727,0.27613,1,1
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00065623,0.24712,0.21993,1,1
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.050569,0.247,0.2102,1,1
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00038934,0.24674,0.24009,1,1
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00029782,0.24587,0.23021,1,1
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0034322,0.2458,0.24629,1,1
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0027346,0.24537,0.16134,1,1
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.011612,0.24511,0.23128,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0006154,0.24507,0.18006,1,1
2,GO GLUTATHIONE METABOLIC PROCESS,3.7145e-05,0.24489,0.30063,1,1
2,GO AMINO ACID ACTIVATION,0.00012512,0.2448,0.28844,1,1
2,GO BILE ACID AND BILE SALT TRANSPORT,0.038561,0.24479,0.19904,1,1
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.001191,0.2446,0.23915,1,1
2,GO POSITIVE REGULATION OF TRANSLATION,4.1617e-05,0.24431,0.21518,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.05161,0.24393,0.10771,1,1
2,GO PIGMENT ACCUMULATION,0.0018173,0.24311,0.23967,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.014138,0.24257,0.14992,1,1
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.0020453,0.2422,0.17979,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.046579,0.24218,0.16041,1,1
2,GO ALDITOL METABOLIC PROCESS,0.00042998,0.24196,0.29156,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0033369,0.24189,0.25778,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.001986,0.24169,0.24642,1,1
2,GO SECRETION BY TISSUE,0.00084609,0.24153,0.26552,1,1
2,GO RESPONSE TO X RAY,0.00021167,0.24149,0.32623,1,1
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.02166,0.24111,0.23275,1,1
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00084609,0.24081,0.28566,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0010859,0.24071,0.20213,1,1
2,GO ADAPTIVE IMMUNE RESPONSE,0.00079435,0.24069,0.18663,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0013054,0.24067,0.22835,1,1
2,GO RESPONSE TO PROTOZOAN,0.029719,0.24025,0.1423,1,1
2,GO RESPIRATORY BURST,0.0071468,0.24015,0.208,1,1
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00030804,0.2401,0.23034,1,1
2,GO RESPONSE TO SALT STRESS,0.015203,0.23956,0.21946,1,1
2,GO LIPID OXIDATION,0.0021062,0.23939,0.17205,1,1
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00041602,0.23939,0.21465,1,1
2,GO RESPONSE TO OXYGEN RADICAL,0.0037331,0.23853,0.16552,1,1
2,GO RNA DESTABILIZATION,0.0024367,0.2384,0.17203,1,1
2,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.024846,0.2383,0.23175,1,1
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.025994,0.23823,0.18665,1,1
2,GO MITOCHONDRIAL DNA REPLICATION,0.00065623,0.23789,0.20556,1,1
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0025817,0.23788,0.2218,1,1
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,8.4205e-05,0.2378,0.21736,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0031536,0.23774,0.16335,1,1
2,GO PROTEASOME ASSEMBLY,0.0045306,0.23755,0.17653,1,1
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.00092958,0.23742,0.22919,1,1
2,GO LAMELLIPODIUM ASSEMBLY,0.00072223,0.23741,0.19308,1,1
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0033369,0.23721,0.1863,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,7.547e-05,0.23686,0.22712,1,1
2,GO POSITIVE REGULATION OF COAGULATION,0.0037331,0.23681,0.25739,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0013457,0.23666,0.23242,1,1
2,GO PIGMENT METABOLIC PROCESS,0.00079435,0.23664,0.21849,1,1
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00031859,0.23639,0.23097,1,1
2,GO MITOCHONDRIAL GENE EXPRESSION,0.00069957,0.23604,0.23027,1,1
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.010245,0.23464,0.22901,1,1
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.0069616,0.23437,0.19769,1,1
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.0042883,0.23412,0.21176,1,1
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0069616,0.23371,0.21872,1,1
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.014841,0.23354,0.15149,1,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.0057817,0.23337,0.23912,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0033369,0.23332,0.25122,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0056288,0.23319,0.23287,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.010773,0.23317,0.23857,1,1
2,GO PLATELET MORPHOGENESIS,0.00035231,0.23317,0.22927,1,1
2,GO ERYTHROCYTE DEVELOPMENT,0.0045306,0.23289,0.16763,1,1
2,GO APOPTOTIC CELL CLEARANCE,0.0016129,0.23281,0.16276,1,1
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0014738,0.23278,0.1853,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.017969,0.232,0.23813,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.00087311,0.23158,0.14143,1,1
2,GO NIK NF KAPPAB SIGNALING,0.00069957,0.23138,0.18493,1,1
2,GO PEPTIDYL METHIONINE MODIFICATION,0.0021062,0.23137,0.2324,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.001986,0.23108,0.20533,1,1
2,GO BLASTOCYST FORMATION,0.00018427,0.23087,0.21374,1,1
2,GO RESPONSE TO MANGANESE ION,0.0032441,0.23076,0.21233,1,1
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0027346,0.23076,0.21381,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0006154,0.23059,0.22253,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.23008,0.16171,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,4.4878e-05,0.22963,0.18907,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0022332,0.22962,0.29499,1,1
2,GO MALE GENITALIA DEVELOPMENT,0.0021062,0.22959,0.2365,1,1
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00012074,0.22931,0.24113,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0073363,0.22907,0.20161,1,1
2,GO GOLGI LOCALIZATION,0.013798,0.22894,0.17862,1,1
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0030654,0.22886,0.28273,1,1
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0029794,0.22867,0.16082,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.00014418,0.22856,0.19017,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0010528,0.22811,0.15312,1,1
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.029068,0.22789,0.2342,1,1
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,6.7728e-06,0.2271,0.20914,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00028792,0.22699,0.22064,1,1
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00054072,0.22693,0.18568,1,1
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.05161,0.22623,0.21643,1,1
2,GO RESPONSE TO INTERLEUKIN 1,0.00047456,0.22602,0.17607,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0051916,0.22589,0.25335,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0028957,0.22506,0.15516,1,1
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.0051916,0.22504,0.19169,1,1
2,GO LIVER REGENERATION,0.009256,0.22487,0.17921,1,1
2,GO MATURATION OF 5 8S RRNA,0.0013872,0.22463,0.26926,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0028141,0.22434,0.18227,1,1
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0059384,0.22408,0.14845,1,1
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.0025817,0.22397,0.23425,1,1
2,GO FATTY ACID BETA OXIDATION,0.0097392,0.22386,0.13625,1,1
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0022992,0.22377,0.25427,1,1
2,GO ARGININE METABOLIC PROCESS,0.042857,0.22346,0.19524,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.001191,0.22342,0.23147,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0024367,0.22328,0.16015,1,1
2,GO TRANSLATIONAL TERMINATION,0.001662,0.22313,0.21854,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00353,0.22311,0.19444,1,1
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.047551,0.22297,0.12548,1,1
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.001986,0.22295,0.22217,1,1
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.001228,0.22269,0.1664,1,1
2,GO NUCLEUS LOCALIZATION,0.0022992,0.22255,0.17072,1,1
2,GO INTESTINAL ABSORPTION,0.0087944,0.22167,0.19457,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.1888e-05,0.22099,0.21191,1,1
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0021062,0.22023,0.22781,1,1
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,6.7596e-05,0.22022,0.21071,1,1
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.026586,0.21991,0.22807,1,1
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0073363,0.21941,0.17182,1,1
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.0014299,0.21924,0.20608,1,1
2,GO RIBOSOME BIOGENESIS,0.00027832,0.21919,0.25342,1,1
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0013872,0.21916,0.1558,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00034072,0.21914,0.23942,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0001165,0.21882,0.18182,1,1
2,GO ICOSANOID METABOLIC PROCESS,0.001986,0.21868,0.18629,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,6.2786e-05,0.21847,0.19701,1,1
2,GO T CELL RECEPTOR SIGNALING PATHWAY,7.547e-05,0.21796,0.18325,1,1
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.00057693,0.2177,0.19629,1,1
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.010245,0.21766,0.12813,1,1
2,GO STEM CELL DIVISION,0.0024367,0.21697,0.2289,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.017137,0.21665,0.1399,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00054072,0.21655,0.15534,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0013457,0.21629,0.18669,1,1
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0042883,0.21627,0.18511,1,1
2,GO AMINO SUGAR CATABOLIC PROCESS,0.02843,0.21616,0.17568,1,1
2,GO T CELL APOPTOTIC PROCESS,0.00042998,0.21578,0.23293,1,1
2,GO IRON ION HOMEOSTASIS,0.00353,0.21575,0.16266,1,1
2,GO KERATAN SULFATE METABOLIC PROCESS,0.042857,0.21563,0.1387,1,1
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00047456,0.21534,0.22068,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0054795,0.21529,0.23026,1,1
2,GO MAINTENANCE OF CELL NUMBER,0.00028792,0.21523,0.20008,1,1
2,GO REGULATION OF GENE SILENCING,5.0683e-06,0.21484,0.20369,1,1
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0045306,0.21476,0.17825,1,1
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.0020453,0.2146,0.23118,1,1
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0024367,0.21452,0.16188,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.017969,0.21442,0.17791,1,1
2,GO RESPONSE TO INTERLEUKIN 15,0.0013457,0.21402,0.19559,1,1
2,GO AMYLOID BETA CLEARANCE,0.0053338,0.21354,0.19606,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0013054,0.21353,0.17504,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0014299,0.21348,0.16489,1,1
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00035231,0.2133,0.22123,1,1
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.015953,0.21288,0.16625,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0087944,0.2128,0.19349,1,1
2,GO B CELL HOMEOSTASIS,0.05161,0.21235,0.1073,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.010245,0.21234,0.19501,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.0017641,0.21185,0.19463,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00038934,0.21182,0.21758,1,1
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0062634,0.21164,0.15797,1,1
2,GO B CELL APOPTOTIC PROCESS,0.012203,0.21164,0.14712,1,1
2,GO INTERACTION WITH HOST,0.0015653,0.21138,0.17433,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00059588,0.21126,0.22841,1,1
2,GO MULTI ORGANISM LOCALIZATION,0.00011241,0.21104,0.18282,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0028957,0.21095,0.16386,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00017186,0.21095,0.22245,1,1
2,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0031536,0.21046,0.1433,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00035231,0.21028,0.20847,1,1
2,GO RRNA TRANSCRIPTION,0.00045924,0.21026,0.2361,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.0025817,0.2102,0.1538,1,1
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.035393,0.21012,0.17625,1,1
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00059588,0.21,0.20423,1,1
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.001986,0.20965,0.18519,1,1
2,GO LEUKOCYTE PROLIFERATION,0.00081984,0.20964,0.16127,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,5.0226e-05,0.2095,0.19498,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.00024286,0.20924,0.16592,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00012074,0.20924,0.19773,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.011047,0.20914,0.15851,1,1
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.00353,0.20899,0.1704,1,1
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.010506,0.20862,0.17098,1,1
2,GO REGULATION OF NECROTIC CELL DEATH,0.010773,0.20837,0.21633,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0059384,0.20828,0.15751,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.031059,0.20813,0.13046,1,1
2,GO REGULATION OF B CELL PROLIFERATION,0.0034322,0.20778,0.16856,1,1
2,GO TYPE I INTERFERON PRODUCTION,0.0064317,0.20764,0.17278,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0075304,0.20759,0.20384,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0025817,0.20756,0.17138,1,1
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0079323,0.20737,0.13116,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00013433,0.20735,0.26378,1,1
2,GO RNA POLYADENYLATION,0.00090094,0.20729,0.15255,1,1
2,GO THIOESTER METABOLIC PROCESS,0.0017123,0.20708,0.19953,1,1
2,GO CYTOPLASM ORGANIZATION,0.014138,0.20701,0.22853,1,1
2,GO RNA STABILIZATION,0.0010859,0.20696,0.15655,1,1
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.017549,0.20675,0.17263,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.047551,0.20663,0.1471,1,1
2,GO POSITIVE REGULATION OF WOUND HEALING,0.045624,0.20643,0.17967,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0040578,0.20642,0.15938,1,1
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.00041602,0.20632,0.23578,1,1
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.043763,0.20628,0.15932,1,1
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0050528,0.20625,0.15868,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0010206,0.20549,0.16386,1,1
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.025994,0.20513,0.18979,1,1
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00011241,0.20513,0.18637,1,1
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00098941,0.20481,0.21861,1,1
2,GO RRNA MODIFICATION,0.0064317,0.20453,0.20358,1,1
2,GO NCRNA PROCESSING,0.00041602,0.20423,0.2166,1,1
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0013872,0.20411,0.18274,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,9.7801e-06,0.20398,0.25326,1,1
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00063551,0.20371,0.1765,1,1
2,GO LATERAL VENTRICLE DEVELOPMENT,0.00079435,0.2034,0.26889,1,1
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.0030654,0.20338,0.21657,1,1
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.0099891,0.20327,0.15712,1,1
2,GO COPPER ION TRANSPORT,0.009256,0.2032,0.1839,1,1
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.050569,0.2029,0.10848,1,1
2,GO HISTONE DEUBIQUITINATION,7.547e-05,0.2029,0.18267,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00353,0.20256,0.21796,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0021062,0.20239,0.17034,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00021167,0.20213,0.2128,1,1
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0010859,0.20199,0.18167,1,1
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0006154,0.2018,0.18869,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0099891,0.20159,0.14887,1,1
2,GO COPII COATED VESICLE CARGO LOADING,0.0038387,0.20083,0.15725,1,1
2,GO RESPONSE TO ESTROGEN,0.0087944,0.20081,0.17641,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.031748,0.20068,0.16199,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0051916,0.20066,0.225,1,1
2,GO CELLULAR IRON ION HOMEOSTASIS,0.0028957,0.20054,0.14857,1,1
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0023671,0.20051,0.12722,1,1
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.015203,0.20034,0.11934,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.02166,0.20016,0.1438,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.0038387,0.2001,0.20733,1,1
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.025994,0.20005,0.18769,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,9.0551e-05,0.20004,0.17681,1,1
2,GO REGULATION OF CELLULAR RESPIRATION,0.025414,0.19993,0.16782,1,1
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.00029782,0.19988,0.18905,1,1
2,GO INTERACTION WITH SYMBIONT,0.00013917,0.19985,0.21832,1,1
2,GO TRACHEA DEVELOPMENT,0.036164,0.19939,0.18053,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0039469,0.19936,0.23072,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.010506,0.19913,0.15499,1,1
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0015189,0.19911,0.25399,1,1
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,9.0551e-05,0.19886,0.19566,1,1
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.030383,0.19871,0.14288,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00013917,0.19847,0.1919,1,1
2,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.0085714,0.19833,0.20911,1,1
2,GO B CELL MEDIATED IMMUNITY,0.0059384,0.19809,0.14249,1,1
2,GO RNA METHYLATION,0.00092958,0.19798,0.16294,1,1
2,GO CELLULAR KETONE METABOLIC PROCESS,0.0030654,0.1979,0.13998,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0094949,0.19781,0.19501,1,1
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00017186,0.1976,0.2146,1,1
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0028957,0.19753,0.16624,1,1
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0014299,0.19602,0.1642,1,1
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0049174,0.196,0.18078,1,1
2,GO POLYOL BIOSYNTHETIC PROCESS,0.0075304,0.19591,0.12552,1,1
2,GO REGULATION OF BONE DEVELOPMENT,0.0047853,0.1957,0.14912,1,1
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.049546,0.19565,0.13607,1,1
2,GO LEFT RIGHT PATTERN FORMATION,0.0085714,0.19557,0.23464,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0031536,0.19524,0.19626,1,1
2,GO REGULATION OF T CELL CHEMOTAXIS,0.016339,0.19508,0.18222,1,1
2,GO RRNA METABOLIC PROCESS,0.00055855,0.1949,0.22801,1,1
2,GO PEPTIDYL ARGININE MODIFICATION,5.2139e-05,0.19463,0.21572,1,1
2,GO AEROBIC RESPIRATION,0.00067758,0.19461,0.20015,1,1
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.041967,0.19459,0.11585,1,1
2,GO PRIMARY MIRNA PROCESSING,0.0011549,0.19456,0.20914,1,1
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.011047,0.19441,0.16738,1,1
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.019283,0.19425,0.13959,1,1
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0013054,0.19389,0.16848,1,1
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.017137,0.19358,0.19846,1,1
2,GO INTERLEUKIN 10 PRODUCTION,0.016734,0.19333,0.15527,1,1
2,GO GENITALIA MORPHOGENESIS,0.033894,0.19304,0.18236,1,1
2,GO ORGANIC ACID CATABOLIC PROCESS,0.00081984,0.19263,0.15868,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0053338,0.1925,0.15136,1,1
2,GO CHYLOMICRON ASSEMBLY,0.010245,0.19239,0.13701,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,0.0054795,0.19231,0.21851,1,1
2,GO AXIS ELONGATION,0.0057817,0.19211,0.29493,1,1
2,GO DIGESTIVE SYSTEM PROCESS,0.0019282,0.19199,0.16639,1,1
2,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.030383,0.19172,0.21302,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00021909,0.19153,0.23874,1,1
2,GO NEGATIVE T CELL SELECTION,0.0097392,0.19146,0.10581,1,1
2,GO TRNA TRANSPORT,1.2962e-05,0.19136,0.24443,1,1
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.0022992,0.19126,0.18958,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00017186,0.19105,0.1935,1,1
2,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0015653,0.191,0.15022,1,1
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0013872,0.19076,0.15061,1,1
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.02166,0.19062,0.1709,1,1
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.018836,0.19027,0.12598,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,1.1964e-05,0.19023,0.1697,1,1
2,GO TRNA METABOLIC PROCESS,0.00024286,0.19017,0.18626,1,1
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0064317,0.19007,0.16536,1,1
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.036948,0.18975,0.13877,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.004408,0.18971,0.13579,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0071468,0.18946,0.13467,1,1
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0087944,0.1893,0.17194,1,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.013798,0.18928,0.1723,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.0046564,0.18915,0.16219,1,1
2,GO T CELL PROLIFERATION,0.0013054,0.1891,0.16658,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.00026903,0.18909,0.24946,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,1.8251e-06,0.18902,0.20438,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00057693,0.18899,0.15748,1,1
2,GO THYMUS DEVELOPMENT,0.0037331,0.18875,0.16836,1,1
2,GO NCRNA METABOLIC PROCESS,0.00055855,0.18855,0.19249,1,1
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0051916,0.18804,0.21643,1,1
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0022332,0.18785,0.18755,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.041093,0.18769,0.11979,1,1
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.052669,0.18756,0.18764,1,1
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.001662,0.18718,0.18496,1,1
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,1.104e-05,0.18701,0.20664,1,1
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.001662,0.18686,0.20618,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.0025817,0.18598,0.19064,1,1
2,GO FATTY ACID CATABOLIC PROCESS,0.016734,0.18597,0.12578,1,1
2,GO RNA INTERFERENCE,0.0079323,0.18581,0.17857,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0012662,0.18571,0.18463,1,1
2,GO PIGMENT GRANULE ORGANIZATION,8.7323e-05,0.18527,0.22708,1,1
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0069616,0.18433,0.11737,1,1
2,GO ENAMEL MINERALIZATION,0.05161,0.18393,0.28276,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0069616,0.18345,0.13427,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.052669,0.18337,0.15964,1,1
2,GO PINOCYTOSIS,0.014841,0.18316,0.12439,1,1
2,GO RESPONSE TO ANTIBIOTIC,0.0006154,0.18295,0.19425,1,1
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.0022332,0.18237,0.14422,1,1
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00012964,0.18213,0.16658,1,1
2,GO TERPENOID METABOLIC PROCESS,0.014138,0.18173,0.16093,1,1
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.035393,0.18155,0.17467,1,1
2,GO NECROTIC CELL DEATH,0.020205,0.18127,0.16414,1,1
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0045306,0.18087,0.15133,1,1
2,GO TRICARBOXYLIC ACID CYCLE,0.0022332,0.18054,0.22706,1,1
2,GO INTERLEUKIN 1 PRODUCTION,0.0069616,0.18054,0.22126,1,1
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.046579,0.18021,0.16375,1,1
2,GO RESPONSE TO OSMOTIC STRESS,0.0015653,0.18012,0.16492,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.03245,0.18005,0.25633,1,1
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,7.547e-05,0.17989,0.2359,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.011047,0.17951,0.15129,1,1
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.023741,0.17946,0.15152,1,1
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.016734,0.17875,0.21327,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.001228,0.17842,0.16056,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.030383,0.17838,0.13751,1,1
2,GO FATTY ACID TRANSPORT,0.00047456,0.17825,0.15179,1,1
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.052669,0.17825,0.12082,1,1
2,GO RNA MODIFICATION,0.00044439,0.17762,0.15747,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0024367,0.17744,0.16598,1,1
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.023205,0.17733,0.16175,1,1
2,GO SYMBIOTIC PROCESS,0.00024286,0.17731,0.1543,1,1
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.041093,0.17726,0.15127,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00095906,0.17713,0.16939,1,1
2,GO LIPID MODIFICATION,0.0021689,0.17696,0.12455,1,1
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0034322,0.17693,0.1522,1,1
2,GO NATURAL KILLER CELL PROLIFERATION,0.024288,0.17676,0.2034,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0053338,0.17656,0.13126,1,1
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.00017796,0.17655,0.1617,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,1.0604e-05,0.17621,0.15951,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00044439,0.17616,0.15531,1,1
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.00081984,0.17614,0.17901,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0039469,0.17582,0.12905,1,1
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00026003,0.17577,0.17065,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00023468,0.17535,0.20304,1,1
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.0028957,0.17527,0.15919,1,1
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.020205,0.17464,0.13701,1,1
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0057817,0.17464,0.21213,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.019739,0.17461,0.12015,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0090226,0.17438,0.13526,1,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0094949,0.17437,0.15959,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.047551,0.1743,0.13988,1,1
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0042883,0.17424,0.14521,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0011549,0.17327,0.20141,1,1
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0021689,0.17303,0.13629,1,1
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.014486,0.17283,0.1539,1,1
2,GO ANIMAL ORGAN REGENERATION,0.027188,0.17246,0.12398,1,1
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0037331,0.17227,0.19047,1,1
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.026586,0.17219,0.12706,1,1
2,GO LEUKOCYTE MEDIATED IMMUNITY,0.0059384,0.17209,0.13113,1,1
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.017549,0.17208,0.16465,1,1
2,GO RESPONSE TO CORTICOSTEROID,0.052669,0.17206,0.11945,1,1
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.00050664,0.17196,0.17433,1,1
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.025414,0.17191,0.10941,1,1
2,GO HISTONE H3 K4 TRIMETHYLATION,0.0015653,0.1718,0.17091,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.049546,0.17176,0.11927,1,1
2,GO INTERFERON GAMMA PRODUCTION,0.001662,0.17143,0.14687,1,1
2,GO MYOBLAST DIFFERENTIATION,0.009256,0.17078,0.18835,1,1
2,GO HISTONE H2B UBIQUITINATION,0.007729,0.17077,0.14854,1,1
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.015574,0.17074,0.15454,1,1
2,GO TRNA PROCESSING,0.00049035,0.17067,0.17675,1,1
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.052669,0.17062,0.11496,1,1
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00054072,0.17004,0.17289,1,1
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0006154,0.16995,0.19681,1,1
2,GO CELLULAR RESPONSE TO ALCOHOL,0.00042998,0.1698,0.17626,1,1
2,GO STEROL METABOLIC PROCESS,0.011612,0.16977,0.11677,1,1
2,GO METANEPHROS DEVELOPMENT,0.043763,0.16974,0.14965,1,1
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0025083,0.16922,0.21776,1,1
2,GO APICAL JUNCTION ASSEMBLY,0.023205,0.16919,0.17737,1,1
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.01282,0.16889,0.11203,1,1
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.0046564,0.16874,0.16218,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.00038934,0.1686,0.16018,1,1
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.0027346,0.16813,0.18006,1,1
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.025414,0.16808,0.2129,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00074557,0.16787,0.13555,1,1
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.03939,0.16748,0.16595,1,1
2,GO CELL CELL JUNCTION ORGANIZATION,0.041967,0.16729,0.11507,1,1
2,GO B CELL PROLIFERATION,0.0047853,0.16701,0.14361,1,1
2,GO MRNA METHYLATION,0.043763,0.16696,0.13958,1,1
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.001228,0.16684,0.19329,1,1
2,GO VIRAL LIFE CYCLE,0.0036303,0.16567,0.15337,1,1
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0053338,0.16558,0.16805,1,1
2,GO KERATINOCYTE PROLIFERATION,0.049546,0.16557,0.26095,1,1
2,GO HISTONE H3 K14 ACETYLATION,0.0001165,0.16544,0.16381,1,1
2,GO SCHWANN CELL DIFFERENTIATION,0.018836,0.16524,0.13202,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.0022332,0.16519,0.13686,1,1
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0085714,0.16502,0.17276,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0057817,0.16474,0.13628,1,1
2,GO LIPID HOMEOSTASIS,0.0066042,0.16454,0.13305,1,1
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.03939,0.16403,0.11607,1,1
2,GO GRANULOCYTE CHEMOTAXIS,0.030383,0.16397,0.099348,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.014486,0.16376,0.14946,1,1
2,GO REGULATION OF PHAGOCYTOSIS,0.012203,0.1637,0.1256,1,1
2,GO FC RECEPTOR SIGNALING PATHWAY,0.0024367,0.1636,0.14178,1,1
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0014738,0.16358,0.14047,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0042883,0.16351,0.16534,1,1
2,GO PEPTIDE METABOLIC PROCESS,0.0010528,0.16319,0.1454,1,1
2,GO PHOTOPERIODISM,0.037747,0.163,0.10871,1,1
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.011904,0.16298,0.11383,1,1
2,GO CYTOKINE PRODUCTION,0.0064317,0.16274,0.1265,1,1
2,GO RNA CATABOLIC PROCESS,0.00065623,0.16236,0.15626,1,1
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0036303,0.16221,0.11467,1,1
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.00092958,0.16212,0.13204,1,1
2,GO MRNA TRANSCRIPTION,0.0054795,0.1621,0.15992,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0011199,0.16207,0.18441,1,1
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.023205,0.16192,0.14178,1,1
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.035393,0.16185,0.15526,1,1
2,GO CYTOKINE METABOLIC PROCESS,0.0047853,0.16174,0.13514,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.00045924,0.16152,0.1328,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.017969,0.1614,0.10898,1,1
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0029794,0.16138,0.13888,1,1
2,GO POSITIVE CHEMOTAXIS,0.02068,0.16138,0.13575,1,1
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.014138,0.16136,0.10153,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE,0.010506,0.16111,0.10097,1,1
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.023741,0.16092,0.10399,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.05161,0.16072,0.13974,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0051916,0.16065,0.11368,1,1
2,GO CD40 SIGNALING PATHWAY,0.023205,0.1606,0.1248,1,1
2,GO RESPONSE TO BACTERIUM,0.013798,0.16045,0.1005,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION,0.018398,0.16042,0.12306,1,1
2,GO STEROL BIOSYNTHETIC PROCESS,0.013139,0.16041,0.17544,1,1
2,GO INNATE IMMUNE RESPONSE,0.0066042,0.16021,0.13071,1,1
2,GO ERBB SIGNALING PATHWAY,0.0025083,0.16019,0.13469,1,1
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.023205,0.16015,0.15877,1,1
2,GO REGULATION OF IMMUNE RESPONSE,0.0028141,0.15981,0.12407,1,1
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00050664,0.15975,0.16706,1,1
2,GO MYELOID LEUKOCYTE ACTIVATION,0.0039469,0.15965,0.13605,1,1
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.001662,0.15962,0.17465,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.014841,0.1596,0.14453,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0029794,0.15939,0.13956,1,1
2,GO T CELL DIFFERENTIATION,0.0038387,0.15926,0.13341,1,1
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.035393,0.15896,0.12123,1,1
2,GO REGULATION OF CELL CELL ADHESION,0.014138,0.1585,0.12078,1,1
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0017641,0.15845,0.25468,1,1
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.022165,0.15811,0.16841,1,1
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0020453,0.15803,0.2254,1,1
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.010773,0.1578,0.10157,1,1
2,GO PROTEIN KINASE B SIGNALING,0.024846,0.15722,0.099977,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0099891,0.15693,0.16133,1,1
2,GO REGULATION OF CELL ACTIVATION,0.0036303,0.15647,0.1229,1,1
2,GO TRANSITION METAL ION HOMEOSTASIS,0.0032441,0.15641,0.15467,1,1
2,GO VIRAL RNA GENOME REPLICATION,0.037747,0.15628,0.13703,1,1
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.0071468,0.15591,0.12945,1,1
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.00026003,0.15589,0.16989,1,1
2,GO P BODY ASSEMBLY,0.0021062,0.15574,0.13824,1,1
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00092958,0.15548,0.15424,1,1
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.0099891,0.15546,0.11883,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.02843,0.1554,0.11709,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.00016023,0.15532,0.16415,1,1
2,GO NUCLEOBASE METABOLIC PROCESS,0.0010206,0.15521,0.19759,1,1
2,GO REGULATION OF DEFENSE RESPONSE,0.0037331,0.1552,0.11424,1,1
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.0020453,0.1547,0.12485,1,1
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0087944,0.15451,0.1445,1,1
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0038387,0.15392,0.11986,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0007696,0.15353,0.18701,1,1
2,GO ELECTRON TRANSPORT CHAIN,0.0075304,0.15341,0.1267,1,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00016023,0.15322,0.17951,1,1
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.0012662,0.15321,0.26055,1,1
2,GO VESICLE TARGETING,0.0027346,0.15303,0.13314,1,1
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0064317,0.15296,0.14558,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00055855,0.15295,0.14861,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00019753,0.15285,0.13176,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.038561,0.15277,0.2914,1,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.038561,0.15271,0.13388,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.014138,0.1527,0.15803,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00054072,0.15264,0.1465,1,1
2,GO PHAGOCYTOSIS,0.0053338,0.15245,0.14532,1,1
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0023671,0.15244,0.16936,1,1
2,GO DIGESTION,0.010245,0.15226,0.12736,1,1
2,GO CELLULAR RESPONSE TO VIRUS,0.01282,0.15211,0.13598,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.013139,0.15199,0.095955,1,1
2,GO RESPONSE TO CYTOKINE,0.010245,0.15167,0.11094,1,1
2,GO PLATELET ACTIVATION,0.050569,0.15154,0.089358,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,8.1192e-05,0.15147,0.14497,1,1
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,1.2454e-05,0.15134,0.17892,1,1
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0099891,0.15133,0.228,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0059384,0.15083,0.17458,1,1
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.00025131,0.15068,0.1261,1,1
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0019282,0.15066,0.16843,1,1
2,GO T CELL ACTIVATION,0.0071468,0.15054,0.12592,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00026903,0.15027,0.16241,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0029794,0.15024,0.15125,1,1
2,GO INTERFERON BETA PRODUCTION,0.027803,0.15021,0.14766,1,1
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00029782,0.15017,0.14509,1,1
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.023741,0.14998,0.10987,1,1
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0011549,0.14967,0.1426,1,1
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0028957,0.14932,0.15495,1,1
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.029719,0.14929,0.20822,1,1
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.0094949,0.14907,0.11794,1,1
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0025083,0.1487,0.13906,1,1
2,GO PROGRAMMED NECROTIC CELL DEATH,0.024846,0.14852,0.15197,1,1
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.016734,0.14825,0.22555,1,1
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.014138,0.14815,0.12236,1,1
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0069616,0.14791,0.18175,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE,0.00055855,0.14791,0.14492,1,1
2,GO B CELL DIFFERENTIATION,0.0083534,0.14779,0.11728,1,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.015203,0.14779,0.12728,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00065623,0.14779,0.13653,1,1
2,GO GOLGI VESICLE BUDDING,0.001191,0.1476,0.12614,1,1
2,GO PROTEIN IMPORT,0.0019282,0.14747,0.13069,1,1
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.019283,0.14734,0.19193,1,1
2,GO TRANSEPITHELIAL TRANSPORT,0.0099891,0.14711,0.16459,1,1
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.009256,0.14702,0.13791,1,1
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.030383,0.147,0.13639,1,1
2,GO REGULATION OF T CELL ACTIVATION,0.0067808,0.14699,0.12821,1,1
2,GO LEUKOCYTE CELL CELL ADHESION,0.00353,0.1469,0.14386,1,1
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,4.0073e-05,0.14657,0.1437,1,1
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.041967,0.14637,0.30564,1,1
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0071468,0.14637,0.11556,1,1
2,GO RECEPTOR CATABOLIC PROCESS,0.023205,0.14637,0.15217,1,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0064317,0.14602,0.12032,1,1
2,GO LYMPHOCYTE DIFFERENTIATION,0.0022992,0.14556,0.12527,1,1
2,GO ACTIVATION OF IMMUNE RESPONSE,0.0014299,0.14556,0.13322,1,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0013872,0.14542,0.16642,1,1
2,GO LIPOPROTEIN LOCALIZATION,0.041967,0.14542,0.10338,1,1
2,GO IMPORT INTO NUCLEUS,0.02166,0.14532,0.11211,1,1
2,GO ACTIN FILAMENT ORGANIZATION,0.013465,0.1451,0.10265,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0039469,0.1451,0.16692,1,1
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.029068,0.14507,0.1199,1,1
2,GO CELL KILLING,0.010245,0.14501,0.12763,1,1
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.00045924,0.14451,0.14198,1,1
2,GO RESPONSE TO BIOTIC STIMULUS,0.011904,0.14415,0.10279,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0097392,0.14404,0.10802,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0027346,0.14395,0.22552,1,1
2,GO SMOOTH MUSCLE CELL PROLIFERATION,0.038561,0.14392,0.11589,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.010506,0.14334,0.10937,1,1
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.013139,0.14308,0.11518,1,1
2,GO SERTOLI CELL DIFFERENTIATION,0.023741,0.14298,0.20433,1,1
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.004408,0.1428,0.16105,1,1
2,GO GOLGI RIBBON FORMATION,0.018398,0.14271,0.13842,1,1
2,GO REGULATION OF PROTEIN SUMOYLATION,0.050569,0.14237,0.11908,1,1
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.01282,0.14237,0.09459,1,1
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00065623,0.14228,0.12581,1,1
2,GO ANTIBACTERIAL HUMORAL RESPONSE,0.034637,0.14212,0.12967,1,1
2,GO OXIDATION REDUCTION PROCESS,0.0017641,0.14183,0.12411,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.016339,0.14159,0.09467,1,1
2,GO HEXOSE CATABOLIC PROCESS,0.0079323,0.1415,0.17319,1,1
2,GO IMMUNE EFFECTOR PROCESS,0.0066042,0.14144,0.12496,1,1
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00045924,0.14128,0.12944,1,1
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.012508,0.14123,0.11833,1,1
2,GO RESPONSE TO GAMMA RADIATION,0.001228,0.14088,0.18212,1,1
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.021165,0.14081,0.13514,1,1
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.02843,0.14062,0.16459,1,1
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.00034072,0.14024,0.1391,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0062634,0.14016,0.12479,1,1
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.010245,0.14011,0.14857,1,1
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.011047,0.14009,0.1295,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0021062,0.14006,0.1955,1,1
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00045924,0.14001,0.18454,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.0017641,0.13993,0.1523,1,1
2,GO TRNA WOBBLE BASE MODIFICATION,0.015574,0.13976,0.11239,1,1
2,GO POLYOL METABOLIC PROCESS,0.00022676,0.13931,0.16091,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.014138,0.13922,0.1544,1,1
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0060989,0.13914,0.11523,1,1
2,GO TISSUE HOMEOSTASIS,0.010506,0.13892,0.095562,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,7.8282e-05,0.13869,0.13004,1,1
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0024367,0.13867,0.13598,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,5.8301e-05,0.13846,0.13368,1,1
2,GO INTERFERON ALPHA PRODUCTION,0.027188,0.1384,0.18867,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0075304,0.13836,0.10637,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0090226,0.13832,0.11569,1,1
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.02268,0.13821,0.12472,1,1
2,GO MALE SEX DIFFERENTIATION,0.050569,0.13817,0.12307,1,1
2,GO RESPONSE TO IRON ION,0.050569,0.13805,0.14981,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,3.1888e-05,0.13781,0.14227,1,1
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0017123,0.13778,0.12931,1,1
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.020205,0.13768,0.1028,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,7.8282e-05,0.1376,0.15382,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0034322,0.13759,0.1665,1,1
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.00028792,0.13758,0.17884,1,1
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.018398,0.13753,0.087825,1,1
2,GO ACTIN FILAMENT BASED MOVEMENT,0.013465,0.13733,0.1162,1,1
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0027346,0.13732,0.13605,1,1
2,GO COPII COATED VESICLE BUDDING,0.0010859,0.13715,0.12497,1,1
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.016734,0.1369,0.14322,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.014486,0.13686,0.14357,1,1
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0036303,0.13685,0.11346,1,1
2,GO RESPONSE TO ACTIVITY,0.02843,0.13685,0.096477,1,1
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.023205,0.13679,0.11631,1,1
2,GO REGULATION OF HEMOPOIESIS,0.007729,0.13664,0.11952,1,1
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0059384,0.13645,0.15131,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.00025131,0.13617,0.13029,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.020205,0.13609,0.13976,1,1
2,GO REGULATION OF B CELL ACTIVATION,0.015953,0.13589,0.10866,1,1
2,GO AMIDE BIOSYNTHETIC PROCESS,0.00049035,0.13545,0.15649,1,1
2,GO BASE EXCISION REPAIR,0.0038387,0.13528,0.12574,1,1
2,GO NUCLEAR EXPORT,9.7346e-05,0.13523,0.16091,1,1
2,GO ERK1 AND ERK2 CASCADE,0.019739,0.13512,0.11902,1,1
2,GO FEVER GENERATION,0.050569,0.13509,0.1561,1,1
2,GO ALPHA BETA T CELL ACTIVATION,0.001986,0.13488,0.16073,1,1
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.01282,0.13487,0.12132,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.027188,0.13476,0.15834,1,1
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.019283,0.13353,0.10579,1,1
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.010245,0.13342,0.11188,1,1
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00029782,0.13335,0.15018,1,1
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.013798,0.13291,0.12961,1,1
2,GO TELOMERE ORGANIZATION,0.00038934,0.13287,0.13776,1,1
2,GO LIPID METABOLIC PROCESS,0.0011199,0.13283,0.11064,1,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.0025817,0.13282,0.11717,1,1
2,GO LYMPHOCYTE ACTIVATION,0.010773,0.13245,0.10337,1,1
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.050569,0.13238,0.13667,1,1
2,GO DNA GEOMETRIC CHANGE,0.00014418,0.13213,0.15335,1,1
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00049035,0.13205,0.12337,1,1
2,GO CELL ACTIVATION,0.013465,0.13196,0.098859,1,1
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.034637,0.13135,0.13753,1,1
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.04854,0.13121,0.097599,1,1
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.041967,0.13121,0.16611,1,1
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,7.2754e-05,0.13118,0.13638,1,1
2,GO ORGANIC ACID METABOLIC PROCESS,0.0010859,0.13044,0.11862,1,1
2,GO CELL CELL RECOGNITION,0.016734,0.13043,0.10222,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00052342,0.13042,0.15987,1,1
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0054795,0.12974,0.12503,1,1
2,GO DEFENSE RESPONSE,0.021165,0.12953,0.082723,1,1
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0090226,0.12856,0.12848,1,1
2,GO MRNA CLEAVAGE,2.2524e-05,0.12849,0.1658,1,1
2,GO BODY FLUID SECRETION,0.00090094,0.12831,0.15203,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.011612,0.12821,0.09855,1,1
2,GO MRNA 3 END PROCESSING,0.00045924,0.12808,0.14323,1,1
2,GO HISTONE PHOSPHORYLATION,0.0090226,0.12784,0.10778,1,1
2,GO OXIDATIVE DEMETHYLATION,0.020205,0.12765,0.092979,1,1
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0085714,0.12758,0.1446,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0090226,0.12752,0.13045,1,1
2,GO GOLGI VESICLE TRANSPORT,0.0015189,0.12696,0.098636,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.0022332,0.12681,0.13721,1,1
2,GO NUCLEOTIDE PHOSPHORYLATION,0.042857,0.1268,0.083463,1,1
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.046579,0.12674,0.081802,1,1
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.001872,0.12617,0.12099,1,1
2,GO STEROL IMPORT,0.01282,0.12604,0.17471,1,1
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.019283,0.12555,0.088981,1,1
2,GO LIPID CATABOLIC PROCESS,0.011904,0.1254,0.099419,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,9.7346e-05,0.12488,0.11788,1,1
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.019739,0.12444,0.084239,1,1
2,GO HISTONE H3 DEACETYLATION,0.019283,0.12442,0.11692,1,1
2,GO RESPONSE TO IONIZING RADIATION,0.0015189,0.12418,0.16255,1,1
2,GO RNA PROCESSING,0.00016595,0.12406,0.15172,1,1
2,GO GENE SILENCING,1.4609e-05,0.12385,0.13436,1,1
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.041967,0.12359,0.091026,1,1
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.015574,0.1223,0.1206,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0026572,0.12217,0.14542,1,1
2,GO MRNA METABOLIC PROCESS,0.00017796,0.12179,0.13519,1,1
2,GO PROTEIN SUMOYLATION,0.00012074,0.12162,0.12794,1,1
2,GO STRESS GRANULE ASSEMBLY,0.012203,0.12125,0.11656,1,1
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.038561,0.1209,0.10299,1,1
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.016339,0.1207,0.11852,1,1
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.0069616,0.1204,0.10391,1,1
2,GO RESPONSE TO MUSCLE ACTIVITY,0.024288,0.12038,0.18032,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.00021909,0.12029,0.1183,1,1
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0053338,0.12013,0.14305,1,1
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.033894,0.1196,0.069089,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.029068,0.11945,0.11822,1,1
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0099891,0.11889,0.15156,1,1
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.027803,0.11866,0.083935,1,1
2,GO REGULATION OF MYELINATION,0.038561,0.11862,0.10344,1,1
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.033166,0.11851,0.10815,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0028957,0.11847,0.10615,1,1
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.014486,0.11797,0.090136,1,1
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.02068,0.11795,0.1316,1,1
2,GO PROTEIN NEDDYLATION,0.029719,0.1179,0.10556,1,1
2,GO RESPONSE TO STEROID HORMONE,0.047551,0.11788,0.095905,1,1
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00022676,0.11771,0.13518,1,1
2,GO FOCAL ADHESION ASSEMBLY,0.044685,0.11749,0.15245,1,1
2,GO ACTIN NUCLEATION,0.018836,0.11733,0.11748,1,1
2,GO REGULATION OF ORGAN GROWTH,0.044685,0.11715,0.1211,1,1
2,GO NON RECOMBINATIONAL REPAIR,0.0094949,0.11703,0.1006,1,1
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0037331,0.11662,0.091428,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00084609,0.11653,0.15272,1,1
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.0033369,0.11639,0.10396,1,1
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.0032441,0.11633,0.097154,1,1
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0033369,0.1161,0.10579,1,1
2,GO DNA BIOSYNTHETIC PROCESS,0.00035231,0.11606,0.10502,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.037747,0.11605,0.10562,1,1
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.017137,0.11562,0.16704,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00042998,0.11559,0.13664,1,1
2,GO PEROXISOMAL TRANSPORT,0.0062634,0.11531,0.13382,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0022992,0.11526,0.12147,1,1
2,GO PYRUVATE METABOLIC PROCESS,0.047551,0.11417,0.086022,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0083534,0.11383,0.10364,1,1
2,GO EAR MORPHOGENESIS,0.017969,0.11382,0.13164,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.033894,0.11371,0.11804,1,1
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.033166,0.11368,0.091151,1,1
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0046564,0.11353,0.16041,1,1
2,GO ACTIVATION OF GTPASE ACTIVITY,0.02268,0.11326,0.098049,1,1
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.041967,0.11319,0.066742,1,1
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.017969,0.11311,0.078825,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.015203,0.11295,0.095117,1,1
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.046579,0.11292,0.15119,1,1
2,GO LEUKOCYTE DIFFERENTIATION,0.0099891,0.11272,0.098411,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00047456,0.11254,0.13846,1,1
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.033166,0.11249,0.11698,1,1
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.013139,0.11244,0.092192,1,1
2,GO REGULATION OF MRNA 3 END PROCESSING,0.015203,0.11232,0.11,1,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.0053338,0.11221,0.11821,1,1
2,GO NUCLEAR TRANSPORT,0.0018173,0.11205,0.11881,1,1
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.027803,0.11186,0.085733,1,1
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.033894,0.11167,0.081114,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0018173,0.11141,0.12801,1,1
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.02843,0.11116,0.10349,1,1
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.031748,0.11092,0.13206,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION,0.013798,0.1109,0.1266,1,1
2,GO RNA EXPORT FROM NUCLEUS,0.0001165,0.11068,0.16892,1,1
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0026572,0.11053,0.13885,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.010506,0.11016,0.10935,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0067808,0.11001,0.12022,1,1
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.05161,0.10988,0.07732,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.035393,0.10958,0.078272,1,1
2,GO HUMORAL IMMUNE RESPONSE,0.021165,0.10956,0.070156,1,1
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00020448,0.10956,0.14177,1,1
2,GO PEROXISOME ORGANIZATION,0.0079323,0.10944,0.11875,1,1
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0024367,0.1094,0.11329,1,1
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.00084609,0.10883,0.11147,1,1
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.025414,0.10792,0.091682,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0087944,0.10781,0.10084,1,1
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0029794,0.10774,0.082699,1,1
2,GO REGULATION OF ATP METABOLIC PROCESS,0.016339,0.10697,0.087305,1,1
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.013139,0.1067,0.087767,1,1
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.042857,0.10645,0.11624,1,1
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.035393,0.10585,0.09222,1,1
2,GO VIRAL RELEASE FROM HOST CELL,0.017969,0.10491,0.12078,1,1
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.031748,0.10467,0.10111,1,1
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.036164,0.10462,0.10478,1,1
2,GO MRNA TRANSPORT,0.00098941,0.10385,0.13743,1,1
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00024286,0.1037,0.11292,1,1
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.023741,0.1036,0.13061,1,1
2,GO NEGATIVE REGULATION OF CELL DEATH,0.017137,0.10317,0.081932,1,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.004408,0.10246,0.096349,1,1
2,GO PEPTIDYL TYROSINE MODIFICATION,0.011326,0.10223,0.12461,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,6.2786e-05,0.10215,0.13018,1,1
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.012508,0.10205,0.18478,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0014738,0.10198,0.11941,1,1
2,GO MRNA PROCESSING,0.00098941,0.10175,0.10927,1,1
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0022332,0.10162,0.13468,1,1
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.036164,0.10158,0.11777,1,1
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.02068,0.1014,0.0759,1,1
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.02843,0.10107,0.10756,1,1
2,GO REGULATION OF RESPONSE TO STRESS,0.016734,0.099552,0.073165,1,1
2,GO RNA 3 END PROCESSING,0.0057817,0.099327,0.11797,1,1
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00057693,0.099124,0.098164,1,1
2,GO VESICLE BUDDING FROM MEMBRANE,0.023741,0.098839,0.081716,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.036164,0.098715,0.07261,1,1
2,GO RNA LOCALIZATION,0.00018427,0.098195,0.15138,1,1
2,GO IMMUNE SYSTEM DEVELOPMENT,0.018398,0.097919,0.08746,1,1
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.0025817,0.097503,0.12772,1,1
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.045624,0.097182,0.075032,1,1
2,GO MRNA EXPORT FROM NUCLEUS,0.00037661,0.097151,0.15034,1,1
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.018398,0.096798,0.066552,1,1
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.017969,0.096777,0.11998,1,1
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.014138,0.096221,0.11691,1,1
2,GO REGULATION OF CATABOLIC PROCESS,0.0045306,0.096121,0.075563,1,1
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.03245,0.09567,0.095013,1,1
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.0099891,0.09543,0.095039,1,1
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.019283,0.094969,0.095211,1,1
2,GO DNA METHYLATION,0.009256,0.09471,0.090647,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.007729,0.094352,0.098635,1,1
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.03245,0.094176,0.085156,1,1
2,GO STEM CELL DIFFERENTIATION,0.010506,0.094058,0.12132,1,1
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.03939,0.093606,0.13947,1,1
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.00026903,0.093346,0.10056,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0059384,0.093334,0.12289,1,1
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.013139,0.092965,0.11187,1,1
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0037331,0.092719,0.099204,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.011904,0.091509,0.11392,1,1
2,GO ACTIN FILAMENT BASED PROCESS,0.05161,0.091497,0.07557,1,1
2,GO DNA CONFORMATION CHANGE,0.0094949,0.090581,0.083715,1,1
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.033166,0.09009,0.05905,1,1
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.029068,0.089912,0.078888,1,1
2,GO CELL AGING,0.029719,0.089427,0.077403,1,1
2,GO RESPONSE TO UV,0.0054795,0.089115,0.12713,1,1
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0017123,0.089078,0.099938,1,1
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.029068,0.088773,0.086824,1,1
2,GO RNA SPLICING,0.0020453,0.088566,0.107,1,1
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0001165,0.088133,0.11976,1,1
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00074557,0.0881,0.11853,1,1
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.013465,0.087811,0.079473,1,1
2,GO GLUCOSE METABOLIC PROCESS,0.025414,0.087595,0.056385,1,1
2,GO PROTEIN POLYUBIQUITINATION,0.021165,0.087472,0.072275,1,1
2,GO CARBOHYDRATE METABOLIC PROCESS,0.0064317,0.08741,0.077006,1,1
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.001986,0.087387,0.081898,1,1
2,GO B CELL ACTIVATION,0.0071468,0.087369,0.096825,1,1
2,GO CHROMATIN REMODELING,0.0028141,0.08717,0.097614,1,1
2,GO REGULATION OF HISTONE UBIQUITINATION,0.024288,0.086722,0.099406,1,1
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.037747,0.086203,0.081786,1,1
2,GO CELL CYCLE PHASE TRANSITION,0.013465,0.084988,0.07816,1,1
2,GO MACROMOLECULE CATABOLIC PROCESS,0.0051916,0.084422,0.074039,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.043763,0.083876,0.064938,1,1
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.050569,0.083464,0.052446,1,1
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.011904,0.083078,0.08958,1,1
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.001872,0.082814,0.090291,1,1
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.031059,0.080511,0.077587,1,1
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.014841,0.080462,0.056878,1,1
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00092958,0.080457,0.097065,1,1
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.015203,0.080293,0.083498,1,1
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.018398,0.080161,0.17197,1,1
2,GO HISTONE H3 ACETYLATION,0.0027346,0.079136,0.091673,1,1
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.033166,0.078754,0.15685,1,1
2,GO CELLULAR RESPONSE TO UV,0.0069616,0.078364,0.11375,1,1
2,GO PROTEIN CATABOLIC PROCESS,0.036948,0.077488,0.050192,1,1
2,GO DOUBLE STRAND BREAK REPAIR,0.0094949,0.077022,0.090903,1,1
2,GO EPITHELIAL TUBE FORMATION,0.052669,0.076783,0.11943,1,1
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.024288,0.07674,0.09339,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.02166,0.073512,0.070546,1,1
2,GO MACROAUTOPHAGY,0.017137,0.0718,0.058488,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0064317,0.071385,0.10616,1,1
2,GO REGULATION OF GLUCONEOGENESIS,0.05161,0.071089,0.068492,1,1
2,GO RESPONSE TO RADIATION,0.026586,0.070833,0.063464,1,1
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.015203,0.068177,0.080644,1,1
2,GO REGULATION OF DNA METABOLIC PROCESS,0.0051916,0.068134,0.076837,1,1
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.025994,0.067604,0.060824,1,1
2,GO DNA INTEGRITY CHECKPOINT,0.023741,0.065549,0.083447,1,1
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.02268,0.063877,0.05164,1,1
2,GO DNA METABOLIC PROCESS,0.004408,0.0637,0.06765,1,1
2,GO DNA MODIFICATION,0.015203,0.06315,0.059423,1,1
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.017137,0.062306,0.080172,1,1
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.042857,0.060125,0.1171,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.044685,0.059932,0.075487,1,1
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.01282,0.059742,0.066338,1,1
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.052669,0.059572,0.058881,1,1
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.025414,0.059455,0.10878,1,1
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.02268,0.058892,0.11355,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0056288,0.058792,0.05732,1,1
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.042857,0.057639,0.060944,1,1
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.017137,0.053453,0.051302,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.04854,0.051571,0.065494,1,1
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.014486,0.048574,0.065694,1,1
2,GO CHROMOSOME ORGANIZATION,0.033894,0.03304,0.055595,1,1
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.6228e-06,0.94756,0.94014,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.9301e-06,0.91031,0.81499,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.071e-07,0.80365,0.80566,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.0311e-06,0.79422,0.73973,1,1
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,6.8936e-07,0.7916,0.92578,1,1
3,GO RESPONSE TO HISTAMINE,2.2658e-06,0.74477,0.72042,1,1
3,GO RESPONSE TO L GLUTAMATE,4.2876e-06,0.69465,0.60666,1,1
3,GO SYNAPSE MATURATION,1.4674e-06,0.68545,0.7436,1,1
3,GO SECRETORY GRANULE LOCALIZATION,2.0033e-05,0.65007,0.54422,1,1
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,2.8418e-05,0.62605,0.56859,1,1
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,1.2454e-05,0.61639,0.52145,1,1
3,GO PYRAMIDAL NEURON DIFFERENTIATION,3.3132e-05,0.60719,0.59391,1,1
3,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,4.0073e-05,0.59411,0.55227,1,1
3,GO REGULATION OF SYNAPSE MATURATION,7.2754e-05,0.57877,0.59374,1,1
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,4.1112e-06,0.57691,0.53241,1,1
3,GO BRANCHING MORPHOGENESIS OF A NERVE,4.6623e-06,0.5716,0.67473,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,8.6584e-06,0.5636,0.52821,1,1
3,GO SYNAPTIC VESICLE MATURATION,1.5816e-05,0.56314,0.55209,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,2.2524e-05,0.55993,0.47787,1,1
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,1.906e-06,0.54883,0.56841,1,1
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.013465,0.5278,0.27946,1,1
3,GO TELENCEPHALON GLIAL CELL MIGRATION,3.1888e-05,0.52089,0.44522,1,1
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00026003,0.51822,0.43648,1,1
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,3.8583e-05,0.51426,0.60361,1,1
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00029782,0.51233,0.39413,1,1
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,3.1904e-06,0.50604,0.55189,1,1
3,GO CORPUS CALLOSUM DEVELOPMENT,1.2366e-07,0.50581,0.55815,1,1
3,GO POSTSYNAPSE ASSEMBLY,2.2524e-05,0.50478,0.5522,1,1
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.001662,0.49835,0.41138,1,1
3,GO SUCKLING BEHAVIOR,2.6902e-06,0.49306,0.46816,1,1
3,GO PLASMA MEMBRANE REPAIR,6.0198e-07,0.49163,0.5509,1,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.00019753,0.4888,0.39291,1,1
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,5.2837e-06,0.48509,0.42077,1,1
3,GO UV PROTECTION,3.0576e-06,0.48315,0.47018,1,1
3,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.0026572,0.48243,0.39301,1,1
3,GO OXYGEN TRANSPORT,0.007729,0.48098,0.47859,1,1
3,GO ADULT HEART DEVELOPMENT,2.9532e-05,0.46765,0.43997,1,1
3,GO GLYCINE TRANSPORT,0.010245,0.46638,0.32803,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.1964e-05,0.46059,0.47156,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,7.547e-05,0.45958,0.48595,1,1
3,GO PROTEIN LOCALIZATION TO AXON,0.0037331,0.45649,0.45228,1,1
3,GO TELENCEPHALON REGIONALIZATION,0.0066042,0.45498,0.35935,1,1
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,3.3287e-06,0.45296,0.44,1,1
3,GO MATURATION OF LSU RRNA,0.00014935,0.4519,0.37323,1,1
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00072223,0.45108,0.37243,1,1
3,GO RIBOSOME ASSEMBLY,0.00032948,0.44701,0.35206,1,1
3,GO EXCITATORY SYNAPSE ASSEMBLY,3.3132e-05,0.44645,0.43335,1,1
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,2.3418e-05,0.44561,0.41876,1,1
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,1.5816e-05,0.44531,0.41464,1,1
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00026003,0.44497,0.40363,1,1
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00013433,0.44103,0.35656,1,1
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,7.8282e-05,0.44058,0.41204,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0019282,0.43622,0.29455,1,1
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,3.7145e-05,0.43405,0.49431,1,1
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,5.2139e-05,0.43229,0.44291,1,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.02068,0.42852,0.26809,1,1
3,GO REGULATION OF GONAD DEVELOPMENT,0.00090094,0.42822,0.27321,1,1
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.4039e-05,0.42626,0.40752,1,1
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00036427,0.41768,0.35519,1,1
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00052342,0.41701,0.41583,1,1
3,GO IMP METABOLIC PROCESS,9.0551e-05,0.41481,0.41783,1,1
3,GO CGMP METABOLIC PROCESS,0.00045924,0.41082,0.36304,1,1
3,GO CARDIAC VENTRICLE FORMATION,0.00040247,0.41063,0.57213,1,1
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00044439,0.40928,0.41246,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00034072,0.40609,0.35238,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,9.0551e-05,0.40382,0.32816,1,1
3,GO VITAMIN CATABOLIC PROCESS,0.01282,0.40346,0.31243,1,1
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,8.3127e-06,0.4005,0.35991,1,1
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0062634,0.3971,0.36548,1,1
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.013139,0.39707,0.27753,1,1
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,2.3418e-05,0.39682,0.38372,1,1
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,6.5149e-05,0.39636,0.43113,1,1
3,GO ELASTIC FIBER ASSEMBLY,0.00045924,0.39581,0.47755,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0059384,0.39443,0.26069,1,1
3,GO MYOBLAST PROLIFERATION,4.6623e-06,0.39425,0.4101,1,1
3,GO SIALYLATION,0.0013457,0.39342,0.40768,1,1
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,2.2524e-05,0.3916,0.34173,1,1
3,GO CARDIAC CHAMBER FORMATION,0.00041602,0.39111,0.51814,1,1
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0057817,0.38824,0.30976,1,1
3,GO INNERVATION,0.00052342,0.38703,0.39486,1,1
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00031859,0.38363,0.34614,1,1
3,GO NEGATIVE CHEMOTAXIS,0.00012512,0.38309,0.34246,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0057817,0.38233,0.2726,1,1
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.010773,0.38101,0.2694,1,1
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00019753,0.38097,0.35262,1,1
3,GO CYTOPLASMIC TRANSLATION,0.00049035,0.38017,0.35101,1,1
3,GO VESICLE FUSION TO PLASMA MEMBRANE,7.9801e-06,0.37741,0.47846,1,1
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0069616,0.37522,0.29253,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.001228,0.37444,0.36944,1,1
3,GO HEART VALVE FORMATION,0.00037661,0.37386,0.39291,1,1
3,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.00045924,0.36967,0.38396,1,1
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00018427,0.36937,0.37404,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00012964,0.36873,0.41623,1,1
3,GO CHEMOSENSORY BEHAVIOR,0.0020453,0.36777,0.26236,1,1
3,GO DENTATE GYRUS DEVELOPMENT,7.8282e-05,0.36694,0.51687,1,1
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.009256,0.36495,0.27525,1,1
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0036303,0.35922,0.25656,1,1
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.033166,0.35692,0.22823,1,1
3,GO L GLUTAMATE IMPORT,0.00045924,0.35529,0.29567,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00014418,0.3552,0.31646,1,1
3,GO ADAPTATION OF SIGNALING PATHWAY,0.0014299,0.35044,0.24031,1,1
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0001547,0.34932,0.33442,1,1
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00065623,0.34881,0.3587,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00090094,0.34876,0.44965,1,1
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.5774e-06,0.34625,0.39766,1,1
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00022676,0.34618,0.32216,1,1
3,GO ADULT FEEDING BEHAVIOR,0.00065623,0.34356,0.22249,1,1
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.021165,0.34351,0.2709,1,1
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0022992,0.34218,0.3393,1,1
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.00067758,0.34121,0.27606,1,1
3,GO TRANSLATIONAL INITIATION,0.0010528,0.3411,0.3039,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,1.7806e-05,0.34055,0.31045,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0083534,0.33889,0.32249,1,1
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0010859,0.33694,0.25895,1,1
3,GO GAS TRANSPORT,0.0066042,0.33673,0.37192,1,1
3,GO LIMB BUD FORMATION,0.015203,0.33666,0.37697,1,1
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0017641,0.33651,0.28969,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0015189,0.33579,0.29889,1,1
3,GO TELOMERASE RNA LOCALIZATION,0.00013917,0.32701,0.32189,1,1
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.0604e-05,0.32643,0.36839,1,1
3,GO SYNAPTIC TRANSMISSION GABAERGIC,2.6307e-05,0.32293,0.28974,1,1
3,GO SYNAPTIC VESICLE PRIMING,3.0689e-05,0.32128,0.41314,1,1
3,GO CELL PROLIFERATION IN FOREBRAIN,0.027803,0.32032,0.19312,1,1
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00090094,0.31727,0.30085,1,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.027803,0.317,0.2786,1,1
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.0023671,0.31699,0.27417,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,4.1617e-05,0.31621,0.33865,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00016023,0.31598,0.29368,1,1
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00079435,0.31522,0.36813,1,1
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00087311,0.31486,0.26049,1,1
3,GO AORTA DEVELOPMENT,0.0016129,0.31397,0.20113,1,1
3,GO MATURATION OF SSU RRNA,0.00045924,0.31375,0.29689,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.4609e-05,0.3125,0.37367,1,1
3,GO NEURON PROJECTION ORGANIZATION,3.1904e-06,0.31218,0.30704,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00059588,0.31056,0.29615,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0047853,0.31015,0.32372,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00047456,0.3101,0.30501,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0073363,0.30895,0.2251,1,1
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00081984,0.30788,0.31239,1,1
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.041967,0.30776,0.23304,1,1
3,GO RRNA PSEUDOURIDINE SYNTHESIS,0.011904,0.30728,0.28329,1,1
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00042998,0.30492,0.26796,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0021689,0.30332,0.24321,1,1
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0037331,0.30275,0.20971,1,1
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00069957,0.30273,0.3116,1,1
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00019753,0.2983,0.34389,1,1
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0047853,0.29787,0.27686,1,1
3,GO DIVALENT METAL ION EXPORT,0.00059588,0.29766,0.39797,1,1
3,GO REGULATION OF LYASE ACTIVITY,3.0689e-05,0.29634,0.26996,1,1
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0021062,0.29468,0.22458,1,1
3,GO MATURATION OF 5 8S RRNA,0.0017641,0.29439,0.24399,1,1
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.041967,0.29417,0.18102,1,1
3,GO MATING BEHAVIOR,0.0025817,0.29386,0.21672,1,1
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0010206,0.29365,0.4059,1,1
3,GO PENTOSE METABOLIC PROCESS,0.0037331,0.2933,0.23187,1,1
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0079323,0.29304,0.18715,1,1
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00044439,0.29292,0.22038,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,0.0038387,0.29273,0.25142,1,1
3,GO PEPTIDYL ARGININE N METHYLATION,0.00010462,0.29234,0.31636,1,1
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0075304,0.29187,0.24686,1,1
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0026572,0.29084,0.22203,1,1
3,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.0036303,0.29063,0.33102,1,1
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0010528,0.29002,0.23738,1,1
3,GO NAD METABOLIC PROCESS,0.0028957,0.28961,0.2362,1,1
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0025083,0.28931,0.23327,1,1
3,GO L SERINE METABOLIC PROCESS,0.011904,0.28863,0.29792,1,1
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0071468,0.28737,0.21499,1,1
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,9.7346e-05,0.28657,0.21378,1,1
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00072223,0.28487,0.2813,1,1
3,GO TRNA WOBBLE BASE MODIFICATION,0.0010206,0.28381,0.22364,1,1
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0057817,0.28372,0.27887,1,1
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.015203,0.2822,0.25272,1,1
3,GO RIBOSOME BIOGENESIS,0.00057693,0.27931,0.25228,1,1
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00025131,0.27665,0.31857,1,1
3,GO REGULATION OF MRNA BINDING,0.00026003,0.27398,0.297,1,1
3,GO PEPTIDYL HISTIDINE MODIFICATION,0.00063551,0.27295,0.21766,1,1
3,GO MESODERMAL CELL FATE SPECIFICATION,0.041093,0.27198,0.18829,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.004408,0.27146,0.1994,1,1
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0015653,0.27089,0.28208,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.27016,0.23454,1,1
3,GO STRESS GRANULE ASSEMBLY,1.1493e-05,0.2701,0.24164,1,1
3,GO PROTEIN TARGETING TO MEMBRANE,0.0021689,0.26871,0.22891,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00353,0.26731,0.20427,1,1
3,GO BONE GROWTH,0.009256,0.2629,0.2313,1,1
3,GO NEURON REMODELING,0.0010528,0.2624,0.29998,1,1
3,GO HYPOTONIC RESPONSE,0.025994,0.26188,0.17492,1,1
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.013139,0.26177,0.20083,1,1
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,4.0073e-05,0.26171,0.23927,1,1
3,GO LEARNING,3.5759e-05,0.26107,0.2771,1,1
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.016734,0.26084,0.2363,1,1
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0042883,0.26079,0.20316,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.00014935,0.26009,0.25265,1,1
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00014935,0.25989,0.19652,1,1
3,GO TRANSLATIONAL ELONGATION,0.00038934,0.25826,0.22275,1,1
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0039469,0.25823,0.2013,1,1
3,GO RRNA MODIFICATION,0.007729,0.2571,0.21839,1,1
3,GO RRNA METABOLIC PROCESS,0.00084609,0.25574,0.22872,1,1
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00087311,0.25477,0.26261,1,1
3,GO REPRODUCTIVE BEHAVIOR,0.0018173,0.25446,0.24261,1,1
3,GO CELL JUNCTION DISASSEMBLY,0.0013054,0.25444,0.25289,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,9.0551e-05,0.25444,0.25267,1,1
3,GO VIRAL TRANSLATION,0.0013054,0.25369,0.28863,1,1
3,GO CELL PROLIFERATION IN HINDBRAIN,0.013798,0.25024,0.23231,1,1
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.029068,0.24711,0.20917,1,1
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0051916,0.24683,0.26074,1,1
3,GO PSEUDOURIDINE SYNTHESIS,0.015574,0.2463,0.21943,1,1
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0022332,0.24555,0.21421,1,1
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0066042,0.24493,0.19261,1,1
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0022332,0.24364,0.23682,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0047853,0.24321,0.20474,1,1
3,GO NOREPINEPHRINE TRANSPORT,0.0021689,0.24248,0.20411,1,1
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00079435,0.23776,0.19158,1,1
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.001228,0.23725,0.42057,1,1
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.037747,0.23697,0.22179,1,1
3,GO ASSOCIATIVE LEARNING,5.2139e-05,0.23591,0.24356,1,1
3,GO ONE CARBON COMPOUND TRANSPORT,0.020205,0.23556,0.15196,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0060989,0.23513,0.18145,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00026903,0.23406,0.20807,1,1
3,GO FOREBRAIN REGIONALIZATION,0.016339,0.23337,0.24722,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00026903,0.23286,0.2258,1,1
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.037747,0.23278,0.22524,1,1
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0094949,0.23246,0.20721,1,1
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.0039469,0.2296,0.2025,1,1
3,GO SNORNA 3 END PROCESSING,0.00098941,0.22817,0.34461,1,1
3,GO TRNA MODIFICATION,0.00019079,0.22811,0.22381,1,1
3,GO RRNA TRANSCRIPTION,0.00054072,0.22764,0.21113,1,1
3,GO REGULATION OF CYCLASE ACTIVITY,6.2786e-05,0.22515,0.25885,1,1
3,GO VIRAL GENE EXPRESSION,0.011904,0.22434,0.20572,1,1
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0028141,0.22387,0.20694,1,1
3,GO TRNA METHYLATION,0.0022992,0.22314,0.17565,1,1
3,GO SYNAPTIC VESICLE DOCKING,0.023741,0.22255,0.26474,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0057817,0.22244,0.24928,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.00019753,0.22077,0.19118,1,1
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0031536,0.22073,0.17238,1,1
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0033369,0.22015,0.19904,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0026572,0.21849,0.17044,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,8.7323e-05,0.21784,0.23145,1,1
3,GO AROMATIC AMINO ACID TRANSPORT,0.004408,0.21751,0.34059,1,1
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0028141,0.21551,0.28893,1,1
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00087311,0.21531,0.21643,1,1
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0073363,0.21512,0.19907,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00024286,0.21398,0.23165,1,1
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0083534,0.21394,0.15885,1,1
3,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.011612,0.21373,0.23113,1,1
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.023205,0.21365,0.20936,1,1
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0097392,0.21356,0.18451,1,1
3,GO REGULATION OF RNA BINDING,0.00035231,0.21323,0.24793,1,1
3,GO TUBULIN DEACETYLATION,0.014841,0.2129,0.1902,1,1
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.017969,0.21275,0.19516,1,1
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00045924,0.21256,0.19071,1,1
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.0006154,0.21208,0.1453,1,1
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0015189,0.20967,0.16934,1,1
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0075304,0.20888,0.1496,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0024367,0.20799,0.17967,1,1
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.045624,0.20758,0.15517,1,1
3,GO OXIDATIVE PHOSPHORYLATION,0.0031536,0.20716,0.16271,1,1
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.010506,0.20713,0.17369,1,1
3,GO POSITIVE REGULATION OF HEART GROWTH,0.0071468,0.20653,0.178,1,1
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.00035231,0.20626,0.23644,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00059588,0.20539,0.29311,1,1
3,GO URONIC ACID METABOLIC PROCESS,0.00055855,0.20522,0.1716,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.016734,0.20408,0.20365,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0017641,0.20349,0.19653,1,1
3,GO TELOMERIC LOOP DISASSEMBLY,0.001191,0.20346,0.2066,1,1
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,6.0504e-05,0.2032,0.21928,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00012074,0.20188,0.20711,1,1
3,GO TRANSLATIONAL TERMINATION,0.0039469,0.20079,0.19092,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0034322,0.20069,0.15221,1,1
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.036948,0.19936,0.20169,1,1
3,GO FEAR RESPONSE,0.0097392,0.19857,0.16602,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00050664,0.19822,0.19569,1,1
3,GO NCRNA PROCESSING,0.0012662,0.19782,0.18397,1,1
3,GO GLUCOSE CATABOLIC PROCESS,0.011612,0.19776,0.2154,1,1
3,GO SNORNA METABOLIC PROCESS,0.0031536,0.1972,0.30796,1,1
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0049174,0.19691,0.19162,1,1
3,GO HISTONE ARGININE METHYLATION,0.00067758,0.1969,0.2115,1,1
3,GO IRON COORDINATION ENTITY TRANSPORT,0.0062634,0.19677,0.19911,1,1
3,GO AMINO ACID IMPORT,0.0041716,0.19661,0.18047,1,1
3,GO POSITIVE REGULATION OF MRNA PROCESSING,2.6902e-06,0.19536,0.20291,1,1
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.00028792,0.19524,0.23795,1,1
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.014841,0.19511,0.13259,1,1
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0060989,0.19511,0.20831,1,1
3,GO RESPONSE TO PROSTAGLANDIN E,0.052669,0.1941,0.096069,1,1
3,GO AEROBIC RESPIRATION,0.0016129,0.1938,0.17211,1,1
3,GO RNA POLYADENYLATION,0.00042998,0.19367,0.14716,1,1
3,GO CELLULAR ANION HOMEOSTASIS,0.044685,0.19324,0.18555,1,1
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.017969,0.1928,0.15027,1,1
3,GO MRNA MODIFICATION,0.0007696,0.19273,0.23559,1,1
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0018173,0.19214,0.17905,1,1
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.001191,0.19124,0.22808,1,1
3,GO PLASMA MEMBRANE TUBULATION,0.011326,0.19059,0.15792,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0060989,0.1887,0.20607,1,1
3,GO PROTEIN NITROSYLATION,0.020205,0.18795,0.19961,1,1
3,GO MEMBRANE DISASSEMBLY,0.026586,0.1872,0.12351,1,1
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0028141,0.18641,0.16102,1,1
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0039469,0.18635,0.20534,1,1
3,GO CRISTAE FORMATION,0.010773,0.18633,0.19498,1,1
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.001228,0.18625,0.18231,1,1
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0069616,0.18464,0.14181,1,1
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.0056288,0.18358,0.23025,1,1
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.05161,0.1833,0.11631,1,1
3,GO PEPTIDYL ARGININE METHYLATION,0.00032948,0.18283,0.21665,1,1
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.001191,0.18234,0.20343,1,1
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0049174,0.18212,0.1579,1,1
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.007729,0.18164,0.17887,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0007696,0.17987,0.13438,1,1
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0022992,0.17916,0.17914,1,1
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.01282,0.17876,0.14442,1,1
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,7.547e-05,0.17796,0.2271,1,1
3,GO PYRUVATE METABOLIC PROCESS,0.0045306,0.17695,0.12067,1,1
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0075304,0.17618,0.15109,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0023671,0.17411,0.13803,1,1
3,GO CELLULAR RESPIRATION,0.0041716,0.17387,0.14646,1,1
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0073363,0.17338,0.14406,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.17319,0.13409,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,0.00027832,0.17269,0.15609,1,1
3,GO EXCRETION,0.0056288,0.17257,0.13673,1,1
3,GO CELLULAR RESPONSE TO HEAT,0.0013457,0.17064,0.12044,1,1
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.043763,0.17035,0.16556,1,1
3,GO L AMINO ACID TRANSPORT,0.00063551,0.17017,0.19111,1,1
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.0067808,0.17,0.1241,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00023468,0.16976,0.15496,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0013457,0.16916,0.2218,1,1
3,GO HISTONE H3 K9 DEMETHYLATION,0.0083534,0.16904,0.19259,1,1
3,GO TRNA PROCESSING,0.00090094,0.16875,0.17937,1,1
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.036948,0.16846,0.17184,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.010506,0.16785,0.18837,1,1
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0064317,0.16709,0.21801,1,1
3,GO REGULATION OF SPINDLE CHECKPOINT,0.00092958,0.1669,0.14928,1,1
3,GO RRNA METHYLATION,0.0081404,0.16645,0.18496,1,1
3,GO FOLIC ACID METABOLIC PROCESS,0.041967,0.16632,0.17031,1,1
3,GO CARBOHYDRATE PHOSPHORYLATION,0.012203,0.16623,0.14042,1,1
3,GO STRIATUM DEVELOPMENT,0.016339,0.16617,0.18751,1,1
3,GO MITOCHONDRIAL TRANSLATION,0.0042883,0.16381,0.19525,1,1
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.01282,0.16366,0.17074,1,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.041093,0.16341,0.1333,1,1
3,GO MITOCHONDRIAL GENE EXPRESSION,0.0046564,0.16254,0.19159,1,1
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.014486,0.16219,0.099699,1,1
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010506,0.16121,0.17084,1,1
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.011047,0.1597,0.20058,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0029794,0.15835,0.14723,1,1
3,GO NUCLEAR PORE ORGANIZATION,0.041093,0.15717,0.11028,1,1
3,GO MITOTIC DNA REPLICATION CHECKPOINT,0.010506,0.15666,0.14296,1,1
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.029068,0.15409,0.1588,1,1
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.012203,0.15294,0.16955,1,1
3,GO PROTEIN DEMETHYLATION,0.037747,0.15217,0.11321,1,1
3,GO MRNA METHYLATION,0.01282,0.15177,0.19339,1,1
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.011326,0.15121,0.21752,1,1
3,GO RNA SURVEILLANCE,0.033894,0.1503,0.12882,1,1
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.02268,0.14991,0.1987,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.014486,0.14824,0.12566,1,1
3,GO NCRNA METABOLIC PROCESS,0.0029794,0.14765,0.15371,1,1
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.041093,0.1475,0.12282,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.00069957,0.1464,0.12066,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.015574,0.14537,0.10928,1,1
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.035393,0.14524,0.11023,1,1
3,GO PROTEIN TARGETING,0.007729,0.14409,0.10904,1,1
3,GO TRICARBOXYLIC ACID CYCLE,0.0064317,0.14323,0.14307,1,1
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00026003,0.14301,0.15939,1,1
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,7.013e-05,0.14268,0.18832,1,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.0054795,0.14261,0.13749,1,1
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.031059,0.1397,0.13311,1,1
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0053338,0.13936,0.16664,1,1
3,GO PROTEIN HETEROOLIGOMERIZATION,0.0020453,0.13918,0.15842,1,1
3,GO RNA CATABOLIC PROCESS,0.012203,0.13892,0.11055,1,1
3,GO DNA REPLICATION INITIATION,0.0018173,0.13857,0.14311,1,1
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00047456,0.13806,0.24592,1,1
3,GO REPLICATION FORK PROCESSING,0.0040578,0.13801,0.13472,1,1
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.03245,0.13664,0.1133,1,1
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0042883,0.13658,0.11355,1,1
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0011549,0.13652,0.13207,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,0.0014738,0.13645,0.12815,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0026572,0.13383,0.1528,1,1
3,GO REGULATION OF CELL CYCLE ARREST,0.011047,0.13304,0.088991,1,1
3,GO RNA METHYLATION,0.0039469,0.1329,0.13947,1,1
3,GO DNA REPLICATION CHECKPOINT,0.0041716,0.13282,0.1289,1,1
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.01282,0.13277,0.23479,1,1
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.004408,0.13276,0.139,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0016129,0.1315,0.11326,1,1
3,GO AMINO ACID TRANSPORT,0.00016595,0.13054,0.1682,1,1
3,GO POSITIVE REGULATION OF TRANSLATION,0.0090226,0.13023,0.11092,1,1
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0010206,0.12938,0.11393,1,1
3,GO RESPONSE TO AMPHETAMINE,0.045624,0.1275,0.13089,1,1
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.01282,0.12653,0.14995,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0056288,0.12485,0.12084,1,1
3,GO TRNA TRANSPORT,0.007729,0.12413,0.1308,1,1
3,GO NUCLEOTIDE PHOSPHORYLATION,0.0047853,0.12371,0.12014,1,1
3,GO ATP METABOLIC PROCESS,0.0024367,0.12365,0.10989,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.02268,0.12358,0.10602,1,1
3,GO REGULATION OF MRNA PROCESSING,0.001228,0.12321,0.10397,1,1
3,GO BASE EXCISION REPAIR,0.017549,0.12253,0.087776,1,1
3,GO MATING,0.033166,0.12237,0.091484,1,1
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.02843,0.12167,0.10248,1,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0039469,0.12166,0.10347,1,1
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.029719,0.12095,0.11361,1,1
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0075304,0.12071,0.11613,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.042857,0.11906,0.073813,1,1
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.014138,0.11894,0.08456,1,1
3,GO REGULATION OF TELOMERE MAINTENANCE,0.0046564,0.1189,0.11692,1,1
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.03939,0.11847,0.11502,1,1
3,GO AMIDE BIOSYNTHETIC PROCESS,0.0087944,0.11847,0.11837,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0050528,0.11797,0.10938,1,1
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.014486,0.11788,0.11892,1,1
3,GO NCRNA EXPORT FROM NUCLEUS,0.033166,0.11753,0.11239,1,1
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.053746,0.11627,0.18126,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.024846,0.11601,0.12444,1,1
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.041967,0.11561,0.11825,1,1
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.007729,0.11555,0.076652,1,1
3,GO PROTEIN TETRAMERIZATION,0.00059588,0.11506,0.13276,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0099891,0.11483,0.10236,1,1
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0013054,0.1146,0.172,1,1
3,GO NCRNA 3 END PROCESSING,0.01282,0.11383,0.095253,1,1
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.001986,0.11376,0.13349,1,1
3,GO MUSCLE ORGAN MORPHOGENESIS,0.031059,0.11238,0.095715,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.029068,0.11227,0.098242,1,1
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.022165,0.11169,0.12288,1,1
3,GO CELLULAR RESPONSE TO DRUG,0.0085714,0.11156,0.12578,1,1
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.033166,0.1105,0.076747,1,1
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.036948,0.10884,0.10272,1,1
3,GO RNA 3 END PROCESSING,0.0064317,0.10664,0.082163,1,1
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0050528,0.10659,0.091621,1,1
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.023741,0.10627,0.11456,1,1
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.031059,0.10453,0.11387,1,1
3,GO MRNA 3 END PROCESSING,0.0075304,0.10424,0.078822,1,1
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.018398,0.10337,0.13184,1,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.016734,0.1032,0.091181,1,1
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.034637,0.10317,0.086476,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.02843,0.10275,0.079815,1,1
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0037331,0.10232,0.09644,1,1
3,GO LEUKOCYTE TETHERING OR ROLLING,0.009256,0.1022,0.12556,1,1
3,GO TELOMERE ORGANIZATION,0.0059384,0.1018,0.092471,1,1
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.047551,0.10107,0.0937,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.024288,0.099497,0.10904,1,1
3,GO MRNA METABOLIC PROCESS,0.0014299,0.099475,0.10604,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.017969,0.098288,0.11512,1,1
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.024846,0.097809,0.086502,1,1
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.004408,0.096457,0.12148,1,1
3,GO RNA PROCESSING,0.00044439,0.096204,0.11772,1,1
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.001986,0.096203,0.10604,1,1
3,GO INTERSTRAND CROSS LINK REPAIR,0.0028141,0.095757,0.09109,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.044685,0.095589,0.080866,1,1
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.02268,0.093868,0.12209,1,1
3,GO NCRNA TRANSCRIPTION,0.0025083,0.093842,0.09324,1,1
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.024846,0.091317,0.082704,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0094949,0.090542,0.090551,1,1
3,GO PHOSPHATE ION TRANSPORT,0.02166,0.089491,0.090965,1,1
3,GO PROTEIN HOMOOLIGOMERIZATION,0.0022992,0.089404,0.10202,1,1
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.037747,0.087362,0.086978,1,1
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0012662,0.08686,0.10335,1,1
3,GO RNA LOCALIZATION,0.0079323,0.084538,0.089299,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.025994,0.082868,0.082697,1,1
3,GO PROTEIN HETEROTETRAMERIZATION,0.0050528,0.082708,0.13026,1,1
3,GO POSITIVE REGULATION OF RNA SPLICING,0.044685,0.081949,0.065575,1,1
3,GO MRNA PROCESSING,0.0010859,0.07968,0.091229,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.016339,0.07527,0.067584,1,1
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0056288,0.074586,0.08917,1,1
3,GO RNA SPLICING,0.0023671,0.072933,0.085108,1,1
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.037747,0.069404,0.071298,1,1
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.02068,0.061768,0.062723,1,1
3,GO NUCLEOTIDE EXCISION REPAIR,0.05161,0.059969,0.059967,1,1
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.037747,0.053063,0.05135,1,1
3,GO METHYLATION,0.033166,0.032322,0.058393,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0016129,1.595,1.0811,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.0021062,1.2785,0.85328,1,1
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.001228,1.0061,0.81706,1,1
4,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.9263e-05,0.88673,0.8715,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.004408,0.86861,0.63815,1,1
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,8.7323e-05,0.84853,0.60522,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,3.4421e-05,0.81589,0.71168,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,4.4712e-06,0.77658,0.79908,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,4.7955e-07,0.77592,0.73098,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0041716,0.74103,0.47349,1,1
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.9263e-05,0.73465,0.62227,1,1
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.00038934,0.72145,0.61132,1,1
4,GO REGULATION OF PLASMINOGEN ACTIVATION,0.0028141,0.70946,0.45208,1,1
4,GO HISTAMINE SECRETION,5.4977e-07,0.70834,0.72677,1,1
4,GO TOLERANCE INDUCTION,0.0010206,0.68962,0.56278,1,1
4,GO LIPID DROPLET FORMATION,1.1267e-06,0.68501,0.70527,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,2.2524e-05,0.67693,0.63673,1,1
4,GO HISTAMINE TRANSPORT,6.0198e-07,0.66579,0.70146,1,1
4,GO PROGESTERONE METABOLIC PROCESS,0.00012512,0.66483,0.80898,1,1
4,GO DOPAMINE BIOSYNTHETIC PROCESS,5.9841e-06,0.65554,0.7291,1,1
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0049174,0.65551,0.41467,1,1
4,GO GERMINAL CENTER FORMATION,0.00024286,0.65307,0.50395,1,1
4,GO GLYCOSIDE METABOLIC PROCESS,0.0056288,0.6351,0.67446,1,1
4,GO CYTIDINE TO URIDINE EDITING,0.00034072,0.63072,0.62093,1,1
4,GO T CELL MEDIATED CYTOTOXICITY,0.0026572,0.6241,0.38487,1,1
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0053338,0.62052,0.52918,1,1
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.00084609,0.61928,0.50499,1,1
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,3.0576e-06,0.59804,0.59917,1,1
4,GO POSITIVE REGULATION OF CELL MATURATION,7.3528e-06,0.59551,0.58745,1,1
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00010845,0.59431,0.53559,1,1
4,GO RESPONSE TO TYPE I INTERFERON,0.00011241,0.58387,0.54614,1,1
4,GO INTESTINAL LIPID ABSORPTION,7.9801e-06,0.58025,0.66428,1,1
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.02843,0.57642,0.33379,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.0311e-06,0.56988,0.57077,1,1
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0010859,0.56844,0.47941,1,1
4,GO SIGNAL PEPTIDE PROCESSING,1.1267e-06,0.56665,0.50696,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,2.0833e-05,0.56344,0.53303,1,1
4,GO RENAL ABSORPTION,0.00011241,0.55776,0.52565,1,1
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00030804,0.55518,0.51269,1,1
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,7.0571e-06,0.5551,0.59071,1,1
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00081984,0.55424,0.50367,1,1
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,3.8583e-05,0.55335,0.50894,1,1
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,7.013e-05,0.55179,0.53045,1,1
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.00084609,0.54937,0.43188,1,1
4,GO FRUCTOSE METABOLIC PROCESS,0.00016595,0.54565,0.57965,1,1
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,1.2454e-05,0.54504,0.52495,1,1
4,GO MUCUS SECRETION,0.0011549,0.54137,0.5277,1,1
4,GO RESPONSE TO EPINEPHRINE,0.011047,0.5336,0.32107,1,1
4,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,8.7323e-05,0.53059,0.58643,1,1
4,GO DETOXIFICATION OF INORGANIC COMPOUND,0.05161,0.52689,0.52972,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,2.3418e-05,0.52584,0.41793,1,1
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00028792,0.52573,0.46029,1,1
4,GO ADHESION OF SYMBIONT TO HOST,0.0033369,0.52551,0.37729,1,1
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,6.7596e-05,0.52234,0.52061,1,1
4,GO TOXIN METABOLIC PROCESS,9.3916e-06,0.51812,0.5009,1,1
4,GO LIPID DIGESTION,4.1617e-05,0.51795,0.57927,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00021909,0.51477,0.38194,1,1
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00029782,0.51326,0.44331,1,1
4,GO DETECTION OF OTHER ORGANISM,8.1192e-05,0.51251,0.50699,1,1
4,GO RESPONSE TO COLD,3.1904e-06,0.51096,0.4402,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0034322,0.5105,0.32012,1,1
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00013917,0.50952,0.42326,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0032441,0.50922,0.38982,1,1
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,6.7596e-05,0.50824,0.60333,1,1
4,GO CELLULAR DEFENSE RESPONSE,3.1904e-06,0.50509,0.44051,1,1
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,3.0264e-07,0.50437,0.55941,1,1
4,GO NEGATIVE REGULATION OF BONE REMODELING,1.9263e-05,0.50383,0.52268,1,1
4,GO RESPONSE TO IMMOBILIZATION STRESS,7.547e-05,0.50359,0.39041,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00040247,0.50336,0.38173,1,1
4,GO O GLYCAN PROCESSING,1.2962e-05,0.50276,0.43835,1,1
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.00045924,0.50153,0.42802,1,1
4,GO PHAGOLYSOSOME ASSEMBLY,1.7474e-06,0.49854,0.50119,1,1
4,GO ACTIN FILAMENT SEVERING,0.00052342,0.49705,0.44647,1,1
4,GO DENDRITIC CELL DIFFERENTIATION,0.0013054,0.49693,0.391,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,3.4728e-06,0.49509,0.46133,1,1
4,GO RETINAL METABOLIC PROCESS,0.0022332,0.49188,0.48957,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,2.4346e-05,0.49087,0.47358,1,1
4,GO NEGATIVE REGULATION OF ANOIKIS,0.00026903,0.49059,0.47741,1,1
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.012203,0.48947,0.51317,1,1
4,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.00029782,0.48942,0.3606,1,1
4,GO RESPONSE TO INTERLEUKIN 18,0.010245,0.4872,0.41634,1,1
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00012964,0.48679,0.57939,1,1
4,GO REGULATION OF WATER LOSS VIA SKIN,0.00041602,0.48615,0.40555,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,1.7806e-05,0.48435,0.44853,1,1
4,GO REGULATION OF BONE REMODELING,9.7801e-06,0.4827,0.43633,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00065623,0.48231,0.45014,1,1
4,GO BONE RESORPTION,6.7728e-06,0.47907,0.42225,1,1
4,GO INTESTINAL ABSORPTION,6.2985e-07,0.47706,0.59207,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,4.8379e-05,0.47648,0.42332,1,1
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00016023,0.4758,0.4013,1,1
4,GO RESPONSE TO PAIN,8.3127e-06,0.47426,0.44272,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.7955e-07,0.4733,0.46667,1,1
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,4.1617e-05,0.47324,0.42757,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00035231,0.47281,0.45029,1,1
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,7.3528e-06,0.47261,0.50256,1,1
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0020453,0.4723,0.48549,1,1
4,GO REGULATION OF TOLERANCE INDUCTION,0.0022332,0.47208,0.47211,1,1
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,4.3218e-05,0.47138,0.45162,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,6.7596e-05,0.46663,0.414,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,1.2962e-05,0.46623,0.50132,1,1
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.00028792,0.46621,0.38121,1,1
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.9801e-06,0.46614,0.40505,1,1
4,GO PLASMINOGEN ACTIVATION,0.0020453,0.46443,0.44521,1,1
4,GO ACTIN FILAMENT NETWORK FORMATION,0.0087944,0.46358,0.36719,1,1
4,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.0038387,0.46153,0.49925,1,1
4,GO ZYMOGEN ACTIVATION,0.00026903,0.46097,0.42066,1,1
4,GO GALACTOSE METABOLIC PROCESS,0.00019753,0.46087,0.54289,1,1
4,GO REGULATION OF INTEGRIN ACTIVATION,4.5813e-07,0.45984,0.52123,1,1
4,GO KETONE CATABOLIC PROCESS,0.0015653,0.45459,0.38891,1,1
4,GO REGULATION OF NEURON MATURATION,1.9263e-05,0.45346,0.41919,1,1
4,GO REGULATION OF FIBRINOLYSIS,0.00074557,0.45181,0.42126,1,1
4,GO RESPONSE TO DIETARY EXCESS,5.6174e-05,0.44928,0.45126,1,1
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00031859,0.44767,0.52321,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.8084e-07,0.44507,0.51292,1,1
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00074557,0.44317,0.3744,1,1
4,GO QUINONE METABOLIC PROCESS,0.00020448,0.44188,0.56058,1,1
4,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0022992,0.43887,0.41796,1,1
4,GO PROTEIN DEGLYCOSYLATION,3.3132e-05,0.43817,0.41816,1,1
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.0025083,0.43666,0.34753,1,1
4,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.00032948,0.4358,0.54565,1,1
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.00037661,0.4355,0.37659,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0018173,0.43421,0.32738,1,1
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,7.6603e-06,0.43392,0.44409,1,1
4,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.0054795,0.43366,0.3997,1,1
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.011612,0.43156,0.32006,1,1
4,GO STEROID ESTERIFICATION,0.00029782,0.43018,0.50489,1,1
4,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00098941,0.42937,0.34002,1,1
4,GO SUPEROXIDE ANION GENERATION,0.00054072,0.42911,0.39557,1,1
4,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00013917,0.4289,0.38252,1,1
4,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.00025131,0.42826,0.42708,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0013054,0.42803,0.40386,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,7.8282e-05,0.42778,0.29852,1,1
4,GO REGULATION OF HORMONE METABOLIC PROCESS,0.00041602,0.42654,0.37016,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00040247,0.42572,0.43097,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.001662,0.42545,0.33267,1,1
4,GO ACUTE PHASE RESPONSE,0.00011241,0.42389,0.35077,1,1
4,GO SEROTONIN METABOLIC PROCESS,8.1192e-05,0.41934,0.4831,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,5.0194e-07,0.41833,0.42757,1,1
4,GO L PHENYLALANINE METABOLIC PROCESS,0.00036427,0.41786,0.54878,1,1
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0006154,0.41668,0.333,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0001547,0.41558,0.32405,1,1
4,GO LABYRINTHINE LAYER MORPHOGENESIS,0.0081404,0.41526,0.37354,1,1
4,GO REGULATION OF PLATELET ACTIVATION,0.00011241,0.41524,0.3649,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0039469,0.4143,0.36511,1,1
4,GO REFLEX,0.00059588,0.41425,0.41102,1,1
4,GO REGULATION OF TISSUE REMODELING,2.0833e-05,0.41411,0.37457,1,1
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00052342,0.414,0.37541,1,1
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.00087311,0.41308,0.31154,1,1
4,GO PROTEIN DEMANNOSYLATION,1.2454e-05,0.41187,0.43585,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00012074,0.41051,0.29568,1,1
4,GO AMMONIUM ION METABOLIC PROCESS,9.0179e-06,0.40888,0.48676,1,1
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.00079435,0.40557,0.37389,1,1
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00021167,0.40535,0.33052,1,1
4,GO EOSINOPHIL MIGRATION,0.0027346,0.40498,0.31192,1,1
4,GO RESPONSE TO REDOX STATE,2.4346e-05,0.40495,0.36714,1,1
4,GO VASODILATION,7.547e-05,0.40384,0.49646,1,1
4,GO B CELL APOPTOTIC PROCESS,2.8418e-05,0.40337,0.39571,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0029794,0.4003,0.37916,1,1
4,GO KETONE BODY METABOLIC PROCESS,0.0023671,0.39939,0.33693,1,1
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00022676,0.39914,0.55091,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,9.0179e-06,0.39908,0.38421,1,1
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00081984,0.3976,0.32998,1,1
4,GO MUSCLE ATROPHY,0.0050528,0.39736,0.2785,1,1
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.0066042,0.3966,0.34264,1,1
4,GO PHAGOSOME ACIDIFICATION,1.8084e-07,0.3964,0.41805,1,1
4,GO REGULATION OF ANOIKIS,0.00055855,0.39621,0.38073,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0027346,0.39588,0.34768,1,1
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.049546,0.39544,0.31013,1,1
4,GO CORTICOSTEROID HORMONE SECRETION,0.0028141,0.39465,0.35936,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0034322,0.39441,0.41735,1,1
4,GO INSEMINATION,7.547e-05,0.39426,0.37805,1,1
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,3.5759e-05,0.39393,0.30537,1,1
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00027832,0.39369,0.30518,1,1
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,5.8301e-05,0.39158,0.38092,1,1
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00013433,0.39121,0.30904,1,1
4,GO ACUTE INFLAMMATORY RESPONSE,2.9532e-05,0.39087,0.36534,1,1
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.0226e-05,0.3906,0.47672,1,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.0017641,0.38943,0.37851,1,1
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.034637,0.38868,0.28556,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0016129,0.38747,0.5359,1,1
4,GO POSITIVE REGULATION OF CELL SIZE,2.0033e-05,0.38725,0.40212,1,1
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0059384,0.38654,0.28928,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.018836,0.38547,0.24086,1,1
4,GO SECONDARY METABOLIC PROCESS,0.00044439,0.38505,0.37786,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.0025083,0.38474,0.37657,1,1
4,GO EOSINOPHIL CHEMOTAXIS,0.0024367,0.3814,0.3232,1,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,4.0073e-05,0.38111,0.37753,1,1
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.0037331,0.38069,0.32236,1,1
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00017186,0.38059,0.40923,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.0073e-05,0.3805,0.44097,1,1
4,GO N GLYCAN PROCESSING,0.00050664,0.38045,0.32136,1,1
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00040247,0.3804,0.35657,1,1
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.00067758,0.37956,0.33417,1,1
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.007729,0.37885,0.4228,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00025131,0.37828,0.40212,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0022992,0.37737,0.30442,1,1
4,GO CELLULAR RESPONSE TO COPPER ION,0.013139,0.37585,0.43854,1,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0006154,0.3757,0.30502,1,1
4,GO MITOCHONDRIAL DEPOLARIZATION,3.5759e-05,0.37551,0.34993,1,1
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.010245,0.37543,0.31731,1,1
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00067758,0.37326,0.41009,1,1
4,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00063551,0.37321,0.43614,1,1
4,GO NEUROTRANSMITTER METABOLIC PROCESS,0.0001165,0.37295,0.34964,1,1
4,GO REGULATION OF NEUTROPHIL MIGRATION,4.1617e-05,0.37294,0.34817,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0013872,0.37159,0.23163,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00028792,0.37151,0.35105,1,1
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00079435,0.37136,0.27749,1,1
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,8.1192e-05,0.37094,0.43648,1,1
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0051916,0.37005,0.29284,1,1
4,GO REGULATORY T CELL DIFFERENTIATION,0.0011549,0.37,0.2934,1,1
4,GO RESPONSE TO LITHIUM ION,5.6174e-05,0.36859,0.44612,1,1
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.00057693,0.36847,0.35405,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0090226,0.368,0.326,1,1
4,GO UBIQUINONE METABOLIC PROCESS,1.4039e-05,0.36694,0.33318,1,1
4,GO FOAM CELL DIFFERENTIATION,0.00021909,0.36689,0.29773,1,1
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0017123,0.36613,0.39951,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.00054072,0.3661,0.37392,1,1
4,GO REGULATION OF COAGULATION,0.0012662,0.36578,0.28527,1,1
4,GO METHIONINE METABOLIC PROCESS,2.1663e-05,0.36572,0.32968,1,1
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0028141,0.36452,0.29935,1,1
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00081984,0.36447,0.33336,1,1
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0025817,0.36391,0.27295,1,1
4,GO REGULATION OF ICOSANOID SECRETION,9.3916e-06,0.36362,0.39011,1,1
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00026903,0.36356,0.39258,1,1
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.00010462,0.36328,0.30941,1,1
4,GO METHIONINE BIOSYNTHETIC PROCESS,0.00013433,0.36254,0.40141,1,1
4,GO RESPONSE TO COPPER ION,0.00079435,0.36221,0.4326,1,1
4,GO POSITIVE REGULATION OF WOUND HEALING,0.00016023,0.36186,0.33777,1,1
4,GO IMMUNOGLOBULIN SECRETION,0.00022676,0.36108,0.33069,1,1
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0022332,0.36107,0.30742,1,1
4,GO BONE REMODELING,0.00012964,0.36081,0.33058,1,1
4,GO PARAXIAL MESODERM MORPHOGENESIS,0.004408,0.36077,0.35519,1,1
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,4.1617e-05,0.3604,0.32271,1,1
4,GO CYCLOOXYGENASE PATHWAY,0.0025817,0.35993,0.45011,1,1
4,GO LIVER MORPHOGENESIS,0.0034322,0.35984,0.2949,1,1
4,GO POSITIVE REGULATION OF CELL KILLING,0.00019753,0.35971,0.32092,1,1
4,GO RESPONSE TO INTERLEUKIN 2,2.2524e-05,0.35966,0.31123,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0039469,0.35902,0.29082,1,1
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0050528,0.35873,0.3919,1,1
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.00016023,0.35851,0.33716,1,1
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.001228,0.35821,0.30315,1,1
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0028957,0.3582,0.36495,1,1
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.00021167,0.35782,0.29137,1,1
4,GO SNARE COMPLEX ASSEMBLY,0.00052342,0.35758,0.2769,1,1
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0036303,0.35739,0.28699,1,1
4,GO INTEGRIN ACTIVATION,4.6623e-06,0.35733,0.37397,1,1
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.0015653,0.35664,0.31956,1,1
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0042883,0.35575,0.29032,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.011904,0.35421,0.37455,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0057817,0.35295,0.21203,1,1
4,GO RESPONSE TO MINERALOCORTICOID,7.2754e-05,0.35291,0.30935,1,1
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,9.0551e-05,0.35259,0.28638,1,1
4,GO B CELL MEDIATED IMMUNITY,0.00050664,0.35235,0.23804,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS,0.0010528,0.35215,0.29379,1,1
4,GO T CELL MEDIATED IMMUNITY,0.0039469,0.35209,0.24091,1,1
4,GO DORSAL AORTA DEVELOPMENT,0.0073363,0.35197,0.23866,1,1
4,GO RESPONSE TO THYROID HORMONE,0.0032441,0.35069,0.25742,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.0571e-06,0.35063,0.35641,1,1
4,GO VACUOLAR ACIDIFICATION,3.9926e-07,0.3506,0.41348,1,1
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,9.389e-05,0.3503,0.34583,1,1
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00032948,0.35023,0.26231,1,1
4,GO REGULATION OF VIRAL GENOME REPLICATION,0.0022332,0.35001,0.22364,1,1
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00087311,0.34992,0.35634,1,1
4,GO OSTEOBLAST PROLIFERATION,0.00013917,0.34986,0.33068,1,1
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0014299,0.34975,0.26242,1,1
4,GO REGULATION OF STEROID METABOLIC PROCESS,0.00013433,0.34972,0.28442,1,1
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.029719,0.34962,0.38255,1,1
4,GO PROSTANOID METABOLIC PROCESS,0.0039469,0.34924,0.35375,1,1
4,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2962e-05,0.34921,0.30713,1,1
4,GO TISSUE REMODELING,7.8282e-05,0.34794,0.29049,1,1
4,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00041602,0.34678,0.23432,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,1.9904e-06,0.34628,0.3498,1,1
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0013054,0.34606,0.21377,1,1
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0011199,0.34592,0.24995,1,1
4,GO LYTIC VACUOLE ORGANIZATION,5.4977e-07,0.3459,0.35486,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0015653,0.3458,0.33571,1,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00023468,0.34549,0.41378,1,1
4,GO LIPID DROPLET ORGANIZATION,1.4039e-05,0.3443,0.31936,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0013054,0.34293,0.34049,1,1
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.0022992,0.34252,0.31687,1,1
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0028141,0.34181,0.28569,1,1
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0028957,0.34171,0.29431,1,1
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.011612,0.34158,0.40121,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0071468,0.34143,0.35945,1,1
4,GO RESPONSE TO PEPTIDOGLYCAN,0.00010462,0.34105,0.28362,1,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0013054,0.34086,0.25846,1,1
4,GO STEROID HORMONE SECRETION,0.0025083,0.34067,0.30643,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00024286,0.34043,0.28808,1,1
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,3.1888e-05,0.34024,0.29281,1,1
4,GO RESPONSE TO DEXAMETHASONE,0.0015653,0.33933,0.27199,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00052342,0.33916,0.34166,1,1
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.010773,0.33911,0.34197,1,1
4,GO KETONE BIOSYNTHETIC PROCESS,0.00059588,0.33903,0.31157,1,1
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,2.0833e-05,0.33872,0.34701,1,1
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00027832,0.33837,0.2709,1,1
4,GO POSITIVE REGULATION OF ANION TRANSPORT,5.2139e-05,0.33825,0.33639,1,1
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00030804,0.33752,0.22249,1,1
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,8.1192e-05,0.33703,0.42311,1,1
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0059384,0.33698,0.31224,1,1
4,GO RESPONSE TO INTERLEUKIN 15,0.011612,0.3369,0.24603,1,1
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0032441,0.33547,0.21152,1,1
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0013457,0.3352,0.26747,1,1
4,GO BASIC AMINO ACID TRANSPORT,0.0051916,0.33464,0.37769,1,1
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.007729,0.33439,0.3472,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,3.4421e-05,0.33401,0.32759,1,1
4,GO DIET INDUCED THERMOGENESIS,0.0042883,0.33281,0.24264,1,1
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.0028957,0.33281,0.3556,1,1
4,GO ANOIKIS,0.00013433,0.33217,0.29934,1,1
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.024288,0.33182,0.20022,1,1
4,GO BARBED END ACTIN FILAMENT CAPPING,0.0027346,0.33042,0.35634,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.00055855,0.33028,0.37711,1,1
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,1.104e-05,0.33017,0.31564,1,1
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.00098941,0.33008,0.27321,1,1
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.0045306,0.32937,0.35396,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0010859,0.32843,0.27609,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.00069957,0.32748,0.2624,1,1
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.8379e-05,0.32745,0.25147,1,1
4,GO PROTEIN N LINKED GLYCOSYLATION,0.00013917,0.32517,0.26297,1,1
4,GO RESPONSE TO CORTICOSTERONE,0.0028141,0.32487,0.2846,1,1
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0017123,0.32461,0.23771,1,1
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.7323e-05,0.3242,0.34152,1,1
4,GO INTRACELLULAR STEROL TRANSPORT,9.7346e-05,0.32403,0.33223,1,1
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.00021909,0.32374,0.27691,1,1
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.013139,0.32364,0.2182,1,1
4,GO REGULATION OF ORGANIC ACID TRANSPORT,8.7323e-05,0.32338,0.29358,1,1
4,GO NATURAL KILLER CELL PROLIFERATION,0.014841,0.32314,0.27474,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.00018427,0.32247,0.3615,1,1
4,GO MITOCHONDRIAL RNA PROCESSING,0.0066042,0.32233,0.22346,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.0049174,0.32197,0.30813,1,1
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00031859,0.3216,0.32529,1,1
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0013872,0.32144,0.25445,1,1
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00041602,0.31989,0.31704,1,1
4,GO RESPONSE TO ACIDIC PH,0.0046564,0.31984,0.29136,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00047456,0.31981,0.24396,1,1
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,3.8583e-05,0.31964,0.30786,1,1
4,GO PLATELET DEGRANULATION,0.0021689,0.31951,0.22965,1,1
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00022676,0.31937,0.21772,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00016023,0.31936,0.31621,1,1
4,GO STEROID METABOLIC PROCESS,4.1617e-05,0.31933,0.27811,1,1
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0034322,0.31891,0.27195,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.00027832,0.31834,0.35487,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.00022676,0.31784,0.24115,1,1
4,GO ALPHA BETA T CELL PROLIFERATION,0.00017796,0.3176,0.31414,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0087944,0.31738,0.25928,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.00074557,0.31711,0.43656,1,1
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.0069616,0.31679,0.2761,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,6.7596e-05,0.31671,0.26187,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0027346,0.31629,0.20241,1,1
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.0073e-05,0.31628,0.27377,1,1
4,GO DIGESTION,2.7343e-05,0.31611,0.31485,1,1
4,GO REGULATION OF PROSTAGLANDIN SECRETION,0.00016595,0.31609,0.34448,1,1
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00023468,0.31463,0.30643,1,1
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0011549,0.31441,0.25893,1,1
4,GO ENDOCRINE PROCESS,2.5308e-05,0.31421,0.29166,1,1
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.0071468,0.3141,0.18785,1,1
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00031859,0.31368,0.33412,1,1
4,GO RESPONSE TO ISCHEMIA,0.00025131,0.31362,0.24819,1,1
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.001228,0.31321,0.21952,1,1
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.0011549,0.31296,0.3183,1,1
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.0067808,0.31288,0.21927,1,1
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0022992,0.31253,0.30549,1,1
4,GO MATURE B CELL DIFFERENTIATION,0.00025131,0.31243,0.36736,1,1
4,GO LIPID TRANSLOCATION,0.0001547,0.31241,0.27296,1,1
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,5.8301e-05,0.31231,0.25863,1,1
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00084609,0.31214,0.32233,1,1
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.00010092,0.31186,0.34048,1,1
4,GO PH REDUCTION,1.4674e-06,0.3106,0.28909,1,1
4,GO DEFENSE RESPONSE TO VIRUS,0.00065623,0.3101,0.23514,1,1
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,7.6603e-06,0.31003,0.35506,1,1
4,GO VITAMIN TRANSPORT,0.027188,0.30963,0.19779,1,1
4,GO RESPONSE TO STEROL DEPLETION,0.00026003,0.30929,0.41266,1,1
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.0604e-05,0.30887,0.31794,1,1
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00079435,0.30863,0.27066,1,1
4,GO REGULATION OF ENDOCRINE PROCESS,0.00023468,0.30862,0.25635,1,1
4,GO MACROPHAGE CYTOKINE PRODUCTION,0.019283,0.30841,0.17994,1,1
4,GO REGULATION OF B CELL PROLIFERATION,3.0689e-05,0.30833,0.30201,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.024288,0.30821,0.19918,1,1
4,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.004408,0.30802,0.32943,1,1
4,GO APICAL JUNCTION ASSEMBLY,0.00010462,0.30793,0.3333,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0007696,0.30776,0.28701,1,1
4,GO PROTEIN AUTOPROCESSING,0.00045924,0.30774,0.3341,1,1
4,GO REGULATION OF B CELL ACTIVATION,9.0551e-05,0.30747,0.23871,1,1
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00011241,0.30665,0.23329,1,1
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0059384,0.30664,0.31583,1,1
4,GO NADP METABOLIC PROCESS,0.0049174,0.30661,0.2653,1,1
4,GO DIGESTIVE SYSTEM PROCESS,2.6307e-05,0.30615,0.28104,1,1
4,GO ICOSANOID METABOLIC PROCESS,7.8282e-05,0.30553,0.3253,1,1
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.014841,0.30548,0.22724,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,4.4878e-05,0.30517,0.299,1,1
4,GO PHAGOSOME MATURATION,5.0683e-06,0.30491,0.32552,1,1
4,GO MAGNESIUM ION TRANSPORT,8.1192e-05,0.30477,0.30069,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.8521e-05,0.30398,0.30173,1,1
4,GO LIPID LOCALIZATION,3.0689e-05,0.30354,0.26213,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0094949,0.30217,0.2755,1,1
4,GO REGULATION OF B CELL DIFFERENTIATION,0.00057693,0.30145,0.26539,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,1.4044e-06,0.30129,0.33221,1,1
4,GO RESPONSE TO INTERLEUKIN 6,0.00029782,0.3011,0.31162,1,1
4,GO GOLGI TO ENDOSOME TRANSPORT,2.7343e-05,0.30093,0.31898,1,1
4,GO RELAXATION OF CARDIAC MUSCLE,0.0053338,0.30079,0.27983,1,1
4,GO IMMUNE EFFECTOR PROCESS,0.00021167,0.30072,0.21808,1,1
4,GO RESPONSE TO PROTOZOAN,0.0022992,0.30048,0.20259,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,4.4878e-05,0.30046,0.32573,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.0066042,0.30039,0.2353,1,1
4,GO CELL KILLING,4.3218e-05,0.29987,0.24761,1,1
4,GO ETHANOL METABOLIC PROCESS,0.0064317,0.29986,0.24883,1,1
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,9.389e-05,0.29962,0.24112,1,1
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,2.5308e-05,0.2996,0.30351,1,1
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0040578,0.29938,0.2709,1,1
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.0033369,0.29919,0.30881,1,1
4,GO IMMUNOLOGICAL MEMORY PROCESS,0.00020448,0.29898,0.34112,1,1
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00074557,0.2984,0.26641,1,1
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00055855,0.29821,0.24874,1,1
4,GO RESPIRATORY BURST,0.00016023,0.29796,0.28415,1,1
4,GO MAST CELL ACTIVATION,8.7323e-05,0.29759,0.27691,1,1
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.0069616,0.29745,0.24606,1,1
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00012074,0.29735,0.26422,1,1
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0028957,0.29704,0.25557,1,1
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0075304,0.29703,0.22399,1,1
4,GO HORMONE CATABOLIC PROCESS,0.0019282,0.29681,0.37656,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,7.2754e-05,0.29679,0.24452,1,1
4,GO LYMPHOCYTE MIGRATION,0.001228,0.29638,0.19151,1,1
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.0184e-05,0.29586,0.26682,1,1
4,GO DEFENSE RESPONSE TO BACTERIUM,6.2367e-06,0.2957,0.25904,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00031859,0.29547,0.30001,1,1
4,GO DOPAMINE METABOLIC PROCESS,0.00026003,0.29511,0.32856,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0017123,0.2948,0.25018,1,1
4,GO DETERMINATION OF ADULT LIFESPAN,0.0010528,0.29478,0.27456,1,1
4,GO SMOOTH MUSCLE CELL MIGRATION,0.013139,0.29423,0.23898,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00026903,0.29357,0.26319,1,1
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00018427,0.29311,0.23011,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,9.389e-05,0.293,0.26679,1,1
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.030383,0.29296,0.21189,1,1
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00012074,0.2927,0.22744,1,1
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.0010206,0.29244,0.29609,1,1
4,GO RESPONSE TO INTERFERON GAMMA,0.0013457,0.29243,0.28085,1,1
4,GO INNATE IMMUNE RESPONSE,0.0001547,0.29238,0.22227,1,1
4,GO VIRAL GENOME REPLICATION,0.0028141,0.29216,0.18185,1,1
4,GO ANTIBACTERIAL HUMORAL RESPONSE,0.00029782,0.29154,0.30628,1,1
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0094949,0.29118,0.28743,1,1
4,GO HORMONE METABOLIC PROCESS,0.00087311,0.29104,0.26804,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,2.6902e-06,0.29102,0.25226,1,1
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.010245,0.29061,0.28544,1,1
4,GO FUCOSYLATION,0.025994,0.29047,0.20927,1,1
4,GO REGULATION OF RESPIRATORY BURST,0.00012074,0.29029,0.31574,1,1
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.0057817,0.29013,0.31288,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0021689,0.28967,0.26753,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,0.001662,0.28963,0.24584,1,1
4,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00018427,0.28946,0.3194,1,1
4,GO LEUKOTRIENE METABOLIC PROCESS,0.00026003,0.28903,0.30125,1,1
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.00067758,0.28875,0.19712,1,1
4,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.027188,0.28873,0.23263,1,1
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0018173,0.28846,0.23715,1,1
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00063551,0.28833,0.2204,1,1
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.015953,0.28706,0.17888,1,1
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0028957,0.2869,0.24765,1,1
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,8.7323e-05,0.2869,0.26977,1,1
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.03939,0.28687,0.21513,1,1
4,GO T CELL MIGRATION,0.0073363,0.28671,0.18459,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,4.3218e-05,0.28616,0.30773,1,1
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0030654,0.28611,0.22509,1,1
4,GO PHOSPHOLIPID HOMEOSTASIS,0.053746,0.28593,0.19981,1,1
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,3.7791e-06,0.28585,0.29216,1,1
4,GO PHOSPHOLIPID CATABOLIC PROCESS,5.6174e-05,0.28581,0.33354,1,1
4,GO PHOSPHOLIPID TRANSPORT,4.6597e-05,0.28562,0.23401,1,1
4,GO REGULATION OF EXOSOMAL SECRETION,0.00072223,0.28558,0.24719,1,1
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.00054072,0.28556,0.26403,1,1
4,GO TRANSFERRIN TRANSPORT,1.8251e-06,0.28526,0.34201,1,1
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,9.389e-05,0.28481,0.21748,1,1
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0015653,0.28468,0.19799,1,1
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0015653,0.28462,0.27205,1,1
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.027803,0.28459,0.17562,1,1
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0041716,0.2844,0.19447,1,1
4,GO BILE ACID BIOSYNTHETIC PROCESS,0.00014418,0.28432,0.29704,1,1
4,GO DEFENSE RESPONSE,0.00013433,0.28421,0.20869,1,1
4,GO LEUKOCYTE MEDIATED IMMUNITY,0.00014418,0.28416,0.2352,1,1
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.011047,0.28385,0.20931,1,1
4,GO POLYOL TRANSPORT,0.001986,0.28374,0.31014,1,1
4,GO VITAMIN D METABOLIC PROCESS,0.001662,0.28303,0.28357,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.015203,0.28293,0.22309,1,1
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.021165,0.2826,0.1951,1,1
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00038934,0.28254,0.35091,1,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,3.4421e-05,0.2821,0.25613,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00010092,0.28204,0.29344,1,1
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00072223,0.2817,0.22878,1,1
4,GO REGULATION OF CELL KILLING,0.00035231,0.28088,0.27697,1,1
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.007729,0.28078,0.24389,1,1
4,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0022332,0.28072,0.2795,1,1
4,GO KERATAN SULFATE METABOLIC PROCESS,0.0018173,0.28033,0.2293,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,0.00022676,0.28032,0.27095,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.00092958,0.28011,0.21892,1,1
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0013872,0.27973,0.25592,1,1
4,GO NUCLEOTIDE SALVAGE,0.015953,0.27959,0.24396,1,1
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,5.2139e-05,0.27947,0.25012,1,1
4,GO DOPAMINE TRANSPORT,0.00084609,0.27926,0.34873,1,1
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.00052342,0.27887,0.25208,1,1
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,1.7118e-05,0.27852,0.25077,1,1
4,GO REGULATION OF LIGASE ACTIVITY,0.0028957,0.27833,0.22072,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0010859,0.27827,0.29887,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0097392,0.27813,0.20336,1,1
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,2.7343e-05,0.27789,0.2719,1,1
4,GO CELLULAR RESPONSE TO STARVATION,7.6603e-06,0.2776,0.25237,1,1
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.00017186,0.27745,0.20202,1,1
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.043763,0.27741,0.19016,1,1
4,GO REGULATION OF FERTILIZATION,0.0046564,0.27741,0.27883,1,1
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.011047,0.27734,0.22922,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00027832,0.2773,0.29079,1,1
4,GO LABYRINTHINE LAYER DEVELOPMENT,0.001662,0.27728,0.2623,1,1
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.0007696,0.27723,0.27123,1,1
4,GO CELLULAR RESPONSE TO FATTY ACID,0.0006154,0.27711,0.30374,1,1
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.00038934,0.27689,0.26082,1,1
4,GO CATECHOLAMINE UPTAKE,0.0047853,0.27661,0.26865,1,1
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00012512,0.27651,0.23111,1,1
4,GO TYPE I INTERFERON PRODUCTION,0.00045924,0.27642,0.21997,1,1
4,GO STEROL METABOLIC PROCESS,0.00047456,0.27641,0.23023,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,2.6307e-05,0.2763,0.23759,1,1
4,GO RESPONSE TO GROWTH HORMONE,4.1617e-05,0.2762,0.34265,1,1
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.00049035,0.27598,0.28413,1,1
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.00035231,0.27592,0.23157,1,1
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,5.4121e-05,0.27587,0.31258,1,1
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00084609,0.27527,0.1961,1,1
4,GO AMINE METABOLIC PROCESS,2.2658e-06,0.27516,0.28574,1,1
4,GO REGULATION OF ACTIN NUCLEATION,7.013e-05,0.27475,0.31106,1,1
4,GO EPITHELIAL CELL CELL ADHESION,0.0050528,0.27454,0.38021,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0017123,0.27445,0.1912,1,1
4,GO INTERLEUKIN 8 PRODUCTION,0.00036427,0.27402,0.24962,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0016129,0.27394,0.19362,1,1
4,GO MYELOID LEUKOCYTE MIGRATION,0.0001547,0.27359,0.20838,1,1
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.015574,0.27322,0.27614,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0030654,0.27309,0.26651,1,1
4,GO INTERLEUKIN 10 PRODUCTION,0.00013917,0.27291,0.23118,1,1
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.010506,0.27288,0.2817,1,1
4,GO REGULATION OF WOUND HEALING,0.0010206,0.27212,0.2491,1,1
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00012512,0.27153,0.25612,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0085714,0.27145,0.21997,1,1
4,GO MACROMOLECULE DEPALMITOYLATION,2.3418e-05,0.27122,0.30709,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.014138,0.27108,0.22079,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00095906,0.2706,0.2356,1,1
4,GO STEROL HOMEOSTASIS,0.0010206,0.27055,0.29223,1,1
4,GO RESPONSE TO BACTERIUM,0.00047456,0.27036,0.19233,1,1
4,GO REGULATION OF CHLORIDE TRANSPORT,0.0073363,0.27025,0.31019,1,1
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00019753,0.27017,0.24342,1,1
4,GO OXALATE TRANSPORT,0.0007696,0.26994,0.2247,1,1
4,GO GLYCOSYLATION,0.0001547,0.26985,0.25143,1,1
4,GO ADAPTIVE IMMUNE RESPONSE,0.00049035,0.26963,0.2285,1,1
4,GO CHEMOKINE PRODUCTION,0.0031536,0.2693,0.18698,1,1
4,GO CORNIFICATION,0.00016595,0.26926,0.28866,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00041602,0.26912,0.22562,1,1
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0079323,0.26898,0.19251,1,1
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.02268,0.26884,0.2171,1,1
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.0051916,0.26826,0.20997,1,1
4,GO RETINOL METABOLIC PROCESS,0.0025817,0.26806,0.34027,1,1
4,GO RESPONSE TO PROGESTERONE,0.0029794,0.26796,0.21446,1,1
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00098941,0.2677,0.18706,1,1
4,GO ANTIMICROBIAL HUMORAL RESPONSE,3.5759e-05,0.26765,0.25325,1,1
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,8.7323e-05,0.26762,0.2202,1,1
4,GO INDOLALKYLAMINE METABOLIC PROCESS,0.00041602,0.26728,0.29735,1,1
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00353,0.26716,0.23297,1,1
4,GO NEUTROPHIL MIGRATION,9.0551e-05,0.26713,0.2118,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0014738,0.26655,0.2444,1,1
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,3.8583e-05,0.26625,0.25098,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,4.3218e-05,0.26598,0.23072,1,1
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00065623,0.26589,0.19641,1,1
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00016023,0.26582,0.20729,1,1
4,GO PARTURITION,0.024846,0.26554,0.19824,1,1
4,GO EXTRACELLULAR VESICLE BIOGENESIS,0.00069957,0.26544,0.21192,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,0.00045924,0.26475,0.20693,1,1
4,GO PROTEIN PROCESSING,2.8418e-05,0.26463,0.26721,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00081984,0.2646,0.20248,1,1
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0006154,0.26458,0.24807,1,1
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,3.1904e-06,0.26386,0.25955,1,1
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0010528,0.26347,0.27029,1,1
4,GO PROGRAMMED NECROTIC CELL DEATH,0.00040247,0.26345,0.27085,1,1
4,GO SEQUESTERING OF TRIGLYCERIDE,0.016734,0.26302,0.20198,1,1
4,GO ALANINE TRANSPORT,0.0081404,0.26223,0.30307,1,1
4,GO ARACHIDONIC ACID METABOLIC PROCESS,4.6597e-05,0.26211,0.30428,1,1
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.00018427,0.26196,0.24827,1,1
4,GO MYELOID LEUKOCYTE ACTIVATION,0.00021909,0.26194,0.22643,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0010528,0.26159,0.19013,1,1
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00016595,0.26145,0.23099,1,1
4,GO CARNITINE METABOLIC PROCESS,0.053746,0.26116,0.17979,1,1
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00045924,0.26106,0.20809,1,1
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0013457,0.26097,0.3118,1,1
4,GO KERATINIZATION,0.00016595,0.26076,0.25312,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.001191,0.26047,0.19919,1,1
4,GO HYALURONAN BIOSYNTHETIC PROCESS,0.001191,0.26047,0.23076,1,1
4,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.015953,0.26035,0.20382,1,1
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00016023,0.26031,0.21088,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00026903,0.25968,0.24072,1,1
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.0047853,0.25948,0.20299,1,1
4,GO RESPONSE TO PH,0.0053338,0.25929,0.18537,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.001872,0.25901,0.26317,1,1
4,GO FATTY ACID CATABOLIC PROCESS,2.3418e-05,0.25898,0.27499,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0029794,0.25894,0.20244,1,1
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,5.4121e-05,0.25851,0.23795,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00042998,0.25803,0.25909,1,1
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,4.0073e-05,0.25795,0.22811,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0067808,0.25795,0.25664,1,1
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0023671,0.25794,0.16741,1,1
4,GO RESPONSE TO BIOTIC STIMULUS,0.00028792,0.25788,0.18422,1,1
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0028957,0.25773,0.20469,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.001662,0.25765,0.18699,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.013798,0.25761,0.23924,1,1
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.011612,0.2573,0.24174,1,1
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0053338,0.25713,0.2115,1,1
4,GO TRANSCYTOSIS,0.00010845,0.25705,0.28141,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.013465,0.25681,0.14611,1,1
4,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00059588,0.25654,0.35614,1,1
4,GO T HELPER CELL LINEAGE COMMITMENT,0.00090094,0.25631,0.21072,1,1
4,GO B CELL PROLIFERATION,2.9532e-05,0.2563,0.25004,1,1
4,GO WATER HOMEOSTASIS,0.00079435,0.25618,0.24077,1,1
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.0013457,0.25587,0.20785,1,1
4,GO RESPONSE TO CADMIUM ION,0.0025083,0.25583,0.25747,1,1
4,GO EPITHELIAL CELL MORPHOGENESIS,0.0075304,0.25572,0.27329,1,1
4,GO LIPID STORAGE,0.00069957,0.25546,0.23549,1,1
4,GO INFLAMMATORY RESPONSE,0.00025131,0.25514,0.20001,1,1
4,GO ADRENAL GLAND DEVELOPMENT,0.001986,0.25507,0.30531,1,1
4,GO AUTOPHAGY OF NUCLEUS,0.017549,0.25502,0.20017,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,0.00021167,0.25492,0.20947,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.00027832,0.25415,0.21149,1,1
4,GO REGULATION OF ANION TRANSPORT,0.00022676,0.2538,0.24724,1,1
4,GO REGULATION OF FATTY ACID TRANSPORT,2.9532e-05,0.25342,0.37274,1,1
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0012662,0.25329,0.38885,1,1
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.02166,0.25302,0.16227,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0041716,0.25294,0.24309,1,1
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00017796,0.25211,0.21791,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0036303,0.25182,0.32254,1,1
4,GO BILE ACID AND BILE SALT TRANSPORT,0.0027346,0.25172,0.48053,1,1
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00084609,0.25169,0.26142,1,1
4,GO GOLGI VESICLE BUDDING,0.00026003,0.25163,0.21767,1,1
4,GO RESPONSE TO GONADOTROPIN,0.0032441,0.25162,0.23008,1,1
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0020453,0.25122,0.22517,1,1
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,8.7323e-05,0.25115,0.29993,1,1
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.00067758,0.25103,0.21849,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,3.4421e-05,0.2499,0.21183,1,1
4,GO BILE ACID METABOLIC PROCESS,1.1964e-05,0.2499,0.36384,1,1
4,GO RESPONSE TO CYTOKINE,0.00041602,0.24975,0.18535,1,1
4,GO REGULATION OF CELLULAR PH,2.1702e-06,0.24968,0.23634,1,1
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00074557,0.2495,0.19852,1,1
4,GO FATTY ACID DERIVATIVE TRANSPORT,0.00037661,0.24941,0.25372,1,1
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.02268,0.24882,0.14218,1,1
4,GO NUCLEOTIDE TRANSPORT,9.7801e-06,0.24847,0.25004,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.053746,0.24835,0.22895,1,1
4,GO CELL CELL JUNCTION ORGANIZATION,0.00081984,0.24823,0.21151,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00072223,0.24817,0.16958,1,1
4,GO MUSCLE HYPERTROPHY,0.0012662,0.24771,0.1832,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.001662,0.24766,0.24673,1,1
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.001662,0.24753,0.23111,1,1
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.011904,0.24749,0.16308,1,1
4,GO CELL REDOX HOMEOSTASIS,0.00057693,0.24746,0.27065,1,1
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.00353,0.24736,0.17833,1,1
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00026903,0.24729,0.28674,1,1
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.014486,0.24729,0.20539,1,1
4,GO PURINE NUCLEOTIDE TRANSPORT,2.0033e-05,0.24717,0.24994,1,1
4,GO SPLEEN DEVELOPMENT,0.00092958,0.24694,0.21036,1,1
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.5149e-05,0.2468,0.223,1,1
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.00081984,0.24636,0.20233,1,1
4,GO HEXOSE CATABOLIC PROCESS,0.0090226,0.24629,0.20909,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0010206,0.24612,0.24495,1,1
4,GO LIPOSACCHARIDE METABOLIC PROCESS,0.0028957,0.24599,0.21829,1,1
4,GO ORGANELLE MEMBRANE FUSION,0.0020453,0.24579,0.18928,1,1
4,GO CATECHOLAMINE METABOLIC PROCESS,0.00044439,0.2457,0.29716,1,1
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.014138,0.24554,0.20152,1,1
4,GO ZINC ION HOMEOSTASIS,0.0053338,0.24552,0.30155,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0025817,0.24548,0.19284,1,1
4,GO CHYLOMICRON ASSEMBLY,0.023205,0.24524,0.25732,1,1
4,GO COAGULATION,0.0040578,0.24514,0.15032,1,1
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00055855,0.24503,0.31514,1,1
4,GO ER NUCLEUS SIGNALING PATHWAY,0.0045306,0.24462,0.24599,1,1
4,GO SECRETION BY TISSUE,0.0025083,0.24267,0.19931,1,1
4,GO MITOCHONDRIAL TRNA PROCESSING,0.0099891,0.24253,0.21379,1,1
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.001872,0.2425,0.17157,1,1
4,GO GRANULOCYTE MIGRATION,0.00030804,0.24218,0.19869,1,1
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.014841,0.24201,0.19135,1,1
4,GO INOSITOL METABOLIC PROCESS,7.013e-05,0.24192,0.30562,1,1
4,GO RESPONSE TO VIRUS,0.00090094,0.24177,0.19584,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0026572,0.24138,0.3229,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.0016129,0.24132,0.18116,1,1
4,GO OPTIC NERVE DEVELOPMENT,0.004408,0.24101,0.32286,1,1
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0011549,0.24068,0.20872,1,1
4,GO REGULATION OF LIPID TRANSPORT,0.00067758,0.24066,0.22827,1,1
4,GO HOMOTYPIC CELL CELL ADHESION,0.00059588,0.24044,0.24393,1,1
4,GO AMINO ACID ACTIVATION,0.0087944,0.24029,0.19191,1,1
4,GO CYTOKINE PRODUCTION,0.00047456,0.24024,0.1901,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0067808,0.24021,0.17852,1,1
4,GO AMELOGENESIS,0.017137,0.24017,0.2072,1,1
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.011904,0.24005,0.18158,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.00049035,0.23999,0.24096,1,1
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.007729,0.23994,0.23774,1,1
4,GO LEUKOCYTE MIGRATION,0.00052342,0.23987,0.19182,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,2.8418e-05,0.23956,0.24701,1,1
4,GO CELLULAR GLUCAN METABOLIC PROCESS,0.00079435,0.23943,0.19177,1,1
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,4.3218e-05,0.23909,0.28202,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0045306,0.2388,0.19395,1,1
4,GO REGULATION OF PH,3.3287e-06,0.23879,0.23247,1,1
4,GO CELL CHEMOTAXIS,0.00022676,0.23876,0.19305,1,1
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0007696,0.23875,0.27035,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00041602,0.23875,0.25042,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00019753,0.23807,0.27107,1,1
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00021167,0.23803,0.23356,1,1
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.012203,0.23797,0.26024,1,1
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.0062634,0.23794,0.19349,1,1
4,GO DISACCHARIDE METABOLIC PROCESS,0.0039469,0.23783,0.33152,1,1
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,9.0551e-05,0.2378,0.23017,1,1
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.00010845,0.23737,0.19231,1,1
4,GO B CELL ACTIVATION,0.0001547,0.23724,0.18739,1,1
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.0027346,0.23703,0.25983,1,1
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0025817,0.2367,0.21592,1,1
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0075304,0.23666,0.21115,1,1
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.014486,0.23626,0.22646,1,1
4,GO PIGMENTATION,0.00037661,0.23614,0.16762,1,1
4,GO RESPONSE TO STARVATION,9.3916e-06,0.23612,0.24104,1,1
4,GO LIPID EXPORT FROM CELL,0.0067808,0.23604,0.26883,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00072223,0.23604,0.23179,1,1
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.0010859,0.23595,0.21955,1,1
4,GO STEROL BIOSYNTHETIC PROCESS,0.0014299,0.23584,0.22203,1,1
4,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.0041716,0.23565,0.33539,1,1
4,GO INTERLEUKIN 12 PRODUCTION,2.5308e-05,0.23558,0.27325,1,1
4,GO RENAL SYSTEM PROCESS,0.001662,0.23557,0.18909,1,1
4,GO ER OVERLOAD RESPONSE,0.0050528,0.23538,0.24868,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00045924,0.23537,0.22598,1,1
4,GO REGULATION OF BODY FLUID LEVELS,0.0017123,0.23509,0.15832,1,1
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,1.7806e-05,0.23464,0.2607,1,1
4,GO REGULATION OF INNATE IMMUNE RESPONSE,7.547e-05,0.2346,0.22465,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0010206,0.23441,0.22973,1,1
4,GO REGULATION OF LIPID LOCALIZATION,0.00079435,0.23392,0.20973,1,1
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.017137,0.23364,0.15586,1,1
4,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00023468,0.23356,0.31971,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00037661,0.23342,0.2302,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00045924,0.23333,0.20144,1,1
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00065623,0.23319,0.17611,1,1
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0022992,0.23308,0.185,1,1
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0021689,0.23272,0.18474,1,1
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,4.4878e-05,0.23236,0.23365,1,1
4,GO ENERGY HOMEOSTASIS,0.0042883,0.23234,0.20942,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0014299,0.23224,0.2601,1,1
4,GO RESPONSE TO FATTY ACID,0.0031536,0.23217,0.20012,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,0.00017796,0.23205,0.24099,1,1
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0071468,0.23204,0.15781,1,1
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.041093,0.23181,0.15351,1,1
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.001191,0.23167,0.17902,1,1
4,GO HAIR CELL DIFFERENTIATION,0.00079435,0.23114,0.20797,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00014935,0.23114,0.21426,1,1
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.00074557,0.23071,0.16844,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00092958,0.23058,0.19924,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00016023,0.23035,0.21326,1,1
4,GO COPII COATED VESICLE BUDDING,0.00047456,0.23024,0.2073,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.4421e-05,0.2302,0.21426,1,1
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0024367,0.22985,0.2358,1,1
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.0031536,0.22982,0.17892,1,1
4,GO REGULATION OF FATTY ACID OXIDATION,0.001986,0.22979,0.22082,1,1
4,GO REGULATION OF IMMUNE RESPONSE,0.0017641,0.22978,0.15356,1,1
4,GO ANDROGEN METABOLIC PROCESS,0.0014299,0.2293,0.37706,1,1
4,GO B CELL HOMEOSTASIS,0.0010859,0.22922,0.23961,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0022332,0.22907,0.21412,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.010506,0.22906,0.15647,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,6.5149e-05,0.22906,0.24193,1,1
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.016734,0.22866,0.24846,1,1
4,GO PEPTIDE SECRETION,0.00010845,0.22862,0.18969,1,1
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,2.4346e-05,0.22834,0.30203,1,1
4,GO RESPONSE TO CAFFEINE,0.0033369,0.22816,0.23139,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0085714,0.22812,0.24569,1,1
4,GO CELL CELL JUNCTION ASSEMBLY,0.00038934,0.22795,0.22436,1,1
4,GO ALCOHOL METABOLIC PROCESS,0.00032948,0.22791,0.21374,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.022165,0.22788,0.20304,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE,0.00072223,0.22781,0.17869,1,1
4,GO NEUTRAL AMINO ACID TRANSPORT,0.0040578,0.22774,0.27942,1,1
4,GO CELLULAR RESPONSE TO STEROL,0.0026572,0.22772,0.25908,1,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0066042,0.22763,0.17479,1,1
4,GO RESPONSE TO METAL ION,6.2786e-05,0.22759,0.20544,1,1
4,GO MEMBRANE FUSION,0.0014738,0.22715,0.17574,1,1
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0010859,0.22714,0.19129,1,1
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0034322,0.22706,0.20867,1,1
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.00038934,0.22676,0.20862,1,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.00038934,0.22664,0.24287,1,1
4,GO REGULATION OF T CELL MIGRATION,0.011047,0.22642,0.17571,1,1
4,GO REGULATION OF DEFENSE RESPONSE,0.00019079,0.22607,0.18849,1,1
4,GO STEROL TRANSPORT,0.00021909,0.22606,0.25024,1,1
4,GO REGULATION OF BLOOD PRESSURE,0.00010092,0.22584,0.2001,1,1
4,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.018398,0.22567,0.24775,1,1
4,GO INTRACELLULAR LIPID TRANSPORT,0.0011549,0.22557,0.22434,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00010845,0.22496,0.25385,1,1
4,GO RESPONSE TO KETONE,0.0022992,0.22491,0.16417,1,1
4,GO GLUCOSE METABOLIC PROCESS,2.8418e-05,0.22467,0.23722,1,1
4,GO ARACHIDONIC ACID SECRETION,0.00041602,0.22466,0.24377,1,1
4,GO FLUID TRANSPORT,0.00040247,0.22446,0.21188,1,1
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00095906,0.2243,0.23148,1,1
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00024286,0.22425,0.27376,1,1
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0010528,0.22407,0.17573,1,1
4,GO SENSORY PERCEPTION OF SMELL,5.2837e-06,0.22403,0.21557,1,1
4,GO INSULIN SECRETION,0.0006154,0.2234,0.17869,1,1
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.013465,0.22332,0.23636,1,1
4,GO CYTOPLASM ORGANIZATION,0.0094949,0.22302,0.23652,1,1
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.00016023,0.22224,0.27843,1,1
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.00353,0.22217,0.23485,1,1
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.0094949,0.22214,0.29388,1,1
4,GO VESICLE TARGETING,0.0045306,0.2221,0.19234,1,1
4,GO PROTEIN MATURATION,6.0504e-05,0.22207,0.21483,1,1
4,GO SEQUESTERING OF CALCIUM ION,0.0013054,0.22199,0.1637,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.0039469,0.22198,0.29783,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.00032948,0.22198,0.20356,1,1
4,GO CELLULAR KETONE METABOLIC PROCESS,0.00041602,0.22177,0.2219,1,1
4,GO POSITIVE CHEMOTAXIS,0.0071468,0.22176,0.15169,1,1
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.018836,0.22162,0.14473,1,1
4,GO RESPONSE TO NUTRIENT,0.024846,0.22084,0.13716,1,1
4,GO PIRNA METABOLIC PROCESS,0.0034322,0.22081,0.27367,1,1
4,GO LOCOMOTOR RHYTHM,0.02843,0.22063,0.16205,1,1
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.009256,0.2206,0.15195,1,1
4,GO REGULATION OF DOPAMINE SECRETION,0.038561,0.22053,0.3059,1,1
4,GO INTERLEUKIN 6 PRODUCTION,0.00028792,0.22038,0.20603,1,1
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.012508,0.22017,0.26367,1,1
4,GO REGULATION OF GLUCONEOGENESIS,3.3132e-05,0.21997,0.26577,1,1
4,GO VESICLE BUDDING FROM MEMBRANE,0.0099891,0.21992,0.17105,1,1
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0025817,0.21983,0.22775,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0015189,0.21919,0.19361,1,1
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.014138,0.21906,0.15283,1,1
4,GO RESPONSE TO ALCOHOL,0.0014738,0.21895,0.1486,1,1
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.00014418,0.21881,0.21363,1,1
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.0025083,0.21868,0.21896,1,1
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0032441,0.21836,0.14937,1,1
4,GO CELLULAR RESPONSE TO KETONE,0.0039469,0.21795,0.20123,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.025994,0.21767,0.15194,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,2.0833e-05,0.21719,0.22847,1,1
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,2.4346e-05,0.21696,0.19885,1,1
4,GO MONOCYTE CHEMOTAXIS,0.024288,0.21681,0.14552,1,1
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0001547,0.2168,0.1977,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0030654,0.21637,0.177,1,1
4,GO MUSCLE CELL APOPTOTIC PROCESS,0.0013872,0.21613,0.17763,1,1
4,GO RESPONSE TO CALCIUM ION,0.001662,0.2153,0.18327,1,1
4,GO REGULATION OF NUCLEASE ACTIVITY,0.0021062,0.21527,0.18296,1,1
4,GO REGULATION OF ACTION POTENTIAL,0.050569,0.21524,0.1488,1,1
4,GO STEROID CATABOLIC PROCESS,0.018398,0.21516,0.25193,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0017123,0.21504,0.16804,1,1
4,GO THIOESTER BIOSYNTHETIC PROCESS,0.0024367,0.21459,0.19448,1,1
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00028792,0.21421,0.25639,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00040247,0.21378,0.17172,1,1
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.0011199,0.21374,0.17427,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.0030654,0.21369,0.20502,1,1
4,GO LEUKOCYTE CHEMOTAXIS,0.00032948,0.21327,0.1901,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,0.00022676,0.21312,0.21133,1,1
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.0022992,0.21312,0.2907,1,1
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.0038387,0.21278,0.30019,1,1
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.037747,0.21274,0.15035,1,1
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.02843,0.21234,0.13685,1,1
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.0027346,0.21223,0.26158,1,1
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.041967,0.21219,0.19196,1,1
4,GO CARBOHYDRATE TRANSPORT,2.1663e-05,0.21193,0.23913,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00072223,0.21192,0.19142,1,1
4,GO RESPONSE TO CHEMOKINE,5.4121e-05,0.2119,0.20808,1,1
4,GO REGULATION OF MAST CELL ACTIVATION,0.0083534,0.2118,0.1864,1,1
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0027346,0.21173,0.17626,1,1
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0081404,0.21168,0.28187,1,1
4,GO REGULATION OF HORMONE LEVELS,0.00021909,0.21148,0.2085,1,1
4,GO REGULATION OF RESPONSE TO WOUNDING,0.0060989,0.21123,0.1771,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,5.0226e-05,0.21123,0.2045,1,1
4,GO GROOMING BEHAVIOR,0.043763,0.21118,0.17115,1,1
4,GO ORGANIC ANION TRANSPORT,0.00021167,0.21079,0.19507,1,1
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.017969,0.21073,0.28477,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0025817,0.21064,0.16523,1,1
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0079323,0.21063,0.23423,1,1
4,GO REGULATION OF HORMONE SECRETION,0.00029782,0.21048,0.17868,1,1
4,GO BONE CELL DEVELOPMENT,0.031748,0.21044,0.15487,1,1
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00037661,0.21041,0.18962,1,1
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00059588,0.21012,0.20825,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.2962e-05,0.21008,0.20086,1,1
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,4.4878e-05,0.20998,0.21745,1,1
4,GO SODIUM ION HOMEOSTASIS,0.0094949,0.20987,0.15676,1,1
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.00019079,0.20977,0.24758,1,1
4,GO T CELL LINEAGE COMMITMENT,5.0226e-05,0.20969,0.21873,1,1
4,GO RESPONSE TO OSMOTIC STRESS,0.0066042,0.20964,0.17879,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0026572,0.20958,0.23325,1,1
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0094949,0.20952,0.15841,1,1
4,GO LIPID OXIDATION,0.00087311,0.20944,0.19594,1,1
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.013798,0.20917,0.21226,1,1
4,GO REGULATION OF BONE DEVELOPMENT,0.029719,0.209,0.13126,1,1
4,GO TISSUE HOMEOSTASIS,0.00020448,0.20899,0.19356,1,1
4,GO ADAPTIVE THERMOGENESIS,1.2962e-05,0.20858,0.20853,1,1
4,GO REGULATION OF PEPTIDE SECRETION,3.5759e-05,0.20813,0.19281,1,1
4,GO VACUOLE ORGANIZATION,8.6584e-06,0.20791,0.22589,1,1
4,GO DIOL METABOLIC PROCESS,0.0028957,0.20781,0.268,1,1
4,GO SULFUR COMPOUND TRANSPORT,0.00042998,0.20763,0.20573,1,1
4,GO NEUTRAL LIPID METABOLIC PROCESS,0.001986,0.2076,0.17315,1,1
4,GO WOUND HEALING,0.0097392,0.20755,0.13282,1,1
4,GO INTERLEUKIN 1 PRODUCTION,0.00353,0.2075,0.1831,1,1
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00037661,0.20747,0.22374,1,1
4,GO LONG CHAIN FATTY ACID TRANSPORT,2.2524e-05,0.20745,0.23258,1,1
4,GO KERATINOCYTE DIFFERENTIATION,0.00049035,0.20742,0.21185,1,1
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00027832,0.20739,0.19998,1,1
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0038387,0.20731,0.17504,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,0.00013433,0.2071,0.21207,1,1
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00069957,0.20684,0.15524,1,1
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.00026003,0.20677,0.27158,1,1
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0067808,0.20673,0.14454,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00054072,0.20641,0.18353,1,1
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0022332,0.20589,0.18477,1,1
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0047853,0.20579,0.15893,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,0.00023468,0.20559,0.19148,1,1
4,GO REGULATION OF TUBE SIZE,0.0011549,0.20554,0.19609,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,3.3132e-05,0.20535,0.25691,1,1
4,GO NECROTIC CELL DEATH,0.00052342,0.20525,0.25568,1,1
4,GO T CELL HOMEOSTASIS,0.0081404,0.20516,0.14397,1,1
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00092958,0.20504,0.15039,1,1
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0053338,0.205,0.19393,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,0.013798,0.205,0.14276,1,1
4,GO LEUKOCYTE PROLIFERATION,0.00090094,0.20451,0.17689,1,1
4,GO PLATELET MORPHOGENESIS,0.0045306,0.20448,0.20021,1,1
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,8.7323e-05,0.20427,0.19564,1,1
4,GO LYMPHOCYTE HOMEOSTASIS,0.0011199,0.20407,0.18468,1,1
4,GO EXOCYTOSIS,0.00040247,0.20403,0.17819,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0037331,0.20375,0.17618,1,1
4,GO REGULATION OF LIPID STORAGE,0.0017123,0.20338,0.18859,1,1
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.011047,0.20336,0.13983,1,1
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.00047456,0.20335,0.16849,1,1
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.017137,0.20324,0.17564,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0036303,0.20301,0.16124,1,1
4,GO CELLULAR RESPONSE TO ALKALOID,0.00016595,0.20278,0.21577,1,1
4,GO XENOBIOTIC TRANSPORT,0.0015189,0.20258,0.30323,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,0.00016595,0.20252,0.2295,1,1
4,GO PLASMA MEMBRANE FUSION,0.031059,0.20173,0.18856,1,1
4,GO NEUTROPHIL CHEMOTAXIS,0.00034072,0.20165,0.1609,1,1
4,GO RESPONSE TO STEROL,0.0073363,0.20111,0.20083,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.0011199,0.2011,0.18533,1,1
4,GO HORMONE TRANSPORT,0.00027832,0.20107,0.18676,1,1
4,GO INTERFERON ALPHA PRODUCTION,0.0006154,0.20102,0.21289,1,1
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0062634,0.20101,0.24506,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0057817,0.20068,0.12764,1,1
4,GO LIPID HOMEOSTASIS,0.0024367,0.20065,0.20847,1,1
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.05161,0.20049,0.13015,1,1
4,GO AMYLOID BETA METABOLIC PROCESS,0.013139,0.20047,0.1643,1,1
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.004408,0.20045,0.2162,1,1
4,GO TRANSITION METAL ION HOMEOSTASIS,0.0031536,0.20029,0.15812,1,1
4,GO GPI ANCHOR METABOLIC PROCESS,0.0050528,0.20009,0.20274,1,1
4,GO GRANULOCYTE CHEMOTAXIS,0.0012662,0.19955,0.15737,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0075304,0.19923,0.16629,1,1
4,GO RESPONSE TO INORGANIC SUBSTANCE,6.7596e-05,0.19901,0.16314,1,1
4,GO LYMPHOCYTE COSTIMULATION,0.018398,0.19877,0.12169,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.015574,0.19848,0.22181,1,1
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0021062,0.19813,0.15758,1,1
4,GO T CELL DIFFERENTIATION,0.00055855,0.19787,0.14586,1,1
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0017123,0.19785,0.15333,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.004408,0.19775,0.2024,1,1
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.010773,0.19752,0.14951,1,1
4,GO CELL ACTIVATION,0.00069957,0.19749,0.16341,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.8301e-05,0.197,0.17846,1,1
4,GO RESPONSE TO CORTICOSTEROID,0.0041716,0.19698,0.18199,1,1
4,GO FATTY ACID TRANSPORT,0.00017796,0.19647,0.2171,1,1
4,GO ENDOCYTIC RECYCLING,0.0050528,0.19645,0.13333,1,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0099891,0.19617,0.16393,1,1
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.014486,0.1959,0.19989,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.004408,0.19587,0.29264,1,1
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.0021062,0.19561,0.14825,1,1
4,GO ADIPOSE TISSUE DEVELOPMENT,0.0037331,0.19553,0.16901,1,1
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.011612,0.19547,0.16621,1,1
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.02068,0.19543,0.15046,1,1
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.024846,0.1953,0.15097,1,1
4,GO ALPHA BETA T CELL ACTIVATION,0.00036427,0.1952,0.20036,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0010528,0.19503,0.15773,1,1
4,GO BICARBONATE TRANSPORT,0.014138,0.195,0.15798,1,1
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.029068,0.19483,0.15962,1,1
4,GO POSITIVE REGULATION OF COAGULATION,0.0046564,0.19466,0.20868,1,1
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.019739,0.19448,0.15479,1,1
4,GO PLATELET ACTIVATION,0.0025817,0.19427,0.15621,1,1
4,GO MUSCLE ADAPTATION,0.0041716,0.1942,0.15346,1,1
4,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0025817,0.19414,0.38803,1,1
4,GO LIPID METABOLIC PROCESS,0.00052342,0.19374,0.17421,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0020453,0.19367,0.19864,1,1
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00074557,0.19362,0.15775,1,1
4,GO AMINO SUGAR CATABOLIC PROCESS,0.00041602,0.19344,0.31372,1,1
4,GO HETEROTYPIC CELL CELL ADHESION,0.044685,0.19341,0.14182,1,1
4,GO CARNITINE SHUTTLE,0.0064317,0.19337,0.20901,1,1
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0017123,0.1929,0.17518,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0040578,0.19284,0.14983,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0036303,0.19265,0.15793,1,1
4,GO MANNOSYLATION,0.00010845,0.19248,0.23192,1,1
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.00031859,0.19246,0.13781,1,1
4,GO B CELL DIFFERENTIATION,0.00010845,0.19222,0.19459,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00022676,0.19206,0.20093,1,1
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.00087311,0.19201,0.16165,1,1
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.020205,0.19192,0.11477,1,1
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00030804,0.19148,0.18377,1,1
4,GO COPPER ION TRANSPORT,0.025994,0.19116,0.17314,1,1
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,3.0689e-05,0.19115,0.24516,1,1
4,GO APOPTOTIC SIGNALING PATHWAY,0.00098941,0.1907,0.15521,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0029794,0.19021,0.21231,1,1
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.001228,0.18998,0.15393,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0029794,0.18998,0.17009,1,1
4,GO REGULATION OF HEART RATE,0.015953,0.18981,0.15731,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,0.00041602,0.18974,0.1715,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0087944,0.1897,0.20357,1,1
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0019282,0.18967,0.1341,1,1
4,GO GOLGI RIBBON FORMATION,0.0027346,0.18949,0.18899,1,1
4,GO PROSTAGLANDIN TRANSPORT,0.0017123,0.18943,0.30416,1,1
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0016129,0.1894,0.14009,1,1
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.019283,0.18937,0.17288,1,1
4,GO MONOCARBOXYLIC ACID TRANSPORT,0.00063551,0.18933,0.20662,1,1
4,GO RESPONSE TO DSRNA,0.0007696,0.18921,0.1646,1,1
4,GO PEPTIDE HORMONE SECRETION,0.00042998,0.18902,0.17569,1,1
4,GO REGULATION OF APPETITE,0.015574,0.18891,0.12117,1,1
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.031748,0.18885,0.14214,1,1
4,GO PROTEIN KINASE B SIGNALING,0.013798,0.18885,0.11886,1,1
4,GO SECRETION,0.00069957,0.1888,0.15625,1,1
4,GO CELLULAR LIPID METABOLIC PROCESS,0.00037661,0.18835,0.17746,1,1
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0049174,0.18826,0.1133,1,1
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0059384,0.18816,0.17562,1,1
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0023671,0.18811,0.1393,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0049174,0.18789,0.12777,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00028792,0.18757,0.17307,1,1
4,GO MANGANESE ION TRANSPORT,0.00067758,0.18694,0.22277,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0021062,0.18686,0.14028,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,0.00012512,0.1868,0.2338,1,1
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0081404,0.18676,0.14923,1,1
4,GO COPULATION,0.015953,0.18665,0.17526,1,1
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.025414,0.18646,0.18181,1,1
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0026572,0.18632,0.14451,1,1
4,GO ANION TRANSPORT,0.00028792,0.18622,0.17573,1,1
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.035393,0.1861,0.22119,1,1
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0075304,0.18595,0.12466,1,1
4,GO HUMORAL IMMUNE RESPONSE,0.00012964,0.18589,0.20554,1,1
4,GO REGULATION OF VASCULAR PERMEABILITY,0.0059384,0.18587,0.20703,1,1
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.014486,0.1858,0.25052,1,1
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0010528,0.18541,0.18868,1,1
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,7.8282e-05,0.18537,0.21402,1,1
4,GO RESPONSE TO IRON ION,0.03939,0.18519,0.15753,1,1
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0038387,0.18475,0.14084,1,1
4,GO ESTROGEN BIOSYNTHETIC PROCESS,0.021165,0.18464,0.23428,1,1
4,GO PHOSPHOLIPID METABOLIC PROCESS,0.0001165,0.18452,0.16062,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,0.00087311,0.18445,0.18102,1,1
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0046564,0.18424,0.13018,1,1
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.030383,0.18408,0.134,1,1
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0054795,0.184,0.21004,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0053338,0.18382,0.14319,1,1
4,GO REGULATION OF INSULIN SECRETION,0.0012662,0.18372,0.16095,1,1
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.027188,0.18341,0.1529,1,1
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00067758,0.18307,0.16295,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,0.007729,0.18305,0.27538,1,1
4,GO POSITIVE REGULATION OF CELL AGING,0.02166,0.18302,0.19212,1,1
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.047551,0.183,0.17792,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.033166,0.18294,0.17523,1,1
4,GO RESPONSE TO ETHER,0.0022992,0.18285,0.18454,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00022676,0.1828,0.16908,1,1
4,GO SUPEROXIDE METABOLIC PROCESS,0.0027346,0.18252,0.20026,1,1
4,GO OXIDATION REDUCTION PROCESS,0.00045924,0.18239,0.19152,1,1
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0024367,0.18233,0.15992,1,1
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00090094,0.18208,0.21707,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,8.6584e-06,0.18201,0.22909,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,0.00059588,0.1817,0.15981,1,1
4,GO TEMPERATURE HOMEOSTASIS,8.4205e-05,0.18151,0.1784,1,1
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,2.2524e-05,0.18148,0.19671,1,1
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00016023,0.18139,0.22489,1,1
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0045306,0.18135,0.11833,1,1
4,GO RESPONSE TO WOUNDING,0.024288,0.18134,0.10984,1,1
4,GO REGULATION OF CELL CELL ADHESION,0.0032441,0.18111,0.1536,1,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00017186,0.18069,0.1772,1,1
4,GO RESPONSE TO LIPID,0.0073363,0.18018,0.12293,1,1
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0019282,0.18,0.18953,1,1
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.011612,0.17997,0.14204,1,1
4,GO ACYLGLYCEROL HOMEOSTASIS,0.042857,0.17994,0.1566,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION,0.0038387,0.17991,0.15959,1,1
4,GO EATING BEHAVIOR,0.0021062,0.17985,0.17067,1,1
4,GO IRON ION TRANSPORT,0.00014935,0.17984,0.2298,1,1
4,GO REGULATION OF CELL ACTIVATION,0.0057817,0.17976,0.12743,1,1
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.001872,0.17949,0.22231,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00010462,0.17943,0.17041,1,1
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.00028792,0.17925,0.17055,1,1
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.014138,0.17907,0.14114,1,1
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0017641,0.17877,0.12574,1,1
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0023671,0.1785,0.19758,1,1
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.017137,0.17844,0.25372,1,1
4,GO INORGANIC ANION TRANSPORT,0.00092958,0.1784,0.14201,1,1
4,GO CHEMICAL HOMEOSTASIS,0.00023468,0.17812,0.15675,1,1
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.004408,0.17806,0.16216,1,1
4,GO TETRAPYRROLE METABOLIC PROCESS,0.013798,0.17776,0.21733,1,1
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.024846,0.17769,0.13476,1,1
4,GO RESPONSE TO INSULIN,0.00081984,0.17768,0.15663,1,1
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0029794,0.17746,0.15182,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.018836,0.17741,0.27669,1,1
4,GO POSITIVE REGULATION OF SECRETION,0.00014935,0.17691,0.18341,1,1
4,GO T CELL ACTIVATION,0.0017123,0.1769,0.14667,1,1
4,GO FATTY ACID METABOLIC PROCESS,0.00034072,0.17685,0.21303,1,1
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00098941,0.17684,0.16069,1,1
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0028957,0.17674,0.16496,1,1
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.0075304,0.17665,0.15192,1,1
4,GO HEPATOCYTE DIFFERENTIATION,0.018836,0.17645,0.21004,1,1
4,GO ACTIVATION OF IMMUNE RESPONSE,0.001872,0.17637,0.15033,1,1
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.0016129,0.17635,0.17096,1,1
4,GO CELLULAR PIGMENTATION,0.0010859,0.17593,0.1741,1,1
4,GO SENSORY PERCEPTION OF TASTE,0.0042883,0.1757,0.14594,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.030383,0.17568,0.11857,1,1
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00054072,0.1756,0.13331,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0021062,0.17551,0.16439,1,1
4,GO RESPONSE TO MECHANICAL STIMULUS,0.00049035,0.17538,0.17888,1,1
4,GO CELLULAR RESPONSE TO ALCOHOL,0.019283,0.17533,0.13938,1,1
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0014738,0.17501,0.12894,1,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0012662,0.17468,0.14524,1,1
4,GO LYMPHOCYTE ACTIVATION,0.0036303,0.17441,0.12449,1,1
4,GO CHLORIDE TRANSPORT,0.0012662,0.17441,0.14403,1,1
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00057693,0.17424,0.16731,1,1
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0014738,0.17423,0.11478,1,1
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0056288,0.17372,0.12311,1,1
4,GO METAL ION HOMEOSTASIS,0.00035231,0.17349,0.13924,1,1
4,GO REGULATION OF MUSCLE ADAPTATION,0.016734,0.17348,0.13455,1,1
4,GO LYMPHOCYTE DIFFERENTIATION,0.0015653,0.17346,0.12193,1,1
4,GO ACTIN NUCLEATION,0.00022676,0.17312,0.18032,1,1
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.011904,0.1726,0.1268,1,1
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00090094,0.17256,0.13921,1,1
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.0013872,0.17248,0.17769,1,1
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.041967,0.17218,0.1353,1,1
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0010528,0.17216,0.16293,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0090226,0.17214,0.12609,1,1
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.014486,0.17205,0.23783,1,1
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0051916,0.17188,0.12682,1,1
4,GO GLUTAMATE METABOLIC PROCESS,0.0087944,0.17184,0.16055,1,1
4,GO POLYOL BIOSYNTHETIC PROCESS,0.001986,0.17159,0.19703,1,1
4,GO AGING,0.0014299,0.17152,0.13455,1,1
4,GO ORGANELLE FUSION,0.0025817,0.17146,0.16009,1,1
4,GO VESICLE ORGANIZATION,0.0031536,0.17145,0.15405,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.049546,0.17129,0.1396,1,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0034322,0.17109,0.16096,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.010245,0.17101,0.13868,1,1
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.014138,0.1706,0.1471,1,1
4,GO PANCREAS DEVELOPMENT,0.042857,0.17031,0.13549,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0054795,0.17022,0.19474,1,1
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0015653,0.17015,0.15561,1,1
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.013798,0.16973,0.11841,1,1
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0053338,0.16955,0.12482,1,1
4,GO RESPONSE TO STEROID HORMONE,0.0073363,0.16952,0.13714,1,1
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0066042,0.16952,0.13982,1,1
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.0051916,0.16952,0.18469,1,1
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0097392,0.16942,0.12775,1,1
4,GO RESPONSE TO FUNGUS,0.00063551,0.16914,0.15966,1,1
4,GO CHOLESTEROL STORAGE,0.03245,0.16884,0.16508,1,1
4,GO REGULATION OF T CELL DIFFERENTIATION,0.004408,0.16842,0.11876,1,1
4,GO PROTEOLYSIS,0.00030804,0.1684,0.13651,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,3.0689e-05,0.1684,0.23441,1,1
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.0051916,0.16769,0.13711,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0081404,0.16753,0.13304,1,1
4,GO REGULATION OF CARDIAC CONDUCTION,0.02166,0.16751,0.1222,1,1
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.022165,0.16725,0.12456,1,1
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,4.4878e-05,0.167,0.18134,1,1
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00031859,0.16665,0.15748,1,1
4,GO GLYCEROLIPID METABOLIC PROCESS,0.0001547,0.16649,0.15849,1,1
4,GO PEROXISOME ORGANIZATION,0.00069957,0.16595,0.19799,1,1
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.0050528,0.16571,0.12899,1,1
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00024286,0.1657,0.20405,1,1
4,GO CYTOKINE SECRETION,0.0006154,0.16552,0.19209,1,1
4,GO POSITIVE REGULATION OF EXOCYTOSIS,0.0020453,0.16489,0.17654,1,1
4,GO ERK1 AND ERK2 CASCADE,0.046579,0.16487,0.10394,1,1
4,GO REGULATION OF SECRETION,0.0013872,0.16487,0.13895,1,1
4,GO FATTY ACID BETA OXIDATION,0.0021689,0.16475,0.21026,1,1
4,GO ORGANIC ACID TRANSPORT,0.00067758,0.16425,0.19392,1,1
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.02843,0.16417,0.1336,1,1
4,GO GLUCOSE IMPORT,0.0042883,0.16372,0.15853,1,1
4,GO MACROPHAGE ACTIVATION,0.0028957,0.16371,0.14928,1,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.031059,0.16333,0.21637,1,1
4,GO RESPONSE TO TUMOR CELL,0.03245,0.16333,0.22183,1,1
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0015653,0.16322,0.1381,1,1
4,GO REGULATION OF PROTEOLYSIS,0.0021689,0.16314,0.14356,1,1
4,GO MONOAMINE TRANSPORT,0.018398,0.163,0.2258,1,1
4,GO REGULATION OF RESPONSE TO STRESS,0.0030654,0.16256,0.11543,1,1
4,GO ION HOMEOSTASIS,0.00044439,0.1624,0.1432,1,1
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.046579,0.16238,0.1008,1,1
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0020453,0.16199,0.13582,1,1
4,GO LIPID CATABOLIC PROCESS,7.8282e-05,0.16197,0.21809,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.004408,0.16174,0.12155,1,1
4,GO SULFUR COMPOUND METABOLIC PROCESS,0.010506,0.16158,0.15158,1,1
4,GO RESPONSE TO OXIDATIVE STRESS,0.0019282,0.16105,0.13896,1,1
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0050528,0.16087,0.12632,1,1
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0090226,0.16084,0.15104,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.0022332,0.16075,0.1393,1,1
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.019739,0.16031,0.1779,1,1
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.037747,0.16026,0.14022,1,1
4,GO PROTEIN DESTABILIZATION,0.0014299,0.15978,0.14863,1,1
4,GO RENAL SODIUM EXCRETION,0.023205,0.15976,0.16111,1,1
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.011612,0.15953,0.2102,1,1
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.010506,0.15939,0.15944,1,1
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0036303,0.15933,0.14548,1,1
4,GO REGULATION OF CELL MATURATION,0.0041716,0.15932,0.17053,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,0.0007696,0.15887,0.18558,1,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.004408,0.15855,0.13289,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0025083,0.15841,0.12373,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00072223,0.15833,0.17043,1,1
4,GO CELLULAR RESPONSE TO LIPID,0.022165,0.15798,0.11253,1,1
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.013465,0.15796,0.15038,1,1
4,GO PEROXISOMAL TRANSPORT,0.00079435,0.1578,0.20749,1,1
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.036164,0.15744,0.14788,1,1
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0087944,0.15731,0.14714,1,1
4,GO DETECTION OF STIMULUS,8.4205e-05,0.15724,0.13002,1,1
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0022332,0.15707,0.12027,1,1
4,GO CIRCULATORY SYSTEM PROCESS,0.0024367,0.15704,0.12859,1,1
4,GO MUSCLE CELL MIGRATION,0.05161,0.15687,0.13874,1,1
4,GO CERAMIDE METABOLIC PROCESS,0.00074557,0.15681,0.20123,1,1
4,GO ION TRANSPORT,0.0011549,0.15653,0.13849,1,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.025414,0.15637,0.10801,1,1
4,GO ENDOCRINE HORMONE SECRETION,0.0071468,0.15629,0.14803,1,1
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.010245,0.15628,0.12688,1,1
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0038387,0.15578,0.15019,1,1
4,GO DRUG METABOLIC PROCESS,0.00063551,0.15573,0.28706,1,1
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0040578,0.15571,0.1681,1,1
4,GO RESPONSE TO DRUG,0.0094949,0.15559,0.12911,1,1
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0046564,0.15553,0.14611,1,1
4,GO CELLULAR ION HOMEOSTASIS,0.00054072,0.15544,0.13283,1,1
4,GO DEFENSE RESPONSE TO FUNGUS,0.0038387,0.1552,0.13015,1,1
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.004408,0.15504,0.17135,1,1
4,GO REGULATION OF BLOOD CIRCULATION,0.023741,0.15503,0.1037,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0071468,0.15457,0.18061,1,1
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0022992,0.15457,0.18675,1,1
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0067808,0.15439,0.11455,1,1
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0059384,0.1543,0.16796,1,1
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.033166,0.15422,0.12452,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00020448,0.15383,0.15629,1,1
4,GO HOMEOSTATIC PROCESS,0.00028792,0.1538,0.12848,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0036303,0.1537,0.14827,1,1
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.0028141,0.15368,0.18393,1,1
4,GO REGULATION OF HEMOPOIESIS,0.001662,0.15367,0.12237,1,1
4,GO LEUKOCYTE CELL CELL ADHESION,0.0022332,0.15356,0.15309,1,1
4,GO REGULATION OF MITOPHAGY,0.033894,0.15345,0.12034,1,1
4,GO LEUKOCYTE DIFFERENTIATION,0.0012662,0.15328,0.13467,1,1
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.022165,0.15326,0.12745,1,1
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0017641,0.15309,0.21308,1,1
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.011326,0.15246,0.22569,1,1
4,GO SECRETORY GRANULE ORGANIZATION,0.030383,0.15242,0.13464,1,1
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.0021062,0.15226,0.13423,1,1
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.001986,0.15167,0.13973,1,1
4,GO CALCIUM ION IMPORT,0.034637,0.15116,0.081625,1,1
4,GO GOLGI ORGANIZATION,0.00013433,0.15093,0.17678,1,1
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.0021689,0.15075,0.16718,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0099891,0.15033,0.12333,1,1
4,GO ORGANIC ACID CATABOLIC PROCESS,0.0014738,0.15028,0.19599,1,1
4,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0094949,0.15001,0.13513,1,1
4,GO ENDOSOME ORGANIZATION,0.0014299,0.14987,0.16393,1,1
4,GO REGULATION OF PEPTIDE TRANSPORT,0.00024286,0.14986,0.13307,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.047551,0.14963,0.094516,1,1
4,GO AMINO ACID IMPORT,0.052669,0.14954,0.15667,1,1
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.014138,0.14945,0.13139,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0013872,0.14924,0.1419,1,1
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.033166,0.14921,0.17326,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.023741,0.14919,0.1103,1,1
4,GO ALCOHOL CATABOLIC PROCESS,0.0021062,0.14918,0.1831,1,1
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00072223,0.14891,0.14108,1,1
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0030654,0.14864,0.11738,1,1
4,GO RESPONSE TO ALKALOID,0.027188,0.14861,0.1066,1,1
4,GO RESPONSE TO ACID CHEMICAL,0.0099891,0.14832,0.12,1,1
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0054795,0.14817,0.14885,1,1
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.0045306,0.14815,0.22262,1,1
4,GO REGULATION OF CELL ADHESION,0.010245,0.14791,0.12754,1,1
4,GO MULTIVESICULAR BODY ORGANIZATION,0.0057817,0.14721,0.12671,1,1
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.0015653,0.14673,0.17821,1,1
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0033369,0.14622,0.14676,1,1
4,GO RESPONSE TO HORMONE,0.0056288,0.14619,0.1261,1,1
4,GO REGULATION OF ION TRANSPORT,0.02068,0.14615,0.096612,1,1
4,GO LEUKOCYTE HOMEOSTASIS,0.014138,0.14598,0.12667,1,1
4,GO OOCYTE DIFFERENTIATION,0.0073363,0.14594,0.12295,1,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.046579,0.14591,0.077232,1,1
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0047853,0.14588,0.18855,1,1
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.011612,0.14578,0.2101,1,1
4,GO PROSTAGLANDIN SECRETION,0.011326,0.14553,0.22229,1,1
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0097392,0.14545,0.14636,1,1
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.015203,0.14504,0.15872,1,1
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.027803,0.14482,0.13994,1,1
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.00052342,0.14445,0.15411,1,1
4,GO MAMMARY GLAND DEVELOPMENT,0.03939,0.14443,0.095823,1,1
4,GO AMINE TRANSPORT,0.021165,0.14384,0.20282,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE,0.0083534,0.14378,0.10592,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,0.0079323,0.1437,0.20253,1,1
4,GO EXECUTION PHASE OF APOPTOSIS,2.1663e-05,0.14353,0.18619,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0025083,0.14353,0.12248,1,1
4,GO ENERGY RESERVE METABOLIC PROCESS,0.010506,0.14346,0.14575,1,1
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.035393,0.14343,0.15478,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.035393,0.1434,0.13271,1,1
4,GO METAL ION TRANSPORT,0.0079323,0.1428,0.10564,1,1
4,GO REGULATION OF ATP METABOLIC PROCESS,0.010506,0.14271,0.11114,1,1
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0031536,0.14188,0.1163,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0073363,0.1417,0.14905,1,1
4,GO REGULATION OF GLUCOSE IMPORT,0.0041716,0.1417,0.15449,1,1
4,GO MYOTUBE DIFFERENTIATION,0.0056288,0.14153,0.13736,1,1
4,GO CELL CELL ADHESION,0.025994,0.14152,0.10675,1,1
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0060989,0.14145,0.15022,1,1
4,GO MONONUCLEAR CELL MIGRATION,0.047551,0.14095,0.098299,1,1
4,GO T CELL SELECTION,0.00040247,0.14084,0.14498,1,1
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.02843,0.14068,0.13094,1,1
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0079323,0.14066,0.11531,1,1
4,GO T CELL PROLIFERATION,0.00353,0.14065,0.15408,1,1
4,GO ISOPRENOID METABOLIC PROCESS,0.03245,0.14061,0.1489,1,1
4,GO MYELOID CELL DIFFERENTIATION,0.0017123,0.14042,0.12269,1,1
4,GO RETINA HOMEOSTASIS,0.033166,0.14015,0.070132,1,1
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0094949,0.13999,0.10401,1,1
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0036303,0.13993,0.17429,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00037661,0.13962,0.13887,1,1
4,GO RESPONSE TO ETHANOL,0.02166,0.13943,0.10623,1,1
4,GO CELL MATURATION,0.0029794,0.13936,0.11862,1,1
4,GO PLASMA MEMBRANE ORGANIZATION,0.0090226,0.13929,0.14494,1,1
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.04854,0.13928,0.11573,1,1
4,GO RESPONSE TO PEPTIDE HORMONE,0.0031536,0.13919,0.12097,1,1
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.03939,0.13918,0.1993,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.034637,0.13913,0.09679,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.022165,0.13911,0.089462,1,1
4,GO EPITHELIUM DEVELOPMENT,0.0049174,0.13897,0.10469,1,1
4,GO VITAMIN METABOLIC PROCESS,0.013139,0.1389,0.18117,1,1
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0057817,0.13844,0.10697,1,1
4,GO ORGANIC ACID METABOLIC PROCESS,0.001662,0.13844,0.16647,1,1
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.031748,0.13838,0.18722,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0047853,0.13818,0.18329,1,1
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00353,0.13817,0.17069,1,1
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0025083,0.13803,0.17074,1,1
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.018398,0.13802,0.10379,1,1
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.046579,0.13757,0.085564,1,1
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0064317,0.13742,0.23951,1,1
4,GO LYSOSOME LOCALIZATION,0.0051916,0.13734,0.13872,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.029068,0.13731,0.19606,1,1
4,GO TRANSMEMBRANE TRANSPORT,0.0010206,0.13669,0.13515,1,1
4,GO REGULATION OF PROTEIN BINDING,0.021165,0.13663,0.10579,1,1
4,GO MULTIVESICULAR BODY SORTING PATHWAY,0.0039469,0.13646,0.13555,1,1
4,GO PROTEIN MANNOSYLATION,0.015203,0.13642,0.15749,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.022165,0.13623,0.18303,1,1
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.00052342,0.1362,0.16113,1,1
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.041967,0.13613,0.10801,1,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.014138,0.13609,0.10936,1,1
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.001191,0.13592,0.16393,1,1
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.029068,0.13589,0.13634,1,1
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.0049174,0.13563,0.10733,1,1
4,GO CATION TRANSPORT,0.0042883,0.13521,0.11534,1,1
4,GO ION TRANSMEMBRANE TRANSPORT,0.0036303,0.13509,0.11597,1,1
4,GO IMMUNE SYSTEM DEVELOPMENT,0.0010859,0.13503,0.11075,1,1
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0066042,0.13489,0.10645,1,1
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.02268,0.13472,0.10893,1,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0037331,0.1347,0.12116,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0083534,0.13455,0.1276,1,1
4,GO PROTEIN AUTOUBIQUITINATION,9.0551e-05,0.13427,0.13172,1,1
4,GO WATER TRANSPORT,0.045624,0.13358,0.088047,1,1
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0046564,0.13308,0.18828,1,1
4,GO NCRNA CATABOLIC PROCESS,0.02166,0.13308,0.11901,1,1
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.045624,0.13304,0.12961,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.050569,0.13271,0.10264,1,1
4,GO RESPONSE TO NITROGEN COMPOUND,0.0045306,0.13271,0.10346,1,1
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.014841,0.13263,0.092704,1,1
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0013872,0.1323,0.16685,1,1
4,GO ORGANELLE DISASSEMBLY,0.0017641,0.13216,0.15359,1,1
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.0073363,0.13187,0.19967,1,1
4,GO EXCRETION,0.020205,0.13179,0.12397,1,1
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.0019282,0.13176,0.13008,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0010859,0.13153,0.16051,1,1
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0067808,0.13149,0.13668,1,1
4,GO LIPID MODIFICATION,0.0030654,0.13139,0.14706,1,1
4,GO REGULATION OF T CELL ACTIVATION,0.0066042,0.13116,0.12252,1,1
4,GO FEEDING BEHAVIOR,0.025994,0.13077,0.11935,1,1
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.0032441,0.13074,0.1527,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0013457,0.13043,0.12381,1,1
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.029719,0.12942,0.16349,1,1
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.018836,0.12927,0.10456,1,1
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.009256,0.12914,0.1151,1,1
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0013457,0.12908,0.16156,1,1
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.00079435,0.12907,0.1908,1,1
4,GO RESPONSE TO ANTIBIOTIC,0.035393,0.12845,0.10099,1,1
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0053338,0.12835,0.11978,1,1
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0028141,0.12821,0.13955,1,1
4,GO RESPONSE TO ACTIVITY,0.011047,0.12816,0.17768,1,1
4,GO RESPONSE TO PEPTIDE,0.0087944,0.12796,0.10245,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.019283,0.12789,0.10897,1,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0045306,0.12728,0.11195,1,1
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0042883,0.12728,0.15045,1,1
4,GO RESPONSE TO TOXIC SUBSTANCE,0.0066042,0.12666,0.16814,1,1
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0021062,0.1265,0.12409,1,1
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.020205,0.12589,0.099783,1,1
4,GO RESPONSE TO OXYGEN LEVELS,0.011047,0.12546,0.11442,1,1
4,GO CATION TRANSMEMBRANE TRANSPORT,0.013798,0.12544,0.097266,1,1
4,GO EPITHELIAL CELL PROLIFERATION,0.053746,0.12521,0.077179,1,1
4,GO REGULATION OF HYDROLASE ACTIVITY,0.015574,0.12442,0.091448,1,1
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.010245,0.1244,0.12295,1,1
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0075304,0.12427,0.14766,1,1
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0085714,0.12421,0.11012,1,1
4,GO REGULATION OF CHEMOTAXIS,0.031059,0.12418,0.087359,1,1
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0060989,0.12387,0.15842,1,1
4,GO SIGNAL RELEASE,0.0051916,0.12365,0.1183,1,1
4,GO KILLING OF CELLS OF OTHER ORGANISM,0.00023468,0.12317,0.18084,1,1
4,GO SODIUM ION TRANSPORT,0.019739,0.12274,0.11762,1,1
4,GO RESPONSE TO INTERLEUKIN 4,0.012203,0.12263,0.13477,1,1
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.042857,0.12253,0.12075,1,1
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.029068,0.12247,0.091116,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.0075304,0.12242,0.12654,1,1
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.025994,0.12195,0.097517,1,1
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.012203,0.12174,0.11391,1,1
4,GO TISSUE MIGRATION,0.038561,0.12168,0.11105,1,1
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.001872,0.12166,0.11488,1,1
4,GO RESPONSE TO SALT,0.04854,0.12162,0.10418,1,1
4,GO REGULATION OF TOR SIGNALING,0.00016023,0.12162,0.12297,1,1
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0083534,0.12135,0.13051,1,1
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.02166,0.12105,0.12361,1,1
4,GO TRANSITION METAL ION TRANSPORT,0.00024286,0.12063,0.209,1,1
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.015203,0.12046,0.096999,1,1
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.015574,0.12043,0.1116,1,1
4,GO ACTIVATION OF MAPK ACTIVITY,0.0081404,0.12006,0.11286,1,1
4,GO REGULATION OF CELL DEATH,0.011326,0.11905,0.089582,1,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.0097392,0.11863,0.15488,1,1
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0022332,0.11851,0.1205,1,1
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.017137,0.11831,0.11073,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0056288,0.11815,0.14667,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00035231,0.11767,0.145,1,1
4,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0028141,0.11759,0.13269,1,1
4,GO GLAND DEVELOPMENT,0.0073363,0.11753,0.099768,1,1
4,GO ACID SECRETION,0.026586,0.11727,0.13644,1,1
4,GO CALCIUM MEDIATED SIGNALING,0.0085714,0.11724,0.079847,1,1
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.013798,0.11692,0.10756,1,1
4,GO ORGANIC CATION TRANSPORT,0.014138,0.11682,0.16507,1,1
4,GO FAT CELL DIFFERENTIATION,0.012203,0.11682,0.11679,1,1
4,GO TOR SIGNALING,5.0226e-05,0.11657,0.10942,1,1
4,GO PIGMENT GRANULE LOCALIZATION,0.012203,0.11653,0.13513,1,1
4,GO RESPONSE TO MONOSACCHARIDE,0.01282,0.11552,0.11974,1,1
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0039469,0.11548,0.14531,1,1
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0081404,0.11536,0.13808,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.011326,0.11529,0.089672,1,1
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.0081404,0.11468,0.15172,1,1
4,GO VIRAL BUDDING,0.0039469,0.11466,0.14479,1,1
4,GO MITOCHONDRIAL TRANSPORT,0.0050528,0.11463,0.092525,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00084609,0.11459,0.11491,1,1
4,GO RESPONSE TO CARBOHYDRATE,0.017969,0.11442,0.11598,1,1
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0056288,0.11396,0.14831,1,1
4,GO CATECHOLAMINE SECRETION,0.041967,0.11319,0.23026,1,1
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.050569,0.11268,0.11182,1,1
4,GO CELLULAR HOMEOSTASIS,0.0022332,0.11259,0.11704,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.020205,0.11245,0.079325,1,1
4,GO APOPTOTIC PROCESS,0.007729,0.11227,0.093199,1,1
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.0067808,0.11215,0.10042,1,1
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0087944,0.1121,0.096927,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0087944,0.11157,0.14641,1,1
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.025994,0.11114,0.082216,1,1
4,GO MULTICELLULAR ORGANISM AGING,0.0046564,0.11083,0.12448,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION,0.0097392,0.11066,0.082445,1,1
4,GO REGULATION OF MAPK CASCADE,0.029719,0.1101,0.097867,1,1
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.016339,0.10963,0.11508,1,1
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.025414,0.1095,0.16478,1,1
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.011904,0.1094,0.12678,1,1
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.037747,0.10924,0.095895,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.015953,0.10897,0.11068,1,1
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.0087944,0.10896,0.16001,1,1
4,GO CYTOSOLIC TRANSPORT,0.0011199,0.10866,0.11796,1,1
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.025994,0.10852,0.082465,1,1
4,GO REGULATION OF TRANSPORT,0.013139,0.10851,0.083908,1,1
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.017549,0.10803,0.10013,1,1
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.052669,0.1076,0.12641,1,1
4,GO REGULATION OF MAP KINASE ACTIVITY,0.015953,0.10741,0.11865,1,1
4,GO ELECTRON TRANSPORT CHAIN,0.0041716,0.10666,0.19625,1,1
4,GO SOMITOGENESIS,0.011612,0.10662,0.10824,1,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0019282,0.10642,0.11835,1,1
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.022165,0.10612,0.12073,1,1
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.015203,0.10586,0.12885,1,1
4,GO BODY FLUID SECRETION,0.042857,0.10578,0.084114,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.033166,0.10518,0.12265,1,1
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.014486,0.10481,0.087373,1,1
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.031748,0.10471,0.096442,1,1
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0053338,0.10445,0.10948,1,1
4,GO REGULATION OF PROTEIN STABILITY,0.0045306,0.10438,0.10486,1,1
4,GO BIOMINERALIZATION,0.029068,0.10376,0.10807,1,1
4,GO RESPONSE TO ABIOTIC STIMULUS,0.011612,0.10349,0.085473,1,1
4,GO RESPONSE TO ORGANOPHOSPHORUS,0.036164,0.10283,0.11437,1,1
4,GO POSITIVE REGULATION OF SIGNALING,0.0053338,0.10224,0.097361,1,1
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.041967,0.10216,0.12316,1,1
4,GO ACTIVATION OF GTPASE ACTIVITY,0.0090226,0.10181,0.094217,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.033894,0.10158,0.064627,1,1
4,GO ACTIVATED T CELL PROLIFERATION,0.042857,0.10009,0.1239,1,1
4,GO CIRCADIAN RHYTHM,0.011326,0.099818,0.086953,1,1
4,GO POSITIVE REGULATION OF TRANSPORT,0.013465,0.098743,0.091038,1,1
4,GO SENSORY PERCEPTION,0.0071468,0.098146,0.080199,1,1
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.014841,0.098044,0.088794,1,1
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.03939,0.097285,0.075656,1,1
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.010506,0.096729,0.14359,1,1
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.027803,0.096359,0.09122,1,1
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.018836,0.095571,0.082763,1,1
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.019283,0.095282,0.082678,1,1
4,GO ANATOMICAL STRUCTURE MATURATION,0.014841,0.095022,0.08576,1,1
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.027803,0.09446,0.076484,1,1
4,GO POSITIVE REGULATION OF JNK CASCADE,0.0099891,0.094436,0.11334,1,1
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0097392,0.09434,0.12971,1,1
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.010245,0.094026,0.10664,1,1
4,GO MEMBRANE ORGANIZATION,0.026586,0.093429,0.084777,1,1
4,GO POSITIVE REGULATION OF CELL GROWTH,0.050569,0.092329,0.070225,1,1
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0094949,0.091356,0.12081,1,1
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.027803,0.091296,0.088025,1,1
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.050569,0.090993,0.091672,1,1
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.017969,0.090371,0.079633,1,1
4,GO REGULATION OF PHOSPHORYLATION,0.031059,0.089747,0.076616,1,1
4,GO REGULATION OF AUTOPHAGY,0.0017123,0.089513,0.11434,1,1
4,GO POLYOL CATABOLIC PROCESS,0.013139,0.087931,0.13474,1,1
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.0032441,0.087897,0.11781,1,1
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.029719,0.087496,0.072014,1,1
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.021165,0.087258,0.098165,1,1
4,GO BLASTOCYST DEVELOPMENT,0.011904,0.085403,0.085945,1,1
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.030383,0.084292,0.073914,1,1
4,GO POSITIVE REGULATION OF NEURON DEATH,0.036164,0.081358,0.098822,1,1
4,GO RUFFLE ORGANIZATION,0.038561,0.080076,0.12498,1,1
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.036948,0.079875,0.07782,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.014486,0.079585,0.092333,1,1
4,GO RESPONSE TO GAMMA RADIATION,0.050569,0.079242,0.085309,1,1
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.035393,0.079241,0.10493,1,1
4,GO JNK CASCADE,0.053746,0.078653,0.080888,1,1
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.041967,0.07659,0.14539,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.024288,0.072115,0.096386,1,1
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.052669,0.071907,0.064819,1,1
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.041093,0.071664,0.052813,1,1
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.024288,0.069543,0.072765,1,1
4,GO DNA CATABOLIC PROCESS,0.0073363,0.067745,0.10496,1,1
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.009256,0.067519,0.10746,1,1
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.022165,0.066628,0.075155,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0079323,0.062937,0.058477,1,1
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.047551,0.060799,0.047111,1,1
4,GO TORC1 SIGNALING,0.010506,0.056692,0.091293,1,1
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.02166,0.054742,0.11309,1,1
4,GO INTRACELLULAR TRANSPORT,0.017549,0.053311,0.064805,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0001165,1.4705,1.2051,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,5.0226e-05,1.3173,1.0493,1,1
5,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00026903,0.97764,0.93919,1,1
5,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,5.2837e-06,0.96372,1.0244,1,1
5,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00028792,0.9206,0.65636,1,1
5,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,4.8379e-05,0.8948,0.78918,1,1
5,GO CYTIDINE TO URIDINE EDITING,0.0001165,0.85495,0.70006,1,1
5,GO RESPONSE TO INTERFERON ALPHA,0.00098941,0.79168,0.59036,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00037661,0.78837,0.56159,1,1
5,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00016023,0.78462,0.56666,1,1
5,GO TOLERANCE INDUCTION,6.5149e-05,0.78315,0.64551,1,1
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,9.3916e-06,0.76102,0.64734,1,1
5,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.00017186,0.75855,0.57548,1,1
5,GO T CELL MEDIATED CYTOTOXICITY,0.00032948,0.69462,0.46489,1,1
5,GO LIVER MORPHOGENESIS,6.4994e-06,0.69023,0.54486,1,1
5,GO REGULATION OF TOLERANCE INDUCTION,5.7413e-06,0.68781,0.61927,1,1
5,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00013433,0.67978,0.59502,1,1
5,GO REGULATION OF HEPATOCYTE PROLIFERATION,3.0576e-06,0.66579,0.68364,1,1
5,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00041602,0.66437,0.43974,1,1
5,GO NEGATIVE REGULATION OF CELL KILLING,0.0011549,0.66407,0.44856,1,1
5,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,3.1904e-06,0.66155,0.64919,1,1
5,GO REGULATION OF PLASMINOGEN ACTIVATION,0.03939,0.65647,0.40533,1,1
5,GO RESPONSE TO TYPE I INTERFERON,1.5201e-05,0.65391,0.64012,1,1
5,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00044439,0.64697,0.53105,1,1
5,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,1.9263e-05,0.64213,0.55082,1,1
5,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.00026903,0.63915,0.52255,1,1
5,GO HISTAMINE SECRETION,0.00069957,0.63903,0.51411,1,1
5,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00019753,0.63881,0.482,1,1
5,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,8.6584e-06,0.62823,0.55122,1,1
5,GO EOSINOPHIL CHEMOTAXIS,7.547e-05,0.62597,0.55242,1,1
5,GO LIPID DROPLET FORMATION,2.5774e-06,0.62311,0.67704,1,1
5,GO TYPE B PANCREATIC CELL PROLIFERATION,4.1802e-07,0.61781,0.68271,1,1
5,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,2.5308e-05,0.61642,0.63116,1,1
5,GO SEROTONIN METABOLIC PROCESS,1.6015e-06,0.61609,0.68674,1,1
5,GO EOSINOPHIL MIGRATION,5.6174e-05,0.61533,0.52705,1,1
5,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,5.6174e-05,0.60371,0.465,1,1
5,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00042998,0.60169,0.41704,1,1
5,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,2.6307e-05,0.5953,0.63048,1,1
5,GO GLIAL CELL FATE COMMITMENT,0.00013917,0.5951,0.51817,1,1
5,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.0689e-05,0.58844,0.70014,1,1
5,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,5.9841e-06,0.58839,0.56694,1,1
5,GO REGULATION OF VASCULOGENESIS,2.0833e-05,0.58453,0.54908,1,1
5,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,1.2862e-06,0.58332,0.60314,1,1
5,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.014841,0.58247,0.34089,1,1
5,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,1.104e-05,0.57985,0.49998,1,1
5,GO DETECTION OF OTHER ORGANISM,2.9532e-05,0.57735,0.52266,1,1
5,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,3.4421e-05,0.5732,0.54136,1,1
5,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00010462,0.57291,0.51736,1,1
5,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00079435,0.57157,0.39425,1,1
5,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,5.0683e-06,0.56821,0.55318,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.2139e-05,0.56637,0.42838,1,1
5,GO IMMUNOGLOBULIN SECRETION,3.3132e-05,0.56546,0.44892,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,2.8418e-05,0.56463,0.50519,1,1
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.9263e-05,0.56174,0.45522,1,1
5,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,2.2524e-05,0.55839,0.46994,1,1
5,GO REVERSE CHOLESTEROL TRANSPORT,9.7346e-05,0.55828,0.39683,1,1
5,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.00030804,0.55168,0.44297,1,1
5,GO KERATINOCYTE DEVELOPMENT,0.00010845,0.54974,0.47056,1,1
5,GO RESPONSE TO IMMOBILIZATION STRESS,0.00012074,0.54918,0.43792,1,1
5,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0011199,0.54291,0.40856,1,1
5,GO POSITIVE REGULATION OF VASCULOGENESIS,0.00044439,0.54264,0.45967,1,1
5,GO MATURE B CELL DIFFERENTIATION,0.0094949,0.53995,0.30324,1,1
5,GO REGULATION OF PLATELET AGGREGATION,2.1663e-05,0.53961,0.46883,1,1
5,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.00016595,0.53687,0.49434,1,1
5,GO POSITIVE REGULATION OF CELL MATURATION,0.00021909,0.53139,0.39641,1,1
5,GO INDOLALKYLAMINE METABOLIC PROCESS,0.00010092,0.52981,0.44562,1,1
5,GO GERMINAL CENTER FORMATION,0.00041602,0.52748,0.51324,1,1
5,GO LIPOXYGENASE PATHWAY,0.0001547,0.52719,0.45634,1,1
5,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,1.4044e-06,0.52674,0.65287,1,1
5,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00054072,0.52616,0.37168,1,1
5,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.00037661,0.52522,0.55724,1,1
5,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,2.9532e-05,0.52481,0.53725,1,1
5,GO O GLYCAN PROCESSING,3.7145e-05,0.52388,0.404,1,1
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,2.1663e-05,0.52306,0.38943,1,1
5,GO LUNG CELL DIFFERENTIATION,7.8282e-05,0.52117,0.51109,1,1
5,GO DNA DEAMINATION,0.0022992,0.51892,0.37802,1,1
5,GO REGULATION OF TRANSPOSITION,0.00044439,0.51863,0.38081,1,1
5,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.00028792,0.51801,0.45377,1,1
5,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.00012512,0.51753,0.41192,1,1
5,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.7806e-05,0.51735,0.51145,1,1
5,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,4.6623e-06,0.51396,0.54644,1,1
5,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,5.0226e-05,0.5111,0.49782,1,1
5,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0032441,0.50993,0.3752,1,1
5,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0053338,0.50976,0.555,1,1
5,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.040234,0.50919,0.31541,1,1
5,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,5.6174e-05,0.50882,0.55954,1,1
5,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0007696,0.50509,0.39277,1,1
5,GO REGULATORY T CELL DIFFERENTIATION,9.4334e-07,0.50439,0.48269,1,1
5,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,5.0226e-05,0.50141,0.5601,1,1
5,GO NEGATIVE REGULATION OF ANOIKIS,2.2524e-05,0.50139,0.62582,1,1
5,GO MUCUS SECRETION,0.013465,0.50074,0.37249,1,1
5,GO N GLYCAN PROCESSING,4.4712e-06,0.50059,0.47949,1,1
5,GO HISTAMINE TRANSPORT,0.00055855,0.49981,0.4591,1,1
5,GO RESPONSE TO WATER,2.6307e-05,0.49941,0.45571,1,1
5,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0060989,0.49924,0.45608,1,1
5,GO REGULATION OF RECEPTOR CLUSTERING,6.2786e-05,0.49909,0.4781,1,1
5,GO DETECTION OF TEMPERATURE STIMULUS,9.389e-05,0.49877,0.43639,1,1
5,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,2.3418e-05,0.4975,0.45459,1,1
5,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00017186,0.49695,0.34889,1,1
5,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00029782,0.49603,0.47639,1,1
5,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.00021909,0.49531,0.4828,1,1
5,GO TRANSPOSITION,5.6174e-05,0.49027,0.40095,1,1
5,GO REGULATION OF VIRAL GENOME REPLICATION,0.0016129,0.48981,0.31006,1,1
5,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00017186,0.48963,0.41492,1,1
5,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00098941,0.48809,0.32614,1,1
5,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,3.0689e-05,0.48716,0.4112,1,1
5,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.00025131,0.48692,0.38759,1,1
5,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00018427,0.48396,0.37802,1,1
5,GO RESPONSE TO MUSCLE STRETCH,0.00034072,0.48281,0.40273,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00012074,0.47967,0.40695,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,1.0604e-05,0.47952,0.50538,1,1
5,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.4609e-05,0.47789,0.43297,1,1
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0041716,0.47733,0.35898,1,1
5,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00038934,0.4757,0.32211,1,1
5,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0022332,0.47494,0.43903,1,1
5,GO REFLEX,0.010245,0.47397,0.41514,1,1
5,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.011326,0.4734,0.46296,1,1
5,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,5.2139e-05,0.47295,0.48633,1,1
5,GO POSITIVE REGULATION OF B CELL PROLIFERATION,1.1964e-05,0.47206,0.38379,1,1
5,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.00016023,0.4712,0.43868,1,1
5,GO RESPONSE TO INTERLEUKIN 18,0.0027346,0.47031,0.35866,1,1
5,GO BASE CONVERSION OR SUBSTITUTION EDITING,8.7323e-05,0.47018,0.40104,1,1
5,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.011904,0.46951,0.35313,1,1
5,GO MICROVILLUS ASSEMBLY,0.00037661,0.46912,0.40986,1,1
5,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.0025817,0.46835,0.35845,1,1
5,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,4.4712e-06,0.46666,0.44681,1,1
5,GO MITOCHONDRIAL DEPOLARIZATION,5.8301e-05,0.46621,0.35238,1,1
5,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,4.0073e-05,0.46542,0.43338,1,1
5,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0007696,0.46535,0.49368,1,1
5,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,3.7145e-05,0.46387,0.43392,1,1
5,GO T CELL MEDIATED IMMUNITY,0.00017186,0.46362,0.31333,1,1
5,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.1964e-05,0.46264,0.44357,1,1
5,GO ENDOTHELIAL CELL CHEMOTAXIS,1.5816e-05,0.46048,0.44254,1,1
5,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00042998,0.46035,0.41117,1,1
5,GO CORTICOSTEROID HORMONE SECRETION,0.00040247,0.45903,0.39076,1,1
5,GO HEPATOCYTE APOPTOTIC PROCESS,0.0032441,0.45627,0.41795,1,1
5,GO DOPAMINE BIOSYNTHETIC PROCESS,0.0071468,0.45539,0.38568,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00069957,0.45449,0.42038,1,1
5,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,9.3916e-06,0.45188,0.42308,1,1
5,GO REGULATION OF T CELL CYTOKINE PRODUCTION,7.2754e-05,0.45171,0.3163,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00084609,0.45053,0.28829,1,1
5,GO REGULATION OF GLIAL CELL PROLIFERATION,1.7806e-05,0.44944,0.37052,1,1
5,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,5.7413e-06,0.44943,0.53699,1,1
5,GO MYELIN MAINTENANCE,2.3418e-05,0.44886,0.43148,1,1
5,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00072223,0.44872,0.38595,1,1
5,GO MEMBRANE RAFT ORGANIZATION,0.0033369,0.44866,0.30305,1,1
5,GO SYNAPTIC MEMBRANE ADHESION,0.0085714,0.44852,0.32707,1,1
5,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,1.9263e-05,0.44788,0.42349,1,1
5,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.0010206,0.44761,0.39071,1,1
5,GO EPITHELIAL CELL MORPHOGENESIS,0.00036427,0.44739,0.40474,1,1
5,GO T CELL EXTRAVASATION,0.00026003,0.44719,0.46245,1,1
5,GO REGULATION OF ASTROCYTE DIFFERENTIATION,1.0604e-05,0.44678,0.38144,1,1
5,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,1.7806e-05,0.44672,0.46811,1,1
5,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.00054072,0.44672,0.46241,1,1
5,GO RESPONSE TO PAIN,0.00036427,0.44636,0.32515,1,1
5,GO NEURONAL ION CHANNEL CLUSTERING,0.0001547,0.44495,0.46294,1,1
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00063551,0.44411,0.35761,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,5.4121e-05,0.44411,0.46871,1,1
5,GO B CELL APOPTOTIC PROCESS,0.00042998,0.44408,0.3792,1,1
5,GO RESPONSE TO COLD,1.5816e-05,0.4426,0.38448,1,1
5,GO GLIAL CELL APOPTOTIC PROCESS,0.00028792,0.44183,0.47113,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00035231,0.44097,0.30852,1,1
5,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,3.3132e-05,0.43924,0.3552,1,1
5,GO MYOBLAST FUSION,5.2139e-05,0.43896,0.35794,1,1
5,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00020448,0.43886,0.28821,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00042998,0.43873,0.40504,1,1
5,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00026903,0.43627,0.32734,1,1
5,GO MINERALOCORTICOID METABOLIC PROCESS,0.015574,0.43358,0.32173,1,1
5,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0030654,0.43292,0.31064,1,1
5,GO REGULATION OF CGMP MEDIATED SIGNALING,0.00072223,0.43282,0.33949,1,1
5,GO CELLULAR RESPONSE TO COPPER ION,0.0027346,0.43172,0.42256,1,1
5,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0017641,0.42938,0.37001,1,1
5,GO REGULATION OF EXOSOMAL SECRETION,0.00019079,0.42821,0.29307,1,1
5,GO RESPONSE TO DIETARY EXCESS,5.2139e-05,0.42755,0.43927,1,1
5,GO REGULATION OF MYOBLAST FUSION,0.0016129,0.42725,0.32271,1,1
5,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00023468,0.426,0.42378,1,1
5,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.013465,0.42553,0.32407,1,1
5,GO ZYMOGEN ACTIVATION,0.00035231,0.42489,0.37919,1,1
5,GO REGULATION OF PLATELET ACTIVATION,3.0689e-05,0.42458,0.39006,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,8.6584e-06,0.42449,0.40676,1,1
5,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.7474e-06,0.42382,0.5218,1,1
5,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.00042998,0.42349,0.41872,1,1
5,GO RADIAL GLIAL CELL DIFFERENTIATION,0.00014935,0.42232,0.43495,1,1
5,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.0097392,0.42211,0.29518,1,1
5,GO PROSTATE GLAND MORPHOGENESIS,0.016339,0.42078,0.28116,1,1
5,GO SIALYLATION,0.0022992,0.41957,0.30614,1,1
5,GO REGULATION OF B CELL PROLIFERATION,2.2524e-05,0.41947,0.34433,1,1
5,GO INDUCTION OF POSITIVE CHEMOTAXIS,1.2454e-05,0.41899,0.45682,1,1
5,GO CELLULAR DEFENSE RESPONSE,0.001228,0.41847,0.25571,1,1
5,GO CAMP BIOSYNTHETIC PROCESS,4.8379e-05,0.41758,0.38963,1,1
5,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.040234,0.4163,0.38497,1,1
5,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,6.0504e-05,0.41601,0.41177,1,1
5,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.001191,0.41586,0.38542,1,1
5,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00074557,0.41575,0.32907,1,1
5,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,5.0226e-05,0.41575,0.40489,1,1
5,GO REGULATION OF VIRAL LIFE CYCLE,0.0023671,0.41516,0.28016,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00025131,0.41481,0.28252,1,1
5,GO FUCOSE METABOLIC PROCESS,0.00011241,0.41471,0.31452,1,1
5,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00050664,0.41402,0.30961,1,1
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.00034072,0.41361,0.42412,1,1
5,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,3.9418e-06,0.41288,0.35677,1,1
5,GO INTERLEUKIN 10 PRODUCTION,5.0226e-05,0.41222,0.28806,1,1
5,GO RESPONSE TO INTERFERON GAMMA,3.5759e-05,0.41161,0.41657,1,1
5,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,8.7323e-05,0.41155,0.32576,1,1
5,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0016129,0.41089,0.47276,1,1
5,GO PROTEIN KINASE C SIGNALING,5.8301e-05,0.41043,0.37041,1,1
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00019079,0.40996,0.41562,1,1
5,GO MYELIN ASSEMBLY,0.00021909,0.40967,0.33233,1,1
5,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0060989,0.40924,0.30246,1,1
5,GO TOXIN METABOLIC PROCESS,7.2754e-05,0.40916,0.40373,1,1
5,GO REGULATION OF TISSUE REMODELING,2.9532e-05,0.40913,0.31746,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00016023,0.40906,0.27706,1,1
5,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,6.0504e-05,0.40878,0.3512,1,1
5,GO CERAMIDE CATABOLIC PROCESS,0.0016129,0.40828,0.27927,1,1
5,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.00011241,0.40806,0.42595,1,1
5,GO PROTEIN O LINKED GLYCOSYLATION,1.9263e-05,0.40782,0.28794,1,1
5,GO VIRAL GENOME REPLICATION,0.0010206,0.40778,0.27906,1,1
5,GO AMINE BIOSYNTHETIC PROCESS,1.349e-05,0.40629,0.39726,1,1
5,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,4.1617e-05,0.40625,0.42112,1,1
5,GO LUNG ALVEOLUS DEVELOPMENT,3.3287e-06,0.40589,0.37475,1,1
5,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,7.013e-05,0.40557,0.334,1,1
5,GO REGULATION OF BONE REMODELING,2.4346e-05,0.40482,0.34042,1,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.011612,0.40455,0.30577,1,1
5,GO GLIAL CELL PROLIFERATION,0.00037661,0.40442,0.2808,1,1
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0097392,0.40421,0.22544,1,1
5,GO DENDRITIC CELL DIFFERENTIATION,1.2454e-05,0.40416,0.40788,1,1
5,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.0024367,0.40396,0.34186,1,1
5,GO ECTODERMAL PLACODE DEVELOPMENT,0.0022332,0.40391,0.35451,1,1
5,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00021909,0.4039,0.3142,1,1
5,GO MICROVILLUS ORGANIZATION,0.0015189,0.40312,0.29128,1,1
5,GO STEROID ESTERIFICATION,0.00013917,0.40268,0.45,1,1
5,GO NEUROTRANSMITTER METABOLIC PROCESS,9.0551e-05,0.40204,0.34603,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0027346,0.40123,0.23796,1,1
5,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00047456,0.40029,0.36818,1,1
5,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.00019753,0.40012,0.35584,1,1
5,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.0041716,0.39935,0.4042,1,1
5,GO STEROID HORMONE SECRETION,0.00044439,0.39896,0.32443,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0028957,0.39895,0.28922,1,1
5,GO AMYLOID FIBRIL FORMATION,0.0012662,0.39882,0.31417,1,1
5,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00010092,0.39859,0.44928,1,1
5,GO RELAXATION OF CARDIAC MUSCLE,0.00098941,0.39857,0.36219,1,1
5,GO KETONE CATABOLIC PROCESS,0.0012662,0.39846,0.35288,1,1
5,GO MAGNESIUM ION TRANSPORT,8.1192e-05,0.39815,0.29817,1,1
5,GO IMMUNOLOGICAL MEMORY PROCESS,2.9532e-05,0.39808,0.37597,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0066042,0.39753,0.31566,1,1
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,1.9263e-05,0.3969,0.40521,1,1
5,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00059588,0.39672,0.38513,1,1
5,GO PARAXIAL MESODERM MORPHOGENESIS,0.00014935,0.39646,0.46902,1,1
5,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.004408,0.39459,0.26357,1,1
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0010528,0.39387,0.34059,1,1
5,GO RESPONSE TO AUDITORY STIMULUS,4.4878e-05,0.39298,0.41209,1,1
5,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00011241,0.39222,0.46475,1,1
5,GO XENOBIOTIC CATABOLIC PROCESS,0.033166,0.3912,0.2712,1,1
5,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.00042998,0.3903,0.33174,1,1
5,GO ESTROUS CYCLE,2.3418e-05,0.39026,0.39322,1,1
5,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.00027832,0.39006,0.31066,1,1
5,GO ALPHA BETA T CELL PROLIFERATION,9.0551e-05,0.38925,0.35113,1,1
5,GO VASCULAR WOUND HEALING,3.7145e-05,0.38848,0.46227,1,1
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,5.8301e-05,0.38827,0.3046,1,1
5,GO SERTOLI CELL DIFFERENTIATION,0.00087311,0.38803,0.36627,1,1
5,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0018173,0.38755,0.37852,1,1
5,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.00049035,0.38743,0.28364,1,1
5,GO BONE RESORPTION,7.2754e-05,0.38696,0.2838,1,1
5,GO NEGATIVE REGULATION OF LIPID STORAGE,2.6307e-05,0.38675,0.33254,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00013917,0.38668,0.3555,1,1
5,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,9.7346e-05,0.38574,0.37754,1,1
5,GO NEGATIVE REGULATION OF CELL CELL ADHESION,6.4994e-06,0.38551,0.32592,1,1
5,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,2.0833e-05,0.38477,0.342,1,1
5,GO TYPE 2 IMMUNE RESPONSE,0.00022676,0.38474,0.41645,1,1
5,GO SMOOTH MUSCLE CELL MIGRATION,8.7323e-05,0.38462,0.33186,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,1.7806e-05,0.38462,0.38399,1,1
5,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00021167,0.38456,0.38896,1,1
5,GO POSITIVE REGULATION OF CELL KILLING,0.00010845,0.38431,0.30671,1,1
5,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.001191,0.38428,0.41895,1,1
5,GO DEFENSE RESPONSE TO VIRUS,0.00034072,0.3841,0.28382,1,1
5,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00036427,0.38312,0.32923,1,1
5,GO LUNG EPITHELIUM DEVELOPMENT,3.7145e-05,0.38307,0.3846,1,1
5,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.0013872,0.38287,0.33587,1,1
5,GO MECHANOSENSORY BEHAVIOR,0.0099891,0.38276,0.38809,1,1
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00022676,0.38258,0.30762,1,1
5,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00030804,0.38182,0.37205,1,1
5,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,7.5427e-07,0.38093,0.36317,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,4.0073e-05,0.38056,0.3022,1,1
5,GO VASODILATION,0.00025131,0.37998,0.30832,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00012074,0.37983,0.30584,1,1
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00011241,0.37938,0.31565,1,1
5,GO ASYMMETRIC CELL DIVISION,0.0010528,0.37848,0.30099,1,1
5,GO NEGATIVE REGULATION OF B CELL ACTIVATION,4.4878e-05,0.37837,0.35159,1,1
5,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00012512,0.37786,0.3204,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00084609,0.37771,0.28287,1,1
5,GO RESPONSE TO COPPER ION,0.00022676,0.37641,0.40105,1,1
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00026903,0.37621,0.33406,1,1
5,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00019079,0.37556,0.38226,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.7806e-05,0.37531,0.37471,1,1
5,GO GLYCINE TRANSPORT,0.0064317,0.37514,0.31496,1,1
5,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,1.1493e-05,0.37481,0.33396,1,1
5,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00018427,0.37478,0.29642,1,1
5,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.011326,0.37473,0.30715,1,1
5,GO SYNAPSE MATURATION,0.0010206,0.37443,0.44265,1,1
5,GO LIPID DROPLET ORGANIZATION,2.8077e-06,0.37349,0.3625,1,1
5,GO GLAND MORPHOGENESIS,0.00016595,0.37323,0.31556,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,4.4878e-05,0.37323,0.34143,1,1
5,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0066042,0.37273,0.2791,1,1
5,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00028792,0.37188,0.33026,1,1
5,GO ASTROCYTE ACTIVATION,7.2754e-05,0.37182,0.35429,1,1
5,GO CELL ADHESION MEDIATED BY INTEGRIN,0.0010206,0.3712,0.30636,1,1
5,GO REGULATION OF AMINO ACID TRANSPORT,2.0833e-05,0.37075,0.33309,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,9.389e-05,0.37039,0.24945,1,1
5,GO IMMUNE RESPONSE TO TUMOR CELL,0.0042883,0.37034,0.32047,1,1
5,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,7.2754e-05,0.37007,0.38782,1,1
5,GO GALACTOSE METABOLIC PROCESS,0.0064317,0.36957,0.26773,1,1
5,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.0034322,0.36944,0.31647,1,1
5,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00054072,0.36918,0.27602,1,1
5,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.00026903,0.36896,0.28984,1,1
5,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00040247,0.3688,0.27473,1,1
5,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00092958,0.36872,0.27148,1,1
5,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,7.547e-05,0.36853,0.24707,1,1
5,GO ENTRY INTO HOST,0.0014299,0.36832,0.2341,1,1
5,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.0015189,0.36784,0.3032,1,1
5,GO OSTEOBLAST PROLIFERATION,2.0033e-05,0.36775,0.37047,1,1
5,GO REGULATION OF ANOIKIS,0.00012512,0.3676,0.44921,1,1
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.2962e-05,0.36751,0.29422,1,1
5,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00038934,0.36739,0.24479,1,1
5,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,5.8301e-05,0.36709,0.35463,1,1
5,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,2.3418e-05,0.36693,0.31454,1,1
5,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.009256,0.36628,0.30724,1,1
5,GO REGULATION OF LEUKOCYTE PROLIFERATION,7.0571e-06,0.36539,0.3027,1,1
5,GO VITAMIN D METABOLIC PROCESS,3.5759e-05,0.36539,0.34887,1,1
5,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00090094,0.36482,0.29643,1,1
5,GO DETECTION OF CALCIUM ION,0.0042883,0.36405,0.31678,1,1
5,GO DORSAL AORTA DEVELOPMENT,0.010245,0.36357,0.2641,1,1
5,GO REGULATION OF MICROVILLUS ORGANIZATION,0.024288,0.36339,0.24982,1,1
5,GO NERVE DEVELOPMENT,1.5201e-05,0.36274,0.32314,1,1
5,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0027346,0.36248,0.27729,1,1
5,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.00049035,0.36048,0.30667,1,1
5,GO REGULATION OF DENDRITE EXTENSION,0.0032441,0.36048,0.35919,1,1
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.01282,0.36005,0.32167,1,1
5,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00031859,0.35933,0.27761,1,1
5,GO EMBRYONIC PLACENTA DEVELOPMENT,5.9841e-06,0.35932,0.34063,1,1
5,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00018427,0.35925,0.45777,1,1
5,GO EPOXYGENASE P450 PATHWAY,0.0016129,0.3591,0.3413,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00024286,0.35895,0.3099,1,1
5,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00014935,0.35876,0.27265,1,1
5,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,6.2786e-05,0.3586,0.32266,1,1
5,GO CELL MIGRATION IN HINDBRAIN,0.00022676,0.35849,0.39326,1,1
5,GO TISSUE REMODELING,5.8301e-05,0.35846,0.28436,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0011549,0.35803,0.287,1,1
5,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00045924,0.35775,0.2767,1,1
5,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,5.0226e-05,0.35733,0.36437,1,1
5,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00024286,0.35732,0.30055,1,1
5,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00035231,0.35717,0.32026,1,1
5,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,8.3127e-06,0.35669,0.39446,1,1
5,GO RESPONSE TO THYROID HORMONE,0.0024367,0.35641,0.30341,1,1
5,GO OLIGODENDROCYTE DEVELOPMENT,4.8612e-06,0.35627,0.31138,1,1
5,GO REGULATION OF B CELL MEDIATED IMMUNITY,8.1192e-05,0.35614,0.28984,1,1
5,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00021909,0.35606,0.34796,1,1
5,GO POSITIVE REGULATION OF CILIUM MOVEMENT,5.6174e-05,0.35604,0.31051,1,1
5,GO LYMPHOCYTE MEDIATED IMMUNITY,5.8301e-05,0.35571,0.29162,1,1
5,GO B CELL MEDIATED IMMUNITY,0.00010092,0.35547,0.34518,1,1
5,GO ACUTE INFLAMMATORY RESPONSE,1.1964e-05,0.35545,0.33784,1,1
5,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00028792,0.35516,0.23867,1,1
5,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.8521e-05,0.35503,0.31049,1,1
5,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.00095906,0.35488,0.28553,1,1
5,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0042883,0.35479,0.26485,1,1
5,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00014935,0.3546,0.24443,1,1
5,GO RETINAL ROD CELL DIFFERENTIATION,0.013139,0.35441,0.26568,1,1
5,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00079435,0.35398,0.33118,1,1
5,GO RESPONSE TO FORSKOLIN,0.0014738,0.35395,0.33743,1,1
5,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,4.3218e-05,0.35358,0.28536,1,1
5,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00017186,0.35317,0.31479,1,1
5,GO ASTROCYTE DIFFERENTIATION,0.00016023,0.3525,0.2833,1,1
5,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,8.1192e-05,0.35237,0.29769,1,1
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.00092958,0.35204,0.27245,1,1
5,GO REGULATION OF MEMBRANE REPOLARIZATION,0.00014935,0.35166,0.29314,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,4.1617e-05,0.35082,0.27783,1,1
5,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00035231,0.35074,0.26362,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,1.1493e-05,0.3506,0.28573,1,1
5,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.0090226,0.35055,0.30381,1,1
5,GO THALAMUS DEVELOPMENT,0.0017641,0.35048,0.32742,1,1
5,GO FOAM CELL DIFFERENTIATION,0.0001547,0.34981,0.35845,1,1
5,GO ANTIBACTERIAL HUMORAL RESPONSE,9.3916e-06,0.34961,0.33707,1,1
5,GO ENDOTHELIAL CELL DEVELOPMENT,2.8418e-05,0.34933,0.27961,1,1
5,GO GAMMA DELTA T CELL ACTIVATION,0.00023468,0.34931,0.37252,1,1
5,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.0075304,0.34907,0.25738,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.049546,0.34821,0.18547,1,1
5,GO CELLULAR RESPONSE TO NUTRIENT,0.00036427,0.34818,0.30469,1,1
5,GO REGULATION OF FAT CELL DIFFERENTIATION,1.0311e-06,0.34817,0.30918,1,1
5,GO HYALURONAN BIOSYNTHETIC PROCESS,0.00010462,0.34815,0.29052,1,1
5,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,2.6322e-07,0.34807,0.34916,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00020448,0.34805,0.30554,1,1
5,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,7.8282e-05,0.34794,0.36257,1,1
5,GO SYNCYTIUM FORMATION,0.00023468,0.34746,0.26279,1,1
5,GO T CELL CYTOKINE PRODUCTION,0.00026903,0.34742,0.23582,1,1
5,GO RESPONSE TO MAGNESIUM ION,0.0047853,0.34739,0.27046,1,1
5,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00029782,0.34731,0.26299,1,1
5,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00059588,0.3473,0.30764,1,1
5,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00029782,0.3465,0.31681,1,1
5,GO MESENCHYMAL CELL PROLIFERATION,0.0024367,0.34597,0.25881,1,1
5,GO GABAERGIC NEURON DIFFERENTIATION,0.0066042,0.34564,0.45169,1,1
5,GO ADRENAL GLAND DEVELOPMENT,3.4421e-05,0.34487,0.41326,1,1
5,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0032441,0.34465,0.33426,1,1
5,GO RESPONSE TO AMPHETAMINE,0.00012074,0.34454,0.3179,1,1
5,GO SEQUESTERING OF ACTIN MONOMERS,0.00020448,0.34452,0.44057,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00084609,0.34442,0.24628,1,1
5,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.00021167,0.34409,0.28462,1,1
5,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.001872,0.3439,0.24229,1,1
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.012203,0.3439,0.2318,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,1.7806e-05,0.34387,0.3066,1,1
5,GO EPITHELIAL CELL MATURATION,0.00038934,0.34385,0.33467,1,1
5,GO BASEMENT MEMBRANE ORGANIZATION,0.0053338,0.34355,0.30963,1,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0059384,0.34341,0.27284,1,1
5,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00055855,0.34335,0.25675,1,1
5,GO POSITIVE REGULATION OF WOUND HEALING,4.1617e-05,0.34315,0.36958,1,1
5,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0013054,0.3431,0.33892,1,1
5,GO LINOLEIC ACID METABOLIC PROCESS,0.00041602,0.34263,0.31122,1,1
5,GO B CELL PROLIFERATION,5.6174e-05,0.34254,0.26054,1,1
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,1.6455e-05,0.34244,0.40596,1,1
5,GO MAST CELL MEDIATED IMMUNITY,5.2139e-05,0.34231,0.30449,1,1
5,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.00081984,0.34182,0.28091,1,1
5,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00029782,0.34169,0.27519,1,1
5,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.001872,0.34116,0.27339,1,1
5,GO REGULATION OF B CELL ACTIVATION,3.3287e-06,0.33997,0.29303,1,1
5,GO ENDOTHELIUM DEVELOPMENT,2.6902e-06,0.33937,0.29422,1,1
5,GO ENDOCARDIUM DEVELOPMENT,0.00013433,0.33894,0.38228,1,1
5,GO LEUKOTRIENE METABOLIC PROCESS,0.00044439,0.33885,0.275,1,1
5,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.00024286,0.33883,0.33083,1,1
5,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0001547,0.33866,0.26628,1,1
5,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.00016023,0.33835,0.30269,1,1
5,GO RESPONSE TO INTERLEUKIN 2,0.00013433,0.33808,0.28782,1,1
5,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00016023,0.33742,0.27979,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00010092,0.33721,0.2312,1,1
5,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0049174,0.33721,0.24964,1,1
5,GO PROTEIN DEMANNOSYLATION,5.6174e-05,0.33632,0.29424,1,1
5,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.0020453,0.33629,0.18961,1,1
5,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,5.6174e-05,0.33593,0.33894,1,1
5,GO EPITHELIAL CELL APOPTOTIC PROCESS,9.389e-05,0.3359,0.27034,1,1
5,GO AMMONIUM TRANSPORT,0.00019079,0.33492,0.31882,1,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.00035231,0.33492,0.43363,1,1
5,GO BROWN FAT CELL DIFFERENTIATION,5.9841e-06,0.3349,0.33631,1,1
5,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.017969,0.3347,0.41842,1,1
5,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0056288,0.33449,0.35494,1,1
5,GO FAT CELL DIFFERENTIATION,4.1802e-07,0.33447,0.29173,1,1
5,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.001872,0.33445,0.28071,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0028141,0.33433,0.24895,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.0007696,0.33423,0.32718,1,1
5,GO GLIAL CELL DEVELOPMENT,5.2837e-06,0.33396,0.28694,1,1
5,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.6307e-05,0.33381,0.29268,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.0017123,0.33379,0.21797,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,8.7323e-05,0.33353,0.28025,1,1
5,GO REGULATION OF POSITIVE CHEMOTAXIS,3.1888e-05,0.33316,0.33286,1,1
5,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00090094,0.33302,0.30368,1,1
5,GO LIPID TRANSLOCATION,1.2862e-06,0.33301,0.34597,1,1
5,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.001191,0.33219,0.32183,1,1
5,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00021167,0.33209,0.28562,1,1
5,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00069957,0.3319,0.2963,1,1
5,GO RESPONSE TO LITHIUM ION,0.00022676,0.33085,0.36914,1,1
5,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0022332,0.33085,0.30029,1,1
5,GO AMMONIUM ION METABOLIC PROCESS,0.00014935,0.33081,0.34148,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0046564,0.33054,0.21556,1,1
5,GO MONOCYTE CHEMOTAXIS,0.0013054,0.33054,0.21625,1,1
5,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,4.0073e-05,0.33027,0.36248,1,1
5,GO NEGATIVE REGULATION OF CELL ADHESION,5.9841e-06,0.32978,0.27977,1,1
5,GO AMINOGLYCAN CATABOLIC PROCESS,0.0016129,0.32944,0.2646,1,1
5,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.0037331,0.32921,0.20546,1,1
5,GO METANEPHROS MORPHOGENESIS,0.00010092,0.32917,0.28992,1,1
5,GO MAST CELL ACTIVATION,1.7806e-05,0.32814,0.29746,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0069616,0.32806,0.2765,1,1
5,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.00067758,0.32805,0.29793,1,1
5,GO CYTOKINE MEDIATED SIGNALING PATHWAY,4.8379e-05,0.32787,0.25826,1,1
5,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00019079,0.32686,0.28652,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.1964e-05,0.32663,0.30084,1,1
5,GO CGMP METABOLIC PROCESS,0.020205,0.32632,0.21612,1,1
5,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00059588,0.32629,0.21426,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00031859,0.32618,0.27135,1,1
5,GO REGULATION OF ORGANIC ACID TRANSPORT,6.7728e-06,0.32617,0.2957,1,1
5,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.02268,0.32589,0.23683,1,1
5,GO RESPONSE TO INTERLEUKIN 15,0.0034322,0.32569,0.26257,1,1
5,GO POSITIVE REGULATION OF AMINE TRANSPORT,1.349e-05,0.32562,0.38784,1,1
5,GO APICAL JUNCTION ASSEMBLY,1.8521e-05,0.32562,0.32392,1,1
5,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,1.5816e-05,0.3254,0.31707,1,1
5,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00013433,0.32492,0.30237,1,1
5,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.00038934,0.3249,0.33686,1,1
5,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,1.7118e-05,0.32482,0.30241,1,1
5,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.00027832,0.32432,0.26905,1,1
5,GO BONE REMODELING,3.4421e-05,0.32424,0.31132,1,1
5,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,8.1192e-05,0.32422,0.27416,1,1
5,GO POSITIVE REGULATION OF OSSIFICATION,8.4205e-05,0.32416,0.3219,1,1
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.00049035,0.32414,0.38693,1,1
5,GO CELLULAR RESPONSE TO VITAMIN,0.004408,0.32399,0.29022,1,1
5,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.001662,0.32311,0.25388,1,1
5,GO REGULATION OF CELL MATRIX ADHESION,2.6307e-05,0.32238,0.29293,1,1
5,GO ANOIKIS,3.3132e-05,0.32204,0.36997,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00021167,0.32202,0.32914,1,1
5,GO PRO B CELL DIFFERENTIATION,0.0059384,0.32193,0.24784,1,1
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.001986,0.32155,0.17801,1,1
5,GO NEGATIVE REGULATION OF BONE REMODELING,0.0006154,0.32141,0.36758,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00017186,0.32141,0.2922,1,1
5,GO MEMBRANE DEPOLARIZATION,8.1192e-05,0.32132,0.2849,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00041602,0.3213,0.28093,1,1
5,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.00092958,0.32105,0.3281,1,1
5,GO POSITIVE REGULATION OF CHEMOTAXIS,2.4692e-06,0.32082,0.29684,1,1
5,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.013798,0.32071,0.27598,1,1
5,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.00044439,0.32049,0.32982,1,1
5,GO REGULATION OF SODIUM ION TRANSPORT,1.8521e-05,0.32044,0.27044,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,3.8583e-05,0.32033,0.33457,1,1
5,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.031748,0.32025,0.17845,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,7.9801e-06,0.32021,0.30269,1,1
5,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0022992,0.3202,0.29298,1,1
5,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.00012512,0.31981,0.26457,1,1
5,GO BLOOD VESSEL REMODELING,0.001986,0.31837,0.2232,1,1
5,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0081404,0.31787,0.33676,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.6597e-05,0.31759,0.2796,1,1
5,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,2.1663e-05,0.31719,0.31615,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION,0.00072223,0.31716,0.23337,1,1
5,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00030804,0.31709,0.21304,1,1
5,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0037331,0.31694,0.27023,1,1
5,GO REGULATION OF AMYLOID BETA FORMATION,8.4205e-05,0.31668,0.35779,1,1
5,GO AMYLOID BETA METABOLIC PROCESS,1.9263e-05,0.31656,0.29847,1,1
5,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0001165,0.31653,0.26336,1,1
5,GO EPITHELIAL CELL DEVELOPMENT,8.6584e-06,0.31623,0.25904,1,1
5,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00017796,0.31616,0.27085,1,1
5,GO STRIATED MUSCLE ADAPTATION,0.00016023,0.31611,0.25318,1,1
5,GO AMYLOID BETA FORMATION,1.9263e-05,0.31609,0.33496,1,1
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0028957,0.31593,0.23828,1,1
5,GO NEGATIVE REGULATION OF COAGULATION,0.0066042,0.31578,0.21864,1,1
5,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00029782,0.31553,0.27302,1,1
5,GO REGULATION OF CELL KILLING,0.00050664,0.3154,0.24902,1,1
5,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00084609,0.31492,0.21404,1,1
5,GO RESPONSE TO VIRUS,0.00035231,0.31482,0.23504,1,1
5,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,1.4039e-05,0.31476,0.27779,1,1
5,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00072223,0.3143,0.24241,1,1
5,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.023741,0.31374,0.23761,1,1
5,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.00025131,0.31355,0.28336,1,1
5,GO NEGATIVE REGULATION OF CELL ACTIVATION,2.3418e-05,0.31302,0.25541,1,1
5,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.053746,0.31285,0.20908,1,1
5,GO VITAMIN D BIOSYNTHETIC PROCESS,0.00050664,0.31268,0.33251,1,1
5,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0067808,0.31257,0.32388,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,6.7728e-06,0.31229,0.28684,1,1
5,GO MOVEMENT IN HOST ENVIRONMENT,0.0021062,0.31229,0.20086,1,1
5,GO CIRCADIAN REGULATION OF GENE EXPRESSION,1.3605e-07,0.31227,0.32428,1,1
5,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,5.7413e-06,0.3122,0.33932,1,1
5,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.02166,0.31215,0.5051,1,1
5,GO INTERFERON ALPHA PRODUCTION,8.7323e-05,0.31211,0.30276,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,7.3528e-06,0.31206,0.27162,1,1
5,GO CELLULAR RESPONSE TO VITAMIN D,0.015574,0.31203,0.25257,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.0014738,0.31197,0.24253,1,1
5,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.0017123,0.31158,0.20542,1,1
5,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.023741,0.31141,0.2037,1,1
5,GO REGULATION OF CARDIAC CONDUCTION,9.7801e-06,0.31135,0.28355,1,1
5,GO INTERFERON BETA PRODUCTION,0.00026903,0.31123,0.238,1,1
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0017641,0.31106,0.30352,1,1
5,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.04854,0.31092,0.15977,1,1
5,GO SKELETAL MUSCLE ADAPTATION,2.2524e-05,0.31068,0.31164,1,1
5,GO POLYSACCHARIDE METABOLIC PROCESS,9.0221e-07,0.31054,0.276,1,1
5,GO SUPEROXIDE ANION GENERATION,0.00047456,0.31039,0.30718,1,1
5,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00030804,0.31027,0.22368,1,1
5,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,8.7323e-05,0.31017,0.24906,1,1
5,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,4.4878e-05,0.31007,0.30028,1,1
5,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,1.2454e-05,0.30996,0.33553,1,1
5,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.00063551,0.30995,0.22957,1,1
5,GO BRANCH ELONGATION OF AN EPITHELIUM,0.027803,0.30972,0.31975,1,1
5,GO RESPONSE TO PROTOZOAN,0.001191,0.30944,0.26033,1,1
5,GO REGULATION OF GTP BINDING,0.016339,0.3094,0.23562,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.00084609,0.30902,0.27402,1,1
5,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.00019753,0.30873,0.37041,1,1
5,GO MACROPHAGE CYTOKINE PRODUCTION,0.0013054,0.30864,0.39948,1,1
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.00098941,0.30856,0.3057,1,1
5,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.0031536,0.30854,0.25514,1,1
5,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00012512,0.30853,0.39837,1,1
5,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.012508,0.30828,0.16348,1,1
5,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00081984,0.30822,0.20348,1,1
5,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,3.4772e-07,0.30805,0.31539,1,1
5,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.010773,0.30796,0.23563,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0030654,0.30788,0.25851,1,1
5,GO SODIUM ION TRANSMEMBRANE TRANSPORT,3.3287e-06,0.30783,0.27934,1,1
5,GO LIPID STORAGE,1.9263e-05,0.30741,0.26119,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0036303,0.3066,0.23894,1,1
5,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.00026003,0.30621,0.33207,1,1
5,GO REGULATION OF CELL SUBSTRATE ADHESION,0.00047456,0.30589,0.23578,1,1
5,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,6.2786e-05,0.30583,0.3056,1,1
5,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00047456,0.30581,0.25421,1,1
5,GO OPTIC NERVE DEVELOPMENT,0.0016129,0.30565,0.35347,1,1
5,GO NEPHRON MORPHOGENESIS,0.00036427,0.30562,0.20848,1,1
5,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0073363,0.30558,0.28764,1,1
5,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00010845,0.30545,0.23846,1,1
5,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00025131,0.30495,0.23708,1,1
5,GO KERATINOCYTE PROLIFERATION,0.016734,0.30475,0.18674,1,1
5,GO RENAL FILTRATION,0.015203,0.30466,0.32712,1,1
5,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00026903,0.30455,0.22085,1,1
5,GO MYOTUBE DIFFERENTIATION,8.6584e-06,0.30438,0.25841,1,1
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00054072,0.30426,0.26428,1,1
5,GO REGULATION OF ERBB SIGNALING PATHWAY,3.7145e-05,0.30354,0.25073,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,7.013e-05,0.30352,0.25023,1,1
5,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00047456,0.30336,0.26573,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,6.5149e-05,0.30334,0.30722,1,1
5,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,4.1112e-06,0.30331,0.29175,1,1
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00010845,0.30328,0.23415,1,1
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00013433,0.30319,0.25669,1,1
5,GO REGULATION OF COAGULATION,0.0027346,0.30309,0.2325,1,1
5,GO MEMBRANE LIPID METABOLIC PROCESS,2.7343e-05,0.30295,0.2299,1,1
5,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0085714,0.30272,0.304,1,1
5,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.00017796,0.30271,0.2707,1,1
5,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.0014299,0.30242,0.42624,1,1
5,GO REGULATION OF CELL CELL ADHESION,7.0571e-06,0.30238,0.25739,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00063551,0.30232,0.33011,1,1
5,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0034322,0.30232,0.26662,1,1
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0028957,0.30211,0.27773,1,1
5,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,3.8583e-05,0.30211,0.26213,1,1
5,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,1.1493e-05,0.30203,0.27825,1,1
5,GO PARTURITION,0.0054795,0.3016,0.28162,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.00050664,0.30112,0.25498,1,1
5,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00016595,0.30103,0.45185,1,1
5,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00038934,0.30096,0.27681,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.030383,0.30076,0.22531,1,1
5,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.011904,0.30065,0.20435,1,1
5,GO MACROPHAGE DIFFERENTIATION,5.2139e-05,0.30058,0.24418,1,1
5,GO ADAPTIVE IMMUNE RESPONSE,5.4121e-05,0.30053,0.29698,1,1
5,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00041602,0.3005,0.29736,1,1
5,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,1.1964e-05,0.30042,0.25218,1,1
5,GO EPITHELIAL CELL PROLIFERATION,3.7145e-05,0.30007,0.24075,1,1
5,GO EXOCRINE SYSTEM DEVELOPMENT,0.00035231,0.30001,0.29414,1,1
5,GO ASTROCYTE DEVELOPMENT,0.001872,0.29984,0.27219,1,1
5,GO ADIPOSE TISSUE DEVELOPMENT,5.9841e-06,0.29983,0.28157,1,1
5,GO CRANIAL NERVE DEVELOPMENT,1.8521e-05,0.29978,0.30955,1,1
5,GO LUNG MORPHOGENESIS,0.0045306,0.29921,0.20896,1,1
5,GO TRANSMISSION OF NERVE IMPULSE,0.0006154,0.2992,0.2771,1,1
5,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,6.5149e-05,0.29919,0.31291,1,1
5,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,2.0033e-05,0.29907,0.26925,1,1
5,GO MALE SEX DETERMINATION,0.011612,0.29888,0.23258,1,1
5,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.0062634,0.29881,0.25687,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00017796,0.29881,0.28894,1,1
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.022165,0.29874,0.28465,1,1
5,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00034072,0.29856,0.27051,1,1
5,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,1.4609e-05,0.29848,0.24456,1,1
5,GO INNATE IMMUNE RESPONSE,0.00013433,0.29824,0.22635,1,1
5,GO REGULATION OF WOUND HEALING,0.0010206,0.29818,0.24148,1,1
5,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00095906,0.29798,0.28753,1,1
5,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00016595,0.29786,0.21688,1,1
5,GO RENAL TUBULE DEVELOPMENT,0.00024286,0.29778,0.22314,1,1
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0037331,0.29752,0.24463,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0053338,0.29718,0.21313,1,1
5,GO POSITIVE REGULATION OF GLIOGENESIS,1.8521e-05,0.29713,0.25815,1,1
5,GO REGULATION OF LYMPHOCYTE MIGRATION,5.2139e-05,0.29689,0.25879,1,1
5,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.0069616,0.29676,0.27746,1,1
5,GO CELL CELL ADHESION MEDIATED BY CADHERIN,6.5149e-05,0.29672,0.3158,1,1
5,GO LEUKOCYTE PROLIFERATION,2.4346e-05,0.29671,0.24561,1,1
5,GO SPINAL CORD PATTERNING,0.012203,0.2966,0.2545,1,1
5,GO COMMISSURAL NEURON AXON GUIDANCE,0.03939,0.29641,0.29252,1,1
5,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,9.0551e-05,0.29637,0.24658,1,1
5,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00090094,0.29603,0.19959,1,1
5,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.0010528,0.29602,0.30372,1,1
5,GO SECONDARY PALATE DEVELOPMENT,2.0833e-05,0.29594,0.33606,1,1
5,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0017641,0.29591,0.21273,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0015189,0.29562,0.20792,1,1
5,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.00012512,0.2955,0.30716,1,1
5,GO CHEMOKINE PRODUCTION,8.4205e-05,0.29549,0.27671,1,1
5,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00010092,0.29537,0.20594,1,1
5,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.014841,0.29531,0.26256,1,1
5,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,8.1192e-05,0.29449,0.28428,1,1
5,GO RESPONSE TO MECHANICAL STIMULUS,2.8077e-06,0.29414,0.28136,1,1
5,GO RESPONSE TO AXON INJURY,0.00019753,0.29412,0.24319,1,1
5,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.010245,0.29408,0.30403,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.0090226,0.29407,0.24104,1,1
5,GO GANGLION DEVELOPMENT,0.027188,0.29405,0.31594,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00095906,0.29397,0.21928,1,1
5,GO CELLULAR RESPONSE TO INTERFERON BETA,0.02068,0.29395,0.20309,1,1
5,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00353,0.29383,0.33418,1,1
5,GO REGULATION OF RESPIRATORY BURST,0.0013457,0.29379,0.27784,1,1
5,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.042857,0.29359,0.15985,1,1
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00025131,0.29309,0.26243,1,1
5,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0029794,0.29298,0.2937,1,1
5,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,4.0073e-05,0.29294,0.26734,1,1
5,GO PROTEIN TARGETING TO LYSOSOME,0.0056288,0.29289,0.24635,1,1
5,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.0011199,0.29288,0.21366,1,1
5,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00022676,0.29286,0.26828,1,1
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00069957,0.29245,0.28444,1,1
5,GO SPHINGOID METABOLIC PROCESS,0.00014418,0.29242,0.27355,1,1
5,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0037331,0.29235,0.25644,1,1
5,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00084609,0.29212,0.33813,1,1
5,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,3.0576e-06,0.29196,0.28253,1,1
5,GO GLYCOGEN BIOSYNTHETIC PROCESS,1.9904e-06,0.29192,0.27601,1,1
5,GO TYPE I INTERFERON PRODUCTION,0.00098941,0.2918,0.2141,1,1
5,GO REGULATION OF NEURON MATURATION,0.0027346,0.29163,0.27229,1,1
5,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.0031536,0.29147,0.29605,1,1
5,GO DETECTION OF BIOTIC STIMULUS,0.00065623,0.29146,0.33029,1,1
5,GO MUSCLE CELL MIGRATION,0.00042998,0.29121,0.26814,1,1
5,GO RESPONSE TO IRON ION,0.00055855,0.29098,0.23747,1,1
5,GO CELLULAR SODIUM ION HOMEOSTASIS,0.0021062,0.29088,0.35697,1,1
5,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,3.8583e-05,0.29082,0.25021,1,1
5,GO ENDOTHELIAL CELL PROLIFERATION,5.6174e-05,0.29081,0.24958,1,1
5,GO LEUKOCYTE MIGRATION,1.5816e-05,0.29077,0.24515,1,1
5,GO ALPHA BETA T CELL DIFFERENTIATION,6.5149e-05,0.29057,0.24761,1,1
5,GO NEGATIVE REGULATION OF HEMOPOIESIS,2.4346e-05,0.29029,0.24113,1,1
5,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0053338,0.29015,0.18942,1,1
5,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,3.8583e-05,0.29013,0.24484,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.6455e-05,0.29011,0.26087,1,1
5,GO REGULATION OF SYMBIOTIC PROCESS,0.0051916,0.29003,0.18426,1,1
5,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.00045924,0.28953,0.30677,1,1
5,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00022676,0.2895,0.30191,1,1
5,GO REGULATION OF CARTILAGE DEVELOPMENT,4.3218e-05,0.28946,0.29364,1,1
5,GO REGULATION OF ODONTOGENESIS,0.0059384,0.28931,0.31016,1,1
5,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00092958,0.28931,0.3841,1,1
5,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00063551,0.28919,0.24326,1,1
5,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0014738,0.28917,0.32716,1,1
5,GO POSITIVE REGULATION OF B CELL ACTIVATION,1.104e-05,0.2891,0.27328,1,1
5,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00030804,0.28904,0.27635,1,1
5,GO KIDNEY MORPHOGENESIS,0.00036427,0.28899,0.21667,1,1
5,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,1.4674e-06,0.28893,0.25288,1,1
5,GO NEURON CELL CELL ADHESION,0.01282,0.28893,0.40063,1,1
5,GO PARAXIAL MESODERM DEVELOPMENT,0.0019282,0.28883,0.29394,1,1
5,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00041602,0.28849,0.23982,1,1
5,GO KERATAN SULFATE METABOLIC PROCESS,0.004408,0.28832,0.20139,1,1
5,GO GLYCOSYLATION,4.6623e-06,0.28817,0.24681,1,1
5,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.00353,0.28814,0.22593,1,1
5,GO FATTY ACID HOMEOSTASIS,0.0018173,0.28811,0.31366,1,1
5,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,7.013e-05,0.28802,0.25735,1,1
5,GO MECHANORECEPTOR DIFFERENTIATION,1.7118e-05,0.28801,0.24853,1,1
5,GO BEHAVIORAL RESPONSE TO PAIN,0.010506,0.28794,0.27138,1,1
5,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.00014418,0.28756,0.28581,1,1
5,GO HEART TRABECULA FORMATION,0.0026572,0.28756,0.29249,1,1
5,GO INTERLEUKIN 13 PRODUCTION,0.0060989,0.28753,0.26487,1,1
5,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00023468,0.28746,0.23733,1,1
5,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,2.8077e-06,0.28694,0.28703,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00047456,0.28678,0.2168,1,1
5,GO PLATELET ACTIVATION,0.00016023,0.28675,0.21215,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00054072,0.28666,0.28205,1,1
5,GO REGULATION OF RESPONSE TO TUMOR CELL,0.031748,0.28648,0.18615,1,1
5,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0013457,0.28627,0.24715,1,1
5,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,5.2533e-07,0.28622,0.28949,1,1
5,GO DIGESTIVE SYSTEM DEVELOPMENT,2.6307e-05,0.28621,0.23935,1,1
5,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0014738,0.28618,0.27604,1,1
5,GO PROTEIN DEGLYCOSYLATION,0.00087311,0.28611,0.24597,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,3.8583e-05,0.28603,0.21328,1,1
5,GO PLASMA MEMBRANE FUSION,0.00057693,0.28596,0.27903,1,1
5,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00017796,0.28593,0.3002,1,1
5,GO REGULATION OF ACROSOME REACTION,0.0031536,0.28583,0.24242,1,1
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.00013917,0.28578,0.30404,1,1
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,9.0551e-05,0.2856,0.2829,1,1
5,GO RESPIRATORY SYSTEM DEVELOPMENT,8.1192e-05,0.28537,0.23084,1,1
5,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00016023,0.28497,0.28671,1,1
5,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.00045924,0.28485,0.25409,1,1
5,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.00024286,0.28479,0.23764,1,1
5,GO REGULATION OF LEUKOCYTE MIGRATION,4.8379e-05,0.28453,0.22734,1,1
5,GO GLIAL CELL DIFFERENTIATION,7.3528e-06,0.2844,0.25245,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,7.013e-05,0.28434,0.23098,1,1
5,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00036427,0.28414,0.22685,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010462,0.28413,0.25277,1,1
5,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.001872,0.28411,0.52034,1,1
5,GO MIDGUT DEVELOPMENT,0.0094949,0.28409,0.28321,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.1888e-05,0.28397,0.2317,1,1
5,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.034637,0.28395,0.30263,1,1
5,GO COCHLEA MORPHOGENESIS,0.042857,0.28356,0.18298,1,1
5,GO REGULATION OF RESPONSE TO WOUNDING,0.00050664,0.28339,0.2338,1,1
5,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.004408,0.28332,0.21169,1,1
5,GO OLIGODENDROCYTE DIFFERENTIATION,5.0683e-06,0.28291,0.27914,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0025083,0.28279,0.18785,1,1
5,GO POSITIVE REGULATION OF T CELL PROLIFERATION,7.8282e-05,0.28247,0.24485,1,1
5,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.0015189,0.28227,0.35543,1,1
5,GO LONG TERM SYNAPTIC POTENTIATION,8.1192e-05,0.28226,0.27703,1,1
5,GO REGULATION OF LYMPHOCYTE ACTIVATION,2.4346e-05,0.28224,0.22216,1,1
5,GO PLACENTA DEVELOPMENT,0.00026903,0.28206,0.21533,1,1
5,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.017969,0.282,0.19649,1,1
5,GO SPHINGOLIPID METABOLIC PROCESS,2.4346e-05,0.28199,0.22685,1,1
5,GO REGULATION OF CELL ADHESION,4.3218e-05,0.28193,0.23128,1,1
5,GO REGULATION OF GLUCOSE METABOLIC PROCESS,7.889e-07,0.28153,0.26718,1,1
5,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,1.5816e-05,0.28153,0.259,1,1
5,GO REGULATION OF CELL ACTIVATION,2.7343e-05,0.28133,0.20932,1,1
5,GO B CELL ACTIVATION,2.7343e-05,0.28122,0.22007,1,1
5,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00018427,0.28116,0.25536,1,1
5,GO NEUROEPITHELIAL CELL DIFFERENTIATION,1.349e-05,0.28114,0.35374,1,1
5,GO ALPHA BETA T CELL ACTIVATION,7.547e-05,0.28101,0.24011,1,1
5,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00063551,0.2808,0.32995,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.02268,0.28065,0.20864,1,1
5,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00012512,0.28048,0.22638,1,1
5,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0014299,0.28036,0.22841,1,1
5,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0033369,0.28008,0.16131,1,1
5,GO CELL CELL ADHESION,1.0604e-05,0.27989,0.21908,1,1
5,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.01282,0.27983,0.24583,1,1
5,GO CELL MATRIX ADHESION,9.389e-05,0.27968,0.22629,1,1
5,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.0081404,0.27946,0.20644,1,1
5,GO INTERLEUKIN 12 PRODUCTION,1.5816e-05,0.27932,0.27607,1,1
5,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0081404,0.27924,0.2149,1,1
5,GO CERAMIDE BIOSYNTHETIC PROCESS,5.4121e-05,0.27891,0.23172,1,1
5,GO REGULATION OF SYNAPSE MATURATION,0.014138,0.27883,0.26532,1,1
5,GO POSITIVE REGULATION OF FERTILIZATION,0.015574,0.27866,0.23412,1,1
5,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,5.9841e-06,0.27849,0.26406,1,1
5,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0039469,0.27848,0.28566,1,1
5,GO FUCOSYLATION,1.9263e-05,0.27821,0.2794,1,1
5,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00019753,0.27816,0.23979,1,1
5,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.037747,0.27812,0.20209,1,1
5,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.0064317,0.27808,0.37857,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,2.2524e-05,0.27784,0.25065,1,1
5,GO REGULATION OF MAST CELL ACTIVATION,0.001228,0.27777,0.22006,1,1
5,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0050528,0.27773,0.22017,1,1
5,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.0057817,0.27768,0.35072,1,1
5,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0012662,0.2774,0.30828,1,1
5,GO ACYLGLYCEROL HOMEOSTASIS,0.00084609,0.27698,0.19011,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.017137,0.27684,0.20318,1,1
5,GO PROTEIN LOCALIZATION TO ENDOSOME,0.00047456,0.27664,0.24842,1,1
5,GO CAMP METABOLIC PROCESS,0.0039469,0.27652,0.19225,1,1
5,GO EPITHELIAL CELL FATE COMMITMENT,0.0047853,0.27646,0.29102,1,1
5,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00031859,0.27623,0.27099,1,1
5,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00026003,0.27601,0.2526,1,1
5,GO GLIOGENESIS,2.0833e-05,0.27577,0.22888,1,1
5,GO INTERLEUKIN 4 PRODUCTION,8.7323e-05,0.27569,0.26059,1,1
5,GO EMBRYONIC BODY MORPHOGENESIS,0.0050528,0.27529,0.28137,1,1
5,GO OVARIAN FOLLICLE DEVELOPMENT,4.3218e-05,0.27519,0.22873,1,1
5,GO LIPOSACCHARIDE METABOLIC PROCESS,3.0689e-05,0.27499,0.21938,1,1
5,GO POSITIVE REGULATION OF CELL CELL ADHESION,3.0689e-05,0.27497,0.2318,1,1
5,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0001547,0.2749,0.2699,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.024846,0.27481,0.20713,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00021909,0.27477,0.19855,1,1
5,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.016734,0.27466,0.24032,1,1
5,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00027832,0.27462,0.24119,1,1
5,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.0019282,0.27447,0.249,1,1
5,GO ADHESION OF SYMBIONT TO HOST,0.00059588,0.27428,0.35327,1,1
5,GO IMMUNE EFFECTOR PROCESS,0.00035231,0.27424,0.2094,1,1
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0010859,0.27415,0.28936,1,1
5,GO CARDIAC CONDUCTION,9.7346e-05,0.27406,0.24967,1,1
5,GO POSITIVE REGULATION OF CELL ADHESION,0.00010845,0.27395,0.23166,1,1
5,GO MEMBRANE REPOLARIZATION,0.00047456,0.2738,0.25232,1,1
5,GO WHITE FAT CELL DIFFERENTIATION,0.00010845,0.27362,0.2678,1,1
5,GO MAMMARY GLAND MORPHOGENESIS,0.0017123,0.27347,0.23492,1,1
5,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00012074,0.27327,0.22895,1,1
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.018398,0.27326,0.2384,1,1
5,GO CELL CHEMOTAXIS,1.5201e-05,0.27325,0.25428,1,1
5,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.0042883,0.27298,0.29481,1,1
5,GO REGULATION OF T CELL ACTIVATION,1.9263e-05,0.27254,0.2287,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0097392,0.27223,0.21252,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00059588,0.27221,0.2191,1,1
5,GO BILE ACID AND BILE SALT TRANSPORT,0.0087944,0.27209,0.16966,1,1
5,GO REGULATION OF MUSCLE HYPERTROPHY,0.00067758,0.27202,0.22634,1,1
5,GO RETINA LAYER FORMATION,0.036948,0.27199,0.27869,1,1
5,GO INTESTINAL ABSORPTION,0.0016129,0.27197,0.23903,1,1
5,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00021909,0.27187,0.2326,1,1
5,GO CRANIAL NERVE MORPHOGENESIS,0.0038387,0.27184,0.23693,1,1
5,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00098941,0.27184,0.27321,1,1
5,GO STEROL HOMEOSTASIS,6.7596e-05,0.27086,0.22829,1,1
5,GO T CELL PROLIFERATION,3.8583e-05,0.27077,0.23869,1,1
5,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.0689e-05,0.27041,0.2293,1,1
5,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.0017641,0.27041,0.22841,1,1
5,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0018173,0.27012,0.25623,1,1
5,GO INNERVATION,0.022165,0.27011,0.26918,1,1
5,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00020448,0.26993,0.2067,1,1
5,GO HAIR CELL DIFFERENTIATION,9.7346e-05,0.26977,0.23196,1,1
5,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,9.0179e-06,0.2697,0.26716,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.0064317,0.26968,0.27117,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0094949,0.26961,0.18948,1,1
5,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00024286,0.2694,0.20461,1,1
5,GO AMINO SUGAR CATABOLIC PROCESS,0.0069616,0.26928,0.20732,1,1
5,GO METANEPHROS DEVELOPMENT,0.00069957,0.26921,0.20028,1,1
5,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.014138,0.26902,0.28735,1,1
5,GO CELLULAR GLUCAN METABOLIC PROCESS,1.5201e-05,0.26902,0.24721,1,1
5,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0040578,0.26864,0.27566,1,1
5,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00012074,0.26829,0.19486,1,1
5,GO CYTOKINE PRODUCTION,0.00011241,0.26823,0.21327,1,1
5,GO RESPONSE TO STEROL DEPLETION,0.0064317,0.26815,0.20889,1,1
5,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0057817,0.2679,0.21785,1,1
5,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.0001547,0.26777,0.24804,1,1
5,GO RESPONSE TO GROWTH HORMONE,0.0031536,0.26772,0.21089,1,1
5,GO REGULATION OF FLAGELLATED SPERM MOTILITY,2.5308e-05,0.26768,0.23621,1,1
5,GO LEUKOCYTE CHEMOTAXIS,3.0689e-05,0.26764,0.23029,1,1
5,GO POSITIVE REGULATION OF HEMOPOIESIS,7.2754e-05,0.26751,0.20867,1,1
5,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00012074,0.26749,0.29515,1,1
5,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0073363,0.26749,0.16896,1,1
5,GO CERAMIDE METABOLIC PROCESS,4.6597e-05,0.26742,0.21796,1,1
5,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0036303,0.26739,0.20456,1,1
5,GO WATER HOMEOSTASIS,2.0833e-05,0.26729,0.27452,1,1
5,GO REGULATION OF MUSCLE ADAPTATION,0.00045924,0.26712,0.20136,1,1
5,GO INTERACTION WITH HOST,0.0037331,0.26696,0.15918,1,1
5,GO AXIS ELONGATION,0.010245,0.26665,0.18155,1,1
5,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0017641,0.26648,0.24761,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,4.4878e-05,0.2661,0.20558,1,1
5,GO POSITIVE REGULATION OF CELL ACTIVATION,5.0226e-05,0.26594,0.21603,1,1
5,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00072223,0.26576,0.20612,1,1
5,GO MUSCLE ATROPHY,0.014486,0.26561,0.19161,1,1
5,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00014418,0.26548,0.22756,1,1
5,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0041716,0.2654,0.30631,1,1
5,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.0007696,0.26528,0.28344,1,1
5,GO SODIUM ION TRANSPORT,3.0576e-06,0.26528,0.23323,1,1
5,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.3418e-05,0.26525,0.2517,1,1
5,GO DEVELOPMENTAL INDUCTION,3.3132e-05,0.26521,0.26108,1,1
5,GO NATURAL KILLER CELL DIFFERENTIATION,0.00016595,0.2647,0.21481,1,1
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00057693,0.26468,0.2159,1,1
5,GO HOMOTYPIC CELL CELL ADHESION,0.00026903,0.26465,0.26166,1,1
5,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.019739,0.26455,0.30579,1,1
5,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0025083,0.26451,0.15408,1,1
5,GO ENGULFMENT OF APOPTOTIC CELL,0.00029782,0.2644,0.29758,1,1
5,GO T CELL ACTIVATION,5.2139e-05,0.26402,0.21646,1,1
5,GO RESPONSE TO CYTOKINE,0.00026003,0.26399,0.18981,1,1
5,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00019753,0.26396,0.27768,1,1
5,GO TERPENOID BIOSYNTHETIC PROCESS,0.040234,0.26388,0.20317,1,1
5,GO LEUKOCYTE CELL CELL ADHESION,8.1192e-05,0.2638,0.21978,1,1
5,GO RESPONSE TO ACIDIC PH,0.001191,0.26352,0.26664,1,1
5,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,9.3916e-06,0.26334,0.24129,1,1
5,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0090226,0.26332,0.29373,1,1
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00057693,0.26323,0.21696,1,1
5,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0023671,0.26308,0.25846,1,1
5,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,1.1493e-05,0.26288,0.24325,1,1
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.024288,0.26264,0.26034,1,1
5,GO MULTICELLULAR ORGANISM AGING,1.9263e-05,0.26244,0.22792,1,1
5,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00044439,0.26237,0.19847,1,1
5,GO CELLULAR RESPONSE TO AMYLOID BETA,9.0551e-05,0.26218,0.2475,1,1
5,GO RENAL SYSTEM PROCESS,1.8521e-05,0.26217,0.22916,1,1
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,3.1888e-05,0.26182,0.24705,1,1
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0069616,0.2617,0.22168,1,1
5,GO REGULATION OF GLIOGENESIS,1.8521e-05,0.26165,0.23995,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0079323,0.26161,0.22339,1,1
5,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00041602,0.26107,0.19726,1,1
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.001986,0.26104,0.19298,1,1
5,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00017186,0.26102,0.23588,1,1
5,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.03939,0.26081,0.12467,1,1
5,GO GLIAL CELL MIGRATION,0.007729,0.26067,0.16315,1,1
5,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0015653,0.26062,0.2348,1,1
5,GO RESPONSE TO TUMOR CELL,0.0034322,0.25995,0.26009,1,1
5,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.0083534,0.2596,0.3415,1,1
5,GO SODIUM ION HOMEOSTASIS,2.9532e-05,0.25951,0.24732,1,1
5,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.004408,0.25951,0.20856,1,1
5,GO REGULATION OF TUBULIN DEACETYLATION,0.024288,0.25943,0.22425,1,1
5,GO SERTOLI CELL DEVELOPMENT,0.0025083,0.25938,0.33961,1,1
5,GO INACTIVATION OF MAPK ACTIVITY,0.0010859,0.25931,0.28288,1,1
5,GO BIOLOGICAL ADHESION,5.8301e-05,0.25917,0.20082,1,1
5,GO RESPONSE TO CORTICOSTERONE,0.007729,0.25911,0.24061,1,1
5,GO RESPONSE TO INSECTICIDE,0.001191,0.25911,0.32019,1,1
5,GO CARDIAC CELL DEVELOPMENT,0.00012964,0.25904,0.20108,1,1
5,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0047853,0.25897,0.28766,1,1
5,GO INFLAMMATORY RESPONSE,3.3132e-05,0.25875,0.22379,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.010245,0.25875,0.25717,1,1
5,GO LIPOPROTEIN CATABOLIC PROCESS,0.0083534,0.25869,0.22359,1,1
5,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,3.4421e-05,0.2584,0.22473,1,1
5,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.025414,0.25837,0.21315,1,1
5,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0017123,0.25819,0.21138,1,1
5,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00012964,0.25818,0.30095,1,1
5,GO INTERLEUKIN 6 PRODUCTION,1.4609e-05,0.25816,0.22499,1,1
5,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00010092,0.25809,0.28449,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0037331,0.25802,0.17299,1,1
5,GO REGULATION OF GONAD DEVELOPMENT,0.030383,0.25782,0.15973,1,1
5,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.00018427,0.25769,0.24962,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00084609,0.25765,0.24669,1,1
5,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,3.5759e-05,0.25751,0.24117,1,1
5,GO INTERLEUKIN 1 PRODUCTION,0.00098941,0.25736,0.22885,1,1
5,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,6.7596e-05,0.25702,0.22583,1,1
5,GO REGULATION OF FATTY ACID TRANSPORT,1.2962e-05,0.257,0.29852,1,1
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0042883,0.25663,0.21172,1,1
5,GO REGULATION OF NOTCH SIGNALING PATHWAY,1.0184e-05,0.25647,0.27121,1,1
5,GO TUBE MORPHOGENESIS,0.00012512,0.25629,0.18492,1,1
5,GO PROGRAMMED NECROTIC CELL DEATH,0.0015653,0.25613,0.25454,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,4.0073e-05,0.25613,0.19194,1,1
5,GO RESPONSE TO WOUNDING,0.00092958,0.25603,0.18975,1,1
5,GO BLOOD VESSEL MORPHOGENESIS,0.00050664,0.25593,0.17984,1,1
5,GO REGULATION OF RESPONSE TO FOOD,4.6597e-05,0.25591,0.25733,1,1
5,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.023741,0.25585,0.17018,1,1
5,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,1.6455e-05,0.25583,0.21522,1,1
5,GO PROTEIN CONTAINING COMPLEX REMODELING,0.00027832,0.25579,0.2442,1,1
5,GO DIOL METABOLIC PROCESS,0.00024286,0.25561,0.24063,1,1
5,GO DEFENSE RESPONSE,6.0504e-05,0.25539,0.21036,1,1
5,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.00069957,0.25537,0.37301,1,1
5,GO ANATOMICAL STRUCTURE REGRESSION,0.036164,0.25506,0.24692,1,1
5,GO SKIN EPIDERMIS DEVELOPMENT,0.0015189,0.25489,0.17586,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,6.0504e-05,0.25482,0.25305,1,1
5,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.033166,0.25479,0.21644,1,1
5,GO MESONEPHROS DEVELOPMENT,2.5308e-05,0.25479,0.25642,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00010845,0.25476,0.1974,1,1
5,GO OXALATE TRANSPORT,0.0059384,0.25468,0.17439,1,1
5,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00092958,0.25466,0.24209,1,1
5,GO REGULATION OF ENDOCRINE PROCESS,2.2524e-05,0.25465,0.27173,1,1
5,GO DRUG CATABOLIC PROCESS,0.0022992,0.25464,0.1746,1,1
5,GO LIPOPROTEIN METABOLIC PROCESS,1.104e-05,0.25464,0.24433,1,1
5,GO MYOTUBE CELL DEVELOPMENT,0.00042998,0.25452,0.23829,1,1
5,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0022992,0.2544,0.24819,1,1
5,GO POSITIVE REGULATION OF CYTOKINE SECRETION,5.4121e-05,0.25424,0.23108,1,1
5,GO T CELL MIGRATION,0.00042998,0.25423,0.21492,1,1
5,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00040247,0.25421,0.2188,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0049174,0.25421,0.16561,1,1
5,GO VIRAL LIFE CYCLE,0.0064317,0.2542,0.15918,1,1
5,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.014138,0.25416,0.1992,1,1
5,GO CELL CELL JUNCTION ASSEMBLY,0.00013917,0.25396,0.22356,1,1
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,3.0689e-05,0.25388,0.23428,1,1
5,GO INSEMINATION,0.030383,0.25382,0.24606,1,1
5,GO NECROTIC CELL DEATH,0.00063551,0.25362,0.26121,1,1
5,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00023468,0.25361,0.18627,1,1
5,GO RESPONSE TO CAFFEINE,0.001872,0.25352,0.23,1,1
5,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,5.2139e-05,0.25349,0.33577,1,1
5,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,1.349e-05,0.25348,0.22309,1,1
5,GO POSITIVE CHEMOTAXIS,0.00016023,0.25328,0.25212,1,1
5,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.011612,0.25322,0.14777,1,1
5,GO DNA DEMETHYLATION,0.00087311,0.25287,0.22601,1,1
5,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0062634,0.25286,0.32457,1,1
5,GO ICOSANOID METABOLIC PROCESS,0.00059588,0.25267,0.22957,1,1
5,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0032441,0.25262,0.20391,1,1
5,GO LYMPHOCYTE MIGRATION,8.4205e-05,0.25253,0.21855,1,1
5,GO NEGATIVE REGULATION OF OSSIFICATION,0.00010462,0.2525,0.25857,1,1
5,GO CELL KILLING,0.00021167,0.25244,0.2055,1,1
5,GO INTERLEUKIN 8 PRODUCTION,0.0040578,0.25238,0.20487,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00010462,0.25235,0.23305,1,1
5,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00063551,0.2523,0.25979,1,1
5,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.00010845,0.25222,0.31295,1,1
5,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,6.2367e-06,0.25219,0.21279,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00019079,0.25218,0.23789,1,1
5,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.023205,0.25216,0.20791,1,1
5,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0039469,0.25203,0.19557,1,1
5,GO MEMBRANE BIOGENESIS,0.0017123,0.2518,0.2487,1,1
5,GO LYMPHOCYTE ACTIVATION,4.0073e-05,0.25177,0.19108,1,1
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0014299,0.25163,0.18651,1,1
5,GO LEUKOCYTE MEDIATED IMMUNITY,0.00034072,0.25149,0.20533,1,1
5,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.0056288,0.25137,0.25008,1,1
5,GO CELL ACTIVATION,0.00020448,0.25127,0.1826,1,1
5,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0015189,0.25122,0.27878,1,1
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0030654,0.25108,0.16803,1,1
5,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.045624,0.25105,0.15243,1,1
5,GO B CELL HOMEOSTASIS,0.00072223,0.25091,0.2521,1,1
5,GO ENDOCRINE HORMONE SECRETION,3.4728e-06,0.25061,0.3007,1,1
5,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0064317,0.25037,0.18377,1,1
5,GO NEGATIVE REGULATION OF GLIOGENESIS,3.7145e-05,0.25025,0.34212,1,1
5,GO NOTCH SIGNALING PATHWAY,7.0571e-06,0.24999,0.23588,1,1
5,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0059384,0.24977,0.28794,1,1
5,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00055855,0.24966,0.27367,1,1
5,GO REGULATION OF STEM CELL DIVISION,0.0054795,0.24959,0.20174,1,1
5,GO POSITIVE REGULATION OF HEART CONTRACTION,0.00031859,0.24955,0.27465,1,1
5,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0013872,0.24947,0.23894,1,1
5,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.0057817,0.24943,0.20297,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0056288,0.2494,0.22555,1,1
5,GO ACTIVATION OF JUN KINASE ACTIVITY,9.7801e-06,0.24923,0.23923,1,1
5,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.033166,0.24917,0.12553,1,1
5,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.0054795,0.24904,0.20377,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,6.2786e-05,0.24889,0.20867,1,1
5,GO CELL CELL JUNCTION ORGANIZATION,0.00019079,0.24884,0.2116,1,1
5,GO POSITIVE REGULATION OF COAGULATION,0.0042883,0.24881,0.24988,1,1
5,GO REGULATION OF IMMUNE SYSTEM PROCESS,3.7145e-05,0.2488,0.18454,1,1
5,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,1.4039e-05,0.2486,0.19533,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00012074,0.2485,0.3004,1,1
5,GO ANION HOMEOSTASIS,0.0011199,0.24835,0.18807,1,1
5,GO NEPHRON EPITHELIUM DEVELOPMENT,0.00023468,0.24834,0.21532,1,1
5,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.031748,0.24817,0.1841,1,1
5,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,2.5774e-06,0.24815,0.27008,1,1
5,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00095906,0.24786,0.18677,1,1
5,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,6.0504e-05,0.24778,0.22265,1,1
5,GO POSITIVE REGULATION OF CELL DIVISION,8.4205e-05,0.24777,0.2134,1,1
5,GO ICOSANOID BIOSYNTHETIC PROCESS,0.033166,0.2476,0.15566,1,1
5,GO KIDNEY EPITHELIUM DEVELOPMENT,6.5149e-05,0.24745,0.23307,1,1
5,GO MACROPHAGE MIGRATION,0.001228,0.24735,0.20586,1,1
5,GO PROTEIN ADP RIBOSYLATION,0.0007696,0.2473,0.21347,1,1
5,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00018427,0.24727,0.24235,1,1
5,GO ACTIVATION OF MAPK ACTIVITY,1.7118e-05,0.24718,0.23391,1,1
5,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.00012074,0.24714,0.26222,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,1.0184e-05,0.24662,0.21456,1,1
5,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.001662,0.24643,0.17802,1,1
5,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00010462,0.24636,0.18206,1,1
5,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0081404,0.24626,0.20867,1,1
5,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0007696,0.246,0.18586,1,1
5,GO MACROPHAGE APOPTOTIC PROCESS,0.041093,0.24579,0.16866,1,1
5,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,1.2962e-05,0.24575,0.2251,1,1
5,GO MYELOID LEUKOCYTE MIGRATION,0.00014935,0.24557,0.1943,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,4.6597e-05,0.24542,0.20648,1,1
5,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00035231,0.24533,0.25154,1,1
5,GO RECEPTOR BIOSYNTHETIC PROCESS,0.001662,0.24532,0.18384,1,1
5,GO REGULATION OF ICOSANOID SECRETION,9.7346e-05,0.2452,0.26903,1,1
5,GO GRANULOCYTE CHEMOTAXIS,0.00031859,0.24501,0.18087,1,1
5,GO PROTEIN KINASE B SIGNALING,0.00018427,0.24484,0.18174,1,1
5,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0033369,0.24479,0.2362,1,1
5,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00049035,0.24472,0.18165,1,1
5,GO NEUROPEPTIDE SIGNALING PATHWAY,4.6597e-05,0.24419,0.25848,1,1
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0018173,0.24406,0.19843,1,1
5,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.010773,0.24389,0.16077,1,1
5,GO MULTICELLULAR ORGANISMAL SIGNALING,3.5759e-05,0.24375,0.24452,1,1
5,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.001872,0.24349,0.2937,1,1
5,GO LIPID LOCALIZATION,7.2754e-05,0.24345,0.18282,1,1
5,GO REGULATION OF OSSIFICATION,4.1617e-05,0.24338,0.26116,1,1
5,GO REGULATION OF PEPTIDASE ACTIVITY,0.00013433,0.24334,0.23676,1,1
5,GO INTERLEUKIN 1 BETA PRODUCTION,0.0019282,0.24309,0.21227,1,1
5,GO ENERGY RESERVE METABOLIC PROCESS,2.3418e-05,0.24307,0.23031,1,1
5,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00016023,0.24292,0.18678,1,1
5,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0031536,0.24283,0.15784,1,1
5,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.020205,0.24282,0.28253,1,1
5,GO EATING BEHAVIOR,4.4712e-06,0.24277,0.25669,1,1
5,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0056288,0.24212,0.18289,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0001165,0.24204,0.26692,1,1
5,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.010773,0.24203,0.20221,1,1
5,GO INNER EAR RECEPTOR CELL DEVELOPMENT,4.3218e-05,0.24189,0.22938,1,1
5,GO LEUKOCYTE HOMEOSTASIS,0.00081984,0.24181,0.17714,1,1
5,GO OUTER DYNEIN ARM ASSEMBLY,0.0028957,0.2417,0.20533,1,1
5,GO POSITIVE REGULATION OF BONE RESORPTION,0.0031536,0.24125,0.23492,1,1
5,GO NEUROINFLAMMATORY RESPONSE,0.00047456,0.2411,0.2123,1,1
5,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00018427,0.24102,0.20817,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00013433,0.24097,0.20664,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00047456,0.24076,0.21261,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.00084609,0.24071,0.20579,1,1
5,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,8.4205e-05,0.24067,0.25,1,1
5,GO MACROPHAGE CHEMOTAXIS,0.0015653,0.2406,0.25193,1,1
5,GO AMINOGLYCAN METABOLIC PROCESS,0.00040247,0.24049,0.20774,1,1
5,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00072223,0.24043,0.28978,1,1
5,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0001165,0.24038,0.19754,1,1
5,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00087311,0.24028,0.31726,1,1
5,GO RESPONSE TO INTERLEUKIN 6,0.0011199,0.24016,0.20357,1,1
5,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00067758,0.24011,0.17078,1,1
5,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.0046564,0.23999,0.20189,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00059588,0.23996,0.24559,1,1
5,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00034072,0.23992,0.22337,1,1
5,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0021689,0.23987,0.2076,1,1
5,GO PROTEIN PROCESSING,0.00014935,0.23977,0.19179,1,1
5,GO B CELL DIFFERENTIATION,1.2454e-05,0.23959,0.19455,1,1
5,GO FACIAL NERVE MORPHOGENESIS,0.015574,0.23956,0.29062,1,1
5,GO REGULATION OF NEUTROPHIL MIGRATION,0.00022676,0.23952,0.21297,1,1
5,GO TISSUE REGENERATION,0.015574,0.2395,0.17362,1,1
5,GO EMBRYONIC HEMOPOIESIS,0.0014738,0.23947,0.22804,1,1
5,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.0001165,0.23943,0.22484,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0001165,0.23941,0.19578,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00079435,0.23933,0.1853,1,1
5,GO NEURONAL ACTION POTENTIAL,0.0085714,0.23913,0.29912,1,1
5,GO ANTIMICROBIAL HUMORAL RESPONSE,5.4121e-05,0.23903,0.20409,1,1
5,GO PROTEIN N LINKED GLYCOSYLATION,0.00067758,0.239,0.20666,1,1
5,GO MUSCLE HYPERTROPHY,0.00054072,0.23891,0.1929,1,1
5,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.007729,0.23881,0.17918,1,1
5,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.047551,0.23852,0.23636,1,1
5,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00052342,0.23846,0.1654,1,1
5,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0015653,0.23843,0.17481,1,1
5,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,2.1663e-05,0.23842,0.18539,1,1
5,GO GONADOTROPIN SECRETION,0.0021689,0.23841,0.27498,1,1
5,GO CHONDROCYTE DIFFERENTIATION,0.0060989,0.23829,0.18443,1,1
5,GO BONE MINERALIZATION,0.00023468,0.23821,0.22668,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00018427,0.23821,0.25973,1,1
5,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,4.8379e-05,0.23813,0.20138,1,1
5,GO REGULATION OF FATTY ACID OXIDATION,0.001228,0.238,0.21847,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0013457,0.23775,0.22342,1,1
5,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0014299,0.23748,0.24343,1,1
5,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.00079435,0.2373,0.26144,1,1
5,GO MUSCLE CELL APOPTOTIC PROCESS,0.00029782,0.23695,0.18482,1,1
5,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0032441,0.23693,0.2171,1,1
5,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0053338,0.23689,0.21107,1,1
5,GO VASCULATURE DEVELOPMENT,0.00092958,0.23682,0.15811,1,1
5,GO POSITIVE REGULATION OF HEART RATE,0.0013457,0.23667,0.29673,1,1
5,GO STEROID METABOLIC PROCESS,0.00020448,0.2366,0.18649,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.001191,0.23657,0.18109,1,1
5,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0079323,0.23644,0.16973,1,1
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0013457,0.23644,0.1714,1,1
5,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00045924,0.23636,0.2188,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0014299,0.23626,0.20395,1,1
5,GO AMINE TRANSPORT,0.00040247,0.23618,0.29946,1,1
5,GO REGULATION OF MAP KINASE ACTIVITY,1.4609e-05,0.23616,0.21691,1,1
5,GO CELL SUBSTRATE ADHESION,0.0013054,0.23616,0.19074,1,1
5,GO REGULATION OF MACROPHAGE MIGRATION,0.00044439,0.23602,0.20529,1,1
5,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.8583e-05,0.23599,0.18007,1,1
5,GO STARTLE RESPONSE,0.0022332,0.23594,0.2708,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00017796,0.23586,0.18557,1,1
5,GO WOUND HEALING,0.001662,0.23575,0.17433,1,1
5,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00010092,0.23572,0.28082,1,1
5,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00092958,0.23571,0.19342,1,1
5,GO LEUKOCYTE APOPTOTIC PROCESS,0.0016129,0.23564,0.20807,1,1
5,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.00010092,0.2356,0.21428,1,1
5,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00054072,0.23551,0.20452,1,1
5,GO DIOL BIOSYNTHETIC PROCESS,0.00098941,0.23516,0.18697,1,1
5,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.00020448,0.23466,0.21332,1,1
5,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0054795,0.23459,0.21757,1,1
5,GO CELLULAR RESPONSE TO CALCIUM ION,0.0007696,0.23434,0.2191,1,1
5,GO NOTCH RECEPTOR PROCESSING,0.0029794,0.23434,0.34556,1,1
5,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0015653,0.23416,0.18221,1,1
5,GO NEPHRIC DUCT DEVELOPMENT,0.042857,0.2341,0.17931,1,1
5,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,6.2367e-06,0.23409,0.24246,1,1
5,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,5.4121e-05,0.23388,0.21953,1,1
5,GO MUSCLE ADAPTATION,0.00092958,0.2338,0.17997,1,1
5,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00013917,0.23377,0.25426,1,1
5,GO ENSHEATHMENT OF NEURONS,8.1192e-05,0.23369,0.19781,1,1
5,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.0007696,0.23368,0.20861,1,1
5,GO MYELOID CELL HOMEOSTASIS,0.00023468,0.23351,0.17353,1,1
5,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00052342,0.23348,0.19361,1,1
5,GO LYMPHOCYTE CHEMOTAXIS,0.00079435,0.23343,0.19657,1,1
5,GO TUBE DEVELOPMENT,7.547e-05,0.23342,0.18197,1,1
5,GO REGULATION OF T CELL DIFFERENTIATION,0.00012964,0.23325,0.16986,1,1
5,GO MAST CELL MIGRATION,0.027803,0.23313,0.29862,1,1
5,GO POTASSIUM ION HOMEOSTASIS,3.4421e-05,0.23292,0.25678,1,1
5,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,7.2754e-05,0.23292,0.19019,1,1
5,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,2.5308e-05,0.23248,0.28118,1,1
5,GO REGULATION OF CELL POPULATION PROLIFERATION,2.6307e-05,0.23233,0.17356,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0017123,0.23226,0.17374,1,1
5,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00045924,0.23216,0.24562,1,1
5,GO EPIDERMIS DEVELOPMENT,0.00014935,0.23201,0.19574,1,1
5,GO GLAND DEVELOPMENT,6.4994e-06,0.23191,0.20491,1,1
5,GO GRANULOCYTE MIGRATION,0.00079435,0.23178,0.17617,1,1
5,GO NEURON MATURATION,2.2524e-05,0.23169,0.28643,1,1
5,GO REGULATION OF ANION TRANSPORT,5.2139e-05,0.23146,0.20141,1,1
5,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00027832,0.23145,0.27146,1,1
5,GO STEROL METABOLIC PROCESS,0.0010859,0.23137,0.17423,1,1
5,GO CHLORIDE ION HOMEOSTASIS,0.0075304,0.23129,0.1648,1,1
5,GO STEM CELL DIVISION,0.016339,0.23112,0.15396,1,1
5,GO REGULATION OF CHEMOTAXIS,4.8379e-05,0.23108,0.2168,1,1
5,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00092958,0.23102,0.27082,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.0054795,0.23095,0.22342,1,1
5,GO PEPTIDYL TYROSINE MODIFICATION,8.1192e-05,0.23088,0.20679,1,1
5,GO MOLTING CYCLE,0.00092958,0.23081,0.15815,1,1
5,GO MUSCLE CELL DIFFERENTIATION,2.7343e-05,0.23074,0.18881,1,1
5,GO REGULATION OF IMMUNE RESPONSE,0.00020448,0.2306,0.17897,1,1
5,GO ORGANIC CATION TRANSPORT,0.00055855,0.23051,0.22674,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0064317,0.23051,0.17507,1,1
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,1.2454e-05,0.23046,0.21387,1,1
5,GO DISACCHARIDE METABOLIC PROCESS,0.0028141,0.23043,0.20466,1,1
5,GO POSITIVE REGULATION OF JNK CASCADE,2.0033e-05,0.23041,0.19993,1,1
5,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,9.7346e-05,0.2304,0.17281,1,1
5,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0017123,0.23002,0.19621,1,1
5,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00057693,0.23002,0.16912,1,1
5,GO PHOSPHOLIPID TRANSPORT,1.2454e-05,0.22998,0.21246,1,1
5,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.001191,0.22993,0.19044,1,1
5,GO NUCLEOSIDE CATABOLIC PROCESS,0.0039469,0.22989,0.17719,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0010528,0.22981,0.17462,1,1
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00055855,0.22976,0.21478,1,1
5,GO ENDOCRINE PROCESS,0.00032948,0.2295,0.2117,1,1
5,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0011549,0.22946,0.30252,1,1
5,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00031859,0.22912,0.19697,1,1
5,GO BIOMINERALIZATION,0.00012512,0.22907,0.21322,1,1
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.0079323,0.22891,0.16973,1,1
5,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0050528,0.22879,0.24128,1,1
5,GO CELLULAR RESPONSE TO STEROL,0.0025083,0.22872,0.22344,1,1
5,GO ACTIVATED T CELL PROLIFERATION,3.4421e-05,0.22866,0.22077,1,1
5,GO MAGNESIUM ION HOMEOSTASIS,0.047551,0.22861,0.15323,1,1
5,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.00029782,0.22861,0.24021,1,1
5,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00010462,0.22858,0.22847,1,1
5,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00047456,0.22857,0.21334,1,1
5,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00031859,0.22845,0.19944,1,1
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00037661,0.22833,0.18837,1,1
5,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.00074557,0.22826,0.24992,1,1
5,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.00021167,0.22773,0.19277,1,1
5,GO STRIATED MUSCLE CELL DIFFERENTIATION,1.6455e-05,0.22767,0.20825,1,1
5,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00012964,0.22751,0.18172,1,1
5,GO REGULATION OF BLOOD CIRCULATION,5.7413e-06,0.22747,0.22958,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0011549,0.22727,0.22898,1,1
5,GO POSITIVE REGULATION OF ANION TRANSPORT,0.00012074,0.22708,0.20587,1,1
5,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.035393,0.22694,0.17929,1,1
5,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.00079435,0.22688,0.16456,1,1
5,GO DIGESTIVE TRACT MORPHOGENESIS,0.0094949,0.22678,0.16407,1,1
5,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00090094,0.22663,0.16877,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00026003,0.22655,0.22088,1,1
5,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0046564,0.22648,0.17837,1,1
5,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00098941,0.22627,0.2125,1,1
5,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,4.6597e-05,0.22604,0.20022,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0010859,0.22603,0.20743,1,1
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0013054,0.22586,0.16825,1,1
5,GO RESPONSE TO BIOTIC STIMULUS,0.00031859,0.22583,0.17755,1,1
5,GO STEROL TRANSPORT,0.0030654,0.22579,0.15294,1,1
5,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.0020453,0.2257,0.1768,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00022676,0.2257,0.18764,1,1
5,GO NEGATIVE REGULATION OF KINASE ACTIVITY,1.104e-05,0.22569,0.21065,1,1
5,GO REGULATION OF STEROID METABOLIC PROCESS,0.0006154,0.2255,0.20761,1,1
5,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0023671,0.22544,0.27032,1,1
5,GO FIBROBLAST MIGRATION,0.0019282,0.22541,0.1826,1,1
5,GO UROGENITAL SYSTEM DEVELOPMENT,0.00016023,0.22532,0.18658,1,1
5,GO MYELOID LEUKOCYTE ACTIVATION,0.00081984,0.22528,0.18229,1,1
5,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00092958,0.22523,0.18804,1,1
5,GO COCHLEA DEVELOPMENT,0.00353,0.22518,0.20308,1,1
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00026903,0.22512,0.28233,1,1
5,GO CYTOKINE METABOLIC PROCESS,0.0014738,0.22492,0.23585,1,1
5,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.012508,0.2248,0.20728,1,1
5,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00022676,0.22475,0.16272,1,1
5,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0017123,0.22475,0.22259,1,1
5,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0032441,0.22438,0.24345,1,1
5,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0085714,0.22438,0.17252,1,1
5,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00035231,0.22407,0.16634,1,1
5,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.00021167,0.22405,0.1825,1,1
5,GO ENDOTHELIAL CELL MIGRATION,0.00063551,0.22362,0.21097,1,1
5,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00054072,0.22356,0.21059,1,1
5,GO POSITIVE REGULATION OF HORMONE SECRETION,1.7118e-05,0.22325,0.23565,1,1
5,GO LYTIC VACUOLE ORGANIZATION,0.00047456,0.22318,0.17495,1,1
5,GO INTERLEUKIN 5 PRODUCTION,0.033894,0.22309,0.18728,1,1
5,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00010462,0.22306,0.21415,1,1
5,GO RESPONSE TO NICOTINE,0.0013054,0.22305,0.20885,1,1
5,GO CYTOKINE SECRETION,0.00040247,0.22298,0.20522,1,1
5,GO KERATINOCYTE DIFFERENTIATION,0.00020448,0.22279,0.20714,1,1
5,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0024367,0.22278,0.25337,1,1
5,GO IMMUNOGLOBULIN PRODUCTION,0.00065623,0.22244,0.15252,1,1
5,GO BODY MORPHOGENESIS,0.0060989,0.22231,0.18522,1,1
5,GO NEPHRON DEVELOPMENT,0.00031859,0.22223,0.19131,1,1
5,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.0022332,0.22215,0.20733,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00028792,0.22197,0.21208,1,1
5,GO DECIDUALIZATION,0.014138,0.2219,0.20482,1,1
5,GO RESPONSE TO MINERALOCORTICOID,0.03939,0.22187,0.13473,1,1
5,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00087311,0.2217,0.17271,1,1
5,GO ARACHIDONIC ACID METABOLIC PROCESS,0.00035231,0.22163,0.23798,1,1
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00021909,0.22156,0.18921,1,1
5,GO CELL MOTILITY,5.8301e-05,0.22149,0.181,1,1
5,GO ENDOCRINE SYSTEM DEVELOPMENT,0.00012964,0.22147,0.21672,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.015574,0.22134,0.12678,1,1
5,GO ACTIVATION OF JNKK ACTIVITY,0.02843,0.22132,0.1968,1,1
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0010859,0.22114,0.19417,1,1
5,GO PANCREAS DEVELOPMENT,0.0023671,0.22112,0.1963,1,1
5,GO AMEBOIDAL TYPE CELL MIGRATION,0.0022332,0.22094,0.16022,1,1
5,GO LYMPHOCYTE HOMEOSTASIS,0.00032948,0.22092,0.18618,1,1
5,GO COAGULATION,0.0022992,0.22048,0.15453,1,1
5,GO CELL MATURATION,2.1831e-07,0.22044,0.21707,1,1
5,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.041967,0.22044,0.1943,1,1
5,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,4.4878e-05,0.22035,0.16989,1,1
5,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0028141,0.21972,0.16773,1,1
5,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0090226,0.21968,0.20567,1,1
5,GO MONONUCLEAR CELL MIGRATION,0.0010528,0.21948,0.20049,1,1
5,GO REPRODUCTIVE BEHAVIOR,0.027188,0.21937,0.14392,1,1
5,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0051916,0.21931,0.20868,1,1
5,GO RESPONSE TO NUTRIENT,0.00098941,0.21923,0.17608,1,1
5,GO CALCIUM ION IMPORT INTO CYTOSOL,0.0040578,0.2192,0.25017,1,1
5,GO MEMBRANE FISSION,0.0054795,0.21917,0.21971,1,1
5,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,5.7413e-06,0.21908,0.20349,1,1
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0018173,0.21894,0.16844,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.025994,0.21892,0.21379,1,1
5,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.010773,0.21866,0.22679,1,1
5,GO MESENCHYMAL CELL DIFFERENTIATION,0.0011549,0.21828,0.18169,1,1
5,GO ACTION POTENTIAL,0.00036427,0.21824,0.20415,1,1
5,GO REGULATION OF MEMBRANE POTENTIAL,0.00020448,0.21818,0.20038,1,1
5,GO REGULATION OF FIBROBLAST MIGRATION,0.0038387,0.21818,0.17562,1,1
5,GO TRANSLESION SYNTHESIS,0.00016595,0.21806,0.17646,1,1
5,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.029719,0.21798,0.14319,1,1
5,GO PEPTIDE SECRETION,1.3441e-06,0.21792,0.21031,1,1
5,GO TISSUE HOMEOSTASIS,0.00014418,0.21792,0.16181,1,1
5,GO REGULATION OF BIOMINERALIZATION,0.00095906,0.21779,0.18501,1,1
5,GO REGULATION OF SULFUR METABOLIC PROCESS,0.0053338,0.21764,0.21093,1,1
5,GO REGULATION OF HEMOPOIESIS,6.2786e-05,0.21759,0.16965,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.001228,0.21757,0.17604,1,1
5,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0001165,0.2175,0.25389,1,1
5,GO GLYCOPROTEIN METABOLIC PROCESS,2.2524e-05,0.21669,0.19757,1,1
5,GO EPIDERMAL CELL DIFFERENTIATION,0.00020448,0.21661,0.20539,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.024288,0.21653,0.2497,1,1
5,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0011549,0.21647,0.18294,1,1
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0018173,0.21645,0.24423,1,1
5,GO SENSORY PERCEPTION OF TASTE,0.00014418,0.21639,0.18703,1,1
5,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.009256,0.21596,0.24918,1,1
5,GO REGULATION OF INFLAMMATORY RESPONSE,4.6597e-05,0.21588,0.20957,1,1
5,GO GPI ANCHOR METABOLIC PROCESS,0.00079435,0.21577,0.1761,1,1
5,GO REGULATION OF HEART RATE,0.00036427,0.21571,0.22586,1,1
5,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0032441,0.21561,0.14863,1,1
5,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.0001165,0.21539,0.16873,1,1
5,GO POSITIVE REGULATION OF PEPTIDE SECRETION,4.1802e-07,0.21536,0.22884,1,1
5,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,2.2524e-05,0.21522,0.2262,1,1
5,GO POSITIVE REGULATION OF EXOCYTOSIS,0.0001547,0.2152,0.22436,1,1
5,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.012203,0.21503,0.13919,1,1
5,GO ADHERENS JUNCTION ASSEMBLY,0.0010206,0.21502,0.25144,1,1
5,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0013054,0.21482,0.14209,1,1
5,GO SKIN DEVELOPMENT,0.00021167,0.21466,0.20172,1,1
5,GO REGULATION OF FERTILIZATION,0.0045306,0.21465,0.17022,1,1
5,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0051916,0.21456,0.16409,1,1
5,GO LEUKOCYTE DIFFERENTIATION,2.0833e-05,0.21443,0.18459,1,1
5,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.037747,0.21442,0.13398,1,1
5,GO GRANULOCYTE DIFFERENTIATION,0.0067808,0.21427,0.17561,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00090094,0.21417,0.17212,1,1
5,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.0011199,0.21416,0.17794,1,1
5,GO RESPONSE TO AMINE,0.00353,0.21412,0.17757,1,1
5,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,4.8612e-06,0.21396,0.18924,1,1
5,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0021689,0.21386,0.15296,1,1
5,GO REGULATION OF B CELL DIFFERENTIATION,0.0013872,0.21381,0.22314,1,1
5,GO PHOSPHOLIPID CATABOLIC PROCESS,0.0067808,0.21371,0.13931,1,1
5,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00050664,0.21363,0.20568,1,1
5,GO POSITIVE REGULATION OF SECRETION,1.3441e-06,0.21358,0.22064,1,1
5,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0001165,0.21345,0.20435,1,1
5,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.0033369,0.21343,0.19071,1,1
5,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0013872,0.21342,0.18013,1,1
5,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.001191,0.21341,0.18111,1,1
5,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.0053338,0.2134,0.26411,1,1
5,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.00353,0.21336,0.20814,1,1
5,GO EXOCYTOSIS,0.00012074,0.2133,0.17312,1,1
5,GO NEURON PROJECTION REGENERATION,0.0023671,0.21323,0.19254,1,1
5,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.011326,0.21303,0.32239,1,1
5,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0050528,0.21286,0.21971,1,1
5,GO MONOAMINE TRANSPORT,0.001872,0.21284,0.27081,1,1
5,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0094949,0.21281,0.3612,1,1
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00098941,0.21275,0.18805,1,1
5,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.02166,0.21272,0.20324,1,1
5,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.4039e-05,0.21256,0.19189,1,1
5,GO RESPONSE TO BMP,0.00026903,0.21255,0.19267,1,1
5,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,1.4609e-05,0.2125,0.20255,1,1
5,GO PROTEIN PALMITOYLATION,0.00019753,0.21247,0.22873,1,1
5,GO REGULATION OF PEPTIDE SECRETION,9.0221e-07,0.21245,0.20863,1,1
5,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.001191,0.2123,0.21926,1,1
5,GO RESPONSE TO STEROL,0.0021062,0.21228,0.18188,1,1
5,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0017123,0.21228,0.1892,1,1
5,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.019739,0.2122,0.19062,1,1
5,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.004408,0.21219,0.14981,1,1
5,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0097392,0.21218,0.19199,1,1
5,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.00079435,0.2121,0.28433,1,1
5,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.0033369,0.2121,0.21098,1,1
5,GO IMPORT ACROSS PLASMA MEMBRANE,4.8379e-05,0.21209,0.19963,1,1
5,GO REGULATION OF BODY FLUID LEVELS,0.00044439,0.21194,0.16231,1,1
5,GO OSSIFICATION,0.00012074,0.2119,0.22115,1,1
5,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.018398,0.21182,0.14796,1,1
5,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0053338,0.21172,0.2025,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.011047,0.21158,0.18029,1,1
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.00067758,0.21156,0.17947,1,1
5,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.023741,0.2115,0.24649,1,1
5,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.00026003,0.21147,0.23372,1,1
5,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.015574,0.21131,0.20395,1,1
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0073363,0.21116,0.15828,1,1
5,GO PROXIMAL DISTAL PATTERN FORMATION,0.037747,0.21094,0.20096,1,1
5,GO GLYCOLIPID BIOSYNTHETIC PROCESS,9.7346e-05,0.21084,0.21036,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00072223,0.21063,0.17201,1,1
5,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00047456,0.21061,0.20266,1,1
5,GO PHAGOCYTOSIS,0.0047853,0.21043,0.14354,1,1
5,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.023205,0.2104,0.21006,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,5.8301e-05,0.21017,0.17523,1,1
5,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00067758,0.21013,0.19286,1,1
5,GO ORGANIC HYDROXY COMPOUND TRANSPORT,8.4205e-05,0.21002,0.18307,1,1
5,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.00050664,0.21001,0.16475,1,1
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0030654,0.21,0.17812,1,1
5,GO ERYTHROCYTE HOMEOSTASIS,0.00021909,0.20999,0.16854,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION,3.5759e-05,0.20978,0.21079,1,1
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.01282,0.20977,0.13158,1,1
5,GO DEFENSE RESPONSE TO BACTERIUM,7.013e-05,0.20956,0.19482,1,1
5,GO TISSUE MIGRATION,0.001662,0.20941,0.18613,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0037331,0.20941,0.16573,1,1
5,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.001986,0.20933,0.17837,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00063551,0.20929,0.21152,1,1
5,GO LYMPHOCYTE DIFFERENTIATION,4.6597e-05,0.20922,0.16613,1,1
5,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0054795,0.20921,0.1837,1,1
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0012662,0.20914,0.16456,1,1
5,GO POSITIVE REGULATION OF INSULIN SECRETION,3.8583e-05,0.20913,0.21494,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,5.6174e-05,0.20902,0.17639,1,1
5,GO ETHER METABOLIC PROCESS,0.044685,0.20851,0.14522,1,1
5,GO PHOSPHOLIPID HOMEOSTASIS,0.017969,0.20843,0.16687,1,1
5,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.0083534,0.20841,0.16384,1,1
5,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.00018427,0.20832,0.16782,1,1
5,GO REGULATION OF TUBE SIZE,0.0001165,0.20831,0.17749,1,1
5,GO REGULATION OF VASCULAR PERMEABILITY,0.00013433,0.20828,0.23251,1,1
5,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.001986,0.20815,0.165,1,1
5,GO FLUID TRANSPORT,0.0022992,0.20814,0.17632,1,1
5,GO LOCOMOTORY BEHAVIOR,0.0007696,0.20793,0.18989,1,1
5,GO REGULATION OF GLUTAMATE SECRETION,0.0031536,0.20787,0.28641,1,1
5,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.0030654,0.20778,0.17436,1,1
5,GO RESPONSE TO PEPTIDOGLYCAN,0.0024367,0.20777,0.18134,1,1
5,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.047551,0.20758,0.14902,1,1
5,GO RESPONSE TO CATECHOLAMINE,0.00031859,0.20752,0.19773,1,1
5,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0034322,0.20731,0.17967,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00084609,0.20729,0.19185,1,1
5,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.011047,0.20721,0.19152,1,1
5,GO RESPONSE TO VITAMIN,0.012203,0.20713,0.17205,1,1
5,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0025817,0.20708,0.18917,1,1
5,GO ACTIVATION OF IMMUNE RESPONSE,0.00095906,0.20701,0.15504,1,1
5,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.00025131,0.20697,0.18796,1,1
5,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0019282,0.20673,0.20118,1,1
5,GO SEX DETERMINATION,0.0010206,0.2067,0.21599,1,1
5,GO MEMORY,0.00047456,0.20669,0.19289,1,1
5,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.009256,0.20657,0.16064,1,1
5,GO REGULATION OF RUFFLE ASSEMBLY,0.0036303,0.20655,0.21386,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.010506,0.20635,0.13659,1,1
5,GO STRESS FIBER ASSEMBLY,0.0014299,0.20627,0.18676,1,1
5,GO DETECTION OF MECHANICAL STIMULUS,7.8282e-05,0.20624,0.20928,1,1
5,GO T CELL DIFFERENTIATION,7.2754e-05,0.20616,0.17427,1,1
5,GO LYMPHOCYTE COSTIMULATION,0.001662,0.20615,0.18512,1,1
5,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00059588,0.20582,0.18018,1,1
5,GO RESPONSE TO DEXAMETHASONE,0.0051916,0.20558,0.15448,1,1
5,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.00034072,0.20546,0.18237,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.010773,0.20537,0.20997,1,1
5,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,8.4205e-05,0.20528,0.17382,1,1
5,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.0042883,0.20517,0.19867,1,1
5,GO ORGANELLE MEMBRANE FUSION,0.0011549,0.20499,0.16257,1,1
5,GO TRIGLYCERIDE METABOLIC PROCESS,0.00087311,0.20495,0.17256,1,1
5,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.011612,0.20494,0.11883,1,1
5,GO REGULATION OF HORMONE SECRETION,1.2962e-05,0.20478,0.21033,1,1
5,GO MORPHOGENESIS OF AN EPITHELIUM,0.00031859,0.20459,0.15101,1,1
5,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.014841,0.20457,0.15259,1,1
5,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0026572,0.20443,0.22002,1,1
5,GO LIPID BIOSYNTHETIC PROCESS,5.8301e-05,0.20426,0.16754,1,1
5,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.00072223,0.20423,0.18334,1,1
5,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0017123,0.2042,0.187,1,1
5,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00012964,0.20412,0.25642,1,1
5,GO NEURAL NUCLEUS DEVELOPMENT,0.00041602,0.20408,0.27253,1,1
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,2.1663e-05,0.20402,0.16203,1,1
5,GO REGULATION OF APPETITE,0.00036427,0.20394,0.20832,1,1
5,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.00011241,0.20381,0.20464,1,1
5,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,6.0504e-05,0.20366,0.17691,1,1
5,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00020448,0.20351,0.17003,1,1
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.031748,0.20339,0.16594,1,1
5,GO NEGATIVE REGULATION OF MAPK CASCADE,0.00098941,0.20329,0.18215,1,1
5,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,5.4121e-05,0.20307,0.25373,1,1
5,GO CELLULAR RESPONSE TO LIPID,0.0012662,0.20279,0.14519,1,1
5,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,3.9418e-06,0.2027,0.19063,1,1
5,GO MUSCLE CELL DEVELOPMENT,0.00013917,0.20251,0.19394,1,1
5,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00012512,0.2024,0.21208,1,1
5,GO POSITIVE REGULATION OF CELL DEATH,0.00017796,0.20238,0.1521,1,1
5,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.0018173,0.20212,0.22735,1,1
5,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,7.013e-05,0.20204,0.18873,1,1
5,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0053338,0.20193,0.17116,1,1
5,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0013457,0.20185,0.20942,1,1
5,GO PROTEIN LOCALIZATION TO VACUOLE,0.0042883,0.20175,0.13717,1,1
5,GO DEVELOPMENTAL MATURATION,2.1702e-06,0.20166,0.20656,1,1
5,GO MEMBRANE HYPERPOLARIZATION,0.0062634,0.20161,0.23987,1,1
5,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.00030804,0.20155,0.15036,1,1
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0015653,0.2015,0.15203,1,1
5,GO REGULATION OF BLOOD PRESSURE,0.00032948,0.20136,0.16587,1,1
5,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00090094,0.2013,0.16772,1,1
5,GO EPITHELIUM DEVELOPMENT,4.6597e-05,0.20116,0.17244,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0015653,0.20111,0.17411,1,1
5,GO MAMMARY GLAND DEVELOPMENT,0.00014418,0.20105,0.18649,1,1
5,GO INTEGRIN ACTIVATION,0.0025817,0.20102,0.21258,1,1
5,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0062634,0.20099,0.20745,1,1
5,GO CARBOHYDRATE HOMEOSTASIS,1.5816e-05,0.20089,0.19417,1,1
5,GO HEART PROCESS,1.0184e-05,0.20084,0.21906,1,1
5,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0051916,0.20068,0.19072,1,1
5,GO ACUTE PHASE RESPONSE,0.00044439,0.20065,0.19398,1,1
5,GO CELLULAR ANION HOMEOSTASIS,0.010506,0.20047,0.22182,1,1
5,GO STEROID BIOSYNTHETIC PROCESS,0.0032441,0.20043,0.14088,1,1
5,GO REGULATION OF JUN KINASE ACTIVITY,2.9532e-05,0.20042,0.19857,1,1
5,GO PLATELET AGGREGATION,0.0011549,0.20033,0.21795,1,1
5,GO POLYOL TRANSPORT,0.021165,0.20011,0.15941,1,1
5,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0036303,0.20011,0.1827,1,1
5,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,3.4421e-05,0.19996,0.18781,1,1
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0034322,0.19993,0.17665,1,1
5,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0027346,0.19991,0.15264,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0097392,0.19979,0.27977,1,1
5,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.001228,0.19957,0.21426,1,1
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.026586,0.19955,0.19323,1,1
5,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00019753,0.19944,0.19991,1,1
5,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.014841,0.19941,0.16492,1,1
5,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0017123,0.19935,0.18699,1,1
5,GO GLUCOCORTICOID METABOLIC PROCESS,0.011326,0.19926,0.18798,1,1
5,GO ACTIVATION OF MAPKKK ACTIVITY,0.0069616,0.1991,0.25188,1,1
5,GO SPERM CAPACITATION,0.0018173,0.19902,0.1786,1,1
5,GO RESPONSE TO GONADOTROPIN,0.0081404,0.19897,0.16062,1,1
5,GO GANGLIOSIDE METABOLIC PROCESS,0.0032441,0.19892,0.17557,1,1
5,GO CALCINEURIN MEDIATED SIGNALING,0.00045924,0.19891,0.17508,1,1
5,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.012203,0.19888,0.15684,1,1
5,GO TERPENOID METABOLIC PROCESS,0.001662,0.1988,0.15692,1,1
5,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0051916,0.19878,0.18491,1,1
5,GO REGULATION OF PROTEIN KINASE ACTIVITY,1.8521e-05,0.19873,0.16674,1,1
5,GO REGULATION OF BONE MINERALIZATION,0.0022332,0.1987,0.20047,1,1
5,GO NEGATIVE REGULATION OF GROWTH,4.6597e-05,0.19855,0.17778,1,1
5,GO POSITIVE REGULATION OF SIGNALING,9.3916e-06,0.19853,0.15927,1,1
5,GO BRAIN MORPHOGENESIS,0.02843,0.19825,0.13348,1,1
5,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0014738,0.19821,0.23011,1,1
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.0016129,0.19814,0.16029,1,1
5,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,2.4346e-05,0.19808,0.19122,1,1
5,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00035231,0.19789,0.19406,1,1
5,GO REGULATION OF DEFENSE RESPONSE,0.00024286,0.19771,0.16989,1,1
5,GO CELL JUNCTION ASSEMBLY,0.00011241,0.19764,0.17933,1,1
5,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,8.4205e-05,0.19755,0.16793,1,1
5,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.0057817,0.19745,0.23697,1,1
5,GO CHLORIDE TRANSPORT,4.4878e-05,0.19736,0.19471,1,1
5,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0007696,0.19732,0.14241,1,1
5,GO CATECHOLAMINE METABOLIC PROCESS,0.0051916,0.19729,0.23558,1,1
5,GO REGULATION OF DEACETYLASE ACTIVITY,0.019283,0.19714,0.16327,1,1
5,GO RESPONSE TO POTASSIUM ION,0.0046564,0.19713,0.24542,1,1
5,GO LIPID HOMEOSTASIS,0.00010845,0.19709,0.16348,1,1
5,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0015653,0.19707,0.17531,1,1
5,GO SECRETION,9.7801e-06,0.19689,0.17197,1,1
5,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0028957,0.19666,0.18721,1,1
5,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.001662,0.19658,0.29057,1,1
5,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0022992,0.19652,0.15073,1,1
5,GO THYMIC T CELL SELECTION,0.00027832,0.19641,0.1833,1,1
5,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0010528,0.19635,0.16217,1,1
5,GO NATURAL KILLER CELL ACTIVATION,0.00067758,0.19634,0.1801,1,1
5,GO CATECHOLAMINE SECRETION,0.0071468,0.19631,0.28702,1,1
5,GO REGULATION OF MYELOID CELL DIFFERENTIATION,7.8282e-05,0.19616,0.17114,1,1
5,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0075304,0.19598,0.14852,1,1
5,GO REGULATION OF LIPID STORAGE,0.00027832,0.19552,0.19676,1,1
5,GO NEGATIVE REGULATION OF AUTOPHAGY,0.00020448,0.1955,0.17853,1,1
5,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0054795,0.19547,0.11664,1,1
5,GO REGULATION OF HISTONE DEACETYLATION,0.001191,0.19522,0.20416,1,1
5,GO RECEPTOR CLUSTERING,0.014841,0.19519,0.15786,1,1
5,GO REGULATION OF TRANSMEMBRANE TRANSPORT,5.8301e-05,0.19517,0.16578,1,1
5,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,6.7596e-05,0.19502,0.19707,1,1
5,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0045306,0.19498,0.2084,1,1
5,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0012662,0.1949,0.1602,1,1
5,GO CIRCULATORY SYSTEM DEVELOPMENT,0.00072223,0.19476,0.14347,1,1
5,GO MYELOID CELL DIFFERENTIATION,0.00016595,0.19476,0.15622,1,1
5,GO REGULATION OF PROTEOLYSIS,0.00095906,0.19468,0.1583,1,1
5,GO TUMOR NECROSIS FACTOR SECRETION,0.0040578,0.1946,0.14075,1,1
5,GO RESPONSE TO FATTY ACID,0.0037331,0.19458,0.16312,1,1
5,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00020448,0.19441,0.21086,1,1
5,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0038387,0.1944,0.15811,1,1
5,GO REGULATION OF PROTEIN DEACETYLATION,0.0001547,0.19438,0.1984,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.0081404,0.19435,0.21532,1,1
5,GO HUMORAL IMMUNE RESPONSE,1.4609e-05,0.19426,0.24977,1,1
5,GO MALE SEX DIFFERENTIATION,0.00044439,0.19425,0.16142,1,1
5,GO INNER EAR MORPHOGENESIS,0.00079435,0.1939,0.15953,1,1
5,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.033166,0.19388,0.18038,1,1
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.053746,0.19372,0.095748,1,1
5,GO RESPONSE TO DRUG,0.00090094,0.1937,0.15286,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,6.2786e-05,0.19356,0.16204,1,1
5,GO EXPORT ACROSS PLASMA MEMBRANE,0.00025131,0.19334,0.27098,1,1
5,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00084609,0.19333,0.20107,1,1
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0013054,0.19303,0.16733,1,1
5,GO RESPONSE TO METAL ION,1.0604e-05,0.19299,0.19662,1,1
5,GO CELLULAR KETONE METABOLIC PROCESS,0.014841,0.19296,0.11131,1,1
5,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00098941,0.19293,0.1843,1,1
5,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.00018427,0.19288,0.16428,1,1
5,GO PROTEIN MATURATION,0.00063551,0.19278,0.14228,1,1
5,GO REGULATION OF PEPTIDE HORMONE SECRETION,6.5149e-05,0.19272,0.20252,1,1
5,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,3.5759e-05,0.19248,0.1697,1,1
5,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.00059588,0.19237,0.1794,1,1
5,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.00030804,0.19219,0.19958,1,1
5,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.033894,0.19204,0.17911,1,1
5,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.015574,0.19197,0.099104,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00069957,0.19154,0.19617,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00036427,0.19141,0.20901,1,1
5,GO SECRETION BY TISSUE,0.010245,0.19139,0.1658,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00017796,0.19136,0.15634,1,1
5,GO AMINE METABOLIC PROCESS,0.00036427,0.19134,0.16829,1,1
5,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.014486,0.19106,0.14153,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0067808,0.19093,0.12792,1,1
5,GO CONNECTIVE TISSUE DEVELOPMENT,0.00079435,0.1909,0.16039,1,1
5,GO RELAXATION OF MUSCLE,0.0083534,0.19063,0.18436,1,1
5,GO REGULATION OF SECRETION,2.0784e-06,0.19057,0.18813,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,2.7343e-05,0.19029,0.17722,1,1
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0040578,0.19021,0.21031,1,1
5,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0097392,0.18997,0.14502,1,1
5,GO HORMONE TRANSPORT,5.508e-06,0.18997,0.22444,1,1
5,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.012203,0.18985,0.20734,1,1
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.012508,0.1898,0.2039,1,1
5,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00090094,0.18961,0.17177,1,1
5,GO REGULATION OF CATION CHANNEL ACTIVITY,0.0049174,0.18938,0.1606,1,1
5,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0012662,0.18933,0.18683,1,1
5,GO REGULATION OF HORMONE LEVELS,4.2876e-06,0.18924,0.19768,1,1
5,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.020205,0.18923,0.12188,1,1
5,GO RESPONSE TO DOPAMINE,0.0010206,0.18919,0.18305,1,1
5,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,7.8282e-05,0.18903,0.15797,1,1
5,GO RESPONSE TO CALCIUM ION,0.00074557,0.18892,0.16588,1,1
5,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00034072,0.1889,0.24696,1,1
5,GO TISSUE MORPHOGENESIS,0.00047456,0.18886,0.14331,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00034072,0.18886,0.23671,1,1
5,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0013054,0.18884,0.19335,1,1
5,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.0085714,0.18861,0.14124,1,1
5,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.0023671,0.18853,0.22297,1,1
5,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,5.8301e-05,0.18849,0.16169,1,1
5,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00081984,0.18844,0.24708,1,1
5,GO REGULATION OF COLLATERAL SPROUTING,0.023205,0.18844,0.17891,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00017186,0.18839,0.18307,1,1
5,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00010092,0.18837,0.15422,1,1
5,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,7.9801e-06,0.18812,0.18684,1,1
5,GO RESPONSE TO AMYLOID BETA,0.0006154,0.18796,0.19957,1,1
5,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00012512,0.18791,0.1688,1,1
5,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.00031859,0.18783,0.13475,1,1
5,GO RESPONSE TO BACTERIUM,0.00065623,0.18759,0.1677,1,1
5,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0001165,0.18749,0.16629,1,1
5,GO TUBULIN DEACETYLATION,0.015953,0.18746,0.17695,1,1
5,GO PLASMA MEMBRANE ORGANIZATION,0.0007696,0.18745,0.18679,1,1
5,GO ERBB SIGNALING PATHWAY,0.001191,0.18745,0.16772,1,1
5,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0049174,0.18744,0.18443,1,1
5,GO NEUTROPHIL MIGRATION,0.0017641,0.18725,0.13198,1,1
5,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.017137,0.18709,0.23426,1,1
5,GO AXONEME ASSEMBLY,0.0023671,0.18703,0.18732,1,1
5,GO ENDOCYTIC RECYCLING,0.00095906,0.18693,0.16015,1,1
5,GO REGULATION OF PHOSPHORYLATION,8.7323e-05,0.18687,0.1458,1,1
5,GO REGULATION OF SYSTEM PROCESS,1.5201e-05,0.18681,0.1757,1,1
5,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.00012074,0.18678,0.15793,1,1
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,7.2754e-05,0.18669,0.13956,1,1
5,GO ACTIN CROSSLINK FORMATION,0.020205,0.18668,0.15524,1,1
5,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0021062,0.18666,0.17999,1,1
5,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.00010092,0.18641,0.17647,1,1
5,GO RESPONSE TO ISCHEMIA,0.0032441,0.18612,0.16068,1,1
5,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00012964,0.1861,0.21096,1,1
5,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00054072,0.18605,0.13455,1,1
5,GO FIBROBLAST PROLIFERATION,0.0030654,0.1856,0.23013,1,1
5,GO ACID SECRETION,0.00079435,0.18559,0.19513,1,1
5,GO FEMALE GENITALIA DEVELOPMENT,0.0029794,0.18554,0.20569,1,1
5,GO ANATOMICAL STRUCTURE MATURATION,8.2505e-07,0.18544,0.18223,1,1
5,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,7.013e-05,0.18525,0.15689,1,1
5,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,7.547e-05,0.18514,0.15217,1,1
5,GO CELLULAR RESPONSE TO VIRUS,0.0075304,0.18512,0.12663,1,1
5,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0021689,0.18501,0.1777,1,1
5,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0007696,0.18493,0.14258,1,1
5,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00038934,0.18483,0.17338,1,1
5,GO POTASSIUM ION TRANSPORT,0.00026003,0.18478,0.1989,1,1
5,GO INORGANIC ANION TRANSPORT,3.3132e-05,0.18477,0.17389,1,1
5,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,6.5149e-05,0.18477,0.16847,1,1
5,GO CELLULAR RESPONSE TO FATTY ACID,0.0030654,0.18453,0.18299,1,1
5,GO REGULATION OF ION TRANSPORT,3.7145e-05,0.18447,0.17151,1,1
5,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.4346e-05,0.18423,0.20026,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0014738,0.18421,0.19078,1,1
5,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.011612,0.18418,0.098846,1,1
5,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,4.3218e-05,0.18402,0.17561,1,1
5,GO MEMBRANE FUSION,9.7346e-05,0.18392,0.18462,1,1
5,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,1.1964e-05,0.18376,0.15774,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.001986,0.18365,0.18426,1,1
5,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.00095906,0.18358,0.17048,1,1
5,GO REGULATION OF TRANSPORTER ACTIVITY,0.00079435,0.18328,0.1564,1,1
5,GO CELLULAR LIPID METABOLIC PROCESS,0.00019079,0.18326,0.14543,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00034072,0.18323,0.1481,1,1
5,GO MITOTIC CELL CYCLE ARREST,0.019283,0.18318,0.16835,1,1
5,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.04854,0.1831,0.12401,1,1
5,GO REGULATION OF EXIT FROM MITOSIS,0.009256,0.18297,0.12802,1,1
5,GO EAR DEVELOPMENT,0.0006154,0.18295,0.15761,1,1
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.00018427,0.18289,0.14659,1,1
5,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00013917,0.18289,0.13566,1,1
5,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.007729,0.18283,0.16056,1,1
5,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0059384,0.18233,0.1211,1,1
5,GO MANNOSYLATION,0.015953,0.18209,0.1489,1,1
5,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0020453,0.18201,0.21142,1,1
5,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00022676,0.18192,0.2793,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0018173,0.1819,0.22806,1,1
5,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.021165,0.18144,0.13961,1,1
5,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.0022332,0.1814,0.13584,1,1
5,GO RESPONSE TO OSMOTIC STRESS,0.0038387,0.18138,0.14082,1,1
5,GO REGULATION OF MAPK CASCADE,0.00022676,0.18136,0.18492,1,1
5,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,4.1617e-05,0.18135,0.1837,1,1
5,GO STRIATED MUSCLE CONTRACTION,0.00028792,0.18127,0.16446,1,1
5,GO CELL GROWTH,5.2139e-05,0.18126,0.1673,1,1
5,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.044685,0.18114,0.12569,1,1
5,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0013872,0.18112,0.17568,1,1
5,GO GROWTH HORMONE SECRETION,0.0069616,0.18104,0.24425,1,1
5,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0013054,0.18085,0.18067,1,1
5,GO LIPID METABOLIC PROCESS,0.00012512,0.18073,0.14801,1,1
5,GO DETECTION OF STIMULUS,1.104e-05,0.1806,0.15697,1,1
5,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.00014418,0.18047,0.17015,1,1
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0090226,0.18034,0.2288,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.00019753,0.18025,0.13943,1,1
5,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,9.389e-05,0.17988,0.16065,1,1
5,GO CELL AGGREGATION,0.011047,0.17981,0.17437,1,1
5,GO ANIMAL ORGAN MORPHOGENESIS,0.00016023,0.17964,0.15437,1,1
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.014138,0.17955,0.14589,1,1
5,GO REGULATION OF PH,0.00067758,0.17953,0.11973,1,1
5,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.013139,0.17945,0.32098,1,1
5,GO RESPONSE TO LIPID,0.0013872,0.17924,0.14358,1,1
5,GO REGULATION OF CELL DIFFERENTIATION,3.7145e-05,0.17919,0.153,1,1
5,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,9.3916e-06,0.17908,0.2088,1,1
5,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00353,0.179,0.14508,1,1
5,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.00026003,0.1789,0.18026,1,1
5,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0013054,0.17877,0.13243,1,1
5,GO CELL JUNCTION ORGANIZATION,0.00019079,0.17867,0.16385,1,1
5,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.027803,0.17864,0.14521,1,1
5,GO P38MAPK CASCADE,0.021165,0.1786,0.14761,1,1
5,GO ER NUCLEUS SIGNALING PATHWAY,0.0030654,0.17854,0.15682,1,1
5,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.013139,0.17839,0.17488,1,1
5,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.05161,0.17836,0.13745,1,1
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,2.6307e-05,0.17817,0.17577,1,1
5,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,1.2454e-05,0.17793,0.15363,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,3.7145e-05,0.17788,0.17384,1,1
5,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.009256,0.17782,0.2093,1,1
5,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.03245,0.17753,0.12371,1,1
5,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0051916,0.17743,0.19365,1,1
5,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0010528,0.17742,0.13195,1,1
5,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.0006154,0.17741,0.17265,1,1
5,GO REGULATION OF CHOLESTEROL EFFLUX,0.0025817,0.17724,0.14777,1,1
5,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.023741,0.17706,0.14906,1,1
5,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0083534,0.17701,0.16409,1,1
5,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.034637,0.17689,0.19146,1,1
5,GO REGULATION OF T CELL MIGRATION,0.00016023,0.17687,0.21874,1,1
5,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00013917,0.17686,0.13997,1,1
5,GO APOPTOTIC SIGNALING PATHWAY,0.00025131,0.17676,0.14899,1,1
5,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0060989,0.1767,0.11886,1,1
5,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.00029782,0.17662,0.14243,1,1
5,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00072223,0.17657,0.22452,1,1
5,GO DETECTION OF ABIOTIC STIMULUS,5.2139e-05,0.17652,0.17094,1,1
5,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0071468,0.17639,0.20205,1,1
5,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0032441,0.17611,0.19434,1,1
5,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,5.6174e-05,0.1761,0.13961,1,1
5,GO IMPORT INTO CELL,0.00057693,0.17609,0.16949,1,1
5,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0071468,0.17605,0.15227,1,1
5,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,3.3132e-05,0.17604,0.24132,1,1
5,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.03939,0.17602,0.10199,1,1
5,GO PEPTIDE HORMONE SECRETION,4.4878e-05,0.176,0.20989,1,1
5,GO DIET INDUCED THERMOGENESIS,0.016734,0.17595,0.14875,1,1
5,GO LIPID MODIFICATION,0.00010092,0.17584,0.14805,1,1
5,GO CIRCULATORY SYSTEM PROCESS,7.9801e-06,0.1758,0.17958,1,1
5,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.013465,0.17561,0.21914,1,1
5,GO CARBOHYDRATE TRANSPORT,8.4205e-05,0.17556,0.16425,1,1
5,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.0012662,0.1755,0.18117,1,1
5,GO SKELETAL MUSCLE CONTRACTION,0.0015653,0.17532,0.17905,1,1
5,GO ISOPRENOID METABOLIC PROCESS,0.0021062,0.17515,0.14587,1,1
5,GO ADULT LOCOMOTORY BEHAVIOR,0.00098941,0.17499,0.21157,1,1
5,GO MONOVALENT INORGANIC CATION TRANSPORT,2.7343e-05,0.17488,0.18027,1,1
5,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.0028957,0.17482,0.1355,1,1
5,GO TEMPERATURE HOMEOSTASIS,4.1112e-06,0.17464,0.1962,1,1
5,GO RESPONSE TO GROWTH FACTOR,0.00059588,0.17452,0.14811,1,1
5,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.0071468,0.17449,0.18619,1,1
5,GO IMMUNE SYSTEM DEVELOPMENT,6.7596e-05,0.17449,0.14635,1,1
5,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,9.0179e-06,0.17443,0.16355,1,1
5,GO REGULATION OF KIDNEY DEVELOPMENT,0.016734,0.17427,0.16689,1,1
5,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.04854,0.17416,0.16884,1,1
5,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0011199,0.17389,0.12334,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0022992,0.17383,0.16356,1,1
5,GO POSITIVE REGULATION OF TISSUE REMODELING,0.004408,0.17376,0.19688,1,1
5,GO REGULATION OF LIPID TRANSPORT,0.0006154,0.17375,0.16514,1,1
5,GO REGULATION OF HYDROLASE ACTIVITY,0.00026903,0.17374,0.1313,1,1
5,GO REGULATION OF LIPID LOCALIZATION,0.0016129,0.17373,0.15133,1,1
5,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.00065623,0.17361,0.14423,1,1
5,GO REGULATION OF ENDOCYTIC RECYCLING,0.033894,0.1736,0.17213,1,1
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.013465,0.17344,0.14271,1,1
5,GO CHEMICAL HOMEOSTASIS,3.4728e-06,0.17343,0.16754,1,1
5,GO LENS FIBER CELL DIFFERENTIATION,0.0015653,0.17342,0.20972,1,1
5,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.004408,0.1734,0.21892,1,1
5,GO VESICLE TARGETING,0.02843,0.17314,0.09559,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.041093,0.17314,0.12871,1,1
5,GO ACROSOME REACTION,0.0071468,0.17312,0.15687,1,1
5,GO SPROUTING ANGIOGENESIS,0.014841,0.17288,0.12316,1,1
5,GO MUSCLE STRUCTURE DEVELOPMENT,0.00014935,0.17285,0.1479,1,1
5,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.001228,0.17282,0.13726,1,1
5,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.00035231,0.17278,0.12492,1,1
5,GO DRUG METABOLIC PROCESS,0.0010859,0.17266,0.20198,1,1
5,GO NEUTROPHIL CHEMOTAXIS,0.0017123,0.17258,0.12772,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.042857,0.17239,0.15554,1,1
5,GO POSITIVE REGULATION OF TRANSPORT,2.1663e-05,0.17206,0.14977,1,1
5,GO EXCRETION,0.00010845,0.17204,0.18324,1,1
5,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.015574,0.17191,0.1351,1,1
5,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0025817,0.17184,0.17979,1,1
5,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0014299,0.17182,0.1496,1,1
5,GO INSULIN SECRETION,8.4205e-05,0.17172,0.20182,1,1
5,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.0033369,0.17167,0.1597,1,1
5,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.00023468,0.17144,0.17911,1,1
5,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.015574,0.17138,0.095045,1,1
5,GO REGULATION OF SPROUTING ANGIOGENESIS,0.018398,0.17138,0.12615,1,1
5,GO T CELL RECEPTOR SIGNALING PATHWAY,0.012508,0.17117,0.10893,1,1
5,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0024367,0.17101,0.20302,1,1
5,GO POSITIVE T CELL SELECTION,0.00067758,0.17099,0.15461,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.00019753,0.17059,0.12309,1,1
5,GO REGULATION OF HAIR CYCLE,0.0047853,0.17053,0.15134,1,1
5,GO RESPONSE TO UV C,0.017549,0.17037,0.12329,1,1
5,GO LOCALIZATION WITHIN MEMBRANE,0.018836,0.17032,0.12664,1,1
5,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.011326,0.17021,0.18823,1,1
5,GO MICROTUBULE BUNDLE FORMATION,0.0028141,0.16973,0.13752,1,1
5,GO REGULATION OF BMP SIGNALING PATHWAY,0.010773,0.16929,0.16456,1,1
5,GO REGULATION OF CHROMATIN BINDING,0.0050528,0.16911,0.15583,1,1
5,GO NEGATIVE REGULATION OF SIGNALING,0.00016023,0.16911,0.13426,1,1
5,GO CELLULAR RESPONSE TO STARVATION,5.4121e-05,0.16911,0.18229,1,1
5,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0056288,0.16911,0.25391,1,1
5,GO RESPONSE TO INSULIN,0.00012512,0.1691,0.1467,1,1
5,GO EPITHELIAL TUBE MORPHOGENESIS,0.00035231,0.16886,0.14988,1,1
5,GO RESPONSE TO ENDOGENOUS STIMULUS,0.00010092,0.16877,0.13997,1,1
5,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.00045924,0.16876,0.14258,1,1
5,GO TRANSFERRIN TRANSPORT,0.014138,0.1687,0.11383,1,1
5,GO NEGATIVE REGULATION OF DNA BINDING,0.0045306,0.16856,0.15914,1,1
5,GO REGULATION OF INTEGRIN ACTIVATION,0.0047853,0.16853,0.19368,1,1
5,GO MULTICELLULAR ORGANISM GROWTH,0.0011199,0.16846,0.11321,1,1
5,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0014738,0.16841,0.1586,1,1
5,GO VACUOLAR TRANSPORT,0.0051916,0.16838,0.1077,1,1
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.011326,0.16828,0.13332,1,1
5,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,2.1663e-05,0.16817,0.22448,1,1
5,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0022332,0.16812,0.20344,1,1
5,GO RESPONSE TO INORGANIC SUBSTANCE,0.00012074,0.16777,0.15148,1,1
5,GO JNK CASCADE,0.0001547,0.16761,0.15289,1,1
5,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00353,0.1676,0.19618,1,1
5,GO PIGMENTATION,0.00087311,0.16752,0.12996,1,1
5,GO T CELL SELECTION,0.00017186,0.16751,0.16425,1,1
5,GO CGMP MEDIATED SIGNALING,0.033166,0.16749,0.12234,1,1
5,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.00079435,0.1674,0.13532,1,1
5,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.0087944,0.16738,0.13604,1,1
5,GO AUTOPHAGOSOME ORGANIZATION,0.00074557,0.16729,0.14349,1,1
5,GO CELLULAR RESPONSE TO ALKALOID,0.00029782,0.16716,0.20017,1,1
5,GO METAL ION HOMEOSTASIS,1.2962e-05,0.16707,0.15093,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00069957,0.16694,0.15862,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.018836,0.16694,0.12119,1,1
5,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.024846,0.16654,0.12641,1,1
5,GO ION HOMEOSTASIS,1.5816e-05,0.1664,0.14553,1,1
5,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.00012074,0.16629,0.12657,1,1
5,GO LYSOSOME LOCALIZATION,0.00034072,0.16625,0.15841,1,1
5,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,9.0551e-05,0.16619,0.1454,1,1
5,GO REGULATION OF PROSTAGLANDIN SECRETION,0.014841,0.16605,0.19576,1,1
5,GO CELLULAR LIPID CATABOLIC PROCESS,0.0034322,0.16597,0.12551,1,1
5,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00092958,0.16592,0.14971,1,1
5,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.00017796,0.16576,0.13944,1,1
5,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.0026572,0.16568,0.17001,1,1
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00041602,0.16567,0.17383,1,1
5,GO SENSORY PERCEPTION OF SMELL,0.00032948,0.16555,0.14096,1,1
5,GO HINDBRAIN MORPHOGENESIS,0.012508,0.1654,0.12379,1,1
5,GO REGULATION OF TRANSPORT,1.5201e-05,0.1654,0.14347,1,1
5,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.019739,0.16525,0.096974,1,1
5,GO HOMEOSTATIC PROCESS,2.5308e-05,0.16516,0.13084,1,1
5,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00011241,0.16469,0.15778,1,1
5,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0028957,0.16468,0.17655,1,1
5,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.0066042,0.16457,0.19338,1,1
5,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0011199,0.16456,0.14669,1,1
5,GO ORGAN INDUCTION,0.0019282,0.16434,0.18318,1,1
5,GO TAXIS,0.00010462,0.16427,0.16142,1,1
5,GO VACUOLE ORGANIZATION,0.00026903,0.16424,0.13901,1,1
5,GO CIRCADIAN RHYTHM,9.0221e-07,0.16407,0.17717,1,1
5,GO RESPONSE TO FOOD,0.0029794,0.16398,0.13743,1,1
5,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00054072,0.16397,0.14287,1,1
5,GO SLEEP,0.0030654,0.16383,0.15182,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE,7.547e-05,0.16374,0.13828,1,1
5,GO GLUTAMATE METABOLIC PROCESS,0.0015653,0.16372,0.15115,1,1
5,GO HINDBRAIN DEVELOPMENT,0.00025131,0.16368,0.19623,1,1
5,GO DEFINITIVE HEMOPOIESIS,0.029719,0.16351,0.15128,1,1
5,GO REGULATION OF MACROPHAGE ACTIVATION,0.012203,0.1635,0.17006,1,1
5,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.2786e-05,0.16349,0.19342,1,1
5,GO METAL ION TRANSPORT,5.0226e-05,0.16327,0.14615,1,1
5,GO MESENCHYME DEVELOPMENT,0.0046564,0.16326,0.13067,1,1
5,GO EXPLORATION BEHAVIOR,0.0097392,0.16304,0.20762,1,1
5,GO RESPONSE TO ACETYLCHOLINE,0.017137,0.16302,0.1961,1,1
5,GO RESPONSE TO MONOSACCHARIDE,0.00024286,0.163,0.14027,1,1
5,GO PROTEIN DESTABILIZATION,0.00030804,0.16294,0.1644,1,1
5,GO RESPONSE TO INTERLEUKIN 1,0.011904,0.1629,0.10261,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0010206,0.16269,0.15809,1,1
5,GO CALCIUM MEDIATED SIGNALING,1.7806e-05,0.16264,0.15101,1,1
5,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00090094,0.16256,0.12419,1,1
5,GO PROTEOLYSIS,0.0007696,0.16243,0.1092,1,1
5,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0023671,0.16238,0.10313,1,1
5,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.0016129,0.16229,0.11914,1,1
5,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.00013433,0.1622,0.14654,1,1
5,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0045306,0.16159,0.11804,1,1
5,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.00072223,0.16153,0.14499,1,1
5,GO DETERMINATION OF ADULT LIFESPAN,0.0097392,0.16147,0.16523,1,1
5,GO EXECUTION PHASE OF APOPTOSIS,4.1617e-05,0.16107,0.15259,1,1
5,GO POSITIVE REGULATION OF MAPK CASCADE,0.00021167,0.16106,0.18594,1,1
5,GO NUCLEOTIDE TRANSPORT,0.012508,0.161,0.12749,1,1
5,GO GOLGI RIBBON FORMATION,0.010773,0.16079,0.16227,1,1
5,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00092958,0.16075,0.16765,1,1
5,GO FEEDING BEHAVIOR,0.00027832,0.16075,0.15494,1,1
5,GO REGULATION OF RESPONSE TO STRESS,0.0010859,0.16037,0.11279,1,1
5,GO CHONDROCYTE DEVELOPMENT,0.033894,0.16,0.14817,1,1
5,GO NEUTRAL LIPID METABOLIC PROCESS,0.0011199,0.15999,0.13602,1,1
5,GO REGULATION OF EXCRETION,0.043763,0.15982,0.13229,1,1
5,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.00072223,0.1597,0.14059,1,1
5,GO VESICLE ORGANIZATION,0.00041602,0.15967,0.1278,1,1
5,GO RESPONSE TO HORMONE,0.00063551,0.15957,0.12661,1,1
5,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.016339,0.15951,0.12655,1,1
5,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.017137,0.15945,0.11197,1,1
5,GO REGULATION OF SYNAPSE ASSEMBLY,0.013139,0.15919,0.16526,1,1
5,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0033369,0.1591,0.22053,1,1
5,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00050664,0.15906,0.13334,1,1
5,GO IRON ION TRANSPORT,0.007729,0.15891,0.091802,1,1
5,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.017137,0.15885,0.13481,1,1
5,GO CATION TRANSPORT,7.8282e-05,0.15877,0.14171,1,1
5,GO SENSORY PERCEPTION OF PAIN,0.0024367,0.15864,0.15028,1,1
5,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0025817,0.15854,0.14445,1,1
5,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.0024367,0.15851,0.13959,1,1
5,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0029794,0.15843,0.17279,1,1
5,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00050664,0.15837,0.14197,1,1
5,GO REGULATION OF TRANSFERASE ACTIVITY,9.7346e-05,0.15824,0.13158,1,1
5,GO LIPID OXIDATION,0.0032441,0.15822,0.1597,1,1
5,GO GLUCOSE METABOLIC PROCESS,5.6174e-05,0.15813,0.15718,1,1
5,GO CHOLESTEROL STORAGE,0.0028141,0.15808,0.21981,1,1
5,GO OSTEOCLAST DIFFERENTIATION,0.0033369,0.15805,0.12635,1,1
5,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00024286,0.15788,0.15415,1,1
5,GO RESPONSE TO RETINOIC ACID,0.013139,0.15773,0.13317,1,1
5,GO DENDRITIC SPINE MAINTENANCE,0.0069616,0.1577,0.14933,1,1
5,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00050664,0.15762,0.14891,1,1
5,GO ANIMAL ORGAN MATURATION,0.0013872,0.15759,0.2161,1,1
5,GO REGULATION OF REPRODUCTIVE PROCESS,0.00065623,0.15749,0.11631,1,1
5,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.015574,0.15723,0.092093,1,1
5,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00012074,0.15714,0.15967,1,1
5,GO CATION TRANSMEMBRANE TRANSPORT,0.00014935,0.1571,0.13814,1,1
5,GO VESICLE BUDDING FROM MEMBRANE,0.013139,0.157,0.10284,1,1
5,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.035393,0.15689,0.12806,1,1
5,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.050569,0.15664,0.23705,1,1
5,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0099891,0.15659,0.13278,1,1
5,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0010206,0.15637,0.1495,1,1
5,GO REGULATION OF KERATINOCYTE MIGRATION,0.010245,0.15627,0.15963,1,1
5,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00065623,0.15604,0.161,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.00044439,0.15573,0.1477,1,1
5,GO EAR MORPHOGENESIS,0.001662,0.15562,0.12658,1,1
5,GO REGULATION OF INSULIN SECRETION,0.00026003,0.1556,0.1774,1,1
5,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00055855,0.15558,0.17035,1,1
5,GO RESPONSE TO EXTRACELLULAR STIMULUS,4.6597e-05,0.15549,0.16424,1,1
5,GO RESPONSE TO COCAINE,0.013798,0.15548,0.15719,1,1
5,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.031748,0.15547,0.084076,1,1
5,GO REGULATION OF CELL SHAPE,0.00095906,0.15533,0.16702,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.02166,0.15515,0.14205,1,1
5,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00027832,0.15502,0.13199,1,1
5,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.00012512,0.15465,0.12334,1,1
5,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.00019753,0.15464,0.13819,1,1
5,GO RESPONSE TO STEROID HORMONE,0.0016129,0.1545,0.14027,1,1
5,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.00098941,0.15449,0.15279,1,1
5,GO NEGATIVE T CELL SELECTION,0.0038387,0.15443,0.20543,1,1
5,GO REGULATION OF LIPID METABOLIC PROCESS,0.00028792,0.15409,0.16154,1,1
5,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.015203,0.15396,0.12246,1,1
5,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00019079,0.15394,0.13949,1,1
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.021165,0.15383,0.15819,1,1
5,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0026572,0.15376,0.14416,1,1
5,GO LYSOSOMAL TRANSPORT,0.0059384,0.15362,0.12089,1,1
5,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.042857,0.15359,0.18901,1,1
5,GO SARCOMERE ORGANIZATION,0.0028957,0.15348,0.15729,1,1
5,GO PRESYNAPSE ORGANIZATION,0.031748,0.15343,0.16138,1,1
5,GO ENDOSOME ORGANIZATION,0.016734,0.15339,0.089259,1,1
5,GO POSTSYNAPSE ORGANIZATION,0.033166,0.15327,0.13897,1,1
5,GO RESPONSE TO ALKALOID,0.0032441,0.15325,0.13591,1,1
5,GO DIGESTION,0.0020453,0.15317,0.1536,1,1
5,GO SECOND MESSENGER MEDIATED SIGNALING,2.1663e-05,0.15275,0.16329,1,1
5,GO CARTILAGE DEVELOPMENT,0.01282,0.15267,0.12159,1,1
5,GO GOLGI VESICLE BUDDING,0.015574,0.15266,0.08543,1,1
5,GO ANION TRANSPORT,5.2139e-05,0.15257,0.13057,1,1
5,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0018173,0.15246,0.16043,1,1
5,GO RECEPTOR METABOLIC PROCESS,0.0024367,0.1524,0.11792,1,1
5,GO RESPONSE TO ABIOTIC STIMULUS,0.00034072,0.15237,0.1123,1,1
5,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.001662,0.15234,0.13362,1,1
5,GO FATTY ACID METABOLIC PROCESS,0.0015653,0.15232,0.14885,1,1
5,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0085714,0.15204,0.13106,1,1
5,GO REGULATION OF CELLULAR PH,0.001986,0.15195,0.10133,1,1
5,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0025083,0.15179,0.23297,1,1
5,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.00081984,0.15171,0.11661,1,1
5,GO RESPONSE TO TOXIC SUBSTANCE,0.0037331,0.1517,0.12655,1,1
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.037747,0.15141,0.10736,1,1
5,GO REGULATION OF GLIAL CELL MIGRATION,0.0050528,0.15132,0.14321,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0025817,0.1513,0.13947,1,1
5,GO ACTIVATION OF MAPKK ACTIVITY,0.0040578,0.15129,0.18431,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.00040247,0.15128,0.13714,1,1
5,GO POLYSACCHARIDE CATABOLIC PROCESS,0.03245,0.15121,0.13137,1,1
5,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00067758,0.15099,0.16695,1,1
5,GO APOPTOTIC PROCESS,0.00027832,0.15097,0.12405,1,1
5,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.0031536,0.15097,0.10858,1,1
5,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.001662,0.15088,0.18698,1,1
5,GO COLLATERAL SPROUTING,0.031748,0.15077,0.14328,1,1
5,GO DIVALENT INORGANIC CATION HOMEOSTASIS,2.1663e-05,0.15076,0.15002,1,1
5,GO HEART TRABECULA MORPHOGENESIS,0.014486,0.15061,0.14123,1,1
5,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.0010528,0.1506,0.12761,1,1
5,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.047551,0.15057,0.12823,1,1
5,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0054795,0.15051,0.13837,1,1
5,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.00090094,0.15037,0.18503,1,1
5,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00098941,0.15014,0.12294,1,1
5,GO RESPONSE TO CARBOHYDRATE,0.00055855,0.15006,0.12807,1,1
5,GO ZINC ION TRANSPORT,0.013465,0.15,0.12236,1,1
5,GO T CELL DIFFERENTIATION IN THYMUS,0.0037331,0.14993,0.13576,1,1
5,GO GROWTH,0.0001165,0.14991,0.13954,1,1
5,GO NEGATIVE REGULATION OF CELL GROWTH,0.00013917,0.14986,0.16983,1,1
5,GO REGULATION OF PEPTIDE TRANSPORT,4.8612e-06,0.14985,0.14796,1,1
5,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.013798,0.14965,0.09137,1,1
5,GO ION TRANSPORT,2.9532e-05,0.14951,0.14438,1,1
5,GO ADAPTIVE THERMOGENESIS,1.7118e-05,0.14949,0.1885,1,1
5,GO POSITIVE REGULATION OF NEURON DEATH,0.00044439,0.14942,0.17324,1,1
5,GO POSITIVE REGULATION OF ION TRANSPORT,0.0001165,0.14924,0.14568,1,1
5,GO ALCOHOL METABOLIC PROCESS,0.0012662,0.1488,0.11752,1,1
5,GO REGULATION OF GROWTH,2.1663e-05,0.1487,0.15532,1,1
5,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.00026903,0.14865,0.12451,1,1
5,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00079435,0.14856,0.11563,1,1
5,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.029068,0.14819,0.11974,1,1
5,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.0030654,0.14804,0.0934,1,1
5,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0040578,0.14803,0.094486,1,1
5,GO RESPONSE TO CORTICOSTEROID,0.0069616,0.14796,0.13639,1,1
5,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.001191,0.14781,0.11437,1,1
5,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.00044439,0.14779,0.12662,1,1
5,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.031059,0.14778,0.14993,1,1
5,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0081404,0.14775,0.10471,1,1
5,GO BEHAVIOR,0.00084609,0.14763,0.14373,1,1
5,GO RESPONSE TO PEPTIDE,0.00021167,0.14758,0.13137,1,1
5,GO MEMBRANE ORGANIZATION,0.00032948,0.14746,0.12175,1,1
5,GO ION TRANSMEMBRANE TRANSPORT,4.8379e-05,0.14735,0.14433,1,1
5,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.00042998,0.14718,0.121,1,1
5,GO SENSORY PERCEPTION,3.0689e-05,0.14709,0.12829,1,1
5,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00098941,0.14704,0.11472,1,1
5,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.020205,0.14702,0.11471,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION,9.389e-05,0.14695,0.12244,1,1
5,GO LIPID CATABOLIC PROCESS,0.0010206,0.1468,0.12892,1,1
5,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.02068,0.14672,0.14723,1,1
5,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0097392,0.14667,0.1309,1,1
5,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.0018173,0.14662,0.12267,1,1
5,GO NERVOUS SYSTEM PROCESS,9.0551e-05,0.14661,0.13681,1,1
5,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.00018427,0.14653,0.16456,1,1
5,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.00012512,0.14647,0.12087,1,1
5,GO FOCAL ADHESION ASSEMBLY,0.0066042,0.1463,0.15086,1,1
5,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00038934,0.14627,0.16304,1,1
5,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0036303,0.146,0.13222,1,1
5,GO REGULATION OF CILIUM MOVEMENT,0.00090094,0.14597,0.15213,1,1
5,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0054795,0.14588,0.1023,1,1
5,GO REPRODUCTION,0.00017186,0.14587,0.11984,1,1
5,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0010528,0.14574,0.1308,1,1
5,GO ODONTOGENESIS,0.013798,0.14567,0.16429,1,1
5,GO MAINTENANCE OF LOCATION,0.00084609,0.14556,0.12953,1,1
5,GO ORGANELLE FUSION,0.0021689,0.14555,0.12205,1,1
5,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.0050528,0.1454,0.16301,1,1
5,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00040247,0.14523,0.12468,1,1
5,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00031859,0.14523,0.14124,1,1
5,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0087944,0.1451,0.11895,1,1
5,GO RESPONSE TO OXYGEN LEVELS,0.00092958,0.14508,0.13862,1,1
5,GO RESPONSE TO STARVATION,0.00012964,0.14495,0.1703,1,1
5,GO AGING,0.0029794,0.14481,0.11408,1,1
5,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,8.7323e-05,0.14479,0.12366,1,1
5,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,4.3218e-05,0.14468,0.13706,1,1
5,GO RESPONSE TO ETHANOL,0.0007696,0.14451,0.144,1,1
5,GO REGULATION OF CELL DEATH,0.00052342,0.14434,0.11849,1,1
5,GO ACTIN FILAMENT BASED MOVEMENT,0.0047853,0.1443,0.11789,1,1
5,GO SIGNAL RELEASE,2.1663e-05,0.14421,0.17899,1,1
5,GO COPII COATED VESICLE BUDDING,0.026586,0.14406,0.067897,1,1
5,GO CANONICAL WNT SIGNALING PATHWAY,0.0042883,0.14396,0.10813,1,1
5,GO PHOSPHOLIPID METABOLIC PROCESS,0.0006154,0.14391,0.11624,1,1
5,GO RESPONSE TO NITROGEN COMPOUND,9.389e-05,0.14383,0.12668,1,1
5,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.030383,0.1436,0.08011,1,1
5,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0025083,0.14344,0.11141,1,1
5,GO POLYOL CATABOLIC PROCESS,0.021165,0.1433,0.12687,1,1
5,GO LIPID EXPORT FROM CELL,0.02843,0.14322,0.13616,1,1
5,GO CELL VOLUME HOMEOSTASIS,0.0018173,0.14309,0.12351,1,1
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0059384,0.14301,0.13682,1,1
5,GO PROTEOGLYCAN METABOLIC PROCESS,0.031748,0.14299,0.10117,1,1
5,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0013457,0.14293,0.16026,1,1
5,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.014486,0.14282,0.13835,1,1
5,GO CELL CELL SIGNALING,9.0551e-05,0.14281,0.14294,1,1
5,GO CELLULAR RESPONSE TO RETINOIC ACID,0.052669,0.14271,0.13314,1,1
5,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0015653,0.14271,0.10662,1,1
5,GO PROTEIN AUTO ADP RIBOSYLATION,0.052669,0.1427,0.1771,1,1
5,GO MUSCLE SYSTEM PROCESS,0.00079435,0.14258,0.1243,1,1
5,GO REGULATION OF METAL ION TRANSPORT,0.00027832,0.14256,0.1374,1,1
5,GO RESPONSE TO ACID CHEMICAL,0.0024367,0.14251,0.14305,1,1
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00054072,0.14245,0.12148,1,1
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.018398,0.14208,0.10909,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0062634,0.14173,0.13148,1,1
5,GO REGULATION OF VASOCONSTRICTION,0.0024367,0.14172,0.13763,1,1
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.001191,0.14135,0.14572,1,1
5,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0026572,0.14131,0.12868,1,1
5,GO SINGLE FERTILIZATION,0.0018173,0.1412,0.10869,1,1
5,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00098941,0.14118,0.10944,1,1
5,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00026903,0.14101,0.14619,1,1
5,GO RESPONSE TO ESTRADIOL,0.0018173,0.14093,0.13615,1,1
5,GO GLUCOSE IMPORT,0.016339,0.14076,0.1087,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.044685,0.14063,0.18315,1,1
5,GO ESTABLISHMENT OF CELL POLARITY,0.017137,0.14056,0.096734,1,1
5,GO EMBRYONIC ORGAN DEVELOPMENT,0.00013917,0.14051,0.14783,1,1
5,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.031748,0.14049,0.11415,1,1
5,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00353,0.14044,0.13432,1,1
5,GO RESPONSE TO HYDROGEN PEROXIDE,0.011047,0.13963,0.11465,1,1
5,GO ORGANIC ANION TRANSPORT,0.0001547,0.13941,0.12199,1,1
5,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0026572,0.1391,0.10046,1,1
5,GO KERATINOCYTE MIGRATION,0.017969,0.13904,0.14009,1,1
5,GO TRANSMEMBRANE TRANSPORT,8.7323e-05,0.13898,0.12471,1,1
5,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00036427,0.13896,0.14324,1,1
5,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.0034322,0.13888,0.12414,1,1
5,GO CELLULAR EXTRAVASATION,0.004408,0.13866,0.1378,1,1
5,GO GLYCEROLIPID METABOLIC PROCESS,0.00044439,0.13849,0.11537,1,1
5,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0064317,0.13844,0.1272,1,1
5,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0042883,0.13844,0.14615,1,1
5,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.050569,0.13842,0.10211,1,1
5,GO ACTIN FILAMENT ORGANIZATION,0.001986,0.13824,0.12038,1,1
5,GO RHYTHMIC BEHAVIOR,0.0041716,0.13823,0.14217,1,1
5,GO RESPONSE TO ANTIBIOTIC,0.0021689,0.13813,0.15791,1,1
5,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.040234,0.13808,0.11309,1,1
5,GO EMBRYONIC MORPHOGENESIS,0.00050664,0.13807,0.13249,1,1
5,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0039469,0.13789,0.15535,1,1
5,GO NEURAL CREST CELL DIFFERENTIATION,0.05161,0.13781,0.12814,1,1
5,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.013465,0.13779,0.11388,1,1
5,GO REGULATION OF PROTEIN STABILITY,0.015203,0.13779,0.075397,1,1
5,GO NEUROBLAST PROLIFERATION,0.018836,0.13762,0.1285,1,1
5,GO WATER TRANSPORT,0.017137,0.13757,0.12375,1,1
5,GO DEMETHYLATION,0.00019753,0.1375,0.14273,1,1
5,GO ANION TRANSMEMBRANE TRANSPORT,6.0504e-05,0.13736,0.13541,1,1
5,GO THYROID HORMONE METABOLIC PROCESS,0.014841,0.1373,0.13142,1,1
5,GO MODULATION BY VIRUS OF HOST PROCESS,0.022165,0.13723,0.12342,1,1
5,GO SYNAPSE ORGANIZATION,0.014138,0.1371,0.14312,1,1
5,GO DIGESTIVE SYSTEM PROCESS,0.0027346,0.13691,0.14783,1,1
5,GO DEVELOPMENTAL PIGMENTATION,0.03245,0.13681,0.086853,1,1
5,GO REGULATION OF MUSCLE CONTRACTION,0.0022992,0.13676,0.11808,1,1
5,GO POSTREPLICATION REPAIR,0.00353,0.13662,0.11256,1,1
5,GO POSITIVE REGULATION OF CELL GROWTH,7.547e-05,0.13657,0.1579,1,1
5,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.010506,0.1365,0.24481,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0032441,0.13627,0.12491,1,1
5,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00065623,0.13625,0.13829,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0010859,0.13607,0.12688,1,1
5,GO ACTIN FILAMENT BASED PROCESS,0.0010206,0.13594,0.12374,1,1
5,GO NEUROTROPHIN SIGNALING PATHWAY,0.010506,0.13577,0.14432,1,1
5,GO SENSORY PERCEPTION OF BITTER TASTE,0.0050528,0.13556,0.12191,1,1
5,GO NEUTRAL LIPID CATABOLIC PROCESS,0.013798,0.1355,0.15858,1,1
5,GO NEURON DEATH,2.7343e-05,0.13531,0.14266,1,1
5,GO SEX DIFFERENTIATION,0.00032948,0.13513,0.12032,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.010245,0.13511,0.13162,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.013e-05,0.13486,0.15926,1,1
5,GO ASSOCIATIVE LEARNING,0.0060989,0.13486,0.13947,1,1
5,GO RESPONSE TO PEPTIDE HORMONE,0.00072223,0.13464,0.11215,1,1
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0029794,0.1346,0.11939,1,1
5,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.0030654,0.13455,0.14269,1,1
5,GO REGULATION OF PROTEIN BINDING,0.00030804,0.13439,0.14248,1,1
5,GO NEGATIVE REGULATION OF SECRETION,0.00032948,0.1341,0.11948,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00012964,0.13367,0.12222,1,1
5,GO RESPONSE TO TEMPERATURE STIMULUS,0.0039469,0.13359,0.11245,1,1
5,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0071468,0.13358,0.18147,1,1
5,GO ROOF OF MOUTH DEVELOPMENT,0.031748,0.13355,0.11652,1,1
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.00030804,0.13354,0.1321,1,1
5,GO RUFFLE ASSEMBLY,0.011047,0.13353,0.15094,1,1
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0049174,0.13335,0.087322,1,1
5,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0040578,0.13327,0.1089,1,1
5,GO DNA DEALKYLATION,0.0067808,0.13325,0.15762,1,1
5,GO CELLULAR ION HOMEOSTASIS,4.0073e-05,0.13322,0.12678,1,1
5,GO CALCIUM ION IMPORT,0.0050528,0.13299,0.14762,1,1
5,GO CARBOHYDRATE METABOLIC PROCESS,0.00017796,0.13288,0.13342,1,1
5,GO CELLULAR PIGMENTATION,0.014138,0.13286,0.099176,1,1
5,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0046564,0.13274,0.11572,1,1
5,GO DORSAL SPINAL CORD DEVELOPMENT,0.019739,0.13258,0.26048,1,1
5,GO ENDOCYTOSIS,0.0041716,0.13251,0.10522,1,1
5,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00019079,0.13244,0.14276,1,1
5,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.02843,0.13225,0.11557,1,1
5,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0064317,0.13223,0.094871,1,1
5,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.004408,0.13206,0.11893,1,1
5,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00044439,0.13205,0.14736,1,1
5,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0099891,0.13204,0.12943,1,1
5,GO MUSCLE FIBER DEVELOPMENT,0.015953,0.13203,0.13333,1,1
5,GO GLYCEROLIPID CATABOLIC PROCESS,0.0038387,0.13199,0.1418,1,1
5,GO NEGATIVE REGULATION OF NEURON DEATH,7.2754e-05,0.13178,0.13675,1,1
5,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.019739,0.13167,0.097403,1,1
5,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00069957,0.13158,0.12877,1,1
5,GO CAMERA TYPE EYE MORPHOGENESIS,0.0010206,0.13149,0.14463,1,1
5,GO CELLULAR RESPONSE TO KETONE,0.034637,0.1312,0.10538,1,1
5,GO SENSORY ORGAN MORPHOGENESIS,0.00090094,0.13104,0.1194,1,1
5,GO ALCOHOL BIOSYNTHETIC PROCESS,0.011612,0.13103,0.091924,1,1
5,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00353,0.1309,0.14589,1,1
5,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.023741,0.13081,0.11649,1,1
5,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.012508,0.13078,0.10577,1,1
5,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0010859,0.1307,0.1349,1,1
5,GO EXOCYTIC PROCESS,0.0067808,0.13069,0.16065,1,1
5,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00054072,0.13064,0.13817,1,1
5,GO NEUROMUSCULAR PROCESS,0.0066042,0.13061,0.14391,1,1
5,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0011549,0.12998,0.14583,1,1
5,GO REGULATION OF ATP METABOLIC PROCESS,0.038561,0.12989,0.082845,1,1
5,GO NEGATIVE REGULATION OF CELL DEATH,0.0013872,0.12989,0.1126,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00024286,0.12979,0.14913,1,1
5,GO HORMONE METABOLIC PROCESS,0.00098941,0.12966,0.14449,1,1
5,GO APPENDAGE DEVELOPMENT,0.037747,0.12949,0.1077,1,1
5,GO REGULATION OF AUTOPHAGY,0.00026003,0.12919,0.10902,1,1
5,GO LONG TERM MEMORY,0.027803,0.1289,0.1508,1,1
5,GO REGULATION OF LIPID CATABOLIC PROCESS,0.010506,0.12873,0.1148,1,1
5,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0029794,0.12872,0.11295,1,1
5,GO PROTEIN AUTOPHOSPHORYLATION,0.0056288,0.12848,0.097527,1,1
5,GO PHOSPHATE ION TRANSPORT,0.017969,0.12828,0.12069,1,1
5,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0051916,0.12824,0.11264,1,1
5,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0038387,0.12813,0.11389,1,1
5,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.044685,0.1277,0.08672,1,1
5,GO CARDIAC MUSCLE CONTRACTION,0.0023671,0.12732,0.14608,1,1
5,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.012203,0.12716,0.15532,1,1
5,GO MONOSACCHARIDE METABOLIC PROCESS,0.00072223,0.12715,0.12834,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0001165,0.12703,0.14018,1,1
5,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.010773,0.12702,0.12048,1,1
5,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0010528,0.12697,0.13913,1,1
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.020205,0.1268,0.13125,1,1
5,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.03245,0.12679,0.14923,1,1
5,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.00069957,0.12657,0.13296,1,1
5,GO ACTIN MEDIATED CELL CONTRACTION,0.015953,0.12641,0.11137,1,1
5,GO MIDBRAIN DEVELOPMENT,0.0038387,0.12641,0.10713,1,1
5,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0069616,0.12631,0.095309,1,1
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.034637,0.12629,0.12719,1,1
5,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0034322,0.12588,0.11053,1,1
5,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.031059,0.12577,0.12102,1,1
5,GO POSITIVE REGULATION OF TOR SIGNALING,0.0097392,0.12568,0.11122,1,1
5,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.053746,0.12563,0.084523,1,1
5,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0021062,0.12508,0.18685,1,1
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.034637,0.12493,0.12911,1,1
5,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.004408,0.12481,0.086566,1,1
5,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00092958,0.12454,0.14746,1,1
5,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.034637,0.12454,0.12521,1,1
5,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0016129,0.12438,0.10277,1,1
5,GO REGULATION OF ENDOCYTOSIS,0.025994,0.12419,0.086685,1,1
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.018398,0.12405,0.16334,1,1
5,GO MACROPHAGE ACTIVATION,0.0033369,0.1239,0.19988,1,1
5,GO T CELL LINEAGE COMMITMENT,0.0023671,0.12389,0.13373,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.00025131,0.12373,0.12363,1,1
5,GO POLYOL BIOSYNTHETIC PROCESS,0.0081404,0.1235,0.097452,1,1
5,GO REGULATION OF CELL DEVELOPMENT,0.00098941,0.12336,0.12824,1,1
5,GO DNA CATABOLIC PROCESS,0.00040247,0.12335,0.1302,1,1
5,GO MUSCLE ORGAN MORPHOGENESIS,0.0087944,0.12326,0.11608,1,1
5,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.030383,0.12313,0.17456,1,1
5,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.017549,0.12313,0.10671,1,1
5,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.035393,0.12308,0.076226,1,1
5,GO RESPONSE TO CHEMOKINE,0.001986,0.12288,0.1231,1,1
5,GO REGULATION OF WNT SIGNALING PATHWAY,0.0034322,0.12285,0.10502,1,1
5,GO NEGATIVE REGULATION OF BINDING,0.00084609,0.12242,0.12538,1,1
5,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.0031536,0.12204,0.15348,1,1
5,GO PEPTIDYL SERINE MODIFICATION,0.0011199,0.122,0.095855,1,1
5,GO SULFATE TRANSPORT,0.041093,0.12189,0.11098,1,1
5,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.0013054,0.12181,0.096633,1,1
5,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.0033369,0.12175,0.14482,1,1
5,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.030383,0.12151,0.092029,1,1
5,GO THIOESTER BIOSYNTHETIC PROCESS,0.016339,0.12133,0.13724,1,1
5,GO TRANSITION METAL ION TRANSPORT,0.0067808,0.12113,0.081885,1,1
5,GO PH REDUCTION,0.03245,0.12107,0.072662,1,1
5,GO SPERM MOTILITY,0.0036303,0.12092,0.092348,1,1
5,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0034322,0.12086,0.12318,1,1
5,GO REGULATION OF NEURON DIFFERENTIATION,0.0046564,0.12086,0.13574,1,1
5,GO FATTY ACID TRANSPORT,0.017137,0.12066,0.093689,1,1
5,GO DIVALENT INORGANIC CATION TRANSPORT,0.00038934,0.12043,0.12148,1,1
5,GO COENZYME A BIOSYNTHETIC PROCESS,0.029068,0.1204,0.12549,1,1
5,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.0006154,0.12009,0.095523,1,1
5,GO RHYTHMIC PROCESS,4.0073e-05,0.11993,0.12773,1,1
5,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.004408,0.11897,0.099267,1,1
5,GO ONE CARBON COMPOUND TRANSPORT,0.021165,0.11887,0.1433,1,1
5,GO RUFFLE ORGANIZATION,0.012203,0.11868,0.13653,1,1
5,GO ADHERENS JUNCTION ORGANIZATION,0.010506,0.11864,0.14813,1,1
5,GO REGULATION OF BINDING,0.00041602,0.11861,0.11949,1,1
5,GO CELLULAR HOMEOSTASIS,0.00012512,0.11839,0.11591,1,1
5,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.016339,0.11831,0.13723,1,1
5,GO DORSAL VENTRAL PATTERN FORMATION,0.010506,0.11827,0.14515,1,1
5,GO CELL PROJECTION ASSEMBLY,0.0057817,0.11826,0.092905,1,1
5,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0067808,0.11814,0.10005,1,1
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0054795,0.11793,0.092706,1,1
5,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.0025083,0.11768,0.16149,1,1
5,GO HORMONE MEDIATED SIGNALING PATHWAY,0.00054072,0.11759,0.11859,1,1
5,GO EYE MORPHOGENESIS,0.0017123,0.11754,0.12826,1,1
5,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0085714,0.11733,0.15551,1,1
5,GO PEPTIDYL AMINO ACID MODIFICATION,0.0010528,0.11723,0.079625,1,1
5,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0013054,0.11716,0.14622,1,1
5,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.012508,0.11709,0.16998,1,1
5,GO RESPONSE TO OXIDATIVE STRESS,0.021165,0.11696,0.084023,1,1
5,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0006154,0.11692,0.12869,1,1
5,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0029794,0.11689,0.1259,1,1
5,GO MUSCLE TISSUE DEVELOPMENT,0.0030654,0.11661,0.095808,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00040247,0.11658,0.10607,1,1
5,GO PROTEIN CATABOLIC PROCESS,0.014486,0.11656,0.063484,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.023741,0.11626,0.10897,1,1
5,GO POSITIVE THYMIC T CELL SELECTION,0.0020453,0.11605,0.2374,1,1
5,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0087944,0.11597,0.093631,1,1
5,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0069616,0.11594,0.10077,1,1
5,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.00037661,0.11592,0.13748,1,1
5,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.014486,0.1159,0.076785,1,1
5,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.017549,0.11582,0.091373,1,1
5,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.034637,0.1156,0.11879,1,1
5,GO CARDIAC CHAMBER MORPHOGENESIS,0.02068,0.11553,0.11445,1,1
5,GO MUSCLE CONTRACTION,0.0016129,0.1154,0.12094,1,1
5,GO STEM CELL PROLIFERATION,0.0042883,0.11521,0.12947,1,1
5,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.033894,0.11479,0.096633,1,1
5,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.00050664,0.11411,0.12246,1,1
5,GO REGULATION OF CELL SIZE,0.0081404,0.11409,0.11891,1,1
5,GO INOSITOL LIPID MEDIATED SIGNALING,0.030383,0.11391,0.080049,1,1
5,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.031059,0.11386,0.12304,1,1
5,GO POSITIVE REGULATION OF CYTOKINESIS,0.024846,0.11382,0.10645,1,1
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.022165,0.11358,0.087217,1,1
5,GO REGULATION OF CELLULAR COMPONENT SIZE,0.001986,0.1135,0.10933,1,1
5,GO SKELETAL SYSTEM DEVELOPMENT,0.0051916,0.11317,0.10307,1,1
5,GO MULTI ORGANISM PROCESS,0.0014738,0.11298,0.089932,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.00032948,0.11294,0.099072,1,1
5,GO RESPONSE TO ORGANOPHOSPHORUS,0.035393,0.11273,0.080147,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0022992,0.11271,0.089991,1,1
5,GO PROTEIN DEPHOSPHORYLATION,0.0056288,0.11233,0.072729,1,1
5,GO DENDRITE EXTENSION,0.030383,0.11228,0.24677,1,1
5,GO CILIUM MOVEMENT,0.0047853,0.11221,0.095904,1,1
5,GO DEVELOPMENTAL CELL GROWTH,0.0041716,0.11213,0.14746,1,1
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.024288,0.112,0.077166,1,1
5,GO CELLULAR RESPONSE TO CAMP,0.0011199,0.11051,0.15324,1,1
5,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0059384,0.11033,0.13621,1,1
5,GO PROTEIN AUTOUBIQUITINATION,0.00065623,0.11023,0.11625,1,1
5,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0046564,0.11017,0.11507,1,1
5,GO PROTEIN INSERTION INTO MEMBRANE,0.0099891,0.11011,0.11056,1,1
5,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.012508,0.10971,0.1086,1,1
5,GO NEURON APOPTOTIC PROCESS,0.00014935,0.1097,0.12785,1,1
5,GO CELL CELL SIGNALING BY WNT,0.0029794,0.10957,0.10232,1,1
5,GO MONOCARBOXYLIC ACID TRANSPORT,0.0066042,0.10939,0.082047,1,1
5,GO POSITIVE REGULATION OF GROWTH,0.00031859,0.10886,0.1315,1,1
5,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.034637,0.10872,0.083325,1,1
5,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0067808,0.1085,0.10614,1,1
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.0029794,0.10848,0.10005,1,1
5,GO SENSORY ORGAN DEVELOPMENT,0.00065623,0.10775,0.11702,1,1
5,GO DEVELOPMENTAL GROWTH,0.001191,0.10761,0.12197,1,1
5,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00034072,0.10752,0.1177,1,1
5,GO DEPHOSPHORYLATION,0.0013054,0.10732,0.086554,1,1
5,GO CAMERA TYPE EYE DEVELOPMENT,0.0022992,0.10702,0.1063,1,1
5,GO ARACHIDONIC ACID SECRETION,0.041093,0.10686,0.075707,1,1
5,GO COGNITION,0.0085714,0.10671,0.12664,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,4.3218e-05,0.1067,0.11662,1,1
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.017549,0.10623,0.066727,1,1
5,GO FATTY ACID DERIVATIVE TRANSPORT,0.029719,0.10605,0.082642,1,1
5,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.024846,0.10487,0.070912,1,1
5,GO LONG CHAIN FATTY ACID TRANSPORT,0.014841,0.10442,0.090603,1,1
5,GO NEGATIVE REGULATION OF TRANSPORT,0.0026572,0.10393,0.092329,1,1
5,GO GOLGI ORGANIZATION,0.0050528,0.10386,0.087486,1,1
5,GO REGULATION OF CALCIUM ION TRANSPORT,0.0049174,0.1038,0.10754,1,1
5,GO LACTATE METABOLIC PROCESS,0.026586,0.10376,0.19588,1,1
5,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.017137,0.10374,0.085101,1,1
5,GO REGULATION OF CELL MORPHOGENESIS,0.0059384,0.10367,0.12424,1,1
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.0032441,0.10354,0.13876,1,1
5,GO REGULATION OF DNA BINDING,0.0020453,0.1029,0.11433,1,1
5,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.030383,0.10272,0.065709,1,1
5,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.027188,0.10239,0.099958,1,1
5,GO REGULATION OF CELL DIVISION,0.012203,0.10237,0.089601,1,1
5,GO REGULATION OF CELLULAR LOCALIZATION,0.001986,0.10229,0.084918,1,1
5,GO EMBRYO DEVELOPMENT,0.0016129,0.10215,0.098436,1,1
5,GO RESPONSE TO ACTIVITY,0.033166,0.10211,0.092892,1,1
5,GO REGULATION OF DEVELOPMENTAL GROWTH,0.0010206,0.10193,0.1322,1,1
5,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.05161,0.10178,0.094546,1,1
5,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.0075304,0.10149,0.07921,1,1
5,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.012203,0.10147,0.13431,1,1
5,GO MEGAKARYOCYTE DIFFERENTIATION,0.00084609,0.10134,0.12437,1,1
5,GO ORGANIC ACID TRANSPORT,0.00069957,0.10116,0.092756,1,1
5,GO HEART DEVELOPMENT,0.0040578,0.10084,0.099078,1,1
5,GO POLYOL METABOLIC PROCESS,0.0033369,0.10083,0.092968,1,1
5,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0050528,0.099633,0.11051,1,1
5,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0054795,0.099016,0.11732,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0067808,0.098776,0.090506,1,1
5,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.035393,0.098746,0.067181,1,1
5,GO REGULATION OF GLUCONEOGENESIS,0.022165,0.098622,0.087091,1,1
5,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.024846,0.098597,0.13236,1,1
5,GO REGULATION OF EXOCYTOSIS,0.0025817,0.098219,0.16344,1,1
5,GO DETECTION OF LIGHT STIMULUS,0.019739,0.098109,0.073634,1,1
5,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.052669,0.097709,0.11216,1,1
5,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0036303,0.097481,0.09007,1,1
5,GO MESODERM DEVELOPMENT,0.02843,0.097307,0.08028,1,1
5,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.013465,0.097149,0.11384,1,1
5,GO SEXUAL REPRODUCTION,0.0020453,0.096918,0.079569,1,1
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.011612,0.096687,0.088268,1,1
5,GO MYELOID DENDRITIC CELL ACTIVATION,0.0040578,0.096677,0.14079,1,1
5,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,7.2754e-05,0.096551,0.10629,1,1
5,GO GERM CELL DEVELOPMENT,0.0041716,0.096506,0.088094,1,1
5,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.026586,0.096107,0.10917,1,1
5,GO REGULATION OF CHROMATIN ASSEMBLY,0.018398,0.095527,0.11381,1,1
5,GO REGULATION OF CIRCADIAN RHYTHM,0.0060989,0.095093,0.11821,1,1
5,GO HEAD DEVELOPMENT,0.00072223,0.09502,0.1288,1,1
5,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.045624,0.094286,0.11743,1,1
5,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.035393,0.094264,0.079786,1,1
5,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0006154,0.094192,0.10253,1,1
5,GO RESPONSE TO NERVE GROWTH FACTOR,0.02068,0.093854,0.13784,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.017969,0.093811,0.079975,1,1
5,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.00026903,0.093445,0.088794,1,1
5,GO MUSCLE ORGAN DEVELOPMENT,0.0039469,0.093319,0.086496,1,1
5,GO ENDOSOMAL TRANSPORT,0.02068,0.092771,0.067638,1,1
5,GO REGULATION OF TOR SIGNALING,0.00098941,0.092668,0.099557,1,1
5,GO CELLULAR HORMONE METABOLIC PROCESS,0.019739,0.092549,0.10182,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00013917,0.092133,0.11691,1,1
5,GO NEGATIVE REGULATION OF ION TRANSPORT,0.0054795,0.091791,0.097731,1,1
5,GO LEUKOCYTE TETHERING OR ROLLING,0.0037331,0.091756,0.11518,1,1
5,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.044685,0.091626,0.07751,1,1
5,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.014486,0.091594,0.084039,1,1
5,GO ANDROGEN METABOLIC PROCESS,0.025414,0.09143,0.12843,1,1
5,GO EXIT FROM MITOSIS,0.025994,0.091301,0.097154,1,1
5,GO CILIUM ORGANIZATION,0.014486,0.091195,0.083252,1,1
5,GO HEART MORPHOGENESIS,0.0083534,0.091192,0.098118,1,1
5,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0024367,0.090982,0.11968,1,1
5,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.0056288,0.090935,0.077486,1,1
5,GO CIRCADIAN SLEEP WAKE CYCLE,0.030383,0.090836,0.1666,1,1
5,GO CELL PROJECTION ORGANIZATION,0.0027346,0.090437,0.10711,1,1
5,GO STEROID CATABOLIC PROCESS,0.053746,0.090174,0.15381,1,1
5,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.037747,0.089922,0.067295,1,1
5,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.037747,0.089464,0.083202,1,1
5,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.0046564,0.089008,0.078845,1,1
5,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.018398,0.088879,0.066694,1,1
5,GO ORGAN GROWTH,0.024288,0.088271,0.082028,1,1
5,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.016734,0.088126,0.081786,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.018398,0.087683,0.093514,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.018398,0.087673,0.061805,1,1
5,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0017641,0.087544,0.079975,1,1
5,GO NEUROGENESIS,0.0033369,0.087435,0.11379,1,1
5,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.00057693,0.087093,0.079616,1,1
5,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.0081404,0.086408,0.10634,1,1
5,GO SYNAPTIC SIGNALING,0.030383,0.08566,0.13748,1,1
5,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.010773,0.085424,0.10994,1,1
5,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.0064317,0.085232,0.087716,1,1
5,GO REGULATION OF PHOSPHATASE ACTIVITY,0.0051916,0.084586,0.082434,1,1
5,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.0019282,0.084358,0.070138,1,1
5,GO CARDIAC MUSCLE CELL CONTRACTION,0.02166,0.083791,0.13221,1,1
5,GO TOR SIGNALING,0.0059384,0.083163,0.067177,1,1
5,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0090226,0.08264,0.07842,1,1
5,GO SMOOTH MUSCLE CONTRACTION,0.02843,0.082636,0.098668,1,1
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.031748,0.082563,0.10151,1,1
5,GO REGULATION OF SYNAPTIC PLASTICITY,0.047551,0.081203,0.13995,1,1
5,GO CELL FATE COMMITMENT,0.0056288,0.080769,0.11094,1,1
5,GO RESPONSE TO CAMP,0.012508,0.080733,0.10278,1,1
5,GO POSITIVE REGULATION OF BINDING,0.027188,0.080253,0.080541,1,1
5,GO PROTEIN HOMOOLIGOMERIZATION,0.0041716,0.079585,0.081887,1,1
5,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.03245,0.079242,0.085883,1,1
5,GO SENSORY SYSTEM DEVELOPMENT,0.00353,0.079139,0.10712,1,1
5,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0085714,0.078338,0.073543,1,1
5,GO GAMETE GENERATION,0.0067808,0.077942,0.069929,1,1
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0057817,0.077516,0.12706,1,1
5,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0079323,0.077162,0.10999,1,1
5,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.017137,0.076012,0.08877,1,1
5,GO REGULATION OF INTRACELLULAR TRANSPORT,0.04854,0.074517,0.053201,1,1
5,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.034637,0.074394,0.18286,1,1
5,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0079323,0.074306,0.16665,1,1
5,GO NON CANONICAL WNT SIGNALING PATHWAY,0.012508,0.072824,0.094544,1,1
5,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.043763,0.072064,0.051701,1,1
5,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.024846,0.071784,0.059691,1,1
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.021165,0.071643,0.082975,1,1
5,GO MULTICELLULAR ORGANISM REPRODUCTION,0.0014738,0.071512,0.081336,1,1
5,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.027188,0.070707,0.052641,1,1
5,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.0071468,0.070331,0.073632,1,1
5,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.02843,0.069995,0.045681,1,1
5,GO CYTOSKELETON ORGANIZATION,0.0097392,0.069243,0.080522,1,1
5,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.050569,0.068953,0.072718,1,1
5,GO ESTABLISHMENT OF TISSUE POLARITY,0.045624,0.068827,0.080451,1,1
5,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.0066042,0.06715,0.059749,1,1
5,GO REGULATION OF DEPHOSPHORYLATION,0.0075304,0.066803,0.067593,1,1
5,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.050569,0.065793,0.079743,1,1
5,GO MALE GAMETE GENERATION,0.01282,0.064423,0.067384,1,1
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0064317,0.064353,0.084787,1,1
5,GO PROTEIN POLYUBIQUITINATION,0.033894,0.063543,0.057027,1,1
5,GO MACROMOLECULE DEACYLATION,0.02268,0.061741,0.064805,1,1
5,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.02068,0.060143,0.077192,1,1
5,GO FOREBRAIN DEVELOPMENT,0.015574,0.05837,0.12131,1,1
5,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.029068,0.057993,0.075936,1,1
5,GO CELLULAR MACROMOLECULE LOCALIZATION,0.031059,0.054909,0.043462,1,1
5,GO REGULATION OF ORGANELLE ORGANIZATION,0.038561,0.054637,0.049925,1,1
5,GO CELL CYCLE ARREST,0.053746,0.051223,0.052882,1,1
5,GO RESPONSE TO RADIATION,0.04854,0.042287,0.044706,1,1
6,GO FOREBRAIN NEURON FATE COMMITMENT,9.7801e-06,0.81479,0.91256,1,1
6,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0011549,0.56017,0.47345,1,1
6,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00079435,0.51584,0.44216,1,1
6,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,4.4878e-05,0.4627,0.46137,1,1
6,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.00047456,0.37703,0.47374,1,1
6,GO NEURON FATE COMMITMENT,6.2786e-05,0.37058,0.40268,1,1
6,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00026903,0.37051,0.36989,1,1
6,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,5.4121e-05,0.35264,0.39055,1,1
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0056288,0.34707,0.38877,1,1
6,GO THALAMUS DEVELOPMENT,0.0059384,0.33888,0.27404,1,1
6,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.011326,0.28946,0.25551,1,1
6,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.0042883,0.28826,0.32332,1,1
6,GO NOSE DEVELOPMENT,0.0013457,0.28635,0.47707,1,1
6,GO VIRAL LATENCY,0.0014738,0.2738,0.21297,1,1
6,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0025817,0.26395,0.25197,1,1
6,GO V D J RECOMBINATION,0.0012662,0.26271,0.2526,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0033369,0.25949,0.34081,1,1
6,GO MRNA SPLICE SITE SELECTION,1.7118e-05,0.25779,0.2887,1,1
6,GO KINETOCHORE ORGANIZATION,0.00069957,0.25256,0.222,1,1
6,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.00038934,0.2498,0.35072,1,1
6,GO SINGLE STRAND BREAK REPAIR,0.00081984,0.2246,0.19523,1,1
6,GO KINETOCHORE ASSEMBLY,0.0012662,0.22456,0.20442,1,1
6,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.024288,0.22136,0.17864,1,1
6,GO CENTROMERE COMPLEX ASSEMBLY,0.00027832,0.22114,0.20333,1,1
6,GO CHROMATIN REMODELING AT CENTROMERE,0.00028792,0.21491,0.21371,1,1
6,GO HISTONE H4 K16 ACETYLATION,7.6603e-06,0.21251,0.23571,1,1
6,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.0022992,0.20775,0.20371,1,1
6,GO NEURON PROJECTION ARBORIZATION,0.027803,0.19822,0.16437,1,1
6,GO FOREBRAIN REGIONALIZATION,0.0041716,0.19775,0.23619,1,1
6,GO DENDRITE SELF AVOIDANCE,0.040234,0.19426,0.15621,1,1
6,GO HISTONE H2A MONOUBIQUITINATION,0.00016023,0.19233,0.21475,1,1
6,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,1.7118e-05,0.19231,0.21603,1,1
6,GO MITOTIC DNA REPLICATION CHECKPOINT,0.0037331,0.19077,0.1552,1,1
6,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00013917,0.19055,0.17989,1,1
6,GO DENDRITIC TRANSPORT,0.022165,0.19045,0.17703,1,1
6,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.017549,0.18588,0.15829,1,1
6,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.010773,0.18427,0.1371,1,1
6,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.0062634,0.18055,0.15002,1,1
6,GO REGULATION OF SISTER CHROMATID COHESION,0.0046564,0.17143,0.15277,1,1
6,GO HISTONE H4 K5 ACETYLATION,0.00045924,0.17139,0.21176,1,1
6,GO REGULATION OF HELICASE ACTIVITY,0.014486,0.17106,0.1849,1,1
6,GO GENETIC IMPRINTING,0.0019282,0.17101,0.19427,1,1
6,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.00098941,0.16889,0.16602,1,1
6,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.036948,0.1682,0.13995,1,1
6,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.0024367,0.16548,0.18472,1,1
6,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0057817,0.16464,0.1379,1,1
6,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00084609,0.16197,0.16225,1,1
6,GO HISTONE H3 K9 TRIMETHYLATION,0.0037331,0.16147,0.14555,1,1
6,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.026586,0.15991,0.13787,1,1
6,GO RESPONSE TO HYDROXYUREA,0.0099891,0.15834,0.18411,1,1
6,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.05161,0.158,0.12441,1,1
6,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0042883,0.15698,0.13713,1,1
6,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.0046564,0.15284,0.13043,1,1
6,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.023741,0.1525,0.13675,1,1
6,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.010506,0.15239,0.16356,1,1
6,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.0014299,0.1504,0.16297,1,1
6,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00087311,0.14947,0.13492,1,1
6,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,5.0226e-05,0.14905,0.17995,1,1
6,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.0045306,0.14783,0.14935,1,1
6,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0038387,0.14546,0.14541,1,1
6,GO MAINTENANCE OF ORGANELLE LOCATION,0.03245,0.14426,0.087117,1,1
6,GO NUCLEOSOME ASSEMBLY,0.001228,0.14404,0.15267,1,1
6,GO DNA REPLICATION CHECKPOINT,0.012508,0.14369,0.11845,1,1
6,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.027188,0.14333,0.12099,1,1
6,GO CENTRIOLE ASSEMBLY,0.0047853,0.13945,0.11324,1,1
6,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.02166,0.13808,0.15719,1,1
6,GO HISTONE H2A UBIQUITINATION,0.0042883,0.13737,0.13472,1,1
6,GO HISTONE H2A ACETYLATION,0.0018173,0.13688,0.16283,1,1
6,GO POSITIVE REGULATION OF DNA REPAIR,0.0040578,0.13674,0.10822,1,1
6,GO HISTONE EXCHANGE,0.0040578,0.13378,0.12309,1,1
6,GO MITOTIC CHROMOSOME CONDENSATION,0.0039469,0.13352,0.1687,1,1
6,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.043763,0.13329,0.15168,1,1
6,GO ATP DEPENDENT CHROMATIN REMODELING,0.00031859,0.13302,0.14714,1,1
6,GO POST ANAL TAIL MORPHOGENESIS,0.017549,0.13141,0.12828,1,1
6,GO DNA STRAND ELONGATION,0.004408,0.12951,0.12782,1,1
6,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.001191,0.12899,0.12024,1,1
6,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.010773,0.12734,0.16416,1,1
6,GO CENTROSOME DUPLICATION,0.007729,0.12624,0.11754,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.018398,0.12462,0.084787,1,1
6,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.00074557,0.12228,0.15622,1,1
6,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.016734,0.12213,0.13818,1,1
6,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.036164,0.12172,0.094288,1,1
6,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.0060989,0.12056,0.12496,1,1
6,GO HISTONE H4 ACETYLATION,7.013e-05,0.11952,0.1322,1,1
6,GO INTERSTRAND CROSS LINK REPAIR,0.0010206,0.11936,0.10516,1,1
6,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.025414,0.1165,0.080705,1,1
6,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.00090094,0.11605,0.13348,1,1
6,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0054795,0.11323,0.10278,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0064317,0.11293,0.11039,1,1
6,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.017969,0.11285,0.11877,1,1
6,GO CELL CYCLE DNA REPLICATION,0.0073363,0.11205,0.096904,1,1
6,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.027188,0.11098,0.13146,1,1
6,GO PEPTIDYL LYSINE ACETYLATION,0.00020448,0.11007,0.095479,1,1
6,GO HISTONE H3 K4 TRIMETHYLATION,0.027188,0.10928,0.11286,1,1
6,GO REPLICATION FORK PROCESSING,0.010773,0.10873,0.097718,1,1
6,GO G0 TO G1 TRANSITION,0.001228,0.10827,0.14352,1,1
6,GO HISTONE MONOUBIQUITINATION,0.0007696,0.10776,0.12626,1,1
6,GO DOSAGE COMPENSATION,0.014138,0.10692,0.10333,1,1
6,GO NUCLEOSOME ORGANIZATION,0.0014299,0.10243,0.11266,1,1
6,GO HISTONE H3 K27 METHYLATION,0.035393,0.10205,0.092682,1,1
6,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.00098941,0.10178,0.11715,1,1
6,GO REGULATION OF MRNA PROCESSING,0.009256,0.10008,0.085387,1,1
6,GO HISTONE H3 K4 METHYLATION,0.0030654,0.096238,0.13904,1,1
6,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0066042,0.095555,0.084301,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.015574,0.095273,0.086956,1,1
6,GO DNA REPLICATION INITIATION,0.033166,0.093732,0.089037,1,1
6,GO REGULATION OF PROTEIN ACETYLATION,0.017549,0.093142,0.073608,1,1
6,GO PROTEIN ACETYLATION,0.00054072,0.092997,0.076003,1,1
6,GO ERROR PRONE TRANSLESION SYNTHESIS,0.02166,0.088259,0.10079,1,1
6,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.025414,0.086986,0.088262,1,1
6,GO HISTONE UBIQUITINATION,0.019283,0.086052,0.076243,1,1
6,GO PEPTIDYL LYSINE METHYLATION,0.0069616,0.085453,0.091618,1,1
6,GO RECOMBINATIONAL REPAIR,0.007729,0.082085,0.071637,1,1
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.044685,0.081414,0.072278,1,1
6,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.018398,0.079725,0.077727,1,1
6,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0010206,0.07714,0.10846,1,1
6,GO CHROMATIN REMODELING,0.0036303,0.073783,0.085931,1,1
6,GO CHROMATIN SILENCING,0.031748,0.07168,0.082856,1,1
6,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.016734,0.07068,0.085705,1,1
6,GO PEPTIDYL LYSINE MODIFICATION,0.0083534,0.066732,0.050054,1,1
6,GO CHROMOSOME SEGREGATION,0.035393,0.066098,0.052337,1,1
6,GO CELL CYCLE CHECKPOINT,0.015953,0.06405,0.055213,1,1
6,GO DNA PACKAGING,0.0019282,0.063587,0.096256,1,1
6,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.042857,0.063284,0.059921,1,1
6,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.019283,0.060958,0.070494,1,1
6,GO HETEROCHROMATIN ORGANIZATION,0.024288,0.059165,0.078217,1,1
6,GO DNA INTEGRITY CHECKPOINT,0.024846,0.05762,0.050771,1,1
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.034637,0.057433,0.096752,1,1
6,GO REGULATION OF RNA SPLICING,0.025994,0.056808,0.056323,1,1
6,GO PROTEIN MONOUBIQUITINATION,0.029068,0.055354,0.059128,1,1
6,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.029068,0.051795,0.081252,1,1
6,GO CHROMATIN ORGANIZATION,0.014138,0.049741,0.051198,1,1
6,GO DNA REPLICATION,0.047551,0.048134,0.0454,1,1
6,GO PROTEIN ACYLATION,0.04854,0.0439,0.041298,1,1
